data_2cku_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cku _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.792 0.329 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 p -139.71 146.89 40.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.19 139.42 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -114.69 132.27 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -109.27 112.67 24.95 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -64.03 -16.76 62.38 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.565 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 5.8 m-85 -70.59 -45.98 64.32 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -88.8 -48.32 7.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.797 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.33 3.82 47.36 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.791 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.5 m-80 -117.3 138.5 51.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.4 0.6 . . . . 0.0 110.926 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 159.84 27.43 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.907 0.384 . . . . 0.0 110.565 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 73' ' ' ASN . 1.1 m-85 -134.52 138.62 44.82 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.622 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.78 165.9 22.3 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -59.54 128.29 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.115 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.66 24.67 49.23 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.996 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.08 122.79 48.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 92' ' ' CYS . 19.1 p -105.3 149.12 26.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.909 0.385 . . . . 0.0 111.074 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -145.25 -172.63 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.732 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -115.64 129.83 56.64 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.565 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 4.6 tmm_? -130.13 124.95 21.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.097 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 88' ' ' MET . 84.9 Cg_endo -80.55 111.55 2.58 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.841 1.694 . . . . 0.0 112.239 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.505 ' HB3' ' NE1' ' A' ' 90' ' ' TRP . 11.3 tptt -116.88 118.94 33.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.821 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 46.55 73.23 0.19 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.5 m 47.38 41.84 13.16 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.915 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.7 ttp -153.04 164.54 37.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.199 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mm -112.2 122.54 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.505 ' NE1' ' HB3' ' A' ' 85' ' ' LYS . 25.3 m95 -107.97 140.22 41.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.36 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.05 110.19 21.66 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' THR . 75.1 m -109.44 152.81 24.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.458 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -130.73 150.65 51.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.266 179.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 122.18 45.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 110.903 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.78 131.28 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.453 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.59 -169.1 25.85 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.317 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 70.99 114.54 0.05 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.808 0.443 . . . . 0.0 111.811 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.93 -136.82 12.91 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.963 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.25 23.1 9.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.107 0.479 . . . . 0.0 111.158 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.01 70.11 1.35 Allowed Glycine 0 CA--C 1.517 0.179 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.554 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.2 140.43 56.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.535 0.207 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.64 121.1 62.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.307 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.3 t -114.49 121.59 43.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.378 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.1 m -124.35 136.4 54.06 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 p -138.98 141.86 38.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.437 HG13 ' CH2' ' A' ' 90' ' ' TRP . 1.5 mt -51.96 155.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.284 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.08 144.1 28.61 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -80.49 75.77 7.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.75 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -150.17 173.53 13.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.23 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 117' ' ' TYR . 13.0 p -128.64 127.99 43.29 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.504 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.1 p-80 -135.1 -143.28 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 119.495 -0.288 . . . . 0.0 111.037 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.8 175.95 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.503 0.321 . . . . 0.0 111.078 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.43 -77.25 1.74 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.751 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.15 -39.26 0.04 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.936 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -133.71 167.21 20.93 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 32.4 p -84.88 150.83 24.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 111.247 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 110' ' ' CYS . 7.0 m-85 -133.21 139.1 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 1.9 mptm? -85.25 176.31 8.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.637 0.256 . . . . 0.0 111.161 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.1 mm -74.59 124.3 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.334 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.79 -3.14 86.3 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.92 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 169.7 17.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.924 0.393 . . . . 0.0 111.459 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p -133.9 150.31 51.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.488 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -141.28 55.21 1.54 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.27 0.557 . . . . 0.0 109.716 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.66 98.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.706 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.8 mtt180 -132.36 166.99 24.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.751 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.497 ' O ' ' O ' ' A' ' 125' ' ' ARG . 32.8 Cg_exo -39.71 177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.193 2.595 . . . . 0.0 113.956 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.442 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.4 t60 -103.11 129.58 50.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.142 0.496 . . . . 0.0 112.336 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -64.97 -40.49 95.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.276 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 66.5 p -111.38 19.36 18.32 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.8 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -144.79 174.5 24.89 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.49 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.62 28.59 8.86 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.385 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.488 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -133.16 158.3 43.19 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.488 0.185 . . . . 0.0 110.714 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 17.9 mtt -67.26 115.94 7.48 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.452 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 21.5 tp -92.19 144.68 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.869 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.5 pt-20 -125.44 116.16 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.7 157.47 32.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.34 168.47 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.233 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -131.56 124.25 29.64 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.829 0.347 . . . . 0.0 111.419 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.35 127.08 55.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.28 -103.05 0.09 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.979 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.71 22.35 11.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.421 0.288 . . . . 0.0 111.765 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.55 14.9 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.918 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -160.77 -54.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.659 0.23 . . . . 0.0 111.193 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.79 60.16 0.94 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.459 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.44 160.45 15.13 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 161.86 36.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.24 127.26 16.47 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.24 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.33 148.91 50.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.091 0.472 . . . . 0.0 111.403 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -137.92 91.4 13.4 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.918 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 132' ' ' TYR . 36.5 Cg_endo -69.48 164.96 32.27 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.559 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.017 179.357 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 120.666 0.27 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 p -133.3 145.94 50.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.033 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.0 m -118.16 135.49 54.2 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.5 t80 -109.24 124.2 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 10.1 t70 -98.31 103.91 15.9 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 14.9 ptpt -56.57 -27.97 59.09 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.424 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 94.0 m-85 -67.93 -39.64 83.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.772 0.32 . . . . 0.0 111.144 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.483 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 13.4 p -88.18 -53.45 4.7 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.73 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.48 39.51 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.406 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.54 144.06 46.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.095 0.448 . . . . 0.0 110.686 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.52 160.25 21.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.713 0.292 . . . . 0.0 110.872 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.483 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 10.2 m-85 -136.76 131.45 33.42 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.252 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -75.92 140.97 42.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.498 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.46 130.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.23 0.538 . . . . 0.0 111.982 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.45 14.6 56.87 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.97 125.77 54.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.467 HG23 ' CG2' ' A' ' 93' ' ' THR . 18.7 p -105.04 142.24 35.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.907 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -136.71 -173.91 3.56 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.766 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 5.2 mt-10 -119.98 126.84 51.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.202 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -124.27 123.15 25.97 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.1 Cg_endo -78.39 110.01 2.77 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.132 1.888 . . . . 0.0 112.076 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.73 116.57 27.76 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.861 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 48.32 77.51 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.8 m 44.5 43.85 6.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.3 ttp -155.65 166.03 34.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.7 130.84 68.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 22.3 m95 -114.46 143.07 45.53 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -98.56 109.38 22.14 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 80' ' ' THR . 81.7 m -108.99 159.91 16.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.128 0.49 . . . . 0.0 112.29 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.467 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -138.28 153.04 49.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.633 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 6.2 t -104.05 117.92 35.44 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.545 0.688 . . . . 0.0 110.806 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.89 119.93 36.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.424 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.8 -115.97 1.86 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 58.51 33.84 23.43 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.773 0.32 . . . . 0.0 111.198 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.21 45.03 92.86 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.397 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 -67.54 0.59 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.34 56.01 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 121.192 -0.527 . . . . 0.0 112.142 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.7 143.29 9.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.754 0.422 . . . . 0.0 111.737 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.46 120.01 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.257 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 t -111.21 111.89 23.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.7 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.4 m -121.36 127.72 51.53 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.2 p -138.91 138.98 37.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.926 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -45.37 155.86 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.292 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.59 155.29 17.37 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.81 70.94 7.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.436 ' HB3' ' O ' ' A' ' 117' ' ' TYR . 91.3 mtm-85 -150.08 168.14 24.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.9 p -117.16 125.4 51.15 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.787 0.327 . . . . 0.0 110.126 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.594 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -129.76 166.42 19.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.617 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 15.1 pt-20 167.3 138.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.266 0.354 . . . . 0.0 110.923 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -37.6 3.25 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.505 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.54 -94.77 0.1 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.44 177.93 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.29 0.236 . . . . 0.0 111.306 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.4 p -120.1 125.51 48.44 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 111.492 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -95.56 157.3 15.96 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.635 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -93.06 174.53 7.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.08 124.5 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.3 -4.85 82.87 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.794 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.97 160.45 30.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.82 0.31 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p -130.9 145.42 52.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.9 p90 -136.75 53.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.355 0.598 . . . . 0.0 109.619 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.33 102.85 0.06 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.745 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 126' ' ' PRO . 97.5 mtt180 -134.92 161.77 61.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.762 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 125' ' ' ARG . 37.4 Cg_exo -40.28 174.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.176 2.584 . . . . 0.0 113.879 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.498 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.1 t60 -100.15 128.17 46.27 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 111.877 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -72.57 -32.68 66.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.718 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.0 p -112.42 18.43 18.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.326 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.498 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -145.21 174.62 25.18 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.582 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.87 29.11 8.32 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.122 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -136.82 162.93 31.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.491 0.186 . . . . 0.0 110.705 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -70.93 117.16 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.243 0.544 . . . . 0.0 110.774 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 23.3 tp -91.67 145.47 24.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.717 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 5.1 pt-20 -129.59 116.12 18.41 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -120.8 157.34 29.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.65 173.28 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.271 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 18.3 t -128.36 117.81 22.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.759 0.314 . . . . 0.0 110.761 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.2 mt -111.66 113.86 26.52 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.464 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.97 70.45 0.94 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 -53.31 3.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.542 0.21 . . . . 0.0 111.07 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.48 -65.36 0.97 Allowed Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.516 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 pttt -144.5 -44.59 0.25 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.417 0.151 . . . . 0.0 111.316 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -178.21 83.56 0.07 OUTLIER Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.91 159.23 18.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.23 163.79 31.92 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.82 126.6 13.47 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.3 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 136' ' ' CYS . 0.0 OUTLIER -124.62 149.31 47.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 110.932 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -136.36 88.74 20.24 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.837 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 132' ' ' TYR . 29.2 Cg_endo -67.44 168.96 16.6 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 113.645 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.052 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -138.17 148.93 45.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.7 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.93 135.39 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 89.5 t80 -110.19 126.39 54.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 11.1 t70 -102.21 96.87 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.775 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 47.9 pttt -47.69 -29.38 2.99 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.424 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 84.8 m-85 -67.46 -39.87 85.32 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.403 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 6.6 p -87.19 -51.09 6.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 8.75 37.8 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.832 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -119.56 153.33 35.58 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.793 0.296 . . . . 0.0 110.786 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 159.81 14.71 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.403 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 1.0 OUTLIER -138.08 139.71 39.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.806 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -78.76 165.08 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.53 137.12 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 0.0 111.621 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.21 32.27 63.0 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.101 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -113.34 120.89 42.69 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.446 HG23 ' CG2' ' A' ' 93' ' ' THR . 22.0 p -105.26 150.19 25.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 0.0 110.906 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -153.3 179.14 9.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.96 126.83 53.51 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -126.07 126.03 24.76 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.911 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.5 Cg_endo -78.43 116.93 3.94 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.982 1.788 . . . . 0.0 111.347 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.02 123.65 45.04 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.262 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 42.51 74.31 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 t 46.63 42.21 11.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 29.7 ttp -154.59 164.76 38.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mm -110.32 136.58 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -121.9 159.92 25.86 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.04 108.24 18.39 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 80' ' ' THR . 88.6 m -108.35 162.93 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.446 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.3 OUTLIER -141.57 151.68 43.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.11 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.15 114.41 28.59 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.3 mm -74.47 -61.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.125 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.0 129.06 0.05 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.42 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -170.85 55.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.461 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.36 61.45 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.258 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -175.93 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.458 0.303 . . . . 0.0 111.807 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.72 80.83 0.96 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.419 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -90.0 131.99 35.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.634 0.255 . . . . 0.0 111.077 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.61 126.82 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.295 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -127.18 111.22 13.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.9 m -116.53 139.05 50.91 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.6 p -139.84 138.92 36.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.959 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.5 mt -48.7 148.05 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.11 148.37 34.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -93.28 59.25 2.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.19 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -149.15 177.38 9.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.686 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 85.8 m -110.11 128.19 55.31 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.52 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -138.94 145.36 39.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 10.6 pt-20 170.9 166.82 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.304 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.35 -93.52 1.64 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.596 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.86 0.59 1.2 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.05 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.18 -178.32 5.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.8 t -119.04 127.21 53.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.555 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.417 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.1 m-85 -104.37 159.74 15.48 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.158 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 5.2 mmtp -105.82 164.13 12.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.4 124.53 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.514 0.197 . . . . 0.0 111.409 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.3 63.0 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.355 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -71.95 159.68 33.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.388 0.594 . . . . 0.0 111.473 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 p -130.96 152.25 50.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.13 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -144.38 98.34 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 109.977 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -92.37 87.13 5.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.426 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 126' ' ' PRO . 1.0 OUTLIER -120.74 167.41 13.01 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.698 179.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 45.3 Cg_exo -43.15 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.0 2.467 . . . . 0.0 113.633 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.463 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.4 t60 -100.95 129.81 46.86 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 112.194 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.25 -40.33 93.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 74.0 p -112.49 20.04 17.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.777 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.463 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -144.14 173.71 24.76 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.557 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.78 30.89 7.44 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.348 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -136.15 164.52 27.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.427 0.156 . . . . 0.0 110.712 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 12.3 mtt -72.9 116.16 13.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.082 0.467 . . . . 0.0 110.472 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.408 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 21.2 tp -92.23 144.56 25.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.573 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 37.4 mt-10 -120.93 115.69 23.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 92.1 m -112.73 158.2 20.36 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 147' ' ' THR . 0.1 OUTLIER -135.33 169.36 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.864 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 t -138.33 123.65 19.37 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.872 0.367 . . . . 0.0 111.301 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.22 143.83 42.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.453 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.93 77.65 1.86 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.722 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 122.98 12.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.612 0.244 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.8 -90.93 1.47 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.731 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 43.36 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.04 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.696 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.78 127.59 35.99 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.708 0.29 . . . . 0.0 110.572 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -109.53 167.64 9.99 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.6 HG23 HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -149.79 145.98 26.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -141.76 149.94 41.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.427 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -135.23 90.59 20.66 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.615 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 132' ' ' TYR . 38.4 Cg_endo -70.96 161.42 46.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.484 2.123 . . . . 0.0 113.63 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.011 179.183 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.686 0.279 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 5.0 p -125.53 142.3 51.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 147.03 43.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.963 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.2 t80 -121.75 121.13 36.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.731 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 21.9 t70 -104.94 96.38 6.5 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 51.7 pttt -48.97 -17.98 0.25 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.443 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 4.6 m-30 -65.49 -46.19 80.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.662 0.268 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.5 p -86.7 -50.03 7.06 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.26 6.73 33.54 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.207 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.95 150.23 39.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.981 0.391 . . . . 0.0 111.147 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.39 160.26 17.66 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 65' ' ' THR . 2.6 m-85 -134.96 131.01 36.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.563 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.87 179.53 7.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.79 139.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.471 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.48 40.5 96.25 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.708 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.26 124.37 52.34 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 28.7 p -105.62 149.72 26.07 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.892 0.377 . . . . 0.0 111.383 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -161.1 -178.58 6.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -118.39 132.18 56.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 111.023 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.443 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -124.24 124.23 25.87 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.09 63.96 8.81 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 121.964 1.776 . . . . 0.0 112.48 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.52 128.47 36.45 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.864 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.5 t70 37.3 69.1 0.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.895 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m 46.08 47.62 12.85 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 42.5 ttp -160.51 135.81 7.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.37 132.64 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 111.522 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.414 ' CH2' HG12 ' A' ' 106' ' ' ILE . 16.1 m95 -119.84 152.27 37.57 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -108.33 100.31 9.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.4 t -108.6 138.76 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 80' ' ' THR . 1.7 m -116.54 148.18 41.09 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.67 117.7 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.731 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -92.16 142.3 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.611 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.35 -129.62 1.04 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.521 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 62.42 110.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 111.536 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.63 -112.72 4.54 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -139.43 47.09 1.89 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.08 98.08 0.94 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.635 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -105.78 135.51 47.08 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.586 0.231 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.99 121.52 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.2 111.93 12.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.98 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 3.3 m -126.37 148.34 49.61 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 p -141.12 148.91 40.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.165 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.414 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -60.61 146.98 10.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.544 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.63 159.24 31.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.75 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.9 57.48 4.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.171 0.51 . . . . 0.0 110.596 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -144.4 171.6 14.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.9 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 2.3 p -123.23 128.47 50.05 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -134.43 154.4 51.41 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.229 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 7.3 tp10 167.35 140.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.867 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.73 -8.71 54.82 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.417 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.0 -17.79 7.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.089 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -126.04 165.44 18.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.844 0.322 . . . . 0.0 110.34 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.477 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.4 t -108.87 125.72 52.29 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.4 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.02 158.86 16.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.215 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 25.8 mtmt -99.37 161.74 13.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.0 mm -55.19 124.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.509 0.195 . . . . 0.0 111.349 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.13 -12.2 70.34 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.767 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -60.23 167.28 2.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.575 0.688 . . . . 0.0 111.777 -178.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.1 p -142.67 144.72 32.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.254 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.433 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 17.5 p90 -149.74 96.61 2.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.042 0.449 . . . . 0.0 109.97 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -91.73 76.38 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 111.008 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 126' ' ' PRO . 89.1 mtt180 -108.15 163.45 16.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.094 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 125' ' ' ARG . 52.4 Cg_exo -41.08 179.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.301 2.667 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.5 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.1 t60 -100.6 127.41 46.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.674 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.43 -34.21 72.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.742 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.6 p -111.96 19.0 18.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.361 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -147.92 171.18 28.48 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.478 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -108.79 28.48 11.28 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.689 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.422 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.35 162.2 32.87 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.726 0.263 . . . . 0.0 110.906 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 13.1 mtt -68.59 120.74 15.09 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.317 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.404 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 22.3 tp -100.93 144.12 30.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.4 pt-20 -120.62 115.81 24.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.67 158.32 21.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.81 160.32 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.372 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 121.76 37.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.709 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.0 mt -113.82 156.24 24.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.634 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.58 -132.77 1.83 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.034 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.58 33.33 18.35 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.915 0.388 . . . . 0.0 111.089 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.54 -52.2 0.1 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.685 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -147.67 -66.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.648 0.224 . . . . 0.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.34 79.32 0.07 OUTLIER Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.483 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -112.09 135.77 52.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 111.252 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -109.84 166.79 10.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.18 137.31 17.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.515 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.95 149.95 49.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.165 0.507 . . . . 0.0 111.522 179.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.05 92.08 11.07 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.193 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 132' ' ' TYR . 38.2 Cg_endo -71.58 162.2 42.94 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.332 2.021 . . . . 0.0 113.836 -178.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.012 179.246 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.751 0.31 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 74' ' ' THR . 30.1 p -128.34 155.43 44.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.186 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.454 ' N ' ' O ' ' A' ' 75' ' ' TYR . 60.1 m -119.02 135.49 54.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.817 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.8 t80 -121.19 123.11 41.46 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -105.66 95.15 5.61 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.165 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 44.1 pttt -49.01 -21.56 0.71 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -66.3 -44.62 82.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.554 0.216 . . . . 0.0 110.7 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.462 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 17.1 p -86.8 -49.97 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.0 12.05 30.67 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.083 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -118.92 157.43 27.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.807 0.303 . . . . 0.0 110.64 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.409 HG23 ' HB ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -96.95 159.64 14.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 178.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 3.9 m-85 -135.84 127.8 29.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.98 153.28 32.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.7 t -47.85 143.37 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.558 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 21.94 78.32 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -113.06 130.16 56.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.446 HG23 ' CG2' ' A' ' 93' ' ' THR . 21.1 p -105.69 150.27 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.369 . . . . 0.0 111.494 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -149.7 173.96 13.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.081 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.69 131.09 54.37 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.566 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -126.85 135.86 27.95 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.566 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 85.8 Cg_endo -81.53 62.44 8.32 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.945 1.763 . . . . 0.0 112.956 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 122.28 12.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.524 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 40.71 74.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.867 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 94.9 p 41.5 47.9 3.32 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 44.6 ttp -163.15 133.5 4.5 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.7 mm -74.07 137.31 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 111.07 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 106' ' ' ILE . 17.9 m95 -122.63 164.73 17.68 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.978 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 80' ' ' THR . 48.9 m -108.61 161.19 15.31 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.446 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.9 OUTLIER -142.2 153.98 44.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.223 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.3 t -103.33 113.23 26.56 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.94 -31.59 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.133 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.14 177.8 44.68 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.615 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.76 150.21 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.926 0.393 . . . . 0.0 111.678 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.38 39.97 41.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.679 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.02 37.1 21.41 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.708 0.29 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.86 71.46 1.13 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.605 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -80.21 149.1 30.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.818 0.309 . . . . 0.0 110.762 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.83 130.27 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.792 0.329 . . . . 0.0 111.337 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.61 111.46 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 88.3 m -117.4 145.17 44.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 p -140.05 137.97 35.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.031 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.415 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -53.08 143.84 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.04 168.07 10.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.807 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.33 43.79 1.13 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -134.29 159.34 41.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.943 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.6 p -112.14 126.34 55.09 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.452 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -128.93 164.16 23.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.566 -178.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 41.2 tt0 165.41 126.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.441 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.39 -99.0 0.87 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.727 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.5 -17.7 1.36 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -131.9 179.03 6.32 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.223 0.512 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -112.94 125.43 54.38 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.981 0.419 . . . . 0.0 111.156 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -102.12 159.42 15.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -105.23 161.08 14.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.17 124.7 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.651 0.262 . . . . 0.0 110.962 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.64 -22.24 41.36 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.223 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 152.15 44.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.973 0.416 . . . . 0.0 111.649 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.0 p -116.34 152.76 33.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.41 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.415 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 18.5 p90 -147.11 81.12 1.54 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.21 0.529 . . . . 0.0 109.866 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.7 76.01 10.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.214 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 126' ' ' PRO . 14.6 mtt85 -110.66 171.05 4.66 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.689 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 42.5 Cg_exo -43.0 179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.93 2.42 . . . . 0.0 113.473 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -103.8 136.37 43.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.43 0.634 . . . . 0.0 112.707 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.43 -40.09 62.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.373 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 61.1 p -109.09 18.25 20.79 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.84 -79.98 0.07 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.486 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 137.58 29.87 0.27 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 150' ' ' PRO . 2.8 p90 -135.52 151.45 50.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 122.878 0.471 . . . . 0.0 109.765 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.528 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.8 ttt -57.72 107.2 0.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.462 HD11 ' HB3' ' A' ' 150' ' ' PRO . 15.0 tp -91.73 144.84 25.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.974 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 30.5 mt-10 -124.56 115.88 21.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -125.72 157.5 37.22 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.35 171.65 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.254 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.1 t -139.58 124.02 18.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.709 0.29 . . . . 0.0 110.903 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.07 133.16 54.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.29 76.59 1.91 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.726 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -42.47 11.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.53 0.205 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.58 -54.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.679 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -106.21 -55.48 2.32 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.41 54.51 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.12 154.03 32.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.771 0.319 . . . . 0.0 111.328 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -142.27 161.71 37.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.57 127.73 16.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.88 149.73 50.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 0.0 111.749 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -124.78 81.16 61.67 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.61 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.462 ' HB3' HD11 ' A' ' 134' ' ' LEU . 12.9 Cg_endo -67.08 168.01 18.52 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.754 2.303 . . . . 0.0 114.479 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.977 178.696 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.67 0.271 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 p -129.43 145.69 51.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.039 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.3 m -118.49 134.48 55.04 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.491 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 83.8 t80 -110.0 124.57 51.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 12.8 t70 -97.8 97.58 9.11 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 10.8 ptmt -51.47 -28.74 14.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.503 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 82.5 m-85 -66.98 -45.8 76.55 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.67 0.271 . . . . 0.0 111.315 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.449 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 29.1 p -82.06 -51.05 8.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.323 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.16 5.69 43.25 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.29 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -116.86 143.7 45.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.07 0.435 . . . . 0.0 110.436 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.89 159.76 20.28 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.876 0.37 . . . . 0.0 110.907 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.449 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 9.5 m-85 -136.27 130.3 32.8 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -75.08 153.01 38.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.409 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 21.8 t -50.27 144.06 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.188 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.67 79.17 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.269 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.81 125.87 54.82 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 92' ' ' CYS . 21.4 p -104.98 129.36 53.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.905 0.384 . . . . 0.0 111.134 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 39.9 p90 -122.49 -173.65 2.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.782 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -127.69 138.55 52.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.838 0.351 . . . . 0.0 110.935 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.575 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -141.04 130.44 12.85 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.462 ' HD2' ' HE ' ' A' ' 83' ' ' ARG . 61.3 Cg_endo -77.17 64.99 7.91 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.762 1.641 . . . . 0.0 112.851 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.91 130.37 45.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.349 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 55.65 -77.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.855 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 85' ' ' LYS . 78.4 p -158.26 30.94 0.24 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.064 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.89 159.13 43.91 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.7 mm -89.7 112.29 24.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.452 ' CZ2' HG12 ' A' ' 106' ' ' ILE . 28.5 m95 -98.5 144.96 27.27 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.0 111.929 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.18 106.79 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 m -107.28 165.02 11.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.469 . . . . 0.0 112.034 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.444 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.3 OUTLIER -136.52 154.68 50.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.629 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 3.7 t -102.47 114.17 28.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.475 0.655 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -105.74 74.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.834 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.63 139.07 15.67 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.227 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.65 45.56 0.3 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.897 0.379 . . . . 0.0 110.571 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.75 8.52 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.298 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.14 -37.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.26 85.33 0.99 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.166 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt85 -104.69 135.27 46.4 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.735 0.303 . . . . 0.0 111.283 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.75 129.98 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.35 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.2 t -124.45 110.48 14.56 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.269 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 69.3 m -111.22 131.15 55.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.365 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.3 p -137.73 132.96 33.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.452 HG12 ' CZ2' ' A' ' 90' ' ' TRP . 2.7 mt -51.23 142.07 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.927 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.27 19.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 111.489 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -86.54 64.74 8.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -147.0 174.26 11.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.308 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 117' ' ' TYR . 24.2 p -129.89 129.98 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 112' ' ' GLU . 3.5 p-80 -134.94 -140.7 0.17 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.601 -0.237 . . . . 0.0 110.751 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.2 163.94 0.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.86 0.362 . . . . 0.0 111.455 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.94 -83.47 1.59 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.787 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.52 -35.33 0.1 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.26 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -131.27 -178.81 5.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.896 0.348 . . . . 0.0 110.754 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.1 p -107.7 126.67 52.88 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 110.725 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 110' ' ' CYS . 3.0 m-85 -106.65 157.81 17.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.541 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -104.16 158.34 16.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.1 mm -50.14 124.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.75 -9.5 75.52 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.733 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.11 154.57 39.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.402 0.601 . . . . 0.0 111.54 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.9 p -122.87 149.45 44.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.743 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.443 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 12.4 p90 -147.69 82.41 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.298 0.57 . . . . 0.0 109.905 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.3 75.03 5.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.038 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.3 mtt180 -108.76 166.6 10.54 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 63.1 Cg_exo -41.93 178.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.087 2.525 . . . . 0.0 114.077 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -103.54 124.42 48.75 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 111.58 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.43 -24.85 60.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.08 14.43 22.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.71 -179.21 30.63 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.755 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -115.24 28.29 8.02 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.428 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.01 155.44 49.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.546 0.212 . . . . 0.0 111.177 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 11.9 mtt -63.45 114.5 3.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.098 0.475 . . . . 0.0 110.595 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.9 tp -92.46 146.9 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.739 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 26.6 mt-10 -123.04 116.23 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -123.87 157.62 33.77 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.79 171.75 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.662 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 52.7 t -132.67 125.01 29.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.94 154.93 24.53 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.081 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -146.57 55.25 0.53 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.089 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.97 -51.55 7.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.723 0.297 . . . . 0.0 110.353 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.17 -44.97 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -140.53 157.42 45.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.391 0.276 . . . . 0.0 110.31 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.28 93.43 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -114.93 162.46 16.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.16 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -142.79 164.45 30.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.283 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.62 124.81 11.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.879 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -125.52 149.99 47.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.585 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -141.19 99.11 6.59 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.528 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -77.01 170.3 20.02 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.419 2.079 . . . . 0.0 113.56 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.055 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.919 179.32 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.69 0.281 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.7 p -124.16 150.13 45.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.498 ' HB3' ' CD1' ' A' ' 102' ' ' ILE . 85.6 m -118.54 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.371 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -113.62 124.45 52.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.757 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -103.54 99.37 9.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.43 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -57.29 -16.14 7.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.065 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.566 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 5.4 m-30 -66.96 -46.08 75.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.169 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.52 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 7.3 p -91.42 -54.87 3.73 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.782 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.94 11.4 12.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.363 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.63 155.5 32.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.165 0.483 . . . . 0.0 110.792 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.16 159.8 15.13 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.716 0.293 . . . . 0.0 110.253 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.52 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 4.6 m-85 -138.8 129.03 25.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -73.89 154.19 39.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 5.0 t -52.23 136.5 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.915 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.86 21.47 71.34 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.0 123.49 50.45 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.502 HG23 ' CG2' ' A' ' 93' ' ' THR . 16.9 p -105.59 149.17 26.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.391 . . . . 0.0 111.351 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 26.4 p90 -145.83 -175.32 4.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.071 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.2 mp0 -121.05 131.68 54.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.566 ' NE ' ' HB3' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -129.77 132.33 24.11 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.456 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.544 ' N ' ' HD3' ' A' ' 83' ' ' ARG . 56.4 Cg_endo -80.48 114.38 3.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.567 1.511 . . . . 0.0 110.859 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -116.14 113.5 23.19 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.845 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 49.42 77.29 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t 46.06 43.83 11.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 8.9 ttp -157.59 169.5 24.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.461 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -116.82 131.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.423 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.0 m95 -117.72 157.84 25.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.19 111.72 23.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -108.34 156.93 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.502 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.9 OUTLIER -141.1 154.1 45.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.412 0.685 . . . . 0.0 110.648 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -102.87 113.06 26.19 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.74 -31.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.189 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.61 83.04 0.39 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.835 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.54 119.88 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.9 2.07 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.676 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.12 44.92 1.23 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.046 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.07 84.38 0.54 Allowed Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.5 121.96 17.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 66' ' ' CYS . 9.8 mm -103.0 121.97 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.476 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.5 t -127.83 110.53 12.69 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.395 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.4 m -107.83 133.73 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 111.29 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.3 p -138.56 133.15 32.19 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.706 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -43.57 155.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.17 148.59 22.26 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.7 60.01 5.37 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.068 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -150.06 176.98 10.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 9.5 p -120.15 127.29 52.36 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.567 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.5 OUTLIER -136.69 142.71 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.335 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 12.9 pt-20 171.88 159.54 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.59 -79.23 1.43 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.61 -8.84 0.11 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.798 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -142.89 -178.53 5.86 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 117.624 0.712 . . . . 0.0 110.51 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p -114.43 125.84 54.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.797 0.332 . . . . 0.0 110.661 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.06 157.31 17.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.425 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -106.2 156.43 18.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.9 mm -45.85 124.65 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.46 -6.13 71.04 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.633 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 156.86 33.89 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.483 0.641 . . . . 0.0 111.391 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -124.14 146.31 48.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -137.84 67.47 1.42 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 0.0 109.668 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.77 108.78 2.22 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.513 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -137.88 153.02 73.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.341 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 50.4 Cg_exo -42.42 143.71 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.081 2.521 . . . . 0.0 113.701 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.51 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.5 t60 -67.74 127.24 32.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.076 0.465 . . . . 0.0 111.719 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -75.02 -35.51 61.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.288 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.2 p -109.21 17.23 21.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.51 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -124.77 -93.91 1.01 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.305 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.92 20.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.103 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -139.9 161.6 37.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.981 0.513 . . . . 0.0 109.65 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.8 ttt -64.71 110.24 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.343 0.592 . . . . 0.0 111.024 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 127' ' ' HIS . 20.1 tp -92.17 145.67 24.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.581 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.4 pt-20 -128.13 115.68 18.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.0 m -108.59 157.96 18.01 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.075 0.464 . . . . 0.0 111.928 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.3 170.2 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.586 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -123.28 117.81 26.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.794 0.331 . . . . 0.0 111.373 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.08 119.36 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.17 122.05 6.68 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.865 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.19 34.83 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.971 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.9 43.26 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.694 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -163.63 -54.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.095 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.83 73.55 0.54 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.289 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.16 159.9 14.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 111.142 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.47 165.62 26.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.302 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.37 133.37 13.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -126.45 150.46 48.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.973 0.416 . . . . 0.0 111.295 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.97 90.84 13.7 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.254 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 132' ' ' TYR . 24.2 Cg_endo -66.55 167.2 19.55 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.497 2.132 . . . . 0.0 113.746 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.249 1.032 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.998 179.341 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.685 0.278 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 p -123.9 142.11 51.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.6 m -118.41 134.45 55.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 94.2 t80 -111.74 131.63 55.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -108.07 104.83 14.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.148 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 16.3 ptpt -55.17 -24.68 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.445 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 27.0 m-85 -67.73 -46.84 71.01 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.415 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 7.2 p -82.94 -47.5 11.71 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.364 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.6 2.7 46.87 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.18 147.94 42.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.153 0.476 . . . . 0.0 110.983 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.09 159.79 16.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.969 0.414 . . . . 0.0 110.357 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.415 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 0.5 OUTLIER -135.56 131.89 36.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.672 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -74.31 173.16 10.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 t -61.96 139.76 20.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.18 27.06 70.82 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.302 -0.475 . . . . 0.0 113.098 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.22 122.06 46.33 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.437 HG23 ' CG2' ' A' ' 93' ' ' THR . 18.0 p -105.61 141.42 37.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 110.825 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.9 p90 -138.31 -172.84 3.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.564 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.34 137.98 52.08 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.677 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -138.41 124.36 12.6 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -78.52 59.27 7.1 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.766 1.644 . . . . 0.0 113.21 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -64.49 143.73 57.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.6 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 33.91 57.0 0.6 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.4 m 53.16 35.84 20.9 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 ttp -146.73 152.72 39.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 mm -90.13 110.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.196 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.472 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 33.0 m95 -99.32 139.19 35.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.946 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -94.97 104.1 15.97 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 18.2 m -107.82 139.97 41.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.437 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -112.39 152.1 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 114.48 28.75 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 109.953 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -102.11 95.39 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.488 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.54 78.98 1.44 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.646 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.75 -48.18 4.18 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.04 -68.52 0.87 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.412 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.11 48.84 0.98 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 111.161 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.22 77.56 0.69 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.602 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -89.6 141.78 28.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.65 0.262 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.4 mm -102.56 125.16 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.306 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.2 t -124.56 111.52 15.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.428 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 39.4 m -108.96 130.97 55.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.894 0.378 . . . . 0.0 111.838 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 p -135.92 128.75 31.11 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 mt -42.73 137.44 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.229 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.65 161.02 30.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.746 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -79.13 61.61 3.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -150.43 174.5 12.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 117' ' ' TYR . 20.7 p -128.87 129.74 45.94 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.85 157.21 47.41 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.365 -0.209 . . . . 0.0 111.488 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 1.2 pt-20 172.09 -66.79 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.62 91.44 1.07 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.915 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 -84.7 1.24 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.353 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -108.29 176.17 5.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.567 0.223 . . . . 0.0 110.72 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.9 t -84.98 128.29 34.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.562 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' CYS . 79.3 m-85 -93.62 129.11 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.624 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -81.64 167.33 19.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.192 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 18.8 mm -53.83 135.96 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.43 -4.13 43.64 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.16 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.43 158.53 16.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.323 0.562 . . . . 0.0 110.187 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.8 p -138.5 142.06 39.38 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.987 0.422 . . . . 0.0 111.812 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -147.29 123.35 10.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.617 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.93 139.1 53.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.538 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 126' ' ' PRO . 16.1 ptt-85 -174.48 157.6 2.42 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.051 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 125' ' ' ARG . 34.9 Cg_exo -41.23 171.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.141 2.56 . . . . 0.0 113.339 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.547 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.3 t60 -105.24 116.63 32.28 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.27 -40.36 62.38 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.158 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.445 ' OG1' ' CE1' ' A' ' 127' ' ' HIS . 4.3 p -96.7 22.39 8.2 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.342 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.547 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -152.17 -159.86 9.22 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.945 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.8 35.84 2.0 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.17 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.85 146.05 27.78 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.6 mtp -56.52 106.73 0.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.979 0.419 . . . . 0.0 109.927 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 34.2 tp -92.8 145.5 24.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.387 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -141.32 117.48 10.64 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.1 m -117.6 158.59 24.35 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.44 179.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.623 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 9.4 t -113.9 118.06 33.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.494 0.588 . . . . 0.0 111.34 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mt -111.76 155.6 23.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.362 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.15 94.34 0.15 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.837 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.76 35.95 4.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.88 0.371 . . . . 0.0 110.797 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.71 41.56 10.84 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.565 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -160.6 -48.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.439 0.161 . . . . 0.0 111.413 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.78 61.22 0.65 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.288 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.85 155.65 30.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.61 171.44 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.77 127.95 39.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.029 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.59 150.96 48.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.008 0.432 . . . . 0.0 111.312 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -126.28 74.22 72.94 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.508 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 39.9 Cg_endo -72.8 144.65 39.42 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.743 2.295 . . . . 0.0 112.916 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.114 179.259 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.849 0.356 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -139.79 152.22 46.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.916 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.0 m -118.27 134.46 55.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.404 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 87.2 t80 -113.39 121.83 45.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.32 96.15 7.54 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 61.3 pttt -49.14 -23.86 1.43 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 83' ' ' ARG . 20.7 m-85 -66.33 -46.67 76.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.512 0.196 . . . . 0.0 111.524 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.466 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 19.2 p -86.38 -49.66 7.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.077 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.55 11.23 31.49 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.804 -0.634 . . . . 0.0 113.015 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -118.17 148.39 42.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.795 0.298 . . . . 0.0 110.356 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.35 159.57 17.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 110.385 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.466 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 8.3 m-85 -135.97 129.4 32.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -75.84 150.98 37.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.413 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 77.9 t -47.89 143.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.795 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.89 79.67 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.624 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -112.54 128.9 56.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 92' ' ' CYS . 19.0 p -105.33 149.71 25.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.593 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 33.1 p90 -144.73 174.82 10.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.626 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -118.52 131.9 56.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.525 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -134.26 135.6 24.4 Favored Pre-proline 0 N--CA 1.462 0.171 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.448 ' N ' ' HD3' ' A' ' 83' ' ' ARG . 67.5 Cg_endo -83.61 65.11 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.77 1.647 . . . . 0.0 112.755 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.57 125.25 21.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.61 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 t70 59.33 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.075 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' LYS . 11.1 t -165.11 38.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.416 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 3.3 ttp -149.37 154.27 38.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mm -90.78 111.94 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.445 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 28.6 m95 -99.39 155.9 17.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -118.13 107.18 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 9.6 m -107.75 167.82 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 112.01 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.442 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.6 154.47 45.43 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 109.993 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.0 t -103.51 114.39 28.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.404 0.621 . . . . 0.0 109.479 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.29 -52.66 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.44 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.77 63.22 4.8 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.852 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.32 -53.81 4.63 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.63 -61.69 0.66 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.313 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 54.14 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.32 83.51 0.65 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.541 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -96.59 135.36 38.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.48 128.69 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -129.29 111.08 12.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.099 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.59 138.19 46.32 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.5 p -139.24 132.26 29.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.21 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.432 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -49.93 146.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.34 167.86 19.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.538 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.09 52.78 2.2 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.999 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.8 mtm-85 -141.18 162.79 34.64 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 7.0 p -117.95 126.66 52.76 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.37 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.627 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -131.96 156.1 46.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.014 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.627 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 6.9 tp10 167.66 141.29 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.244 0.34 . . . . 0.0 111.033 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.14 -71.84 2.91 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.286 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.02 -97.59 2.07 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.456 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -96.05 -177.78 4.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.7 p -92.81 124.52 36.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.829 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.25 158.73 16.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.803 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -98.14 153.87 18.14 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.913 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.34 124.33 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.575 0.226 . . . . 0.0 111.128 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.81 -14.9 64.48 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.467 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.8 164.25 26.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.297 0.548 . . . . 0.0 111.838 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p -126.46 147.43 49.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.993 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -138.61 34.84 2.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.597 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -50.52 119.14 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.702 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 126' ' ' PRO . 29.9 mmt180 -140.71 162.04 51.04 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.248 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 125' ' ' ARG . 59.5 Cg_exo -41.01 172.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.889 2.392 . . . . 0.0 113.825 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 1.4 t60 -86.27 124.54 32.77 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.16 -32.66 65.0 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.103 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.5 p -108.67 18.9 20.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.3 -176.7 30.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.587 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.86 31.15 6.97 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.884 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 17.5 p90 -130.72 161.07 32.49 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 151' ' ' ILE . 66.7 mtp -70.98 138.73 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 150' ' ' PRO . 33.3 tp -123.16 140.86 52.59 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.597 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 32.2 mt-10 -127.12 116.39 20.59 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 119.833 -0.127 . . . . 0.0 110.704 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.1 m -107.32 158.12 17.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 111.724 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.38 165.09 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.455 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 118.33 27.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.807 0.337 . . . . 0.0 111.288 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.82 113.53 25.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.78 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.29 104.34 1.8 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.003 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.37 38.6 4.15 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.625 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.79 29.88 7.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.57 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -164.14 -54.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.725 0.262 . . . . 0.0 111.056 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.83 73.64 0.86 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.475 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.0 167.95 9.71 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.05 163.93 31.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.413 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.28 138.59 18.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -132.85 151.32 52.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.341 0.591 . . . . 0.0 112.391 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -125.62 111.94 25.35 Favored Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.406 ' HB3' HD11 ' A' ' 134' ' ' LEU . 73.1 Cg_endo -74.15 170.51 19.99 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.019 1.813 . . . . 0.0 114.307 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 133' ' ' MET . 1.1 tp . . . . . 0 C--O 1.25 1.083 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.315 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.806 0.336 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.6 p -131.82 144.27 50.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.86 134.73 54.65 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -111.11 122.13 47.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -99.58 98.44 9.31 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -55.23 -17.7 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.545 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 1.3 m-85 -67.28 -45.77 75.61 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.316 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.6 -52.87 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.99 12.99 16.86 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.432 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.37 148.3 42.65 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.028 0.414 . . . . 0.0 110.259 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.43 159.51 17.97 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.374 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.3 129.69 29.7 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 147.74 38.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.23 141.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.14 -177.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.32 16.74 75.53 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.563 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -112.67 126.97 55.97 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.458 HG23 ' CG2' ' A' ' 93' ' ' THR . 18.9 p -105.2 132.92 50.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.895 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 34.3 p90 -128.53 -177.55 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.744 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.9 mt-10 -124.45 135.41 53.23 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.895 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.545 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -141.33 147.34 46.36 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.778 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 88' ' ' MET . 94.5 Cg_endo -84.86 124.41 2.99 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.143 1.895 . . . . 0.0 111.444 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.489 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -117.58 113.93 22.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.458 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 67.06 -67.88 0.16 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 m -162.94 31.54 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -144.71 167.04 23.52 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.689 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.48 116.99 47.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.489 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 17.6 m95 -99.3 154.34 18.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.92 110.15 20.6 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 80' ' ' THR . 46.7 m -108.83 166.89 10.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 112.214 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.458 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.15 152.76 44.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.648 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -104.41 113.9 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.94 -43.52 24.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.913 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 54.26 63.63 5.01 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.984 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -97.38 -52.06 3.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.651 0.262 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.66 -67.9 0.49 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.337 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.84 44.62 2.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.39 73.13 0.87 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.659 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -77.13 136.68 38.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.047 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.78 123.87 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.481 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 t -118.94 110.53 17.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.7 m -117.05 131.88 56.82 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.8 p -139.89 138.03 35.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.65 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.02 152.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.03 155.98 21.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.813 0.339 . . . . 0.0 111.9 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.62 56.89 3.71 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.294 0.568 . . . . 0.0 110.256 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.21 171.58 15.7 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.034 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 12.2 p -120.23 127.09 52.1 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.591 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.64 149.96 49.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.713 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.591 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 0.0 OUTLIER 169.11 152.37 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.671 0.272 . . . . 0.0 111.362 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.75 -36.8 3.63 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.243 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.46 -10.47 0.29 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.282 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -134.65 175.02 9.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.171 0.486 . . . . 0.0 110.18 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 12.4 p -114.23 125.84 54.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.999 0.428 . . . . 0.0 111.161 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.91 158.02 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.459 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -105.21 158.04 16.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.907 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.15 124.58 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.58 0.228 . . . . 0.0 110.767 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.6 -12.82 61.32 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.241 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 156.6 30.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.216 0.508 . . . . 0.0 111.135 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 p -127.97 150.62 49.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.573 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.402 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 17.8 p90 -142.56 86.49 1.95 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.145 0.498 . . . . 0.0 109.811 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.66 91.07 4.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 126' ' ' PRO . 20.4 mtt-85 -123.12 163.92 30.67 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.826 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 43.3 Cg_exo -43.01 176.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.082 2.521 . . . . 0.0 113.809 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.5 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.2 t60 -101.4 126.43 48.17 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 111.837 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -69.68 -36.56 76.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.794 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.9 p -108.5 18.6 20.75 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -146.52 175.62 25.86 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.575 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -113.78 28.79 8.24 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.302 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -136.09 159.55 41.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.658 0.229 . . . . 0.0 111.055 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.2 mtt -67.59 114.57 6.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.096 0.474 . . . . 0.0 110.749 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.76 145.85 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.618 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.2 mt-10 -121.96 115.52 22.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 94.3 m -111.35 158.13 19.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.606 HG22 HG23 ' A' ' 147' ' ' THR . 0.1 OUTLIER -134.79 171.15 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.889 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 t -133.02 118.36 18.71 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.752 0.311 . . . . 0.0 111.517 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.4 118.83 36.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.403 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.0 97.97 2.32 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.75 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -138.46 52.7 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.71 -76.66 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.492 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -130.08 -42.75 1.22 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.539 0.209 . . . . 0.0 111.393 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.78 91.17 0.08 OUTLIER Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.534 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.9 153.78 20.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.703 0.287 . . . . 0.0 110.823 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -137.22 164.79 27.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.606 HG23 HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -150.78 146.32 26.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -141.3 149.84 41.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.031 0.443 . . . . 0.0 111.393 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -135.3 90.94 19.64 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.545 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.6 168.06 23.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.478 2.119 . . . . 0.0 113.655 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.955 179.283 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 77' ' ' VAL . 1.4 mp0 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.683 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.6 p -132.23 139.1 48.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.167 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.88 136.42 54.05 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 94.8 t80 -112.81 131.68 55.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -108.41 105.08 14.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.209 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -59.08 -17.54 26.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -69.16 -45.89 68.9 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -89.15 -47.88 7.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.71 6.4 40.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.431 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.92 151.31 38.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.098 0.449 . . . . 0.0 110.833 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.78 159.62 15.32 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.118 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.32 131.78 34.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.301 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -76.73 157.79 31.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -46.87 135.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.155 -178.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 29.65 59.02 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.261 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -113.54 120.53 41.27 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 92' ' ' CYS . 15.9 p -105.88 149.54 26.45 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.3 p90 -154.61 -173.71 4.68 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -115.38 133.88 55.62 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.94 136.88 28.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 88' ' ' MET . 80.2 Cg_endo -79.5 114.3 3.24 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 121.779 1.653 . . . . 0.0 112.837 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -117.15 107.57 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 49.53 77.87 0.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m 49.25 43.48 22.88 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.59 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 39.9 ttp -164.44 162.05 21.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.23 144.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m95 -120.27 152.45 37.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.498 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.32 102.47 14.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' THR . 61.1 m -108.04 139.28 42.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 112.594 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.46 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -115.21 152.34 32.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.882 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.75 114.45 28.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.661 0.743 . . . . 0.0 110.237 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.71 112.06 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.192 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.97 62.64 0.29 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.682 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.02 -56.11 10.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.902 0.382 . . . . 0.0 110.303 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.96 -41.31 4.38 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.548 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.4 -87.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.552 0.341 . . . . 0.0 110.181 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.39 56.34 0.55 Allowed Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.761 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -62.13 143.04 57.24 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.639 0.257 . . . . 0.0 111.466 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 mp -107.82 129.46 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.5 t -126.5 120.11 28.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 57.0 m -119.11 135.38 54.68 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.9 p -140.09 139.96 35.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.92 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.99 158.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.382 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.16 161.24 13.81 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.05 67.5 10.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.37 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -148.47 173.32 13.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.982 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 10.0 p -126.21 127.55 45.83 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.571 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.31 169.37 17.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.281 -179.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.571 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 13.7 pt-20 170.68 -51.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.96 0.162 . . . . 0.0 111.166 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -81.88 70.15 3.18 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.74 0.46 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.839 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.89 -177.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.877 0.471 . . . . 0.0 111.882 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -119.29 127.05 52.85 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.137 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -96.24 152.15 18.84 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.504 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -89.28 -177.98 5.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.01 124.21 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.06 -3.65 82.67 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.033 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.8 163.73 25.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.576 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.5 p -131.82 147.74 52.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.29 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 20.3 p90 -142.76 67.05 1.31 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.385 0.612 . . . . 0.0 109.735 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.09 90.08 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.453 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 126' ' ' PRO . 26.3 mtt-85 -121.93 167.86 12.78 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.886 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 65.5 Cg_exo -43.92 178.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.984 2.456 . . . . 0.0 113.877 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.498 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.2 t60 -103.06 127.98 50.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -70.79 -35.31 72.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.704 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 p -109.99 18.55 19.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.369 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.498 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -146.95 174.7 26.68 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.557 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.92 28.99 8.38 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.404 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -135.53 159.53 41.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.574 0.226 . . . . 0.0 110.936 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 18.2 mtm -67.27 116.01 7.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 26.8 tp -91.96 146.25 23.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.912 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 34.9 mt-10 -124.32 116.11 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -122.46 157.53 31.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.62 168.11 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.593 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 117.95 24.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.592 0.234 . . . . 0.0 111.056 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.41 120.98 43.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -84.26 -146.57 7.63 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.66 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.88 -64.79 0.36 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.639 0.375 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.95 -94.2 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.836 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -154.93 68.19 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 54.57 34.04 55.08 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.166 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.21 121.67 18.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.731 0.3 . . . . 0.0 110.868 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 166.26 11.3 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.83 127.5 14.26 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.107 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -125.35 149.46 48.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.467 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -139.71 96.51 8.45 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.774 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 55.9 Cg_endo -75.53 169.28 22.69 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.37 2.047 . . . . 0.0 113.523 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.035 179.304 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.532 0.206 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p -124.53 152.95 42.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.152 0.501 . . . . 0.0 111.2 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' TYR . 68.0 m -119.48 138.64 53.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.046 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -121.17 127.92 51.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.38 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -111.68 109.19 18.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.39 -13.49 51.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.575 0.226 . . . . 0.0 111.592 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.564 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 4.0 m-30 -68.86 -43.27 75.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.857 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.463 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 3.2 p -94.85 -50.0 5.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.76 5.12 33.87 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.856 -0.611 . . . . 0.0 114.036 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.422 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.2 m120 -117.18 141.44 48.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.714 0.757 . . . . 0.0 111.297 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.85 160.35 29.31 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.99 0.424 . . . . 0.0 110.97 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' A' ' 66' ' ' CYS . 6.5 m-85 -134.61 129.01 34.29 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.909 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -78.27 143.4 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.466 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 79.9 t -47.73 123.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.022 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.57 36.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.791 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -113.02 124.07 51.76 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.519 HG23 ' CG2' ' A' ' 93' ' ' THR . 11.9 p -105.81 144.42 32.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.075 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 34.6 p90 -138.89 -175.08 4.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.6 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.1 mt-10 -122.4 126.55 48.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.71 0.291 . . . . 0.0 110.769 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -120.08 128.98 25.57 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -87.19 98.46 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.082 1.854 . . . . 0.0 111.319 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 114.22 27.7 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 47.65 79.84 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.4 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.7 m 45.16 40.35 4.8 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.843 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -150.82 162.09 41.43 Favored 'General case' 0 C--N 1.335 -0.053 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.676 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mm -114.39 132.55 63.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.538 ' CH2' HG12 ' A' ' 106' ' ' ILE . 26.4 m95 -117.48 135.29 54.02 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -97.7 104.25 16.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 80' ' ' THR . 15.0 t -107.63 153.56 22.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.519 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.6 OUTLIER -134.54 154.04 51.65 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.245 -179.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 8.9 t -101.74 113.45 26.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -54.37 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.095 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 56.25 60.89 8.15 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.001 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.32 -45.58 54.48 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.667 0.27 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.58 -58.91 0.72 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 67.14 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.18 93.37 0.48 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.751 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -120.06 151.78 38.51 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.87 119.46 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.078 0.399 . . . . 0.0 110.467 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.98 115.44 17.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.115 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 2.8 m -130.84 144.01 51.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.7 p -139.65 153.44 47.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.44 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.538 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -69.41 -168.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.669 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 108' ' ' ASN . . . 70.68 -164.93 0.15 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 52.0 m-80 82.33 -25.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.281 0.632 . . . . 0.0 111.671 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -138.35 152.65 48.64 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 117' ' ' TYR . 4.3 p -110.22 123.09 49.14 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.928 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -135.61 -174.7 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 25.2 tt0 169.41 123.95 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.735 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 68.88 165.82 4.1 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.249 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -31.46 -31.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 113' ' ' GLY . 52.0 mt-30 -93.53 127.18 39.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.155 0.977 . . . . 0.0 111.641 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -95.46 153.76 17.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.431 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 110' ' ' CYS . 13.1 m-85 -140.35 146.62 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.625 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -94.69 178.73 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.886 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.05 124.13 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.631 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.47 -3.72 84.03 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.243 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.74 151.62 28.97 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.13 0.465 . . . . 0.0 111.016 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.3 p -127.15 144.77 50.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.091 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -137.52 50.06 1.97 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.67 113.63 0.68 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.146 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -144.65 154.17 55.64 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -39.06 149.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.246 2.63 . . . . 0.0 113.619 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.451 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.2 t60 -67.22 135.11 52.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 112.104 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -73.42 -32.71 64.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.429 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 63.5 p -120.0 18.99 12.41 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.637 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.451 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -139.83 176.1 21.41 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.571 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.55 31.98 6.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.312 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.65 170.32 16.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 110.544 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.1 mtt -78.24 115.1 17.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.515 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.423 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 21.0 tp -91.87 144.54 25.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.747 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 40.6 mt-10 -122.32 115.66 22.7 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 99.1 m -110.33 157.71 19.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.03 177.15 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.76 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.6 t -130.49 117.13 19.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.132 0.423 . . . . 0.0 111.583 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.4 mt -112.56 113.58 25.8 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.101 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.63 87.42 0.42 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.868 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.47 -49.24 4.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.612 0.244 . . . . 0.0 110.754 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -165.43 36.1 0.26 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.705 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -171.31 -43.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.612 0.206 . . . . 0.0 111.317 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.08 67.1 0.81 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.597 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.61 152.89 21.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.664 0.268 . . . . 0.0 110.717 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 166.13 14.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.69 134.99 22.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.965 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.2 m -130.33 149.85 51.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.035 0.445 . . . . 0.0 111.387 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.27 96.47 12.54 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.598 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 56.7 Cg_endo -76.48 162.95 32.76 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.267 1.978 . . . . 0.0 113.522 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.986 179.197 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.683 0.278 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 p -131.16 154.98 47.79 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.208 0.528 . . . . 0.0 111.26 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' TYR . 61.3 m -119.04 136.33 54.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -120.56 128.32 52.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.215 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -111.87 103.95 12.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.979 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -58.97 -15.15 11.6 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.697 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.457 ' CD2' ' HD2' ' A' ' 83' ' ' ARG . 3.2 m-85 -67.45 -45.98 74.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.968 0.413 . . . . 0.0 110.346 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -50.5 5.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.056 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.93 10.18 28.78 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.44 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -118.18 153.48 33.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.117 0.458 . . . . 0.0 110.814 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.24 159.73 15.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.885 0.374 . . . . 0.0 110.259 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' CYS . 4.3 m-85 -135.06 127.95 31.36 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.662 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.0 148.65 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.447 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 17.8 t -47.86 142.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.351 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.72 20.99 79.3 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.208 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.39 127.19 56.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.491 HG23 ' CG2' ' A' ' 93' ' ' THR . 15.3 p -105.67 149.34 26.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.782 0.325 . . . . 0.0 110.644 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 30.3 p90 -152.17 -179.11 7.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 3.6 mt-10 -112.84 132.73 55.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.749 0.309 . . . . 0.0 110.373 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HD2' ' CD2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -137.9 128.7 15.73 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 88' ' ' MET . 59.9 Cg_endo -74.86 119.0 5.49 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.617 1.545 . . . . 0.0 111.898 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -118.0 115.56 25.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.045 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 44.67 69.84 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 m 54.57 37.82 28.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.632 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -145.9 160.52 41.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.398 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -110.69 116.33 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.0 m95 -105.48 159.82 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.89 103.72 11.7 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 8.7 t -108.94 141.64 40.72 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.491 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.7 OUTLIER -117.76 153.48 33.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.303 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 15.0 t -103.56 117.04 33.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.218 0.533 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.46 -46.8 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.417 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.67 -94.13 0.19 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.549 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 61.56 21.83 12.41 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.58 -71.41 0.07 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.2 mmm-85 -114.82 -88.04 0.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.03 38.09 0.38 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 ptt-85 -68.7 141.92 55.17 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.857 0.361 . . . . 0.0 110.868 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -112.42 147.85 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.646 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -125.47 111.98 15.72 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.87 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.9 m -108.55 140.34 42.04 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.5 p -140.16 146.86 39.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.54 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.2 mt -55.55 153.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.304 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.6 26.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 111.792 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.96 70.89 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -150.19 177.09 10.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.208 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 14.7 p -124.44 130.5 52.58 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.491 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 6.0 p-80 -133.75 -145.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.156 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 1.3 tp10 89.23 163.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.542 0.337 . . . . 0.0 111.124 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.28 13.4 80.74 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.349 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.91 -16.11 58.79 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.159 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -133.48 170.52 15.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.07 0.435 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 4.9 p -119.05 127.44 53.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.969 0.414 . . . . 0.0 111.068 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -109.15 157.77 18.44 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.633 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 35.5 mttt -103.36 157.14 17.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.54 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm -48.81 124.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.9 67.29 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.688 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -77.31 159.96 29.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.377 0.588 . . . . 0.0 111.709 -179.325 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p -123.42 147.77 46.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.888 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -143.8 40.11 1.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.111 0.481 . . . . 0.0 109.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.59 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -55.77 108.06 0.41 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.191 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' PRO . 19.8 mtt180 -138.53 174.08 4.6 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.156 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.555 ' O ' ' O ' ' A' ' 125' ' ' ARG . 31.6 Cg_exo -41.36 -175.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.825 2.35 . . . . 0.0 113.667 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.625 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 2.6 t60 -104.07 124.74 49.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 112.028 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.02 -37.74 64.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.115 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.498 ' HB ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -80.06 -23.07 41.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.697 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -132.5 -153.03 7.18 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.81 31.2 3.41 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.574 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.625 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 20.0 p90 -127.26 140.47 52.2 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 120.491 0.186 . . . . 0.0 111.367 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 19.9 ttt -47.83 139.39 7.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.253 0.549 . . . . 0.0 112.0 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 125' ' ' ARG . 27.2 tp -133.58 143.72 48.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.567 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.59 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 27.5 mt-10 -127.47 116.87 21.09 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.7 OUTLIER -122.24 157.63 31.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.084 0.469 . . . . 0.0 112.11 -178.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.31 170.1 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.904 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 t -118.55 118.37 31.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.683 0.278 . . . . 0.0 111.288 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 40.3 mt -112.47 134.66 53.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.499 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.15 -114.01 0.99 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.65 -70.37 0.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.672 0.389 . . . . 0.0 111.702 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.29 -91.37 0.83 Allowed Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.567 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -129.63 -42.71 1.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 176.14 73.6 0.05 OUTLIER Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -92.14 161.63 14.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.737 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.07 162.23 36.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.53 125.76 14.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.503 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.12 149.71 50.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.499 0.666 . . . . 0.0 112.279 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -124.69 102.62 32.12 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.502 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 6.1 Cg_exo -71.27 167.94 24.8 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.019 1.812 . . . . 0.0 114.992 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.075 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.811 0.339 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 p -132.19 150.01 52.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.8 m -118.64 139.28 51.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.55 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -120.25 126.7 51.25 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 100.83 10.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -52.56 -21.75 4.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -67.69 -46.41 72.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 7.1 p -86.16 -52.4 5.69 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.67 8.82 31.86 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.439 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.31 145.43 44.0 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.957 0.379 . . . . 0.0 110.393 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 159.43 20.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.977 0.418 . . . . 0.0 110.648 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.473 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 3.1 m-85 -134.49 128.59 33.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.3 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.13 153.05 34.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 t -47.78 140.18 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.896 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.02 21.07 79.58 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.428 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.89 126.26 55.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.482 HG23 ' CG2' ' A' ' 93' ' ' THR . 20.4 p -105.37 132.93 50.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.889 0.376 . . . . 0.0 111.42 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 36.3 p90 -126.2 -176.23 3.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.673 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 138.56 54.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.859 0.362 . . . . 0.0 111.045 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.576 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -137.16 132.22 17.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.9 Cg_endo -79.74 59.85 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.696 1.597 . . . . 0.0 112.822 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -56.73 130.69 46.58 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.899 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 t70 35.21 63.86 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.3 m 53.9 36.04 23.27 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 18.1 mtm -143.16 149.16 37.67 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.65 109.32 21.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.424 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 18.6 m95 -100.01 151.93 20.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.414 -177.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.35 110.82 22.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 33.4 m -108.88 162.33 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.482 ' CG2' HG23 ' A' ' 80' ' ' THR . 1.0 OUTLIER -141.54 154.01 45.22 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.198 -179.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 21.4 t -103.49 113.37 26.82 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.62 -36.47 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.483 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.4 72.64 0.82 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.582 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.05 -55.35 3.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.687 0.279 . . . . 0.0 111.409 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.82 -61.09 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.536 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 24.61 12.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.878 0.37 . . . . 0.0 111.198 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.17 90.1 0.94 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.56 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -91.36 129.48 37.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.595 0.236 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.24 124.5 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.5 t -128.58 111.52 13.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.985 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.2 m -111.72 137.22 49.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.9 p -139.28 136.24 34.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.069 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -50.95 146.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.04 154.22 26.98 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.453 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.422 ' O ' HG12 ' A' ' 119' ' ' ILE . 4.2 p30 -85.87 63.89 8.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.099 0.476 . . . . 0.0 110.57 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -149.8 167.63 26.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.642 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 117' ' ' TYR . 2.7 p -118.95 125.61 49.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.61 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.0 145.32 47.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.746 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.61 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 5.9 pt-20 170.32 157.72 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.206 0.316 . . . . 0.0 111.197 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -77.61 1.98 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.996 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.79 -38.39 0.07 OUTLIER Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.52 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -123.55 172.17 8.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.294 0.547 . . . . 0.0 111.232 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 p -101.9 126.59 48.84 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' CYS . 2.5 m-85 -108.39 157.1 18.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.515 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -98.68 155.38 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 108' ' ' ASN . 22.3 mm -54.78 131.64 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.45 -10.32 73.77 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.567 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 150.54 30.0 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 117.489 0.645 . . . . 0.0 110.439 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.7 p -142.54 141.39 32.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.439 ' HH2' ' CD1' ' A' ' 146' ' ' TRP . 11.2 p90 -140.31 110.63 6.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -123.72 107.57 11.59 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.114 0.483 . . . . 0.0 111.703 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -148.04 159.23 40.57 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.678 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 26.5 Cg_exo -39.77 144.75 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.862 2.375 . . . . 0.0 113.027 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -65.75 137.57 57.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.487 0.661 . . . . 0.0 112.559 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.82 -41.76 59.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.684 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 78.0 p -108.34 17.68 21.89 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.84 -95.33 1.14 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.385 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.53 -22.63 0.42 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.08 171.73 9.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.641 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.1 ptm -69.78 151.28 45.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.514 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 25.1 tp -136.34 129.25 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.7 mt-10 -118.96 119.78 35.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.001 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 147' ' ' THR . 94.3 m -116.12 158.22 23.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 111.912 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.525 HG21 ' CG2' ' A' ' 147' ' ' THR . 0.0 OUTLIER -141.17 165.52 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.85 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 133.34 54.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.861 0.362 . . . . 0.0 111.222 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.09 156.55 19.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.228 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -153.38 39.43 0.71 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.975 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -51.44 5.37 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.658 0.266 . . . . 0.0 110.708 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -117.09 -46.75 0.5 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.389 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -153.81 148.69 26.59 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.526 0.203 . . . . 0.0 110.576 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.94 105.69 1.0 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.464 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.4 173.81 7.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.445 ' HD1' ' HA ' ' A' ' 146' ' ' TRP . 1.0 OUTLIER -117.43 146.25 43.59 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.117 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.525 ' CG2' HG21 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -146.0 122.79 11.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -148.07 151.28 35.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.111 177.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -145.35 90.16 6.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.395 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.514 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 56.3 Cg_endo -73.08 158.17 49.73 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.329 2.019 . . . . 0.0 113.069 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.959 179.259 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.737 0.304 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 4.9 p -129.31 140.74 51.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 150.88 39.01 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.992 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 91.4 t80 -121.01 129.15 53.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -110.24 97.0 6.58 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 39.6 pttt -49.39 -19.0 0.45 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.544 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 2.9 m-85 -65.89 -45.52 81.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.832 0.349 . . . . 0.0 111.22 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -91.46 -52.61 4.7 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.67 9.81 28.04 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.321 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -117.26 138.29 51.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.932 0.366 . . . . 0.0 110.509 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.86 160.07 30.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.172 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.619 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 26.9 m-85 -130.34 128.92 42.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HG3' HG21 ' A' ' 65' ' ' THR . 1.5 mtt180 -85.77 147.56 26.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -46.92 144.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.356 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 27.93 71.82 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.325 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -113.31 127.24 56.08 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.474 HG23 ' CG2' ' A' ' 93' ' ' THR . 22.3 p -105.71 150.5 25.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.839 0.352 . . . . 0.0 111.554 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.4 ' CD1' ' CE1' ' A' ' 75' ' ' TYR . 24.7 p90 -157.4 -175.36 5.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.173 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.77 132.35 54.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.421 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 5.6 tmm_? -128.71 131.79 23.97 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 88' ' ' MET . 87.4 Cg_endo -84.29 64.52 6.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.813 . . . . 0.0 114.158 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.435 ' HG2' ' NE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -59.27 124.4 19.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.924 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 35.31 71.23 0.12 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.6 m 50.66 36.34 13.81 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.63 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.88 148.88 39.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.14 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mm -96.68 112.65 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.981 0.42 . . . . 0.0 109.88 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.543 ' CH2' HG12 ' A' ' 106' ' ' ILE . 19.6 m95 -101.92 148.41 25.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.186 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.92 107.99 19.31 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 70.1 m -108.03 156.29 19.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.474 ' CG2' HG23 ' A' ' 80' ' ' THR . 2.0 m -141.53 150.05 41.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.458 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -106.9 113.65 27.26 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.322 0.965 . . . . 0.0 110.649 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.3 -24.42 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.717 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 97' ' ' ALA . . . 83.04 -75.82 2.33 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.395 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' GLY . . . 17.42 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.26 -113.47 4.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.455 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.28 70.95 1.4 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.145 0.498 . . . . 0.0 111.29 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.81 77.28 1.0 Allowed Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.92 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -102.09 131.66 48.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.603 0.239 . . . . 0.0 110.959 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.24 122.31 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.136 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.14 116.05 17.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.918 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.9 m -123.16 143.89 49.71 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 p -139.9 139.67 36.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.695 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.543 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -62.46 154.77 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.508 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.62 152.67 18.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 111.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.75 68.13 10.27 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.635 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HA ' ' CD1' ' A' ' 119' ' ' ILE . 62.3 mtp180 -150.56 172.04 16.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.172 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.2 m -110.62 127.2 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.549 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -138.77 147.14 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 179.225 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 2.9 tm-20 171.35 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.728 0.299 . . . . 0.0 111.206 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 97.72 -83.69 0.71 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.636 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.56 2.19 0.38 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.434 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.69 -177.93 5.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.346 0.573 . . . . 0.0 111.103 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -119.52 127.71 53.27 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -108.41 159.44 16.66 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.666 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 3.9 tmtt? -103.07 158.08 16.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 109' ' ' ARG . 1.4 mp -49.12 128.13 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.675 0.274 . . . . 0.0 111.197 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.39 61.42 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.312 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -80.78 168.87 18.3 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.355 0.578 . . . . 0.0 111.397 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 p -138.85 152.99 48.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.04 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.443 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 43.3 p90 -141.26 84.39 1.92 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.219 0.533 . . . . 0.0 110.039 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 1.2 mpp_? -85.23 74.16 10.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -110.72 167.16 9.46 Favored Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.726 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 66.5 Cg_exo -44.08 175.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.862 2.375 . . . . 0.0 113.676 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -105.26 128.87 53.65 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.96 -40.24 60.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.983 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.3 p -98.7 15.12 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.27 -69.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.856 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 123.55 19.57 2.79 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -126.4 141.74 51.79 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.038 0.535 . . . . 0.0 109.622 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.2 ptt? -50.41 108.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.547 0.689 . . . . 0.0 111.391 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 150' ' ' PRO . 34.3 tp -91.92 143.87 26.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.336 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 36.1 mt-10 -126.15 116.0 20.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.15 157.33 38.39 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -126.95 174.61 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.862 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.94 118.88 12.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.814 0.34 . . . . 0.0 111.164 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.51 132.3 55.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.514 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -89.58 84.42 1.4 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.667 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 -48.45 6.93 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.556 0.217 . . . . 0.0 111.114 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -140.89 -65.99 0.03 OUTLIER Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.585 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -113.26 -39.13 4.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.427 0.156 . . . . 0.0 111.158 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.25 94.49 0.1 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.623 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -106.76 150.18 26.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.578 0.228 . . . . 0.0 110.645 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.97 165.24 21.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 111.341 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.601 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.6 OUTLIER -145.56 121.02 10.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.605 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -130.95 149.37 52.61 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.371 0.605 . . . . 0.0 111.799 179.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -123.78 90.28 50.76 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.63 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 134' ' ' LEU . 1.7 Cg_endo -80.69 161.63 21.69 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.66 2.24 . . . . 0.0 114.048 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.118 179.053 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.631 0.253 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -70.74 100.22 1.85 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.366 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 p -139.71 146.89 40.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.19 139.42 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -114.69 132.27 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -109.27 112.67 24.95 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -64.03 -16.76 62.38 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.565 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 5.8 m-85 -70.59 -45.98 64.32 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -88.8 -48.32 7.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.797 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.33 3.82 47.36 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.791 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.5 m-80 -117.3 138.5 51.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.4 0.6 . . . . 0.0 110.926 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 159.84 27.43 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.907 0.384 . . . . 0.0 110.565 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 73' ' ' ASN . 1.1 m-85 -134.52 138.62 44.82 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.622 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.78 165.9 22.3 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -59.54 128.29 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.115 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.66 24.67 49.23 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.996 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.08 122.79 48.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 92' ' ' CYS . 19.1 p -105.3 149.12 26.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.909 0.385 . . . . 0.0 111.074 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -145.25 -172.63 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.732 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -115.64 129.83 56.64 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.565 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 4.6 tmm_? -130.13 124.95 21.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.097 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 88' ' ' MET . 84.9 Cg_endo -80.55 111.55 2.58 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.841 1.694 . . . . 0.0 112.239 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.505 ' HB3' ' NE1' ' A' ' 90' ' ' TRP . 11.3 tptt -116.88 118.94 33.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.821 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 46.55 73.23 0.19 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.5 m 47.38 41.84 13.16 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.915 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.7 ttp -153.04 164.54 37.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.199 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mm -112.2 122.54 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.505 ' NE1' ' HB3' ' A' ' 85' ' ' LYS . 25.3 m95 -107.97 140.22 41.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.36 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.05 110.19 21.66 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' THR . 75.1 m -109.44 152.81 24.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.458 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -130.73 150.65 51.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.266 179.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 122.18 45.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 110.903 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -98.78 131.28 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.453 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.59 -169.1 25.85 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.317 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 70.99 114.54 0.05 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.808 0.443 . . . . 0.0 111.811 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.93 -136.82 12.91 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.963 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.25 23.1 9.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.107 0.479 . . . . 0.0 111.158 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.01 70.11 1.35 Allowed Glycine 0 CA--C 1.517 0.179 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.554 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.2 140.43 56.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.535 0.207 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.64 121.1 62.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.307 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.3 t -114.49 121.59 43.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.378 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.1 m -124.35 136.4 54.06 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 p -138.98 141.86 38.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.437 HG13 ' CH2' ' A' ' 90' ' ' TRP . 1.5 mt -51.96 155.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.284 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.08 144.1 28.61 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -80.49 75.77 7.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.75 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -150.17 173.53 13.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.23 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 117' ' ' TYR . 13.0 p -128.64 127.99 43.29 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.504 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.1 p-80 -135.1 -143.28 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 119.495 -0.288 . . . . 0.0 111.037 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.8 175.95 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.503 0.321 . . . . 0.0 111.078 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.43 -77.25 1.74 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.751 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.15 -39.26 0.04 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.936 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -133.71 167.21 20.93 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 32.4 p -84.88 150.83 24.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 111.247 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 110' ' ' CYS . 7.0 m-85 -133.21 139.1 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 1.9 mptm? -85.25 176.31 8.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.637 0.256 . . . . 0.0 111.161 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.1 mm -74.59 124.3 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.334 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.79 -3.14 86.3 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.92 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 169.7 17.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.924 0.393 . . . . 0.0 111.459 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p -133.9 150.31 51.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.488 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -141.28 55.21 1.54 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.27 0.557 . . . . 0.0 109.716 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.66 98.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.706 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.8 mtt180 -132.36 166.99 24.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.751 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.497 ' O ' ' O ' ' A' ' 125' ' ' ARG . 32.8 Cg_exo -39.71 177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.193 2.595 . . . . 0.0 113.956 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.442 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.4 t60 -103.11 129.58 50.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.142 0.496 . . . . 0.0 112.336 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -64.97 -40.49 95.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.276 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 66.5 p -111.38 19.36 18.32 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.8 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -144.79 174.5 24.89 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.49 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.62 28.59 8.86 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.385 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.488 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -133.16 158.3 43.19 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.488 0.185 . . . . 0.0 110.714 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 17.9 mtt -67.26 115.94 7.48 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.452 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 21.5 tp -92.19 144.68 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.869 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.5 pt-20 -125.44 116.16 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.7 157.47 32.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.34 168.47 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.233 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -131.56 124.25 29.64 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.829 0.347 . . . . 0.0 111.419 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.35 127.08 55.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.28 -103.05 0.09 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.979 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.71 22.35 11.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.421 0.288 . . . . 0.0 111.765 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.55 14.9 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.918 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -160.77 -54.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.659 0.23 . . . . 0.0 111.193 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.79 60.16 0.94 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.459 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.44 160.45 15.13 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 161.86 36.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.24 127.26 16.47 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.24 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.33 148.91 50.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.091 0.472 . . . . 0.0 111.403 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -137.92 91.4 13.4 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.918 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 132' ' ' TYR . 36.5 Cg_endo -69.48 164.96 32.27 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.559 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.017 179.357 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.585 0.231 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -78.5 167.88 20.62 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.302 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 p -133.3 145.94 50.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.033 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.0 m -118.16 135.49 54.2 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.5 t80 -109.24 124.2 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 10.1 t70 -98.31 103.91 15.9 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 14.9 ptpt -56.57 -27.97 59.09 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.424 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 94.0 m-85 -67.93 -39.64 83.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.772 0.32 . . . . 0.0 111.144 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.483 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 13.4 p -88.18 -53.45 4.7 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.73 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.48 39.51 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.406 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.54 144.06 46.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.095 0.448 . . . . 0.0 110.686 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.52 160.25 21.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.713 0.292 . . . . 0.0 110.872 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.483 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 10.2 m-85 -136.76 131.45 33.42 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.252 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -75.92 140.97 42.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.498 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.46 130.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.23 0.538 . . . . 0.0 111.982 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.45 14.6 56.87 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.97 125.77 54.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.467 HG23 ' CG2' ' A' ' 93' ' ' THR . 18.7 p -105.04 142.24 35.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.907 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -136.71 -173.91 3.56 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.766 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 5.2 mt-10 -119.98 126.84 51.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.202 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -124.27 123.15 25.97 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.1 Cg_endo -78.39 110.01 2.77 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.132 1.888 . . . . 0.0 112.076 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.73 116.57 27.76 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.861 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 48.32 77.51 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.8 m 44.5 43.85 6.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.3 ttp -155.65 166.03 34.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.7 130.84 68.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 22.3 m95 -114.46 143.07 45.53 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -98.56 109.38 22.14 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 80' ' ' THR . 81.7 m -108.99 159.91 16.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.128 0.49 . . . . 0.0 112.29 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.467 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -138.28 153.04 49.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.633 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 6.2 t -104.05 117.92 35.44 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.545 0.688 . . . . 0.0 110.806 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.89 119.93 36.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.424 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.8 -115.97 1.86 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 58.51 33.84 23.43 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.773 0.32 . . . . 0.0 111.198 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.21 45.03 92.86 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.397 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 -67.54 0.59 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.34 56.01 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 121.192 -0.527 . . . . 0.0 112.142 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.7 143.29 9.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.754 0.422 . . . . 0.0 111.737 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.46 120.01 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.257 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 t -111.21 111.89 23.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.7 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.4 m -121.36 127.72 51.53 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.2 p -138.91 138.98 37.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.926 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -45.37 155.86 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.292 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.59 155.29 17.37 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.81 70.94 7.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.436 ' HB3' ' O ' ' A' ' 117' ' ' TYR . 91.3 mtm-85 -150.08 168.14 24.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.9 p -117.16 125.4 51.15 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.787 0.327 . . . . 0.0 110.126 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.594 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -129.76 166.42 19.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.617 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 15.1 pt-20 167.3 138.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.266 0.354 . . . . 0.0 110.923 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -37.6 3.25 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.505 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.54 -94.77 0.1 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.44 177.93 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.29 0.236 . . . . 0.0 111.306 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.4 p -120.1 125.51 48.44 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 111.492 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -95.56 157.3 15.96 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.635 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -93.06 174.53 7.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.08 124.5 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.3 -4.85 82.87 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.794 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.97 160.45 30.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.82 0.31 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p -130.9 145.42 52.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.9 p90 -136.75 53.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.355 0.598 . . . . 0.0 109.619 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.33 102.85 0.06 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.745 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 126' ' ' PRO . 97.5 mtt180 -134.92 161.77 61.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.762 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 125' ' ' ARG . 37.4 Cg_exo -40.28 174.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.176 2.584 . . . . 0.0 113.879 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.498 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.1 t60 -100.15 128.17 46.27 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 111.877 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -72.57 -32.68 66.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.718 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.0 p -112.42 18.43 18.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.326 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.498 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -145.21 174.62 25.18 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.582 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.87 29.11 8.32 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.122 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -136.82 162.93 31.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.491 0.186 . . . . 0.0 110.705 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -70.93 117.16 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.243 0.544 . . . . 0.0 110.774 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 23.3 tp -91.67 145.47 24.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.717 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 5.1 pt-20 -129.59 116.12 18.41 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -120.8 157.34 29.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.65 173.28 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.271 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 18.3 t -128.36 117.81 22.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.759 0.314 . . . . 0.0 110.761 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.2 mt -111.66 113.86 26.52 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.464 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.97 70.45 0.94 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 -53.31 3.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.542 0.21 . . . . 0.0 111.07 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.48 -65.36 0.97 Allowed Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.516 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 pttt -144.5 -44.59 0.25 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.417 0.151 . . . . 0.0 111.316 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -178.21 83.56 0.07 OUTLIER Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.91 159.23 18.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.23 163.79 31.92 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.82 126.6 13.47 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.3 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 136' ' ' CYS . 0.0 OUTLIER -124.62 149.31 47.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 110.932 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -136.36 88.74 20.24 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.837 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 132' ' ' TYR . 29.2 Cg_endo -67.44 168.96 16.6 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 113.645 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.052 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 120.649 0.261 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -79.13 91.68 4.95 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 111.217 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -138.17 148.93 45.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.7 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.93 135.39 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 89.5 t80 -110.19 126.39 54.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 11.1 t70 -102.21 96.87 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.775 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 47.9 pttt -47.69 -29.38 2.99 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.424 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 84.8 m-85 -67.46 -39.87 85.32 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.403 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 6.6 p -87.19 -51.09 6.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 8.75 37.8 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.832 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -119.56 153.33 35.58 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.793 0.296 . . . . 0.0 110.786 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 159.81 14.71 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.403 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 1.0 OUTLIER -138.08 139.71 39.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.806 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -78.76 165.08 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.53 137.12 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 0.0 111.621 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.21 32.27 63.0 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.101 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.9 OUTLIER -113.34 120.89 42.69 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.446 HG23 ' CG2' ' A' ' 93' ' ' THR . 22.0 p -105.26 150.19 25.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 0.0 110.906 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -153.3 179.14 9.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.96 126.83 53.51 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -126.07 126.03 24.76 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.911 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.5 Cg_endo -78.43 116.93 3.94 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.982 1.788 . . . . 0.0 111.347 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.02 123.65 45.04 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.262 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 42.51 74.31 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 t 46.63 42.21 11.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 29.7 ttp -154.59 164.76 38.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mm -110.32 136.58 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -121.9 159.92 25.86 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.04 108.24 18.39 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 80' ' ' THR . 88.6 m -108.35 162.93 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.446 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.3 OUTLIER -141.57 151.68 43.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.11 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.15 114.41 28.59 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.3 mm -74.47 -61.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.125 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.0 129.06 0.05 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.42 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -170.85 55.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.461 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.36 61.45 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.258 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -175.93 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.458 0.303 . . . . 0.0 111.807 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.72 80.83 0.96 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.419 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -90.0 131.99 35.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.634 0.255 . . . . 0.0 111.077 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.61 126.82 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.295 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -127.18 111.22 13.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.9 m -116.53 139.05 50.91 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.6 p -139.84 138.92 36.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.959 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.5 mt -48.7 148.05 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.11 148.37 34.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -93.28 59.25 2.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.19 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -149.15 177.38 9.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.686 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 85.8 m -110.11 128.19 55.31 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.52 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -138.94 145.36 39.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 10.6 pt-20 170.9 166.82 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.304 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.35 -93.52 1.64 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.596 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.86 0.59 1.2 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.05 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.18 -178.32 5.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.8 t -119.04 127.21 53.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.555 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.417 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.1 m-85 -104.37 159.74 15.48 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.158 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 5.2 mmtp -105.82 164.13 12.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.4 124.53 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.514 0.197 . . . . 0.0 111.409 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.3 63.0 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.355 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -71.95 159.68 33.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.388 0.594 . . . . 0.0 111.473 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 p -130.96 152.25 50.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.13 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -144.38 98.34 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 109.977 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -92.37 87.13 5.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.426 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 126' ' ' PRO . 1.0 OUTLIER -120.74 167.41 13.01 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.698 179.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 45.3 Cg_exo -43.15 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.0 2.467 . . . . 0.0 113.633 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.463 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.4 t60 -100.95 129.81 46.86 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 112.194 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.25 -40.33 93.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 74.0 p -112.49 20.04 17.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.777 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.463 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -144.14 173.71 24.76 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.557 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.78 30.89 7.44 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.348 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -136.15 164.52 27.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.427 0.156 . . . . 0.0 110.712 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 12.3 mtt -72.9 116.16 13.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.082 0.467 . . . . 0.0 110.472 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.408 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 21.2 tp -92.23 144.56 25.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.573 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 37.4 mt-10 -120.93 115.69 23.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 92.1 m -112.73 158.2 20.36 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 147' ' ' THR . 0.1 OUTLIER -135.33 169.36 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.864 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 t -138.33 123.65 19.37 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.872 0.367 . . . . 0.0 111.301 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.22 143.83 42.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.453 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.93 77.65 1.86 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.722 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 122.98 12.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.612 0.244 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.8 -90.93 1.47 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.731 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 43.36 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.04 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.696 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.78 127.59 35.99 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.708 0.29 . . . . 0.0 110.572 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -109.53 167.64 9.99 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.6 HG23 HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -149.79 145.98 26.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -141.76 149.94 41.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.427 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -135.23 90.59 20.66 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.615 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 132' ' ' TYR . 38.4 Cg_endo -70.96 161.42 46.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.484 2.123 . . . . 0.0 113.63 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.011 179.183 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.671 0.272 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.98 143.48 35.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.411 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 5.0 p -125.53 142.3 51.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 147.03 43.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.963 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.2 t80 -121.75 121.13 36.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.731 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 21.9 t70 -104.94 96.38 6.5 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 51.7 pttt -48.97 -17.98 0.25 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.443 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 4.6 m-30 -65.49 -46.19 80.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.662 0.268 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.5 p -86.7 -50.03 7.06 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.26 6.73 33.54 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.207 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.95 150.23 39.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.981 0.391 . . . . 0.0 111.147 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.39 160.26 17.66 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 65' ' ' THR . 2.6 m-85 -134.96 131.01 36.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.563 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.87 179.53 7.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.79 139.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.471 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.48 40.5 96.25 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.708 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.26 124.37 52.34 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 28.7 p -105.62 149.72 26.07 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.892 0.377 . . . . 0.0 111.383 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -161.1 -178.58 6.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -118.39 132.18 56.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 111.023 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.443 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -124.24 124.23 25.87 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.09 63.96 8.81 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 121.964 1.776 . . . . 0.0 112.48 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.52 128.47 36.45 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.864 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.5 t70 37.3 69.1 0.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.895 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m 46.08 47.62 12.85 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 42.5 ttp -160.51 135.81 7.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.37 132.64 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 111.522 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.414 ' CH2' HG12 ' A' ' 106' ' ' ILE . 16.1 m95 -119.84 152.27 37.57 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -108.33 100.31 9.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.4 t -108.6 138.76 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 80' ' ' THR . 1.7 m -116.54 148.18 41.09 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.67 117.7 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.731 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -92.16 142.3 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.611 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.35 -129.62 1.04 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.521 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 62.42 110.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 111.536 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.63 -112.72 4.54 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -139.43 47.09 1.89 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.08 98.08 0.94 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.635 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -105.78 135.51 47.08 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.586 0.231 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.99 121.52 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.2 111.93 12.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.98 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 3.3 m -126.37 148.34 49.61 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 p -141.12 148.91 40.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.165 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.414 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -60.61 146.98 10.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.544 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.63 159.24 31.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.75 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.9 57.48 4.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.171 0.51 . . . . 0.0 110.596 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -144.4 171.6 14.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.9 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 2.3 p -123.23 128.47 50.05 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -134.43 154.4 51.41 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.229 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 7.3 tp10 167.35 140.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.867 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.73 -8.71 54.82 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.417 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.0 -17.79 7.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.089 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -126.04 165.44 18.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.844 0.322 . . . . 0.0 110.34 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.477 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.4 t -108.87 125.72 52.29 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.4 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.02 158.86 16.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.215 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 25.8 mtmt -99.37 161.74 13.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.0 mm -55.19 124.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.509 0.195 . . . . 0.0 111.349 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.13 -12.2 70.34 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.767 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -60.23 167.28 2.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.575 0.688 . . . . 0.0 111.777 -178.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 57.1 p -142.67 144.72 32.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.254 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.433 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 17.5 p90 -149.74 96.61 2.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.042 0.449 . . . . 0.0 109.97 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -91.73 76.38 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 111.008 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 126' ' ' PRO . 89.1 mtt180 -108.15 163.45 16.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.094 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 125' ' ' ARG . 52.4 Cg_exo -41.08 179.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.301 2.667 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.5 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.1 t60 -100.6 127.41 46.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.674 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.43 -34.21 72.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.742 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.6 p -111.96 19.0 18.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.361 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -147.92 171.18 28.48 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.478 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -108.79 28.48 11.28 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.689 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.422 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.35 162.2 32.87 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.726 0.263 . . . . 0.0 110.906 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 13.1 mtt -68.59 120.74 15.09 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.317 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.404 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 22.3 tp -100.93 144.12 30.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.4 pt-20 -120.62 115.81 24.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.67 158.32 21.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.81 160.32 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.372 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 121.76 37.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.709 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.0 mt -113.82 156.24 24.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.634 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.58 -132.77 1.83 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.034 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.58 33.33 18.35 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.915 0.388 . . . . 0.0 111.089 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.54 -52.2 0.1 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.685 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -147.67 -66.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.648 0.224 . . . . 0.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.34 79.32 0.07 OUTLIER Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.483 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -112.09 135.77 52.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 111.252 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -109.84 166.79 10.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.18 137.31 17.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.515 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.95 149.95 49.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.165 0.507 . . . . 0.0 111.522 179.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.05 92.08 11.07 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.193 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 132' ' ' TYR . 38.2 Cg_endo -71.58 162.2 42.94 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.332 2.021 . . . . 0.0 113.836 -178.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.012 179.246 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.57 0.224 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -102.13 158.66 16.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.214 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 74' ' ' THR . 30.1 p -128.34 155.43 44.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.186 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.454 ' N ' ' O ' ' A' ' 75' ' ' TYR . 60.1 m -119.02 135.49 54.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.817 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.8 t80 -121.19 123.11 41.46 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -105.66 95.15 5.61 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.165 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 44.1 pttt -49.01 -21.56 0.71 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -66.3 -44.62 82.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.554 0.216 . . . . 0.0 110.7 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.462 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 17.1 p -86.8 -49.97 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.0 12.05 30.67 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.083 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -118.92 157.43 27.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.807 0.303 . . . . 0.0 110.64 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.409 HG23 ' HB ' ' A' ' 65' ' ' THR . 0.2 OUTLIER -96.95 159.64 14.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 178.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 3.9 m-85 -135.84 127.8 29.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.98 153.28 32.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.7 t -47.85 143.37 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.558 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 21.94 78.32 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -113.06 130.16 56.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.446 HG23 ' CG2' ' A' ' 93' ' ' THR . 21.1 p -105.69 150.27 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.369 . . . . 0.0 111.494 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -149.7 173.96 13.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.081 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.69 131.09 54.37 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.566 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -126.85 135.86 27.95 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.566 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 85.8 Cg_endo -81.53 62.44 8.32 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.945 1.763 . . . . 0.0 112.956 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 122.28 12.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.524 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 40.71 74.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.867 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 94.9 p 41.5 47.9 3.32 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 44.6 ttp -163.15 133.5 4.5 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.7 mm -74.07 137.31 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 111.07 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 106' ' ' ILE . 17.9 m95 -122.63 164.73 17.68 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.978 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 80' ' ' THR . 48.9 m -108.61 161.19 15.31 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.446 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.9 OUTLIER -142.2 153.98 44.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.223 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.3 t -103.33 113.23 26.56 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.94 -31.59 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.133 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.14 177.8 44.68 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.615 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.76 150.21 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.926 0.393 . . . . 0.0 111.678 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.38 39.97 41.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.679 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.02 37.1 21.41 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.708 0.29 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.86 71.46 1.13 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.605 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -80.21 149.1 30.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.818 0.309 . . . . 0.0 110.762 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.83 130.27 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.792 0.329 . . . . 0.0 111.337 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.61 111.46 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 88.3 m -117.4 145.17 44.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 p -140.05 137.97 35.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.031 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.415 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -53.08 143.84 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.04 168.07 10.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.807 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.33 43.79 1.13 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -134.29 159.34 41.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.943 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.6 p -112.14 126.34 55.09 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.452 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -128.93 164.16 23.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.566 -178.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 41.2 tt0 165.41 126.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.441 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.39 -99.0 0.87 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.727 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.5 -17.7 1.36 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -131.9 179.03 6.32 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.223 0.512 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.5 t -112.94 125.43 54.38 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.981 0.419 . . . . 0.0 111.156 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -102.12 159.42 15.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -105.23 161.08 14.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.17 124.7 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.651 0.262 . . . . 0.0 110.962 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.64 -22.24 41.36 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.223 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 152.15 44.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.973 0.416 . . . . 0.0 111.649 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.0 p -116.34 152.76 33.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.41 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.415 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 18.5 p90 -147.11 81.12 1.54 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.21 0.529 . . . . 0.0 109.866 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.7 76.01 10.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.214 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 126' ' ' PRO . 14.6 mtt85 -110.66 171.05 4.66 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.689 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 42.5 Cg_exo -43.0 179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.93 2.42 . . . . 0.0 113.473 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -103.8 136.37 43.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.43 0.634 . . . . 0.0 112.707 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.43 -40.09 62.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.373 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 61.1 p -109.09 18.25 20.79 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.84 -79.98 0.07 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.486 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 137.58 29.87 0.27 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 150' ' ' PRO . 2.8 p90 -135.52 151.45 50.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 122.878 0.471 . . . . 0.0 109.765 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.528 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.8 ttt -57.72 107.2 0.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.462 HD11 ' HB3' ' A' ' 150' ' ' PRO . 15.0 tp -91.73 144.84 25.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.974 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 30.5 mt-10 -124.56 115.88 21.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -125.72 157.5 37.22 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.35 171.65 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.254 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.1 t -139.58 124.02 18.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.709 0.29 . . . . 0.0 110.903 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.07 133.16 54.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.29 76.59 1.91 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.726 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -42.47 11.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.53 0.205 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.58 -54.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.679 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -106.21 -55.48 2.32 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.41 54.51 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.12 154.03 32.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.771 0.319 . . . . 0.0 111.328 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -142.27 161.71 37.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.57 127.73 16.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.88 149.73 50.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 0.0 111.749 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -124.78 81.16 61.67 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.61 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.462 ' HB3' HD11 ' A' ' 134' ' ' LEU . 12.9 Cg_endo -67.08 168.01 18.52 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.754 2.303 . . . . 0.0 114.479 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.977 178.696 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.712 0.292 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.64 169.99 13.79 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.352 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 p -129.43 145.69 51.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.039 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.3 m -118.49 134.48 55.04 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.491 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 83.8 t80 -110.0 124.57 51.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 12.8 t70 -97.8 97.58 9.11 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 10.8 ptmt -51.47 -28.74 14.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.503 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 82.5 m-85 -66.98 -45.8 76.55 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.67 0.271 . . . . 0.0 111.315 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.449 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 29.1 p -82.06 -51.05 8.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.323 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.16 5.69 43.25 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.29 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -116.86 143.7 45.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.07 0.435 . . . . 0.0 110.436 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.89 159.76 20.28 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.876 0.37 . . . . 0.0 110.907 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.449 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 9.5 m-85 -136.27 130.3 32.8 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -75.08 153.01 38.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.409 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 21.8 t -50.27 144.06 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.188 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.67 79.17 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.269 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.81 125.87 54.82 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 92' ' ' CYS . 21.4 p -104.98 129.36 53.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.905 0.384 . . . . 0.0 111.134 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 39.9 p90 -122.49 -173.65 2.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.782 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -127.69 138.55 52.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.838 0.351 . . . . 0.0 110.935 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.575 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -141.04 130.44 12.85 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.462 ' HD2' ' HE ' ' A' ' 83' ' ' ARG . 61.3 Cg_endo -77.17 64.99 7.91 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.762 1.641 . . . . 0.0 112.851 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.91 130.37 45.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.349 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 55.65 -77.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.855 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 85' ' ' LYS . 78.4 p -158.26 30.94 0.24 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.064 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.89 159.13 43.91 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.7 mm -89.7 112.29 24.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.452 ' CZ2' HG12 ' A' ' 106' ' ' ILE . 28.5 m95 -98.5 144.96 27.27 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.0 111.929 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.18 106.79 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 m -107.28 165.02 11.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.469 . . . . 0.0 112.034 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.444 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.3 OUTLIER -136.52 154.68 50.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.629 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 3.7 t -102.47 114.17 28.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.475 0.655 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -105.74 74.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.834 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.63 139.07 15.67 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.227 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.65 45.56 0.3 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.897 0.379 . . . . 0.0 110.571 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.75 8.52 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.298 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.14 -37.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.26 85.33 0.99 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.166 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt85 -104.69 135.27 46.4 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.735 0.303 . . . . 0.0 111.283 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.75 129.98 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.35 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.2 t -124.45 110.48 14.56 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.269 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 69.3 m -111.22 131.15 55.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.365 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.3 p -137.73 132.96 33.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.452 HG12 ' CZ2' ' A' ' 90' ' ' TRP . 2.7 mt -51.23 142.07 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.927 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.27 19.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 111.489 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -86.54 64.74 8.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -147.0 174.26 11.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.308 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 117' ' ' TYR . 24.2 p -129.89 129.98 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 112' ' ' GLU . 3.5 p-80 -134.94 -140.7 0.17 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.601 -0.237 . . . . 0.0 110.751 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.2 163.94 0.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.86 0.362 . . . . 0.0 111.455 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.94 -83.47 1.59 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.787 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.52 -35.33 0.1 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.26 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -131.27 -178.81 5.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.896 0.348 . . . . 0.0 110.754 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.1 p -107.7 126.67 52.88 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 110.725 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 110' ' ' CYS . 3.0 m-85 -106.65 157.81 17.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.541 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -104.16 158.34 16.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.1 mm -50.14 124.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.75 -9.5 75.52 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.733 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.11 154.57 39.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.402 0.601 . . . . 0.0 111.54 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.9 p -122.87 149.45 44.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.743 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.443 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 12.4 p90 -147.69 82.41 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.298 0.57 . . . . 0.0 109.905 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.3 75.03 5.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.038 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.3 mtt180 -108.76 166.6 10.54 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 63.1 Cg_exo -41.93 178.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.087 2.525 . . . . 0.0 114.077 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -103.54 124.42 48.75 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 111.58 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.43 -24.85 60.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.08 14.43 22.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.71 -179.21 30.63 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.755 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -115.24 28.29 8.02 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.428 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.01 155.44 49.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.546 0.212 . . . . 0.0 111.177 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 11.9 mtt -63.45 114.5 3.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.098 0.475 . . . . 0.0 110.595 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.9 tp -92.46 146.9 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.739 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 26.6 mt-10 -123.04 116.23 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -123.87 157.62 33.77 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.79 171.75 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.662 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 52.7 t -132.67 125.01 29.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.94 154.93 24.53 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.081 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -146.57 55.25 0.53 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.089 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.97 -51.55 7.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.723 0.297 . . . . 0.0 110.353 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.17 -44.97 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -140.53 157.42 45.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.391 0.276 . . . . 0.0 110.31 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.28 93.43 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -114.93 162.46 16.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.16 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -142.79 164.45 30.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.283 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.62 124.81 11.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.879 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -125.52 149.99 47.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.585 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -141.19 99.11 6.59 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.528 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -77.01 170.3 20.02 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.419 2.079 . . . . 0.0 113.56 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.055 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.919 179.32 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.639 0.257 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -87.91 161.22 17.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.262 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.7 p -124.16 150.13 45.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.498 ' HB3' ' CD1' ' A' ' 102' ' ' ILE . 85.6 m -118.54 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.371 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -113.62 124.45 52.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.757 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -103.54 99.37 9.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.43 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -57.29 -16.14 7.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.065 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.566 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 5.4 m-30 -66.96 -46.08 75.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.169 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.52 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 7.3 p -91.42 -54.87 3.73 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.782 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.94 11.4 12.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.363 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.63 155.5 32.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.165 0.483 . . . . 0.0 110.792 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.16 159.8 15.13 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.716 0.293 . . . . 0.0 110.253 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.52 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 4.6 m-85 -138.8 129.03 25.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -73.89 154.19 39.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 5.0 t -52.23 136.5 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.915 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.86 21.47 71.34 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.0 123.49 50.45 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.502 HG23 ' CG2' ' A' ' 93' ' ' THR . 16.9 p -105.59 149.17 26.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.391 . . . . 0.0 111.351 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 26.4 p90 -145.83 -175.32 4.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.071 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.2 mp0 -121.05 131.68 54.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.566 ' NE ' ' HB3' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -129.77 132.33 24.11 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.456 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.544 ' N ' ' HD3' ' A' ' 83' ' ' ARG . 56.4 Cg_endo -80.48 114.38 3.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.567 1.511 . . . . 0.0 110.859 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -116.14 113.5 23.19 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.845 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 49.42 77.29 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t 46.06 43.83 11.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 8.9 ttp -157.59 169.5 24.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.461 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -116.82 131.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.423 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.0 m95 -117.72 157.84 25.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.19 111.72 23.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -108.34 156.93 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.502 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.9 OUTLIER -141.1 154.1 45.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.412 0.685 . . . . 0.0 110.648 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -102.87 113.06 26.19 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.74 -31.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.189 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.61 83.04 0.39 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.835 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.54 119.88 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.9 2.07 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.676 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.12 44.92 1.23 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.046 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.07 84.38 0.54 Allowed Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.5 121.96 17.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 66' ' ' CYS . 9.8 mm -103.0 121.97 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.476 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.5 t -127.83 110.53 12.69 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.395 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.4 m -107.83 133.73 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 111.29 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.3 p -138.56 133.15 32.19 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.706 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -43.57 155.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.17 148.59 22.26 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.7 60.01 5.37 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.068 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -150.06 176.98 10.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 9.5 p -120.15 127.29 52.36 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.567 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.5 OUTLIER -136.69 142.71 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.335 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 12.9 pt-20 171.88 159.54 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.59 -79.23 1.43 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.61 -8.84 0.11 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.798 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -142.89 -178.53 5.86 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 117.624 0.712 . . . . 0.0 110.51 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p -114.43 125.84 54.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.797 0.332 . . . . 0.0 110.661 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.06 157.31 17.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.425 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -106.2 156.43 18.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.9 mm -45.85 124.65 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.46 -6.13 71.04 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.633 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 156.86 33.89 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.483 0.641 . . . . 0.0 111.391 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -124.14 146.31 48.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -137.84 67.47 1.42 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 0.0 109.668 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.77 108.78 2.22 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.513 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -137.88 153.02 73.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.341 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 50.4 Cg_exo -42.42 143.71 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.081 2.521 . . . . 0.0 113.701 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.51 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.5 t60 -67.74 127.24 32.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.076 0.465 . . . . 0.0 111.719 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -75.02 -35.51 61.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.288 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.2 p -109.21 17.23 21.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.51 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -124.77 -93.91 1.01 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.305 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.92 20.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.103 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -139.9 161.6 37.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.981 0.513 . . . . 0.0 109.65 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.8 ttt -64.71 110.24 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.343 0.592 . . . . 0.0 111.024 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 127' ' ' HIS . 20.1 tp -92.17 145.67 24.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.581 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.4 pt-20 -128.13 115.68 18.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.0 m -108.59 157.96 18.01 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.075 0.464 . . . . 0.0 111.928 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.3 170.2 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.586 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -123.28 117.81 26.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.794 0.331 . . . . 0.0 111.373 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.08 119.36 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.17 122.05 6.68 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.865 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.19 34.83 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.971 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.9 43.26 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.694 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -163.63 -54.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.095 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.83 73.55 0.54 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.289 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.16 159.9 14.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 111.142 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.47 165.62 26.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.302 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.37 133.37 13.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -126.45 150.46 48.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.973 0.416 . . . . 0.0 111.295 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.97 90.84 13.7 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.254 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 132' ' ' TYR . 24.2 Cg_endo -66.55 167.2 19.55 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.497 2.132 . . . . 0.0 113.746 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.249 1.032 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.998 179.341 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.647 0.26 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -79.59 154.6 28.62 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.275 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 p -123.9 142.11 51.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.6 m -118.41 134.45 55.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 94.2 t80 -111.74 131.63 55.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -108.07 104.83 14.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.148 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 16.3 ptpt -55.17 -24.68 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.445 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 27.0 m-85 -67.73 -46.84 71.01 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.415 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 7.2 p -82.94 -47.5 11.71 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.364 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.6 2.7 46.87 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.18 147.94 42.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.153 0.476 . . . . 0.0 110.983 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.09 159.79 16.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.969 0.414 . . . . 0.0 110.357 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.415 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 0.5 OUTLIER -135.56 131.89 36.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.672 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -74.31 173.16 10.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 t -61.96 139.76 20.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.18 27.06 70.82 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.302 -0.475 . . . . 0.0 113.098 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.22 122.06 46.33 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.437 HG23 ' CG2' ' A' ' 93' ' ' THR . 18.0 p -105.61 141.42 37.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 110.825 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.9 p90 -138.31 -172.84 3.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.564 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.34 137.98 52.08 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.677 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -138.41 124.36 12.6 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -78.52 59.27 7.1 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.766 1.644 . . . . 0.0 113.21 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -64.49 143.73 57.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.6 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 33.91 57.0 0.6 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.4 m 53.16 35.84 20.9 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 ttp -146.73 152.72 39.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 mm -90.13 110.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.196 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.472 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 33.0 m95 -99.32 139.19 35.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.946 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -94.97 104.1 15.97 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 18.2 m -107.82 139.97 41.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.437 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -112.39 152.1 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 114.48 28.75 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 109.953 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -102.11 95.39 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.488 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.54 78.98 1.44 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.646 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.75 -48.18 4.18 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.04 -68.52 0.87 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.412 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.11 48.84 0.98 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 111.161 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.22 77.56 0.69 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.602 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -89.6 141.78 28.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.65 0.262 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.4 mm -102.56 125.16 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.306 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.2 t -124.56 111.52 15.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.428 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 39.4 m -108.96 130.97 55.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.894 0.378 . . . . 0.0 111.838 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 p -135.92 128.75 31.11 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 mt -42.73 137.44 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.229 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.65 161.02 30.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.746 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -79.13 61.61 3.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -150.43 174.5 12.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 117' ' ' TYR . 20.7 p -128.87 129.74 45.94 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.85 157.21 47.41 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.365 -0.209 . . . . 0.0 111.488 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 1.2 pt-20 172.09 -66.79 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.62 91.44 1.07 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.915 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 -84.7 1.24 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.353 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -108.29 176.17 5.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.567 0.223 . . . . 0.0 110.72 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.9 t -84.98 128.29 34.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.562 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' CYS . 79.3 m-85 -93.62 129.11 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.624 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -81.64 167.33 19.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.192 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 18.8 mm -53.83 135.96 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.43 -4.13 43.64 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.16 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.43 158.53 16.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.323 0.562 . . . . 0.0 110.187 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.8 p -138.5 142.06 39.38 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.987 0.422 . . . . 0.0 111.812 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -147.29 123.35 10.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.617 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.93 139.1 53.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.538 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 126' ' ' PRO . 16.1 ptt-85 -174.48 157.6 2.42 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.051 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 125' ' ' ARG . 34.9 Cg_exo -41.23 171.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.141 2.56 . . . . 0.0 113.339 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.547 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.3 t60 -105.24 116.63 32.28 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.27 -40.36 62.38 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.158 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.445 ' OG1' ' CE1' ' A' ' 127' ' ' HIS . 4.3 p -96.7 22.39 8.2 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.342 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.547 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -152.17 -159.86 9.22 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.945 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.8 35.84 2.0 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.17 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.85 146.05 27.78 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.6 mtp -56.52 106.73 0.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.979 0.419 . . . . 0.0 109.927 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 34.2 tp -92.8 145.5 24.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.387 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -141.32 117.48 10.64 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.1 m -117.6 158.59 24.35 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.44 179.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.623 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 9.4 t -113.9 118.06 33.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.494 0.588 . . . . 0.0 111.34 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mt -111.76 155.6 23.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.362 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.15 94.34 0.15 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.837 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.76 35.95 4.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.88 0.371 . . . . 0.0 110.797 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.71 41.56 10.84 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.565 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -160.6 -48.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.439 0.161 . . . . 0.0 111.413 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.78 61.22 0.65 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.288 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.85 155.65 30.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.61 171.44 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.77 127.95 39.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.029 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.59 150.96 48.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.008 0.432 . . . . 0.0 111.312 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -126.28 74.22 72.94 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.508 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 39.9 Cg_endo -72.8 144.65 39.42 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.743 2.295 . . . . 0.0 112.916 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.114 179.259 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.717 0.294 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -85.2 102.91 13.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.142 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -139.79 152.22 46.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.916 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.0 m -118.27 134.46 55.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.404 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 87.2 t80 -113.39 121.83 45.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.32 96.15 7.54 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 61.3 pttt -49.14 -23.86 1.43 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 83' ' ' ARG . 20.7 m-85 -66.33 -46.67 76.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.512 0.196 . . . . 0.0 111.524 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.466 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 19.2 p -86.38 -49.66 7.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.077 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.55 11.23 31.49 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.804 -0.634 . . . . 0.0 113.015 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -118.17 148.39 42.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.795 0.298 . . . . 0.0 110.356 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.35 159.57 17.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 110.385 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.466 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 8.3 m-85 -135.97 129.4 32.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -75.84 150.98 37.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.413 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 77.9 t -47.89 143.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.795 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.89 79.67 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.624 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -112.54 128.9 56.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 92' ' ' CYS . 19.0 p -105.33 149.71 25.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.593 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 33.1 p90 -144.73 174.82 10.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.626 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -118.52 131.9 56.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.525 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -134.26 135.6 24.4 Favored Pre-proline 0 N--CA 1.462 0.171 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.448 ' N ' ' HD3' ' A' ' 83' ' ' ARG . 67.5 Cg_endo -83.61 65.11 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.77 1.647 . . . . 0.0 112.755 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.57 125.25 21.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.61 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 t70 59.33 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.075 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' LYS . 11.1 t -165.11 38.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.416 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 3.3 ttp -149.37 154.27 38.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mm -90.78 111.94 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.445 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 28.6 m95 -99.39 155.9 17.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -118.13 107.18 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 9.6 m -107.75 167.82 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 112.01 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.442 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.6 154.47 45.43 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 109.993 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.0 t -103.51 114.39 28.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.404 0.621 . . . . 0.0 109.479 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.29 -52.66 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.44 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.77 63.22 4.8 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.852 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.32 -53.81 4.63 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.63 -61.69 0.66 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.313 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 54.14 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.32 83.51 0.65 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.541 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -96.59 135.36 38.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.48 128.69 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -129.29 111.08 12.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.099 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.59 138.19 46.32 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.5 p -139.24 132.26 29.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.21 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.432 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -49.93 146.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.34 167.86 19.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.538 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.09 52.78 2.2 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.999 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.8 mtm-85 -141.18 162.79 34.64 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 7.0 p -117.95 126.66 52.76 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.37 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.627 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -131.96 156.1 46.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.014 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.627 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 6.9 tp10 167.66 141.29 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.244 0.34 . . . . 0.0 111.033 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.14 -71.84 2.91 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.286 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.02 -97.59 2.07 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.456 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -96.05 -177.78 4.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.7 p -92.81 124.52 36.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.829 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.25 158.73 16.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.803 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -98.14 153.87 18.14 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.913 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.34 124.33 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.575 0.226 . . . . 0.0 111.128 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.81 -14.9 64.48 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.467 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.8 164.25 26.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.297 0.548 . . . . 0.0 111.838 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p -126.46 147.43 49.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.993 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -138.61 34.84 2.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.597 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -50.52 119.14 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.702 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 126' ' ' PRO . 29.9 mmt180 -140.71 162.04 51.04 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.248 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 125' ' ' ARG . 59.5 Cg_exo -41.01 172.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.889 2.392 . . . . 0.0 113.825 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 1.4 t60 -86.27 124.54 32.77 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.16 -32.66 65.0 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.103 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.5 p -108.67 18.9 20.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.3 -176.7 30.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.587 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.86 31.15 6.97 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.884 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 17.5 p90 -130.72 161.07 32.49 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 151' ' ' ILE . 66.7 mtp -70.98 138.73 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 150' ' ' PRO . 33.3 tp -123.16 140.86 52.59 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.597 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 32.2 mt-10 -127.12 116.39 20.59 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 119.833 -0.127 . . . . 0.0 110.704 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.1 m -107.32 158.12 17.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 111.724 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.38 165.09 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.455 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 118.33 27.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.807 0.337 . . . . 0.0 111.288 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.82 113.53 25.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.78 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.29 104.34 1.8 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.003 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.37 38.6 4.15 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.625 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.79 29.88 7.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.57 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -164.14 -54.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.725 0.262 . . . . 0.0 111.056 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.83 73.64 0.86 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.475 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.0 167.95 9.71 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.05 163.93 31.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.413 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.28 138.59 18.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -132.85 151.32 52.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.341 0.591 . . . . 0.0 112.391 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -125.62 111.94 25.35 Favored Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.406 ' HB3' HD11 ' A' ' 134' ' ' LEU . 73.1 Cg_endo -74.15 170.51 19.99 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.019 1.813 . . . . 0.0 114.307 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 133' ' ' MET . 1.1 tp . . . . . 0 C--O 1.25 1.083 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.315 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.708 0.289 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -123.12 159.71 27.97 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.398 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.6 p -131.82 144.27 50.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.86 134.73 54.65 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -111.11 122.13 47.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -99.58 98.44 9.31 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -55.23 -17.7 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.545 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 1.3 m-85 -67.28 -45.77 75.61 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.316 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.6 -52.87 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.99 12.99 16.86 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.432 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.37 148.3 42.65 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.028 0.414 . . . . 0.0 110.259 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.43 159.51 17.97 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.374 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.3 129.69 29.7 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 147.74 38.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.23 141.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.14 -177.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.32 16.74 75.53 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.563 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -112.67 126.97 55.97 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.458 HG23 ' CG2' ' A' ' 93' ' ' THR . 18.9 p -105.2 132.92 50.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.895 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 34.3 p90 -128.53 -177.55 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.744 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.9 mt-10 -124.45 135.41 53.23 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.895 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.545 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -141.33 147.34 46.36 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.778 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 88' ' ' MET . 94.5 Cg_endo -84.86 124.41 2.99 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.143 1.895 . . . . 0.0 111.444 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.489 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -117.58 113.93 22.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.458 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 67.06 -67.88 0.16 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 m -162.94 31.54 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -144.71 167.04 23.52 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.689 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.48 116.99 47.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.489 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 17.6 m95 -99.3 154.34 18.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.92 110.15 20.6 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 80' ' ' THR . 46.7 m -108.83 166.89 10.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 112.214 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.458 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.15 152.76 44.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.648 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -104.41 113.9 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.94 -43.52 24.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.913 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 54.26 63.63 5.01 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.984 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -97.38 -52.06 3.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.651 0.262 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.66 -67.9 0.49 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.337 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.84 44.62 2.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.39 73.13 0.87 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.659 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -77.13 136.68 38.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.047 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.78 123.87 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.481 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 t -118.94 110.53 17.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.7 m -117.05 131.88 56.82 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.8 p -139.89 138.03 35.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.65 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.02 152.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.03 155.98 21.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.813 0.339 . . . . 0.0 111.9 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.62 56.89 3.71 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.294 0.568 . . . . 0.0 110.256 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.21 171.58 15.7 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.034 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 12.2 p -120.23 127.09 52.1 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.591 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.64 149.96 49.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.713 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.591 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 0.0 OUTLIER 169.11 152.37 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.671 0.272 . . . . 0.0 111.362 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.75 -36.8 3.63 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.243 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.46 -10.47 0.29 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.282 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -134.65 175.02 9.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.171 0.486 . . . . 0.0 110.18 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 12.4 p -114.23 125.84 54.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.999 0.428 . . . . 0.0 111.161 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.91 158.02 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.459 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -105.21 158.04 16.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.907 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.15 124.58 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.58 0.228 . . . . 0.0 110.767 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.6 -12.82 61.32 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.241 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 156.6 30.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.216 0.508 . . . . 0.0 111.135 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 p -127.97 150.62 49.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.573 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.402 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 17.8 p90 -142.56 86.49 1.95 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.145 0.498 . . . . 0.0 109.811 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.66 91.07 4.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 126' ' ' PRO . 20.4 mtt-85 -123.12 163.92 30.67 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.826 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 43.3 Cg_exo -43.01 176.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.082 2.521 . . . . 0.0 113.809 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.5 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.2 t60 -101.4 126.43 48.17 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 111.837 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -69.68 -36.56 76.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.794 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.9 p -108.5 18.6 20.75 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -146.52 175.62 25.86 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.575 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -113.78 28.79 8.24 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.302 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -136.09 159.55 41.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.658 0.229 . . . . 0.0 111.055 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.2 mtt -67.59 114.57 6.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.096 0.474 . . . . 0.0 110.749 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.76 145.85 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.618 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.2 mt-10 -121.96 115.52 22.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 94.3 m -111.35 158.13 19.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.606 HG22 HG23 ' A' ' 147' ' ' THR . 0.1 OUTLIER -134.79 171.15 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.889 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 t -133.02 118.36 18.71 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.752 0.311 . . . . 0.0 111.517 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.4 118.83 36.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.403 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.0 97.97 2.32 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.75 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -138.46 52.7 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.71 -76.66 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.492 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -130.08 -42.75 1.22 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.539 0.209 . . . . 0.0 111.393 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.78 91.17 0.08 OUTLIER Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.534 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.9 153.78 20.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.703 0.287 . . . . 0.0 110.823 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -137.22 164.79 27.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.606 HG23 HG22 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -150.78 146.32 26.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -141.3 149.84 41.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.031 0.443 . . . . 0.0 111.393 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -135.3 90.94 19.64 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.545 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.6 168.06 23.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.478 2.119 . . . . 0.0 113.655 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.955 179.283 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.611 0.243 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 77' ' ' VAL . 1.4 mp0 -65.14 145.07 56.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.683 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.6 p -132.23 139.1 48.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.167 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.88 136.42 54.05 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 94.8 t80 -112.81 131.68 55.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -108.41 105.08 14.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.209 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -59.08 -17.54 26.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -69.16 -45.89 68.9 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -89.15 -47.88 7.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.71 6.4 40.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.431 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.92 151.31 38.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.098 0.449 . . . . 0.0 110.833 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.78 159.62 15.32 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.118 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.32 131.78 34.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.301 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -76.73 157.79 31.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -46.87 135.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.155 -178.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 29.65 59.02 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.261 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -113.54 120.53 41.27 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 92' ' ' CYS . 15.9 p -105.88 149.54 26.45 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.3 p90 -154.61 -173.71 4.68 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -115.38 133.88 55.62 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.94 136.88 28.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 88' ' ' MET . 80.2 Cg_endo -79.5 114.3 3.24 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 121.779 1.653 . . . . 0.0 112.837 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -117.15 107.57 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 49.53 77.87 0.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m 49.25 43.48 22.88 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.59 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 39.9 ttp -164.44 162.05 21.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.23 144.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m95 -120.27 152.45 37.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.498 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.32 102.47 14.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' THR . 61.1 m -108.04 139.28 42.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 112.594 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.46 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.2 OUTLIER -115.21 152.34 32.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.882 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.75 114.45 28.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.661 0.743 . . . . 0.0 110.237 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.71 112.06 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.192 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.97 62.64 0.29 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.682 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.02 -56.11 10.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.902 0.382 . . . . 0.0 110.303 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.96 -41.31 4.38 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.548 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.4 -87.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.552 0.341 . . . . 0.0 110.181 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.39 56.34 0.55 Allowed Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.761 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -62.13 143.04 57.24 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.639 0.257 . . . . 0.0 111.466 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 mp -107.82 129.46 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.5 t -126.5 120.11 28.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 57.0 m -119.11 135.38 54.68 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.9 p -140.09 139.96 35.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.92 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.99 158.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.382 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.16 161.24 13.81 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.05 67.5 10.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.37 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -148.47 173.32 13.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.982 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 10.0 p -126.21 127.55 45.83 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.571 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.31 169.37 17.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.281 -179.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.571 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 13.7 pt-20 170.68 -51.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.96 0.162 . . . . 0.0 111.166 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -81.88 70.15 3.18 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.74 0.46 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.839 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.89 -177.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.877 0.471 . . . . 0.0 111.882 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -119.29 127.05 52.85 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.137 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -96.24 152.15 18.84 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.504 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -89.28 -177.98 5.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.01 124.21 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.06 -3.65 82.67 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.033 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.8 163.73 25.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.576 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.5 p -131.82 147.74 52.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.29 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 20.3 p90 -142.76 67.05 1.31 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.385 0.612 . . . . 0.0 109.735 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.09 90.08 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.453 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 126' ' ' PRO . 26.3 mtt-85 -121.93 167.86 12.78 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.886 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 65.5 Cg_exo -43.92 178.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.984 2.456 . . . . 0.0 113.877 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.498 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.2 t60 -103.06 127.98 50.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -70.79 -35.31 72.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.704 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 p -109.99 18.55 19.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.369 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.498 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -146.95 174.7 26.68 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.557 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.92 28.99 8.38 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.404 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -135.53 159.53 41.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.574 0.226 . . . . 0.0 110.936 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 18.2 mtm -67.27 116.01 7.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 26.8 tp -91.96 146.25 23.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.912 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 34.9 mt-10 -124.32 116.11 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -122.46 157.53 31.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.62 168.11 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.593 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 117.95 24.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.592 0.234 . . . . 0.0 111.056 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.41 120.98 43.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -84.26 -146.57 7.63 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.66 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.88 -64.79 0.36 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.639 0.375 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.95 -94.2 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.836 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -154.93 68.19 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 54.57 34.04 55.08 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.166 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.21 121.67 18.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.731 0.3 . . . . 0.0 110.868 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 166.26 11.3 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.83 127.5 14.26 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.107 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -125.35 149.46 48.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.467 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -139.71 96.51 8.45 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.774 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 55.9 Cg_endo -75.53 169.28 22.69 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.37 2.047 . . . . 0.0 113.523 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.035 179.304 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.653 0.263 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.89 160.62 19.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.054 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p -124.53 152.95 42.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.152 0.501 . . . . 0.0 111.2 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' TYR . 68.0 m -119.48 138.64 53.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.046 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -121.17 127.92 51.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.38 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -111.68 109.19 18.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.39 -13.49 51.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.575 0.226 . . . . 0.0 111.592 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.564 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 4.0 m-30 -68.86 -43.27 75.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.857 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.463 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 3.2 p -94.85 -50.0 5.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.76 5.12 33.87 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.856 -0.611 . . . . 0.0 114.036 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.422 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.2 m120 -117.18 141.44 48.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.714 0.757 . . . . 0.0 111.297 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.85 160.35 29.31 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.99 0.424 . . . . 0.0 110.97 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' A' ' 66' ' ' CYS . 6.5 m-85 -134.61 129.01 34.29 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.909 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -78.27 143.4 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.466 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 79.9 t -47.73 123.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.022 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.57 36.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.791 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -113.02 124.07 51.76 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.519 HG23 ' CG2' ' A' ' 93' ' ' THR . 11.9 p -105.81 144.42 32.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.075 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 34.6 p90 -138.89 -175.08 4.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.6 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.1 mt-10 -122.4 126.55 48.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.71 0.291 . . . . 0.0 110.769 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -120.08 128.98 25.57 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -87.19 98.46 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.082 1.854 . . . . 0.0 111.319 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 114.22 27.7 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 47.65 79.84 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.4 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.7 m 45.16 40.35 4.8 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.843 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -150.82 162.09 41.43 Favored 'General case' 0 C--N 1.335 -0.053 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.676 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mm -114.39 132.55 63.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.538 ' CH2' HG12 ' A' ' 106' ' ' ILE . 26.4 m95 -117.48 135.29 54.02 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -97.7 104.25 16.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 80' ' ' THR . 15.0 t -107.63 153.56 22.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.519 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.6 OUTLIER -134.54 154.04 51.65 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.245 -179.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 8.9 t -101.74 113.45 26.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -54.37 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.095 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 56.25 60.89 8.15 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.001 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.32 -45.58 54.48 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.667 0.27 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.58 -58.91 0.72 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 67.14 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.18 93.37 0.48 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.751 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -120.06 151.78 38.51 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.87 119.46 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.078 0.399 . . . . 0.0 110.467 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.98 115.44 17.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.115 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 2.8 m -130.84 144.01 51.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.7 p -139.65 153.44 47.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.44 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.538 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -69.41 -168.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.669 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 108' ' ' ASN . . . 70.68 -164.93 0.15 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 52.0 m-80 82.33 -25.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.281 0.632 . . . . 0.0 111.671 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -138.35 152.65 48.64 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 117' ' ' TYR . 4.3 p -110.22 123.09 49.14 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.928 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -135.61 -174.7 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 25.2 tt0 169.41 123.95 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.735 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 68.88 165.82 4.1 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.249 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -31.46 -31.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 113' ' ' GLY . 52.0 mt-30 -93.53 127.18 39.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.155 0.977 . . . . 0.0 111.641 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -95.46 153.76 17.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.431 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 110' ' ' CYS . 13.1 m-85 -140.35 146.62 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.625 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -94.69 178.73 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.886 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.05 124.13 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.631 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.47 -3.72 84.03 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.243 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.74 151.62 28.97 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.13 0.465 . . . . 0.0 111.016 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.3 p -127.15 144.77 50.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.091 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -137.52 50.06 1.97 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.67 113.63 0.68 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.146 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -144.65 154.17 55.64 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -39.06 149.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.246 2.63 . . . . 0.0 113.619 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.451 ' CD2' ' HA2' ' A' ' 130' ' ' GLY . 1.2 t60 -67.22 135.11 52.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 112.104 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -73.42 -32.71 64.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.429 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 63.5 p -120.0 18.99 12.41 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.637 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.451 ' HA2' ' CD2' ' A' ' 127' ' ' HIS . . . -139.83 176.1 21.41 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.571 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.55 31.98 6.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.312 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.65 170.32 16.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 110.544 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.1 mtt -78.24 115.1 17.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.515 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.423 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 21.0 tp -91.87 144.54 25.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.747 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 40.6 mt-10 -122.32 115.66 22.7 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 99.1 m -110.33 157.71 19.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.03 177.15 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.76 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.6 t -130.49 117.13 19.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.132 0.423 . . . . 0.0 111.583 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.4 mt -112.56 113.58 25.8 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.101 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.63 87.42 0.42 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.868 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.47 -49.24 4.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.612 0.244 . . . . 0.0 110.754 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -165.43 36.1 0.26 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.705 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -171.31 -43.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.612 0.206 . . . . 0.0 111.317 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.08 67.1 0.81 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.597 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.61 152.89 21.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.664 0.268 . . . . 0.0 110.717 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 166.13 14.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.69 134.99 22.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.965 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.2 m -130.33 149.85 51.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.035 0.445 . . . . 0.0 111.387 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.27 96.47 12.54 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.598 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 56.7 Cg_endo -76.48 162.95 32.76 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.267 1.978 . . . . 0.0 113.522 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.986 179.197 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.904 0.383 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.59 159.79 19.13 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 p -131.16 154.98 47.79 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.208 0.528 . . . . 0.0 111.26 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' TYR . 61.3 m -119.04 136.33 54.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -120.56 128.32 52.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.215 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -111.87 103.95 12.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.979 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -58.97 -15.15 11.6 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.697 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.457 ' CD2' ' HD2' ' A' ' 83' ' ' ARG . 3.2 m-85 -67.45 -45.98 74.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.968 0.413 . . . . 0.0 110.346 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -50.5 5.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.056 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.93 10.18 28.78 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.44 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -118.18 153.48 33.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.117 0.458 . . . . 0.0 110.814 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.24 159.73 15.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.885 0.374 . . . . 0.0 110.259 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' CYS . 4.3 m-85 -135.06 127.95 31.36 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.662 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.0 148.65 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.447 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 17.8 t -47.86 142.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.351 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.72 20.99 79.3 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.208 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.39 127.19 56.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.491 HG23 ' CG2' ' A' ' 93' ' ' THR . 15.3 p -105.67 149.34 26.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.782 0.325 . . . . 0.0 110.644 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 30.3 p90 -152.17 -179.11 7.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 3.6 mt-10 -112.84 132.73 55.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.749 0.309 . . . . 0.0 110.373 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HD2' ' CD2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -137.9 128.7 15.73 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 88' ' ' MET . 59.9 Cg_endo -74.86 119.0 5.49 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.617 1.545 . . . . 0.0 111.898 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -118.0 115.56 25.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.045 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 44.67 69.84 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 m 54.57 37.82 28.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.632 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -145.9 160.52 41.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.398 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -110.69 116.33 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.0 m95 -105.48 159.82 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.89 103.72 11.7 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 8.7 t -108.94 141.64 40.72 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.491 ' CG2' HG23 ' A' ' 80' ' ' THR . 0.7 OUTLIER -117.76 153.48 33.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.303 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 15.0 t -103.56 117.04 33.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.218 0.533 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.46 -46.8 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.417 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.67 -94.13 0.19 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.549 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 61.56 21.83 12.41 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.58 -71.41 0.07 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.2 mmm-85 -114.82 -88.04 0.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.03 38.09 0.38 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 ptt-85 -68.7 141.92 55.17 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.857 0.361 . . . . 0.0 110.868 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -112.42 147.85 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.646 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -125.47 111.98 15.72 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.87 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.9 m -108.55 140.34 42.04 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.5 p -140.16 146.86 39.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.54 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.2 mt -55.55 153.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.304 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.6 26.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 111.792 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.96 70.89 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -150.19 177.09 10.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.208 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 14.7 p -124.44 130.5 52.58 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.491 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 6.0 p-80 -133.75 -145.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.156 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 1.3 tp10 89.23 163.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.542 0.337 . . . . 0.0 111.124 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.28 13.4 80.74 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.349 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.91 -16.11 58.79 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.159 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -133.48 170.52 15.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.07 0.435 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 4.9 p -119.05 127.44 53.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.969 0.414 . . . . 0.0 111.068 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -109.15 157.77 18.44 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.633 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 35.5 mttt -103.36 157.14 17.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.54 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm -48.81 124.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.9 67.29 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.688 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -77.31 159.96 29.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.377 0.588 . . . . 0.0 111.709 -179.325 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p -123.42 147.77 46.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.888 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -143.8 40.11 1.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.111 0.481 . . . . 0.0 109.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.59 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -55.77 108.06 0.41 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.191 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' PRO . 19.8 mtt180 -138.53 174.08 4.6 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.156 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.555 ' O ' ' O ' ' A' ' 125' ' ' ARG . 31.6 Cg_exo -41.36 -175.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.825 2.35 . . . . 0.0 113.667 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.625 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 2.6 t60 -104.07 124.74 49.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 112.028 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.02 -37.74 64.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.115 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.498 ' HB ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -80.06 -23.07 41.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.697 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -132.5 -153.03 7.18 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.81 31.2 3.41 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.574 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.625 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 20.0 p90 -127.26 140.47 52.2 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 120.491 0.186 . . . . 0.0 111.367 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 19.9 ttt -47.83 139.39 7.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.253 0.549 . . . . 0.0 112.0 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 125' ' ' ARG . 27.2 tp -133.58 143.72 48.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.567 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.59 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 27.5 mt-10 -127.47 116.87 21.09 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.7 OUTLIER -122.24 157.63 31.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.084 0.469 . . . . 0.0 112.11 -178.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.31 170.1 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.904 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 t -118.55 118.37 31.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.683 0.278 . . . . 0.0 111.288 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 40.3 mt -112.47 134.66 53.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.499 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.15 -114.01 0.99 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.65 -70.37 0.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.672 0.389 . . . . 0.0 111.702 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.29 -91.37 0.83 Allowed Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.567 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -129.63 -42.71 1.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 176.14 73.6 0.05 OUTLIER Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -92.14 161.63 14.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.737 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.07 162.23 36.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.53 125.76 14.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.503 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.12 149.71 50.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.499 0.666 . . . . 0.0 112.279 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -124.69 102.62 32.12 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.502 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 6.1 Cg_exo -71.27 167.94 24.8 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.019 1.812 . . . . 0.0 114.992 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.075 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.712 0.291 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -119.43 161.7 20.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.179 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 p -132.19 150.01 52.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.8 m -118.64 139.28 51.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.55 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -120.25 126.7 51.25 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 100.83 10.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -52.56 -21.75 4.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -67.69 -46.41 72.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' OH ' ' A' ' 75' ' ' TYR . 7.1 p -86.16 -52.4 5.69 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.67 8.82 31.86 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.439 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.31 145.43 44.0 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.957 0.379 . . . . 0.0 110.393 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 159.43 20.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.977 0.418 . . . . 0.0 110.648 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.473 ' OH ' ' OG1' ' A' ' 71' ' ' THR . 3.1 m-85 -134.49 128.59 33.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.3 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.13 153.05 34.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 t -47.78 140.18 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.896 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.02 21.07 79.58 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.428 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.89 126.26 55.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.482 HG23 ' CG2' ' A' ' 93' ' ' THR . 20.4 p -105.37 132.93 50.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.889 0.376 . . . . 0.0 111.42 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 36.3 p90 -126.2 -176.23 3.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.673 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 138.56 54.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.859 0.362 . . . . 0.0 111.045 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.576 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -137.16 132.22 17.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.9 Cg_endo -79.74 59.85 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.696 1.597 . . . . 0.0 112.822 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -56.73 130.69 46.58 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.899 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 t70 35.21 63.86 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.3 m 53.9 36.04 23.27 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 18.1 mtm -143.16 149.16 37.67 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.65 109.32 21.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.424 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 18.6 m95 -100.01 151.93 20.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.414 -177.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.35 110.82 22.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 33.4 m -108.88 162.33 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.482 ' CG2' HG23 ' A' ' 80' ' ' THR . 1.0 OUTLIER -141.54 154.01 45.22 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.198 -179.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 21.4 t -103.49 113.37 26.82 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.62 -36.47 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.483 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.4 72.64 0.82 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.582 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.05 -55.35 3.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.687 0.279 . . . . 0.0 111.409 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.82 -61.09 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.536 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 24.61 12.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.878 0.37 . . . . 0.0 111.198 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.17 90.1 0.94 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.56 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -91.36 129.48 37.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.595 0.236 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.24 124.5 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.5 t -128.58 111.52 13.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.985 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.2 m -111.72 137.22 49.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.9 p -139.28 136.24 34.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.069 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -50.95 146.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.04 154.22 26.98 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.453 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.422 ' O ' HG12 ' A' ' 119' ' ' ILE . 4.2 p30 -85.87 63.89 8.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.099 0.476 . . . . 0.0 110.57 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -149.8 167.63 26.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.642 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 117' ' ' TYR . 2.7 p -118.95 125.61 49.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.61 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.0 145.32 47.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.746 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.61 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 5.9 pt-20 170.32 157.72 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.206 0.316 . . . . 0.0 111.197 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -77.61 1.98 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.996 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.79 -38.39 0.07 OUTLIER Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.52 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -123.55 172.17 8.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.294 0.547 . . . . 0.0 111.232 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 p -101.9 126.59 48.84 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' CYS . 2.5 m-85 -108.39 157.1 18.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.515 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -98.68 155.38 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 108' ' ' ASN . 22.3 mm -54.78 131.64 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.45 -10.32 73.77 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.567 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 150.54 30.0 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 117.489 0.645 . . . . 0.0 110.439 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.7 p -142.54 141.39 32.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.439 ' HH2' ' CD1' ' A' ' 146' ' ' TRP . 11.2 p90 -140.31 110.63 6.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -123.72 107.57 11.59 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.114 0.483 . . . . 0.0 111.703 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -148.04 159.23 40.57 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.678 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 26.5 Cg_exo -39.77 144.75 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.862 2.375 . . . . 0.0 113.027 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -65.75 137.57 57.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.487 0.661 . . . . 0.0 112.559 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.82 -41.76 59.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.684 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 78.0 p -108.34 17.68 21.89 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.84 -95.33 1.14 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.385 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.53 -22.63 0.42 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.08 171.73 9.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.641 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.1 ptm -69.78 151.28 45.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.514 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 25.1 tp -136.34 129.25 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.7 mt-10 -118.96 119.78 35.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.001 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 147' ' ' THR . 94.3 m -116.12 158.22 23.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 111.912 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.525 HG21 ' CG2' ' A' ' 147' ' ' THR . 0.0 OUTLIER -141.17 165.52 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.85 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 133.34 54.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.861 0.362 . . . . 0.0 111.222 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.09 156.55 19.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.228 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -153.38 39.43 0.71 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.975 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -51.44 5.37 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.658 0.266 . . . . 0.0 110.708 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -117.09 -46.75 0.5 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.389 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -153.81 148.69 26.59 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.526 0.203 . . . . 0.0 110.576 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.94 105.69 1.0 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.464 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.4 173.81 7.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.445 ' HD1' ' HA ' ' A' ' 146' ' ' TRP . 1.0 OUTLIER -117.43 146.25 43.59 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.117 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.525 ' CG2' HG21 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -146.0 122.79 11.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -148.07 151.28 35.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.111 177.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -145.35 90.16 6.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.395 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.514 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 56.3 Cg_endo -73.08 158.17 49.73 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.329 2.019 . . . . 0.0 113.069 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.959 179.259 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.646 0.26 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -84.58 141.1 30.93 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.35 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 4.9 p -129.31 140.74 51.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 150.88 39.01 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.992 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 91.4 t80 -121.01 129.15 53.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -110.24 97.0 6.58 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 39.6 pttt -49.39 -19.0 0.45 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.544 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 2.9 m-85 -65.89 -45.52 81.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.832 0.349 . . . . 0.0 111.22 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -91.46 -52.61 4.7 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.67 9.81 28.04 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.321 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -117.26 138.29 51.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.932 0.366 . . . . 0.0 110.509 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.86 160.07 30.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.172 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.619 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 26.9 m-85 -130.34 128.92 42.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HG3' HG21 ' A' ' 65' ' ' THR . 1.5 mtt180 -85.77 147.56 26.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -46.92 144.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.356 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 27.93 71.82 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.325 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -113.31 127.24 56.08 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.474 HG23 ' CG2' ' A' ' 93' ' ' THR . 22.3 p -105.71 150.5 25.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.839 0.352 . . . . 0.0 111.554 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.4 ' CD1' ' CE1' ' A' ' 75' ' ' TYR . 24.7 p90 -157.4 -175.36 5.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.173 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.77 132.35 54.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.421 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 5.6 tmm_? -128.71 131.79 23.97 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 88' ' ' MET . 87.4 Cg_endo -84.29 64.52 6.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.813 . . . . 0.0 114.158 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.435 ' HG2' ' NE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -59.27 124.4 19.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.924 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 35.31 71.23 0.12 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.6 m 50.66 36.34 13.81 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.63 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.88 148.88 39.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.14 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mm -96.68 112.65 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.981 0.42 . . . . 0.0 109.88 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.543 ' CH2' HG12 ' A' ' 106' ' ' ILE . 19.6 m95 -101.92 148.41 25.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.186 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.92 107.99 19.31 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 70.1 m -108.03 156.29 19.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.474 ' CG2' HG23 ' A' ' 80' ' ' THR . 2.0 m -141.53 150.05 41.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.458 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -106.9 113.65 27.26 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.322 0.965 . . . . 0.0 110.649 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.3 -24.42 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.717 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 97' ' ' ALA . . . 83.04 -75.82 2.33 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.395 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' GLY . . . 17.42 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.26 -113.47 4.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.455 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.28 70.95 1.4 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.145 0.498 . . . . 0.0 111.29 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.81 77.28 1.0 Allowed Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.92 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -102.09 131.66 48.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.603 0.239 . . . . 0.0 110.959 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.24 122.31 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.136 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.14 116.05 17.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.918 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.9 m -123.16 143.89 49.71 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 p -139.9 139.67 36.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.695 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.543 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -62.46 154.77 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.508 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.62 152.67 18.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 111.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.75 68.13 10.27 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.635 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HA ' ' CD1' ' A' ' 119' ' ' ILE . 62.3 mtp180 -150.56 172.04 16.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.172 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.2 m -110.62 127.2 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.549 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -138.77 147.14 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 179.225 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 2.9 tm-20 171.35 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.728 0.299 . . . . 0.0 111.206 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 97.72 -83.69 0.71 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.636 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.56 2.19 0.38 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.434 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.69 -177.93 5.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.346 0.573 . . . . 0.0 111.103 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -119.52 127.71 53.27 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -108.41 159.44 16.66 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.666 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 3.9 tmtt? -103.07 158.08 16.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 109' ' ' ARG . 1.4 mp -49.12 128.13 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.675 0.274 . . . . 0.0 111.197 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.39 61.42 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.312 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -80.78 168.87 18.3 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.355 0.578 . . . . 0.0 111.397 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.4 p -138.85 152.99 48.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.04 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.443 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 43.3 p90 -141.26 84.39 1.92 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.219 0.533 . . . . 0.0 110.039 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 1.2 mpp_? -85.23 74.16 10.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -110.72 167.16 9.46 Favored Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.726 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 66.5 Cg_exo -44.08 175.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.862 2.375 . . . . 0.0 113.676 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -105.26 128.87 53.65 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.96 -40.24 60.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.983 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.3 p -98.7 15.12 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.27 -69.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.856 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 123.55 19.57 2.79 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -126.4 141.74 51.79 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.038 0.535 . . . . 0.0 109.622 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.2 ptt? -50.41 108.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.547 0.689 . . . . 0.0 111.391 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 150' ' ' PRO . 34.3 tp -91.92 143.87 26.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.336 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 36.1 mt-10 -126.15 116.0 20.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.15 157.33 38.39 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -126.95 174.61 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.862 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.94 118.88 12.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.814 0.34 . . . . 0.0 111.164 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.51 132.3 55.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.514 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -89.58 84.42 1.4 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.667 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 -48.45 6.93 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.556 0.217 . . . . 0.0 111.114 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -140.89 -65.99 0.03 OUTLIER Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.585 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -113.26 -39.13 4.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.427 0.156 . . . . 0.0 111.158 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.25 94.49 0.1 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.623 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -106.76 150.18 26.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.578 0.228 . . . . 0.0 110.645 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.97 165.24 21.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 111.341 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.601 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.6 OUTLIER -145.56 121.02 10.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.605 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -130.95 149.37 52.61 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.371 0.605 . . . . 0.0 111.799 179.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -123.78 90.28 50.76 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.63 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 134' ' ' LEU . 1.7 Cg_endo -80.69 161.63 21.69 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.66 2.24 . . . . 0.0 114.048 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.118 179.053 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.792 0.329 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 p -139.71 146.89 40.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.19 139.42 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.413 ' HB2' HG23 ' A' ' 74' ' ' THR . 93.2 t80 -114.69 132.27 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -109.27 112.67 24.95 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -64.03 -16.76 62.38 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 5.8 m-85 -70.59 -45.98 64.32 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -88.8 -48.32 7.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.797 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.33 3.82 47.36 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.791 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.5 m-80 -117.3 138.5 51.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.4 0.6 . . . . 0.0 110.926 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -79.02 159.84 27.43 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.907 0.384 . . . . 0.0 110.565 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 73' ' ' ASN . 1.1 m-85 -134.52 138.62 44.82 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.622 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -79.78 165.9 22.3 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.696 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -59.54 128.29 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.115 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.66 24.67 49.23 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.996 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -113.08 122.79 48.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.974 HG22 HG23 ' A' ' 93' ' ' THR . 19.1 p -105.3 149.12 26.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.909 0.385 . . . . 0.0 111.074 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 18.4 p90 -145.25 -172.63 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.732 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -115.64 129.83 56.64 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.572 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 4.6 tmm_? -130.13 124.95 21.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.097 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 88' ' ' MET . 84.9 Cg_endo -80.55 111.55 2.58 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.841 1.694 . . . . 0.0 112.239 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.546 ' HB3' ' NE1' ' A' ' 90' ' ' TRP . 11.3 tptt -116.88 118.94 33.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.821 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 46.55 73.23 0.19 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.5 m 47.38 41.84 13.16 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.915 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.7 ttp -153.04 164.54 37.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.199 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mm -112.2 122.54 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.546 ' NE1' ' HB3' ' A' ' 85' ' ' LYS . 25.3 m95 -107.97 140.22 41.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.36 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.05 110.19 21.66 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' THR . 75.1 m -109.44 152.81 24.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.974 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -130.73 150.65 51.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.266 179.095 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 122.18 45.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 110.903 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -98.78 131.28 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.453 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.59 -169.1 25.85 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.317 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 70.99 114.54 0.05 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.808 0.443 . . . . 0.0 111.811 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.93 -136.82 12.91 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.963 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.25 23.1 9.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.107 0.479 . . . . 0.0 111.158 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.541 ' O ' HD12 ' A' ' 102' ' ' ILE . . . 80.01 70.11 1.35 Allowed Glycine 0 CA--C 1.517 0.179 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.554 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.2 140.43 56.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.535 0.207 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.541 HD12 ' O ' ' A' ' 100' ' ' GLY . 3.0 mp -109.64 121.1 62.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.307 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.547 ' HB3' HD13 ' A' ' 95' ' ' ILE . 20.3 t -114.49 121.59 43.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.378 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.1 m -124.35 136.4 54.06 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 p -138.98 141.86 38.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.452 HG13 ' CH2' ' A' ' 90' ' ' TRP . 1.5 mt -51.96 155.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.284 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.08 144.1 28.61 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -80.49 75.77 7.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.75 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -150.17 173.53 13.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.23 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 117' ' ' TYR . 13.0 p -128.64 127.99 43.29 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.1 p-80 -135.1 -143.28 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 119.495 -0.288 . . . . 0.0 111.037 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.8 175.95 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.503 0.321 . . . . 0.0 111.078 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.43 -77.25 1.74 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.751 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.15 -39.26 0.04 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.936 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -133.71 167.21 20.93 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 32.4 p -84.88 150.83 24.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 111.247 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 110' ' ' CYS . 7.0 m-85 -133.21 139.1 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 1.9 mptm? -85.25 176.31 8.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.637 0.256 . . . . 0.0 111.161 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.1 mm -74.59 124.3 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.334 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.79 -3.14 86.3 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.92 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 169.7 17.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.924 0.393 . . . . 0.0 111.459 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.834 HG22 HG23 ' A' ' 137' ' ' VAL . 30.0 p -133.9 150.31 51.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -141.28 55.21 1.54 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.27 0.557 . . . . 0.0 109.716 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -55.66 98.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.706 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.8 mtt180 -132.36 166.99 24.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.751 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 32.8 Cg_exo -39.71 177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.193 2.595 . . . . 0.0 113.956 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.487 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.4 t60 -103.11 129.58 50.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.142 0.496 . . . . 0.0 112.336 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -64.97 -40.49 95.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.276 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 66.5 p -111.38 19.36 18.32 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.8 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -144.79 174.5 24.89 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.49 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.62 28.59 8.86 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.385 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.497 ' O ' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -133.16 158.3 43.19 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.488 0.185 . . . . 0.0 110.714 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 17.9 mtt -67.26 115.94 7.48 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.452 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.569 HD12 ' HB3' ' A' ' 150' ' ' PRO . 21.5 tp -92.19 144.68 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.869 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.5 pt-20 -125.44 116.16 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.7 157.47 32.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.834 HG23 HG22 ' A' ' 122' ' ' THR . 0.4 OUTLIER -126.34 168.47 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.233 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -131.56 124.25 29.64 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.829 0.347 . . . . 0.0 111.419 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.35 127.08 55.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.28 -103.05 0.09 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.979 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.71 22.35 11.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.421 0.288 . . . . 0.0 111.765 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.55 14.9 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.918 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -160.77 -54.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.659 0.23 . . . . 0.0 111.193 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.79 60.16 0.94 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.459 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.44 160.45 15.13 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 161.86 36.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.537 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.24 127.26 16.47 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.24 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.33 148.91 50.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.091 0.472 . . . . 0.0 111.403 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -137.92 91.4 13.4 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.918 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.569 ' HB3' HD12 ' A' ' 134' ' ' LEU . 36.5 Cg_endo -69.48 164.96 32.27 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.559 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.017 179.357 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 120.666 0.27 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 p -133.3 145.94 50.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.033 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.0 m -118.16 135.49 54.2 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.5 t80 -109.24 124.2 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 10.1 t70 -98.31 103.91 15.9 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 14.9 ptpt -56.57 -27.97 59.09 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 94.0 m-85 -67.93 -39.64 83.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.772 0.32 . . . . 0.0 111.144 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -88.18 -53.45 4.7 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.73 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.48 39.51 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.406 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.54 144.06 46.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.095 0.448 . . . . 0.0 110.686 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.52 160.25 21.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.713 0.292 . . . . 0.0 110.872 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -136.76 131.45 33.42 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.252 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -75.92 140.97 42.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.515 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.46 130.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.23 0.538 . . . . 0.0 111.982 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.45 14.6 56.87 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.97 125.77 54.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.99 HG22 HG23 ' A' ' 93' ' ' THR . 18.7 p -105.04 142.24 35.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.907 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -136.71 -173.91 3.56 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.766 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 5.2 mt-10 -119.98 126.84 51.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.202 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -124.27 123.15 25.97 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.1 Cg_endo -78.39 110.01 2.77 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.132 1.888 . . . . 0.0 112.076 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.73 116.57 27.76 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.861 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 48.32 77.51 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.8 m 44.5 43.85 6.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.3 ttp -155.65 166.03 34.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.7 130.84 68.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 22.3 m95 -114.46 143.07 45.53 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -98.56 109.38 22.14 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 80' ' ' THR . 81.7 m -108.99 159.91 16.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.128 0.49 . . . . 0.0 112.29 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.99 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -138.28 153.04 49.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.633 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 6.2 t -104.05 117.92 35.44 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.545 0.688 . . . . 0.0 110.806 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.7 mp -88.89 119.93 36.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.424 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.8 -115.97 1.86 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 58.51 33.84 23.43 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.773 0.32 . . . . 0.0 111.198 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.21 45.03 92.86 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.397 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 -67.54 0.59 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.34 56.01 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 121.192 -0.527 . . . . 0.0 112.142 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.7 143.29 9.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.754 0.422 . . . . 0.0 111.737 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.46 120.01 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.257 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.571 ' HB3' HD13 ' A' ' 95' ' ' ILE . 2.0 t -111.21 111.89 23.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.7 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.4 m -121.36 127.72 51.53 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.2 p -138.91 138.98 37.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.926 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -45.37 155.86 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.292 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.59 155.29 17.37 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.81 70.94 7.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.449 ' HA ' HD12 ' A' ' 119' ' ' ILE . 91.3 mtm-85 -150.08 168.14 24.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.9 p -117.16 125.4 51.15 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.787 0.327 . . . . 0.0 110.126 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.574 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -129.76 166.42 19.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.617 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.574 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 15.1 pt-20 167.3 138.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.266 0.354 . . . . 0.0 110.923 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -37.6 3.25 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.505 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.54 -94.77 0.1 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.44 177.93 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.29 0.236 . . . . 0.0 111.306 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.4 p -120.1 125.51 48.44 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 111.492 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -95.56 157.3 15.96 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.635 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -93.06 174.53 7.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.5 mp -74.08 124.5 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.3 -4.85 82.87 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.794 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.97 160.45 30.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.82 0.31 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.763 HG22 HG23 ' A' ' 137' ' ' VAL . 18.8 p -130.9 145.42 52.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.9 p90 -136.75 53.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.355 0.598 . . . . 0.0 109.619 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.33 102.85 0.06 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.745 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 126' ' ' PRO . 97.5 mtt180 -134.92 161.77 61.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.762 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 125' ' ' ARG . 37.4 Cg_exo -40.28 174.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.176 2.584 . . . . 0.0 113.879 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.5 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.1 t60 -100.15 128.17 46.27 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 111.877 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -72.57 -32.68 66.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.718 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.447 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 16.0 p -112.42 18.43 18.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.326 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -145.21 174.62 25.18 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.582 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.87 29.11 8.32 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.122 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -136.82 162.93 31.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.491 0.186 . . . . 0.0 110.705 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 18.3 ptt? -70.93 117.16 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.243 0.544 . . . . 0.0 110.774 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.563 HD12 ' HB3' ' A' ' 150' ' ' PRO . 23.3 tp -91.67 145.47 24.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.717 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 5.1 pt-20 -129.59 116.12 18.41 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -120.8 157.34 29.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.763 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.65 173.28 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.271 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.421 ' N ' HG13 ' A' ' 137' ' ' VAL . 18.3 t -128.36 117.81 22.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.759 0.314 . . . . 0.0 110.761 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.2 mt -111.66 113.86 26.52 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.464 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.97 70.45 0.94 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 -53.31 3.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.542 0.21 . . . . 0.0 111.07 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.48 -65.36 0.97 Allowed Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.516 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 pttt -144.5 -44.59 0.25 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.417 0.151 . . . . 0.0 111.316 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -178.21 83.56 0.07 OUTLIER Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.91 159.23 18.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.23 163.79 31.92 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.5 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -146.82 126.6 13.47 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.3 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 136' ' ' CYS . 0.0 OUTLIER -124.62 149.31 47.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 110.932 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -136.36 88.74 20.24 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.837 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.563 ' HB3' HD12 ' A' ' 134' ' ' LEU . 29.2 Cg_endo -67.44 168.96 16.6 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 113.645 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.052 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -138.17 148.93 45.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.7 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.93 135.39 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 89.5 t80 -110.19 126.39 54.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 11.1 t70 -102.21 96.87 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.775 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 47.9 pttt -47.69 -29.38 2.99 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 84.8 m-85 -67.46 -39.87 85.32 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.6 p -87.19 -51.09 6.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 8.75 37.8 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.832 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -119.56 153.33 35.58 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.793 0.296 . . . . 0.0 110.786 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 159.81 14.71 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.08 139.71 39.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.806 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -78.76 165.08 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 95' ' ' ILE . 57.8 t -53.53 137.12 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 0.0 111.621 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.21 32.27 63.0 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.101 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.34 120.89 42.69 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.996 HG22 HG23 ' A' ' 93' ' ' THR . 22.0 p -105.26 150.19 25.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 0.0 110.906 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -153.3 179.14 9.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.96 126.83 53.51 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -126.07 126.03 24.76 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.911 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.5 Cg_endo -78.43 116.93 3.94 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.982 1.788 . . . . 0.0 111.347 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -119.02 123.65 45.04 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.262 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 42.51 74.31 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 t 46.63 42.21 11.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 29.7 ttp -154.59 164.76 38.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mm -110.32 136.58 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 20.7 m95 -121.9 159.92 25.86 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.04 108.24 18.39 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 88.6 m -108.35 162.93 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.996 HG23 HG22 ' A' ' 80' ' ' THR . 0.3 OUTLIER -141.57 151.68 43.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.11 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.15 114.41 28.59 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 77' ' ' VAL . 16.3 mm -74.47 -61.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.125 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.0 129.06 0.05 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.42 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -170.85 55.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.461 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.36 61.45 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.258 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -175.93 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.458 0.303 . . . . 0.0 111.807 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.72 80.83 0.96 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.419 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -90.0 131.99 35.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.634 0.255 . . . . 0.0 111.077 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.61 126.82 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.295 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -127.18 111.22 13.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.9 m -116.53 139.05 50.91 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.6 p -139.84 138.92 36.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.959 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.5 mt -48.7 148.05 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.11 148.37 34.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -93.28 59.25 2.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.19 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -149.15 177.38 9.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.686 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 85.8 m -110.11 128.19 55.31 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.507 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -138.94 145.36 39.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.507 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 10.6 pt-20 170.9 166.82 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.304 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.35 -93.52 1.64 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.596 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.86 0.59 1.2 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.05 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.18 -178.32 5.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.8 t -119.04 127.21 53.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.555 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.1 m-85 -104.37 159.74 15.48 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.158 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 5.2 mmtp -105.82 164.13 12.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.4 124.53 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.514 0.197 . . . . 0.0 111.409 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.3 63.0 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.355 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -71.95 159.68 33.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.388 0.594 . . . . 0.0 111.473 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.572 HG22 HG12 ' A' ' 137' ' ' VAL . 2.5 p -130.96 152.25 50.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.13 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -144.38 98.34 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 109.977 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -92.37 87.13 5.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.426 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 126' ' ' PRO . 1.0 OUTLIER -120.74 167.41 13.01 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.698 179.216 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 45.3 Cg_exo -43.15 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.0 2.467 . . . . 0.0 113.633 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.49 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.4 t60 -100.95 129.81 46.86 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 112.194 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.25 -40.33 93.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 74.0 p -112.49 20.04 17.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.777 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.461 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -144.14 173.71 24.76 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.557 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.78 30.89 7.44 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.348 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -136.15 164.52 27.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.427 0.156 . . . . 0.0 110.712 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 12.3 mtt -72.9 116.16 13.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.082 0.467 . . . . 0.0 110.472 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 150' ' ' PRO . 21.2 tp -92.23 144.56 25.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.573 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 37.4 mt-10 -120.93 115.69 23.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 92.1 m -112.73 158.2 20.36 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.98 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -135.33 169.36 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.864 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 t -138.33 123.65 19.37 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.872 0.367 . . . . 0.0 111.301 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.22 143.83 42.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.453 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.93 77.65 1.86 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.722 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 122.98 12.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.612 0.244 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.8 -90.93 1.47 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.731 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 43.36 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.04 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.696 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.78 127.59 35.99 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.708 0.29 . . . . 0.0 110.572 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -109.53 167.64 9.99 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.98 HG22 HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -149.79 145.98 26.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -141.76 149.94 41.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.427 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -135.23 90.59 20.66 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.615 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.526 ' HB3' HD12 ' A' ' 134' ' ' LEU . 38.4 Cg_endo -70.96 161.42 46.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.484 2.123 . . . . 0.0 113.63 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.011 179.183 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.686 0.279 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 5.0 p -125.53 142.3 51.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 147.03 43.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.963 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.2 t80 -121.75 121.13 36.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.731 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 21.9 t70 -104.94 96.38 6.5 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 51.7 pttt -48.97 -17.98 0.25 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.495 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 4.6 m-30 -65.49 -46.19 80.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.662 0.268 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.5 p -86.7 -50.03 7.06 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.26 6.73 33.54 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.207 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.95 150.23 39.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.981 0.391 . . . . 0.0 111.147 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.39 160.26 17.66 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' A' ' 68' ' ' ASP . 2.6 m-85 -134.96 131.01 36.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.563 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HG3' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -79.87 179.53 7.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.79 139.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.471 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.48 40.5 96.25 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.708 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.26 124.37 52.34 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.921 HG22 HG23 ' A' ' 93' ' ' THR . 28.7 p -105.62 149.72 26.07 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.892 0.377 . . . . 0.0 111.383 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -161.1 -178.58 6.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -118.39 132.18 56.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 111.023 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.495 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -124.24 124.23 25.87 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 88' ' ' MET . 81.1 Cg_endo -80.09 63.96 8.81 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 121.964 1.776 . . . . 0.0 112.48 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.52 128.47 36.45 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.864 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.5 t70 37.3 69.1 0.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.895 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m 46.08 47.62 12.85 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.415 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 42.5 ttp -160.51 135.81 7.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.37 132.64 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 111.522 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CH2' HG12 ' A' ' 106' ' ' ILE . 16.1 m95 -119.84 152.27 37.57 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -108.33 100.31 9.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.4 t -108.6 138.76 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.921 HG23 HG22 ' A' ' 80' ' ' THR . 1.7 m -116.54 148.18 41.09 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.67 117.7 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.731 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.1 mp -92.16 142.3 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.611 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.35 -129.62 1.04 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.521 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 62.42 110.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 111.536 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.63 -112.72 4.54 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -139.43 47.09 1.89 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.08 98.08 0.94 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.635 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -105.78 135.51 47.08 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.586 0.231 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.99 121.52 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.2 111.93 12.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.98 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 3.3 m -126.37 148.34 49.61 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 p -141.12 148.91 40.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.165 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.436 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -60.61 146.98 10.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.544 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.63 159.24 31.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.75 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.9 57.48 4.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.171 0.51 . . . . 0.0 110.596 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -144.4 171.6 14.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.9 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 2.3 p -123.23 128.47 50.05 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -134.43 154.4 51.41 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.229 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 7.3 tp10 167.35 140.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.867 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.73 -8.71 54.82 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.417 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.0 -17.79 7.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.089 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -126.04 165.44 18.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.844 0.322 . . . . 0.0 110.34 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.51 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.4 t -108.87 125.72 52.29 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.4 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.02 158.86 16.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.215 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 25.8 mtmt -99.37 161.74 13.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.454 HG23 ' HA3' ' A' ' 140' ' ' GLY . 38.0 mm -55.19 124.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.509 0.195 . . . . 0.0 111.349 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.13 -12.2 70.34 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.767 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -60.23 167.28 2.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.575 0.688 . . . . 0.0 111.777 -178.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.416 HG22 ' CG2' ' A' ' 137' ' ' VAL . 57.1 p -142.67 144.72 32.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.254 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.433 ' CG ' ' O ' ' A' ' 123' ' ' TRP . 17.5 p90 -149.74 96.61 2.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.042 0.449 . . . . 0.0 109.97 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -91.73 76.38 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 111.008 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 126' ' ' PRO . 89.1 mtt180 -108.15 163.45 16.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.094 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 125' ' ' ARG . 52.4 Cg_exo -41.08 179.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.301 2.667 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.649 ' CD2' HD22 ' A' ' 134' ' ' LEU . 15.7 t-160 -100.6 127.41 46.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.674 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.43 -34.21 72.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.742 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.415 ' H ' ' CD2' ' A' ' 127' ' ' HIS . 22.6 p -111.96 19.0 18.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.361 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.92 171.18 28.48 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.478 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -108.79 28.48 11.28 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.689 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -134.35 162.2 32.87 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.726 0.263 . . . . 0.0 110.906 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 13.1 mtt -68.59 120.74 15.09 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.317 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.649 HD22 ' CD2' ' A' ' 127' ' ' HIS . 22.3 tp -100.93 144.12 30.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 4.4 pt-20 -120.62 115.81 24.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.67 158.32 21.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 147' ' ' THR . 0.4 OUTLIER -131.81 160.32 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.372 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 121.76 37.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.709 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.0 mt -113.82 156.24 24.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.634 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.454 ' HA3' HG23 ' A' ' 119' ' ' ILE . . . -152.58 -132.77 1.83 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.034 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.58 33.33 18.35 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.915 0.388 . . . . 0.0 111.089 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.54 -52.2 0.1 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.685 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -147.67 -66.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.648 0.224 . . . . 0.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.34 79.32 0.07 OUTLIER Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.483 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -112.09 135.77 52.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 111.252 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -109.84 166.79 10.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -152.18 137.31 17.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.515 -179.116 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.95 149.95 49.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.165 0.507 . . . . 0.0 111.522 179.036 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.05 92.08 11.07 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.193 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HB3' HD12 ' A' ' 134' ' ' LEU . 38.2 Cg_endo -71.58 162.2 42.94 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.332 2.021 . . . . 0.0 113.836 -178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.012 179.246 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.751 0.31 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.1 p -128.34 155.43 44.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.186 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 75' ' ' TYR . 60.1 m -119.02 135.49 54.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.817 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.8 t80 -121.19 123.11 41.46 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -105.66 95.15 5.61 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.165 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 44.1 pttt -49.01 -21.56 0.71 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -66.3 -44.62 82.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.554 0.216 . . . . 0.0 110.7 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.497 ' HG1' ' HH ' ' A' ' 75' ' ' TYR . 17.1 p -86.8 -49.97 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.0 12.05 30.67 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.083 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -118.92 157.43 27.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.807 0.303 . . . . 0.0 110.64 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.95 159.64 14.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.497 ' HH ' ' HG1' ' A' ' 71' ' ' THR . 3.9 m-85 -135.84 127.8 29.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.98 153.28 32.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 77' ' ' VAL . 5.7 t -47.85 143.37 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.558 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 21.94 78.32 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -113.06 130.16 56.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.93 HG22 HG23 ' A' ' 93' ' ' THR . 21.1 p -105.69 150.27 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.369 . . . . 0.0 111.494 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -149.7 173.96 13.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.081 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.69 131.09 54.37 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.587 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -126.85 135.86 27.95 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.587 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 85.8 Cg_endo -81.53 62.44 8.32 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.945 1.763 . . . . 0.0 112.956 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 122.28 12.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.524 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 40.71 74.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.867 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 94.9 p 41.5 47.9 3.32 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 44.6 ttp -163.15 133.5 4.5 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.7 mm -74.07 137.31 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 111.07 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.434 ' CH2' HG12 ' A' ' 106' ' ' ILE . 17.9 m95 -122.63 164.73 17.68 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.978 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 80' ' ' THR . 48.9 m -108.61 161.19 15.31 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.93 HG23 HG22 ' A' ' 80' ' ' THR . 0.9 OUTLIER -142.2 153.98 44.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.223 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.3 t -103.33 113.23 26.56 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.94 -31.59 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.133 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.14 177.8 44.68 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.615 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.76 150.21 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.926 0.393 . . . . 0.0 111.678 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.38 39.97 41.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.679 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.02 37.1 21.41 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.708 0.29 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.86 71.46 1.13 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.605 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -80.21 149.1 30.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.818 0.309 . . . . 0.0 110.762 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.83 130.27 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.792 0.329 . . . . 0.0 111.337 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.61 111.46 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 88.3 m -117.4 145.17 44.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 p -140.05 137.97 35.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.031 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.434 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -53.08 143.84 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.04 168.07 10.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.807 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.538 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -93.33 43.79 1.13 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -134.29 159.34 41.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.943 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.6 p -112.14 126.34 55.09 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.452 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.568 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -128.93 164.16 23.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.566 -178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 41.2 tt0 165.41 126.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.441 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.39 -99.0 0.87 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.727 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.5 -17.7 1.36 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -131.9 179.03 6.32 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.223 0.512 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 27.5 t -112.94 125.43 54.38 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.981 0.419 . . . . 0.0 111.156 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -102.12 159.42 15.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -105.23 161.08 14.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 108' ' ' ASN . 1.5 mp -59.17 124.7 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.651 0.262 . . . . 0.0 110.962 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.64 -22.24 41.36 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.223 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 152.15 44.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.973 0.416 . . . . 0.0 111.649 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.715 HG22 HG23 ' A' ' 137' ' ' VAL . 44.0 p -116.34 152.76 33.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.41 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.415 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 18.5 p90 -147.11 81.12 1.54 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.21 0.529 . . . . 0.0 109.866 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -84.7 76.01 10.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.214 -178.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 126' ' ' PRO . 14.6 mtt85 -110.66 171.05 4.66 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.689 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 42.5 Cg_exo -43.0 179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.93 2.42 . . . . 0.0 113.473 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.484 ' HD1' HD22 ' A' ' 134' ' ' LEU . 3.7 t60 -103.8 136.37 43.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.43 0.634 . . . . 0.0 112.707 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.43 -40.09 62.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.373 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 61.1 p -109.09 18.25 20.79 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.84 -79.98 0.07 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.486 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 137.58 29.87 0.27 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 150' ' ' PRO . 2.8 p90 -135.52 151.45 50.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 122.878 0.471 . . . . 0.0 109.765 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.8 ttt -57.72 107.2 0.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.484 HD22 ' HD1' ' A' ' 127' ' ' HIS . 15.0 tp -91.73 144.84 25.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.974 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 30.5 mt-10 -124.56 115.88 21.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.9 OUTLIER -125.72 157.5 37.22 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.715 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -128.35 171.65 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.254 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.1 t -139.58 124.02 18.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.709 0.29 . . . . 0.0 110.903 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.07 133.16 54.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.29 76.59 1.91 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.726 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -42.47 11.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.53 0.205 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.58 -54.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.679 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -106.21 -55.48 2.32 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.41 54.51 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.12 154.03 32.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.771 0.319 . . . . 0.0 111.328 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -142.27 161.71 37.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.611 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.57 127.73 16.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.88 149.73 50.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 0.0 111.749 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -124.78 81.16 61.67 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.61 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HB2' ' CE1' ' A' ' 132' ' ' TYR . 12.9 Cg_endo -67.08 168.01 18.52 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.754 2.303 . . . . 0.0 114.479 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.977 178.696 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.67 0.271 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 p -129.43 145.69 51.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.039 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.3 m -118.49 134.48 55.04 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 83.8 t80 -110.0 124.57 51.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 12.8 t70 -97.8 97.58 9.11 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 10.8 ptmt -51.47 -28.74 14.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.524 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 82.5 m-85 -66.98 -45.8 76.55 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.67 0.271 . . . . 0.0 111.315 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.1 p -82.06 -51.05 8.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.323 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.16 5.69 43.25 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.29 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -116.86 143.7 45.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.07 0.435 . . . . 0.0 110.436 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.89 159.76 20.28 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.876 0.37 . . . . 0.0 110.907 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.4 ' HE2' ' CB ' ' A' ' 68' ' ' ASP . 9.5 m-85 -136.27 130.3 32.8 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -75.08 153.01 38.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 21.8 t -50.27 144.06 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.188 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.67 79.17 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.269 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.81 125.87 54.82 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.923 HG22 HG23 ' A' ' 93' ' ' THR . 21.4 p -104.98 129.36 53.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.905 0.384 . . . . 0.0 111.134 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 39.9 p90 -122.49 -173.65 2.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.782 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.3 mp0 -127.69 138.55 52.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.838 0.351 . . . . 0.0 110.935 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.576 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -141.04 130.44 12.85 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 88' ' ' MET . 61.3 Cg_endo -77.17 64.99 7.91 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.762 1.641 . . . . 0.0 112.851 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.91 130.37 45.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.349 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 55.65 -77.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.855 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 85' ' ' LYS . 78.4 p -158.26 30.94 0.24 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.064 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -146.89 159.13 43.91 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.7 mm -89.7 112.29 24.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.467 ' CZ2' HG12 ' A' ' 106' ' ' ILE . 28.5 m95 -98.5 144.96 27.27 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.0 111.929 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.18 106.79 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 m -107.28 165.02 11.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.469 . . . . 0.0 112.034 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.923 HG23 HG22 ' A' ' 80' ' ' THR . 0.3 OUTLIER -136.52 154.68 50.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.629 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 3.7 t -102.47 114.17 28.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.475 0.655 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 95' ' ' ILE . 2.0 mp -105.74 74.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.834 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.63 139.07 15.67 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.227 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.65 45.56 0.3 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.897 0.379 . . . . 0.0 110.571 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.75 8.52 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.298 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.14 -37.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.26 85.33 0.99 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.166 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt85 -104.69 135.27 46.4 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.735 0.303 . . . . 0.0 111.283 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.75 129.98 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.35 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.419 ' HB3' HD13 ' A' ' 95' ' ' ILE . 30.2 t -124.45 110.48 14.56 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.269 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 69.3 m -111.22 131.15 55.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.365 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.3 p -137.73 132.96 33.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.467 HG12 ' CZ2' ' A' ' 90' ' ' TRP . 2.7 mt -51.23 142.07 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.927 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.27 19.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 111.489 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -86.54 64.74 8.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -147.0 174.26 11.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.308 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 117' ' ' TYR . 24.2 p -129.89 129.98 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 3.5 p-80 -134.94 -140.7 0.17 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.601 -0.237 . . . . 0.0 110.751 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.2 163.94 0.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.86 0.362 . . . . 0.0 111.455 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.94 -83.47 1.59 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.787 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.52 -35.33 0.1 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.26 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -131.27 -178.81 5.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.896 0.348 . . . . 0.0 110.754 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.426 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 4.1 p -107.7 126.67 52.88 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 110.725 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 110' ' ' CYS . 3.0 m-85 -106.65 157.81 17.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.541 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -104.16 158.34 16.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.1 mm -50.14 124.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.75 -9.5 75.52 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.733 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.11 154.57 39.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.402 0.601 . . . . 0.0 111.54 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 HG23 ' A' ' 137' ' ' VAL . 30.9 p -122.87 149.45 44.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.743 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.443 ' CG ' ' O ' ' A' ' 123' ' ' TRP . 12.4 p90 -147.69 82.41 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.298 0.57 . . . . 0.0 109.905 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -79.3 75.03 5.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.038 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.3 mtt180 -108.76 166.6 10.54 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 63.1 Cg_exo -41.93 178.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.087 2.525 . . . . 0.0 114.077 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.687 ' CD2' HD22 ' A' ' 134' ' ' LEU . 17.4 t-160 -103.54 124.42 48.75 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 111.58 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.43 -24.85 60.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.564 ' H ' ' CD2' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -110.08 14.43 22.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.128 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.71 -179.21 30.63 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.755 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -115.24 28.29 8.02 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.428 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.501 ' O ' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.01 155.44 49.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.546 0.212 . . . . 0.0 111.177 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.518 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 11.9 mtt -63.45 114.5 3.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.098 0.475 . . . . 0.0 110.595 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.687 HD22 ' CD2' ' A' ' 127' ' ' HIS . 23.9 tp -92.46 146.9 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.739 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 26.6 mt-10 -123.04 116.23 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -123.87 157.62 33.77 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.299 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.58 HG12 HG22 ' A' ' 147' ' ' THR . 0.3 OUTLIER -126.79 171.75 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.662 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 52.7 t -132.67 125.01 29.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.94 154.93 24.53 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.081 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -146.57 55.25 0.53 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.089 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.97 -51.55 7.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.723 0.297 . . . . 0.0 110.353 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.17 -44.97 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -140.53 157.42 45.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.391 0.276 . . . . 0.0 110.31 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.28 93.43 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -114.93 162.46 16.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.16 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -142.79 164.45 30.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.283 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.58 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -147.62 124.81 11.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.879 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -125.52 149.99 47.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.585 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -141.19 99.11 6.59 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.528 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.575 ' HB3' HD12 ' A' ' 134' ' ' LEU . 53.4 Cg_endo -77.01 170.3 20.02 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.419 2.079 . . . . 0.0 113.56 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.055 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.919 179.32 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.69 0.281 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.7 p -124.16 150.13 45.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.573 ' HB3' HD13 ' A' ' 102' ' ' ILE . 85.6 m -118.54 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.371 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -113.62 124.45 52.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.757 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -103.54 99.37 9.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.43 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -57.29 -16.14 7.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.065 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.582 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 5.4 m-30 -66.96 -46.08 75.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.169 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 83' ' ' ARG . 7.3 p -91.42 -54.87 3.73 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.782 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.94 11.4 12.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.363 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.63 155.5 32.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.165 0.483 . . . . 0.0 110.792 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.16 159.8 15.13 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.716 0.293 . . . . 0.0 110.253 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.457 ' HH ' ' HG1' ' A' ' 71' ' ' THR . 4.6 m-85 -138.8 129.03 25.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -73.89 154.19 39.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.485 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 5.0 t -52.23 136.5 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.915 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.86 21.47 71.34 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.0 123.49 50.45 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.957 HG22 HG23 ' A' ' 93' ' ' THR . 16.9 p -105.59 149.17 26.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.391 . . . . 0.0 111.351 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 26.4 p90 -145.83 -175.32 4.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.071 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.2 mp0 -121.05 131.68 54.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.592 ' HG2' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -129.77 132.33 24.11 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.456 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 88' ' ' MET . 56.4 Cg_endo -80.48 114.38 3.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.567 1.511 . . . . 0.0 110.859 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -116.14 113.5 23.19 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.845 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 49.42 77.29 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t 46.06 43.83 11.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 8.9 ttp -157.59 169.5 24.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.461 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -116.82 131.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 19.0 m95 -117.72 157.84 25.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.19 111.72 23.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -108.34 156.93 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.957 HG23 HG22 ' A' ' 80' ' ' THR . 0.9 OUTLIER -141.1 154.1 45.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.412 0.685 . . . . 0.0 110.648 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -102.87 113.06 26.19 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.435 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -80.74 -31.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.189 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.61 83.04 0.39 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.835 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.54 119.88 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.9 2.07 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.676 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.12 44.92 1.23 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.046 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.07 84.38 0.54 Allowed Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.5 121.96 17.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 66' ' ' CYS . 9.8 mm -103.0 121.97 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.476 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.435 ' HB3' HD13 ' A' ' 95' ' ' ILE . 6.5 t -127.83 110.53 12.69 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.395 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.4 m -107.83 133.73 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 111.29 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.3 p -138.56 133.15 32.19 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.706 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -43.57 155.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.17 148.59 22.26 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.7 60.01 5.37 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.068 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -150.06 176.98 10.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 9.5 p -120.15 127.29 52.36 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.558 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.5 OUTLIER -136.69 142.71 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.335 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 12.9 pt-20 171.88 159.54 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.59 -79.23 1.43 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.61 -8.84 0.11 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.798 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -142.89 -178.53 5.86 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 117.624 0.712 . . . . 0.0 110.51 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p -114.43 125.84 54.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.797 0.332 . . . . 0.0 110.661 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.06 157.31 17.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.425 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -106.2 156.43 18.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.9 mm -45.85 124.65 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.46 -6.13 71.04 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.633 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 156.86 33.89 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.483 0.641 . . . . 0.0 111.391 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.637 HG22 HG23 ' A' ' 137' ' ' VAL . 21.5 p -124.14 146.31 48.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -137.84 67.47 1.42 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 0.0 109.668 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.77 108.78 2.22 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.513 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -137.88 153.02 73.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.341 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 50.4 Cg_exo -42.42 143.71 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.081 2.521 . . . . 0.0 113.701 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.722 ' CD2' HD22 ' A' ' 134' ' ' LEU . 17.4 t-160 -67.74 127.24 32.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.076 0.465 . . . . 0.0 111.719 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -75.02 -35.51 61.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.288 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.2 p -109.21 17.23 21.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -124.77 -93.91 1.01 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.305 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.92 20.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.103 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -139.9 161.6 37.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.981 0.513 . . . . 0.0 109.65 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.8 ttt -64.71 110.24 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.343 0.592 . . . . 0.0 111.024 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.722 HD22 ' CD2' ' A' ' 127' ' ' HIS . 20.1 tp -92.17 145.67 24.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.581 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.4 pt-20 -128.13 115.68 18.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.0 m -108.59 157.96 18.01 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.075 0.464 . . . . 0.0 111.928 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -128.3 170.2 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.586 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -123.28 117.81 26.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.794 0.331 . . . . 0.0 111.373 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.08 119.36 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.17 122.05 6.68 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.865 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.19 34.83 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.971 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.9 43.26 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.694 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -163.63 -54.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.095 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.83 73.55 0.54 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.289 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.16 159.9 14.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 111.142 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.47 165.62 26.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.302 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -153.37 133.37 13.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -126.45 150.46 48.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.973 0.416 . . . . 0.0 111.295 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.97 90.84 13.7 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.254 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.516 ' HB3' HD12 ' A' ' 134' ' ' LEU . 24.2 Cg_endo -66.55 167.2 19.55 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.497 2.132 . . . . 0.0 113.746 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.249 1.032 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.998 179.341 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.685 0.278 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 p -123.9 142.11 51.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.671 ' HB3' HD13 ' A' ' 102' ' ' ILE . 3.6 m -118.41 134.45 55.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 74' ' ' THR . 94.2 t80 -111.74 131.63 55.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 23.3 t70 -108.07 104.83 14.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.148 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 16.3 ptpt -55.17 -24.68 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.497 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 27.0 m-85 -67.73 -46.84 71.01 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -82.94 -47.5 11.71 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.364 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.6 2.7 46.87 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.18 147.94 42.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.153 0.476 . . . . 0.0 110.983 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.5 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -90.09 159.79 16.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.969 0.414 . . . . 0.0 110.357 179.007 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.41 ' OH ' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -135.56 131.89 36.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.672 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -74.31 173.16 10.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 t -61.96 139.76 20.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.18 27.06 70.82 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.302 -0.475 . . . . 0.0 113.098 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.22 122.06 46.33 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.936 HG22 HG23 ' A' ' 93' ' ' THR . 18.0 p -105.61 141.42 37.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 110.825 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.9 p90 -138.31 -172.84 3.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.564 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.34 137.98 52.08 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.677 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -138.41 124.36 12.6 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -78.52 59.27 7.1 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.766 1.644 . . . . 0.0 113.21 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -64.49 143.73 57.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.6 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 33.91 57.0 0.6 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.4 m 53.16 35.84 20.9 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 ttp -146.73 152.72 39.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 mm -90.13 110.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.196 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.513 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 33.0 m95 -99.32 139.19 35.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.946 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -94.97 104.1 15.97 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 18.2 m -107.82 139.97 41.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.936 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -112.39 152.1 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 114.48 28.75 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 109.953 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.9 mp -102.11 95.39 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.488 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.54 78.98 1.44 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.646 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.75 -48.18 4.18 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.04 -68.52 0.87 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.412 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.11 48.84 0.98 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 111.161 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.22 77.56 0.69 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.602 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -89.6 141.78 28.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.65 0.262 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' A' ' 66' ' ' CYS . 8.4 mm -102.56 125.16 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.306 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.498 ' HB3' HD13 ' A' ' 95' ' ' ILE . 45.2 t -124.56 111.52 15.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.428 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 39.4 m -108.96 130.97 55.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.894 0.378 . . . . 0.0 111.838 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 p -135.92 128.75 31.11 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 mt -42.73 137.44 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.229 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.65 161.02 30.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.746 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -79.13 61.61 3.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -150.43 174.5 12.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 117' ' ' TYR . 20.7 p -128.87 129.74 45.94 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.85 157.21 47.41 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.365 -0.209 . . . . 0.0 111.488 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 1.2 pt-20 172.09 -66.79 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.62 91.44 1.07 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.915 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 -84.7 1.24 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.353 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -108.29 176.17 5.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.567 0.223 . . . . 0.0 110.72 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.9 t -84.98 128.29 34.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.562 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' CYS . 79.3 m-85 -93.62 129.11 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.624 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -81.64 167.33 19.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.192 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 18.8 mm -53.83 135.96 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.43 -4.13 43.64 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.16 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.43 158.53 16.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.323 0.562 . . . . 0.0 110.187 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.569 HG22 ' CG2' ' A' ' 137' ' ' VAL . 58.8 p -138.5 142.06 39.38 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.987 0.422 . . . . 0.0 111.812 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -147.29 123.35 10.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.617 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.93 139.1 53.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.538 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 126' ' ' PRO . 16.1 ptt-85 -174.48 157.6 2.42 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.051 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 125' ' ' ARG . 34.9 Cg_exo -41.23 171.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.141 2.56 . . . . 0.0 113.339 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.556 ' CD2' HD22 ' A' ' 134' ' ' LEU . 9.3 t-160 -105.24 116.63 32.28 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.27 -40.36 62.38 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.158 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.3 p -96.7 22.39 8.2 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.342 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.17 -159.86 9.22 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.945 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.8 35.84 2.0 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.17 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.85 146.05 27.78 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.6 mtp -56.52 106.73 0.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.979 0.419 . . . . 0.0 109.927 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.556 HD22 ' CD2' ' A' ' 127' ' ' HIS . 34.2 tp -92.8 145.5 24.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.387 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -141.32 117.48 10.64 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.1 m -117.6 158.59 24.35 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.569 ' CG2' HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -122.44 179.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.623 178.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.441 ' N ' HG13 ' A' ' 137' ' ' VAL . 9.4 t -113.9 118.06 33.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.494 0.588 . . . . 0.0 111.34 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.427 HD12 ' HB ' ' A' ' 147' ' ' THR . 2.1 mt -111.76 155.6 23.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.362 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.15 94.34 0.15 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.837 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.76 35.95 4.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.88 0.371 . . . . 0.0 110.797 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.71 41.56 10.84 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.565 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -160.6 -48.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.439 0.161 . . . . 0.0 111.413 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.78 61.22 0.65 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.288 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.85 155.65 30.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.61 171.44 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -130.77 127.95 39.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.029 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.59 150.96 48.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.008 0.432 . . . . 0.0 111.312 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -126.28 74.22 72.94 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.513 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 39.9 Cg_endo -72.8 144.65 39.42 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.743 2.295 . . . . 0.0 112.916 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.114 179.259 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.849 0.356 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -139.79 152.22 46.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.916 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.0 m -118.27 134.46 55.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 87.2 t80 -113.39 121.83 45.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.32 96.15 7.54 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 61.3 pttt -49.14 -23.86 1.43 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 83' ' ' ARG . 20.7 m-85 -66.33 -46.67 76.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.512 0.196 . . . . 0.0 111.524 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.2 p -86.38 -49.66 7.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.077 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.55 11.23 31.49 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.804 -0.634 . . . . 0.0 113.015 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -118.17 148.39 42.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.795 0.298 . . . . 0.0 110.356 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.35 159.57 17.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 110.385 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -135.97 129.4 32.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -75.84 150.98 37.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 77.9 t -47.89 143.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.795 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.89 79.67 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.624 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -112.54 128.9 56.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.945 HG22 HG23 ' A' ' 93' ' ' THR . 19.0 p -105.33 149.71 25.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.593 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.514 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 33.1 p90 -144.73 174.82 10.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.626 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -118.52 131.9 56.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.524 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -134.26 135.6 24.4 Favored Pre-proline 0 N--CA 1.462 0.171 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 88' ' ' MET . 67.5 Cg_endo -83.61 65.11 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.77 1.647 . . . . 0.0 112.755 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.57 125.25 21.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.61 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 t70 59.33 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.075 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' LYS . 11.1 t -165.11 38.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.416 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 3.3 ttp -149.37 154.27 38.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mm -90.78 111.94 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 28.6 m95 -99.39 155.9 17.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -118.13 107.18 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 9.6 m -107.75 167.82 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 112.01 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.945 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.6 154.47 45.43 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 109.993 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.0 t -103.51 114.39 28.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.404 0.621 . . . . 0.0 109.479 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.9 mp -84.29 -52.66 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.44 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.77 63.22 4.8 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.852 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.32 -53.81 4.63 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.63 -61.69 0.66 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.313 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 54.14 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.32 83.51 0.65 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.541 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -96.59 135.36 38.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.48 128.69 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.461 ' HB3' HD13 ' A' ' 95' ' ' ILE . 8.8 t -129.29 111.08 12.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.099 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.59 138.19 46.32 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.5 p -139.24 132.26 29.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.21 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.445 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -49.93 146.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.34 167.86 19.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.538 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.09 52.78 2.2 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.999 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.8 mtm-85 -141.18 162.79 34.64 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 7.0 p -117.95 126.66 52.76 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.37 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.636 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -131.96 156.1 46.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.014 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 6.9 tp10 167.66 141.29 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.244 0.34 . . . . 0.0 111.033 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.14 -71.84 2.91 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.286 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.02 -97.59 2.07 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.456 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -96.05 -177.78 4.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.7 p -92.81 124.52 36.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.829 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.25 158.73 16.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.803 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -98.14 153.87 18.14 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.913 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.34 124.33 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.575 0.226 . . . . 0.0 111.128 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.81 -14.9 64.48 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.467 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.8 164.25 26.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.297 0.548 . . . . 0.0 111.838 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.722 HG22 HG23 ' A' ' 137' ' ' VAL . 34.3 p -126.46 147.43 49.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.993 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -138.61 34.84 2.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.601 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -50.52 119.14 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.702 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 126' ' ' PRO . 29.9 mmt180 -140.71 162.04 51.04 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.248 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 125' ' ' ARG . 59.5 Cg_exo -41.01 172.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.889 2.392 . . . . 0.0 113.825 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.502 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 1.4 t60 -86.27 124.54 32.77 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.16 -32.66 65.0 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.103 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.414 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 4.5 p -108.67 18.9 20.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.3 -176.7 30.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.587 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.86 31.15 6.97 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.884 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.502 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 17.5 p90 -130.72 161.07 32.49 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 151' ' ' ILE . 66.7 mtp -70.98 138.73 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.3 tp -123.16 140.86 52.59 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.601 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 32.2 mt-10 -127.12 116.39 20.59 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 119.833 -0.127 . . . . 0.0 110.704 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.1 m -107.32 158.12 17.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 111.724 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.722 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -134.38 165.09 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.455 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 118.33 27.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.807 0.337 . . . . 0.0 111.288 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.82 113.53 25.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.78 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.29 104.34 1.8 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.003 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.37 38.6 4.15 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.625 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.79 29.88 7.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.57 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -164.14 -54.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.725 0.262 . . . . 0.0 111.056 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.83 73.64 0.86 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.475 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.0 167.95 9.71 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.05 163.93 31.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.413 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.491 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -152.28 138.59 18.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -132.85 151.32 52.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.341 0.591 . . . . 0.0 112.391 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -125.62 111.94 25.35 Favored Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 151' ' ' ILE . 73.1 Cg_endo -74.15 170.51 19.99 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.019 1.813 . . . . 0.0 114.307 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 150' ' ' PRO . 1.1 tp . . . . . 0 C--O 1.25 1.083 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.315 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.806 0.336 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.6 p -131.82 144.27 50.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.86 134.73 54.65 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -111.11 122.13 47.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -99.58 98.44 9.31 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -55.23 -17.7 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.556 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 1.3 m-85 -67.28 -45.77 75.61 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.316 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.6 -52.87 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.99 12.99 16.86 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.432 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.37 148.3 42.65 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.028 0.414 . . . . 0.0 110.259 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.43 159.51 17.97 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.374 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.3 129.69 29.7 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 147.74 38.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.489 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.23 141.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.14 -177.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.32 16.74 75.53 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.563 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -112.67 126.97 55.97 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.981 HG22 HG23 ' A' ' 93' ' ' THR . 18.9 p -105.2 132.92 50.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.895 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 34.3 p90 -128.53 -177.55 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.744 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.9 mt-10 -124.45 135.41 53.23 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.895 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.556 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -141.33 147.34 46.36 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.778 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 88' ' ' MET . 94.5 Cg_endo -84.86 124.41 2.99 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.143 1.895 . . . . 0.0 111.444 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -117.58 113.93 22.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.458 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 67.06 -67.88 0.16 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 m -162.94 31.54 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -144.71 167.04 23.52 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.689 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.48 116.99 47.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 17.6 m95 -99.3 154.34 18.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.92 110.15 20.6 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 46.7 m -108.83 166.89 10.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 112.214 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.981 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.15 152.76 44.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.648 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -104.41 113.9 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.94 -43.52 24.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.913 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 54.26 63.63 5.01 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.984 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -97.38 -52.06 3.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.651 0.262 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.66 -67.9 0.49 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.337 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.84 44.62 2.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.39 73.13 0.87 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.659 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -77.13 136.68 38.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.047 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.78 123.87 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.481 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 t -118.94 110.53 17.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.7 m -117.05 131.88 56.82 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.8 p -139.89 138.03 35.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.65 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.02 152.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.03 155.98 21.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.813 0.339 . . . . 0.0 111.9 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.62 56.89 3.71 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.294 0.568 . . . . 0.0 110.256 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -148.21 171.58 15.7 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.034 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 12.2 p -120.23 127.09 52.1 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.582 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.64 149.96 49.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.713 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.582 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 0.0 OUTLIER 169.11 152.37 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.671 0.272 . . . . 0.0 111.362 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.75 -36.8 3.63 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.243 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.46 -10.47 0.29 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.282 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -134.65 175.02 9.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.171 0.486 . . . . 0.0 110.18 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 12.4 p -114.23 125.84 54.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.999 0.428 . . . . 0.0 111.161 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.91 158.02 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.459 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -105.21 158.04 16.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.907 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.5 mp -52.15 124.58 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.58 0.228 . . . . 0.0 110.767 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.6 -12.82 61.32 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.241 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 156.6 30.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.216 0.508 . . . . 0.0 111.135 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 137' ' ' VAL . 1.5 p -127.97 150.62 49.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.573 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.402 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 17.8 p90 -142.56 86.49 1.95 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.145 0.498 . . . . 0.0 109.811 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -78.66 91.07 4.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 126' ' ' PRO . 20.4 mtt-85 -123.12 163.92 30.67 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.826 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 43.3 Cg_exo -43.01 176.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.082 2.521 . . . . 0.0 113.809 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.655 ' CD2' HD22 ' A' ' 134' ' ' LEU . 16.3 t-160 -101.4 126.43 48.17 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 111.837 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -69.68 -36.56 76.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.794 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.9 p -108.5 18.6 20.75 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.52 175.62 25.86 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.575 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -113.78 28.79 8.24 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.302 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.46 ' O ' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -136.09 159.55 41.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.658 0.229 . . . . 0.0 111.055 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.2 mtt -67.59 114.57 6.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.096 0.474 . . . . 0.0 110.749 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.655 HD22 ' CD2' ' A' ' 127' ' ' HIS . 22.4 tp -91.76 145.85 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.618 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.2 mt-10 -121.96 115.52 22.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 94.3 m -111.35 158.13 19.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.996 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -134.79 171.15 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.889 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 t -133.02 118.36 18.71 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.752 0.311 . . . . 0.0 111.517 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.4 118.83 36.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.403 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.0 97.97 2.32 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.75 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -138.46 52.7 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.71 -76.66 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.492 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -130.08 -42.75 1.22 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.539 0.209 . . . . 0.0 111.393 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.78 91.17 0.08 OUTLIER Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.534 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.9 153.78 20.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.703 0.287 . . . . 0.0 110.823 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -137.22 164.79 27.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.996 HG22 HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -150.78 146.32 26.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -141.3 149.84 41.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.031 0.443 . . . . 0.0 111.393 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -135.3 90.94 19.64 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.545 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 134' ' ' LEU . 36.9 Cg_endo -70.6 168.06 23.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.478 2.119 . . . . 0.0 113.655 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.955 179.283 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HB2' HG22 ' A' ' 77' ' ' VAL . 1.4 mp0 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.683 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.6 p -132.23 139.1 48.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.167 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.88 136.42 54.05 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.443 ' HB2' HG23 ' A' ' 74' ' ' THR . 94.8 t80 -112.81 131.68 55.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.402 ' HB2' ' HE2' ' A' ' 75' ' ' TYR . 40.7 t0 -108.41 105.08 14.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.209 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -59.08 -17.54 26.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -69.16 -45.89 68.9 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -89.15 -47.88 7.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.71 6.4 40.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.431 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.92 151.31 38.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.098 0.449 . . . . 0.0 110.833 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -92.78 159.62 15.32 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.118 178.507 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.402 ' HE2' ' HB2' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -136.32 131.78 34.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.301 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -76.73 157.79 31.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -46.87 135.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.155 -178.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 29.65 59.02 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.261 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -113.54 120.53 41.27 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.023 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 1.01 HG22 HG23 ' A' ' 93' ' ' THR . 15.9 p -105.88 149.54 26.45 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.3 p90 -154.61 -173.71 4.68 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -115.38 133.88 55.62 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.303 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.94 136.88 28.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 88' ' ' MET . 80.2 Cg_endo -79.5 114.3 3.24 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 121.779 1.653 . . . . 0.0 112.837 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -117.15 107.57 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 49.53 77.87 0.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m 49.25 43.48 22.88 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.634 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 39.9 ttp -164.44 162.05 21.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.23 144.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m95 -120.27 152.45 37.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.498 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.32 102.47 14.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 80' ' ' THR . 61.1 m -108.04 139.28 42.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 112.594 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 1.01 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -115.21 152.34 32.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.882 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.75 114.45 28.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.661 0.743 . . . . 0.0 110.237 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.71 112.06 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.192 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.97 62.64 0.29 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.682 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.02 -56.11 10.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.902 0.382 . . . . 0.0 110.303 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.96 -41.31 4.38 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.548 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.4 -87.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.552 0.341 . . . . 0.0 110.181 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.403 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -144.39 56.34 0.55 Allowed Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.761 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -62.13 143.04 57.24 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.639 0.257 . . . . 0.0 111.466 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 100' ' ' GLY . 2.9 mp -107.82 129.46 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.5 t -126.5 120.11 28.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 57.0 m -119.11 135.38 54.68 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.9 p -140.09 139.96 35.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.92 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.99 158.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.382 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.16 161.24 13.81 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.05 67.5 10.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.37 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -148.47 173.32 13.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.982 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 10.0 p -126.21 127.55 45.83 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.552 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.31 169.37 17.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.281 -179.333 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 13.7 pt-20 170.68 -51.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.96 0.162 . . . . 0.0 111.166 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -81.88 70.15 3.18 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.74 0.46 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.839 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.89 -177.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.877 0.471 . . . . 0.0 111.882 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -119.29 127.05 52.85 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.137 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -96.24 152.15 18.84 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.504 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -89.28 -177.98 5.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.01 124.21 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.06 -3.65 82.67 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.033 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.8 163.73 25.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.576 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.665 HG22 HG23 ' A' ' 137' ' ' VAL . 28.5 p -131.82 147.74 52.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.29 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 20.3 p90 -142.76 67.05 1.31 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.385 0.612 . . . . 0.0 109.735 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.09 90.08 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.453 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 126' ' ' PRO . 26.3 mtt-85 -121.93 167.86 12.78 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.886 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 65.5 Cg_exo -43.92 178.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.984 2.456 . . . . 0.0 113.877 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.662 ' CD2' HD22 ' A' ' 134' ' ' LEU . 16.4 t-160 -103.06 127.98 50.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -70.79 -35.31 72.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.704 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.432 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 19.4 p -109.99 18.55 19.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.369 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.95 174.7 26.68 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.557 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.92 28.99 8.38 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.404 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.479 ' O ' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -135.53 159.53 41.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.574 0.226 . . . . 0.0 110.936 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 18.2 mtm -67.27 116.01 7.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.662 HD22 ' CD2' ' A' ' 127' ' ' HIS . 26.8 tp -91.96 146.25 23.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.912 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 34.9 mt-10 -124.32 116.11 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -122.46 157.53 31.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.334 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.665 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.62 168.11 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 117.95 24.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.592 0.234 . . . . 0.0 111.056 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.41 120.98 43.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -84.26 -146.57 7.63 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.66 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.88 -64.79 0.36 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.639 0.375 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.95 -94.2 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.836 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -154.93 68.19 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 54.57 34.04 55.08 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.166 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.21 121.67 18.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.731 0.3 . . . . 0.0 110.868 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 166.26 11.3 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -146.83 127.5 14.26 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.107 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 136' ' ' CYS . 0.0 OUTLIER -125.35 149.46 48.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.467 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -139.71 96.51 8.45 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.774 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.562 ' HB3' HD12 ' A' ' 134' ' ' LEU . 55.9 Cg_endo -75.53 169.28 22.69 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.37 2.047 . . . . 0.0 113.523 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.035 179.304 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.532 0.206 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p -124.53 152.95 42.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.152 0.501 . . . . 0.0 111.2 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' TYR . 68.0 m -119.48 138.64 53.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.046 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -121.17 127.92 51.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.38 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -111.68 109.19 18.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.39 -13.49 51.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.575 0.226 . . . . 0.0 111.592 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.607 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 4.0 m-30 -68.86 -43.27 75.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.857 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -94.85 -50.0 5.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.76 5.12 33.87 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.856 -0.611 . . . . 0.0 114.036 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.422 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.2 m120 -117.18 141.44 48.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.714 0.757 . . . . 0.0 111.297 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.85 160.35 29.31 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.99 0.424 . . . . 0.0 110.97 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' A' ' 66' ' ' CYS . 6.5 m-85 -134.61 129.01 34.29 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.909 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -78.27 143.4 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 79.9 t -47.73 123.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.022 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.57 36.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.791 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -113.02 124.07 51.76 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.968 HG22 HG23 ' A' ' 93' ' ' THR . 11.9 p -105.81 144.42 32.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.075 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 34.6 p90 -138.89 -175.08 4.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.6 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.1 mt-10 -122.4 126.55 48.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.71 0.291 . . . . 0.0 110.769 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.607 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -120.08 128.98 25.57 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -87.19 98.46 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.082 1.854 . . . . 0.0 111.319 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 114.22 27.7 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 47.65 79.84 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.4 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.7 m 45.16 40.35 4.8 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.843 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -150.82 162.09 41.43 Favored 'General case' 0 C--N 1.335 -0.053 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.676 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mm -114.39 132.55 63.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.556 ' CH2' HG12 ' A' ' 106' ' ' ILE . 26.4 m95 -117.48 135.29 54.02 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -97.7 104.25 16.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' THR . 15.0 t -107.63 153.56 22.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.968 HG23 HG22 ' A' ' 80' ' ' THR . 0.6 OUTLIER -134.54 154.04 51.65 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.245 -179.209 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 8.9 t -101.74 113.45 26.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -54.37 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.095 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 56.25 60.89 8.15 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.001 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.32 -45.58 54.48 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.667 0.27 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.58 -58.91 0.72 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 67.14 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.18 93.37 0.48 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.751 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -120.06 151.78 38.51 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.87 119.46 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.078 0.399 . . . . 0.0 110.467 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.98 115.44 17.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.115 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 2.8 m -130.84 144.01 51.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.7 p -139.65 153.44 47.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.44 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.556 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -69.41 -168.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.669 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 106' ' ' ILE . . . 70.68 -164.93 0.15 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 52.0 m-80 82.33 -25.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.281 0.632 . . . . 0.0 111.671 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -138.35 152.65 48.64 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 117' ' ' TYR . 4.3 p -110.22 123.09 49.14 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.928 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -135.61 -174.7 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 25.2 tt0 169.41 123.95 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.735 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 68.88 165.82 4.1 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.249 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -31.46 -31.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 113' ' ' GLY . 52.0 mt-30 -93.53 127.18 39.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.155 0.977 . . . . 0.0 111.641 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -95.46 153.76 17.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.431 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 110' ' ' CYS . 13.1 m-85 -140.35 146.62 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.625 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -94.69 178.73 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.886 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.05 124.13 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.631 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.47 -3.72 84.03 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.243 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.74 151.62 28.97 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.13 0.465 . . . . 0.0 111.016 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.595 HG22 HG23 ' A' ' 137' ' ' VAL . 7.3 p -127.15 144.77 50.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.091 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -137.52 50.06 1.97 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.67 113.63 0.68 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.146 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -144.65 154.17 55.64 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 33.8 Cg_exo -39.06 149.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.246 2.63 . . . . 0.0 113.619 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.576 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.2 t60 -67.22 135.11 52.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 112.104 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -73.42 -32.71 64.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.429 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 63.5 p -120.0 18.99 12.41 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.637 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -139.83 176.1 21.41 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.571 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.55 31.98 6.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.312 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.65 170.32 16.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 110.544 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 14.1 mtt -78.24 115.1 17.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.576 HD22 ' ND1' ' A' ' 127' ' ' HIS . 21.0 tp -91.87 144.54 25.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.747 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 40.6 mt-10 -122.32 115.66 22.7 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 99.1 m -110.33 157.71 19.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.595 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -130.03 177.15 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.76 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.455 ' N ' HG13 ' A' ' 137' ' ' VAL . 2.6 t -130.49 117.13 19.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.132 0.423 . . . . 0.0 111.583 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.4 mt -112.56 113.58 25.8 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.101 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.63 87.42 0.42 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.868 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.47 -49.24 4.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.612 0.244 . . . . 0.0 110.754 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -165.43 36.1 0.26 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.705 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -171.31 -43.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.612 0.206 . . . . 0.0 111.317 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.08 67.1 0.81 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.597 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.61 152.89 21.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.664 0.268 . . . . 0.0 110.717 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 166.13 14.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.69 134.99 22.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.965 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.2 m -130.33 149.85 51.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.035 0.445 . . . . 0.0 111.387 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.27 96.47 12.54 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.598 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 134' ' ' LEU . 56.7 Cg_endo -76.48 162.95 32.76 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.267 1.978 . . . . 0.0 113.522 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.986 179.197 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.683 0.278 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 p -131.16 154.98 47.79 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.208 0.528 . . . . 0.0 111.26 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' TYR . 61.3 m -119.04 136.33 54.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.424 ' O ' HD11 ' A' ' 102' ' ' ILE . 89.2 t80 -120.56 128.32 52.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.215 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -111.87 103.95 12.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.979 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -58.97 -15.15 11.6 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.697 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.477 ' CD2' ' HD2' ' A' ' 83' ' ' ARG . 3.2 m-85 -67.45 -45.98 74.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.968 0.413 . . . . 0.0 110.346 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -50.5 5.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.056 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.93 10.18 28.78 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.44 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -118.18 153.48 33.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.117 0.458 . . . . 0.0 110.814 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.24 159.73 15.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.885 0.374 . . . . 0.0 110.259 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' CYS . 4.3 m-85 -135.06 127.95 31.36 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.662 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.0 148.65 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.553 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.465 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 17.8 t -47.86 142.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.351 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.72 20.99 79.3 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.208 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.39 127.19 56.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.911 HG22 HG23 ' A' ' 93' ' ' THR . 15.3 p -105.67 149.34 26.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.782 0.325 . . . . 0.0 110.644 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 30.3 p90 -152.17 -179.11 7.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 3.6 mt-10 -112.84 132.73 55.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.749 0.309 . . . . 0.0 110.373 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.477 ' HD2' ' CD2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -137.9 128.7 15.73 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 88' ' ' MET . 59.9 Cg_endo -74.86 119.0 5.49 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.617 1.545 . . . . 0.0 111.898 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -118.0 115.56 25.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.045 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 44.67 69.84 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 m 54.57 37.82 28.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.671 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -145.9 160.52 41.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.398 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -110.69 116.33 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.0 m95 -105.48 159.82 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.89 103.72 11.7 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 8.7 t -108.94 141.64 40.72 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.911 HG23 HG22 ' A' ' 80' ' ' THR . 0.7 OUTLIER -117.76 153.48 33.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.303 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 15.0 t -103.56 117.04 33.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.218 0.533 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.46 -46.8 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.417 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.67 -94.13 0.19 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.549 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 61.56 21.83 12.41 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.58 -71.41 0.07 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.2 mmm-85 -114.82 -88.04 0.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.03 38.09 0.38 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 ptt-85 -68.7 141.92 55.17 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.857 0.361 . . . . 0.0 110.868 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.424 HD11 ' O ' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -112.42 147.85 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.646 -178.8 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -125.47 111.98 15.72 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.87 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.9 m -108.55 140.34 42.04 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.5 p -140.16 146.86 39.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.54 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.2 mt -55.55 153.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.304 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.6 26.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 111.792 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.96 70.89 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -150.19 177.09 10.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.208 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 14.7 p -124.44 130.5 52.58 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.505 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 6.0 p-80 -133.75 -145.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.156 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 1.3 tp10 89.23 163.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.542 0.337 . . . . 0.0 111.124 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.28 13.4 80.74 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.349 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.91 -16.11 58.79 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.159 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -133.48 170.52 15.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.07 0.435 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 4.9 p -119.05 127.44 53.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.969 0.414 . . . . 0.0 111.068 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -109.15 157.77 18.44 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.633 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 35.5 mttt -103.36 157.14 17.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.54 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm -48.81 124.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.9 67.29 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.688 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -77.31 159.96 29.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.377 0.588 . . . . 0.0 111.709 -179.325 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.681 HG22 HG23 ' A' ' 137' ' ' VAL . 29.9 p -123.42 147.77 46.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.888 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -143.8 40.11 1.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.111 0.481 . . . . 0.0 109.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.6 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -55.77 108.06 0.41 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.191 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' PRO . 19.8 mtt180 -138.53 174.08 4.6 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.156 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 31.6 Cg_exo -41.36 -175.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.825 2.35 . . . . 0.0 113.667 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.66 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 13.1 t-160 -104.07 124.74 49.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 112.028 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.02 -37.74 64.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.115 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.443 ' HB ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -80.06 -23.07 41.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.697 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -132.5 -153.03 7.18 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.81 31.2 3.41 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.574 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.66 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 20.0 p90 -127.26 140.47 52.2 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 120.491 0.186 . . . . 0.0 111.367 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 19.9 ttt -47.83 139.39 7.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.253 0.549 . . . . 0.0 112.0 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' A' ' 127' ' ' HIS . 27.2 tp -133.58 143.72 48.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.567 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.6 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 27.5 mt-10 -127.47 116.87 21.09 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.7 OUTLIER -122.24 157.63 31.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.084 0.469 . . . . 0.0 112.11 -178.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.31 170.1 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.904 -179.23 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 t -118.55 118.37 31.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.683 0.278 . . . . 0.0 111.288 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 40.3 mt -112.47 134.66 53.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.499 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.15 -114.01 0.99 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.65 -70.37 0.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.672 0.389 . . . . 0.0 111.702 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.29 -91.37 0.83 Allowed Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.567 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -129.63 -42.71 1.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 176.14 73.6 0.05 OUTLIER Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -92.14 161.63 14.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.737 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.07 162.23 36.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.55 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.53 125.76 14.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.503 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.12 149.71 50.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.499 0.666 . . . . 0.0 112.279 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -124.69 102.62 32.12 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.55 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 6.1 Cg_exo -71.27 167.94 24.8 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.019 1.812 . . . . 0.0 114.992 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 151' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.075 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.811 0.339 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 p -132.19 150.01 52.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.8 m -118.64 139.28 51.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.55 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -120.25 126.7 51.25 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 100.83 10.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -52.56 -21.75 4.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -67.69 -46.41 72.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 p -86.16 -52.4 5.69 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.67 8.82 31.86 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.439 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.31 145.43 44.0 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.957 0.379 . . . . 0.0 110.393 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 159.43 20.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.977 0.418 . . . . 0.0 110.648 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.425 ' CE1' ' CG ' ' A' ' 81' ' ' TYR . 3.1 m-85 -134.49 128.59 33.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.3 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.13 153.05 34.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 77' ' ' VAL . 4.2 t -47.78 140.18 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.896 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.02 21.07 79.58 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.428 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.89 126.26 55.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.912 HG22 HG23 ' A' ' 93' ' ' THR . 20.4 p -105.37 132.93 50.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.889 0.376 . . . . 0.0 111.42 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 36.3 p90 -126.2 -176.23 3.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.673 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 138.56 54.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.859 0.362 . . . . 0.0 111.045 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.6 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -137.16 132.22 17.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.9 Cg_endo -79.74 59.85 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.696 1.597 . . . . 0.0 112.822 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -56.73 130.69 46.58 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.899 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 t70 35.21 63.86 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.3 m 53.9 36.04 23.27 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 18.1 mtm -143.16 149.16 37.67 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.65 109.32 21.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.458 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 18.6 m95 -100.01 151.93 20.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.414 -177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.35 110.82 22.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 33.4 m -108.88 162.33 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.912 HG23 HG22 ' A' ' 80' ' ' THR . 1.0 OUTLIER -141.54 154.01 45.22 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.198 -179.054 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 21.4 t -103.49 113.37 26.82 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.504 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -76.62 -36.47 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.483 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.4 72.64 0.82 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.582 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.05 -55.35 3.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.687 0.279 . . . . 0.0 111.409 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.82 -61.09 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.536 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 24.61 12.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.878 0.37 . . . . 0.0 111.198 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.17 90.1 0.94 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.56 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -91.36 129.48 37.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.595 0.236 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.24 124.5 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.504 ' HB3' HD13 ' A' ' 95' ' ' ILE . 13.5 t -128.58 111.52 13.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.985 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.2 m -111.72 137.22 49.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.9 p -139.28 136.24 34.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.069 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.402 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -50.95 146.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.04 154.22 26.98 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.453 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.434 ' O ' HG12 ' A' ' 119' ' ' ILE . 1.1 p-10 -85.87 63.89 8.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.099 0.476 . . . . 0.0 110.57 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -149.8 167.63 26.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.642 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 117' ' ' TYR . 2.7 p -118.95 125.61 49.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.601 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.0 145.32 47.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.746 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.601 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 5.9 pt-20 170.32 157.72 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.206 0.316 . . . . 0.0 111.197 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -77.61 1.98 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.996 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.79 -38.39 0.07 OUTLIER Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.52 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -123.55 172.17 8.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.294 0.547 . . . . 0.0 111.232 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 p -101.9 126.59 48.84 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' CYS . 2.5 m-85 -108.39 157.1 18.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.515 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -98.68 155.38 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.524 HD12 ' HA3' ' A' ' 140' ' ' GLY . 22.3 mm -54.78 131.64 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.45 -10.32 73.77 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.567 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 150.54 30.0 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 117.489 0.645 . . . . 0.0 110.439 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 137' ' ' VAL . 21.7 p -142.54 141.39 32.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.444 ' CZ2' ' HB3' ' A' ' 136' ' ' CYS . 11.2 p90 -140.31 110.63 6.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -123.72 107.57 11.59 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.114 0.483 . . . . 0.0 111.703 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -148.04 159.23 40.57 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.678 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 26.5 Cg_exo -39.77 144.75 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.862 2.375 . . . . 0.0 113.027 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.662 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.9 t60 -65.75 137.57 57.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.487 0.661 . . . . 0.0 112.559 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.82 -41.76 59.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.684 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 78.0 p -108.34 17.68 21.89 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.84 -95.33 1.14 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.385 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.53 -22.63 0.42 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.08 171.73 9.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.641 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.1 ptm -69.78 151.28 45.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.662 HD22 ' ND1' ' A' ' 127' ' ' HIS . 25.1 tp -136.34 129.25 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.7 mt-10 -118.96 119.78 35.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.001 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 147' ' ' THR . 94.3 m -116.12 158.22 23.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 111.912 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.068 HG23 HG23 ' A' ' 147' ' ' THR . 0.0 OUTLIER -141.17 165.52 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.85 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 133.34 54.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.861 0.362 . . . . 0.0 111.222 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.09 156.55 19.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.228 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.524 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -153.38 39.43 0.71 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.975 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -51.44 5.37 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.658 0.266 . . . . 0.0 110.708 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -117.09 -46.75 0.5 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.389 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -153.81 148.69 26.59 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.526 0.203 . . . . 0.0 110.576 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.94 105.69 1.0 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.464 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.4 173.81 7.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.436 ' CD1' ' HH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -117.43 146.25 43.59 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.117 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . 1.068 HG23 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -146.0 122.79 11.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -148.07 151.28 35.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.111 177.523 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -145.35 90.16 6.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.395 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.523 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 56.3 Cg_endo -73.08 158.17 49.73 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.329 2.019 . . . . 0.0 113.069 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.959 179.259 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.737 0.304 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 4.9 p -129.31 140.74 51.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 150.88 39.01 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.992 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 91.4 t80 -121.01 129.15 53.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -110.24 97.0 6.58 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 39.6 pttt -49.39 -19.0 0.45 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.547 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 2.9 m-85 -65.89 -45.52 81.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.832 0.349 . . . . 0.0 111.22 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -91.46 -52.61 4.7 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.67 9.81 28.04 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.321 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -117.26 138.29 51.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.932 0.366 . . . . 0.0 110.509 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.86 160.07 30.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.172 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.644 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 26.9 m-85 -130.34 128.92 42.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.475 ' HG3' HG22 ' A' ' 65' ' ' THR . 1.5 mtt180 -85.77 147.56 26.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.45 HG13 ' C ' ' A' ' 95' ' ' ILE . 2.8 t -46.92 144.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.356 -177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 27.93 71.82 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.325 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -113.31 127.24 56.08 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.871 HG22 HG23 ' A' ' 93' ' ' THR . 22.3 p -105.71 150.5 25.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.839 0.352 . . . . 0.0 111.554 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.4 ' CD1' ' CE1' ' A' ' 75' ' ' TYR . 24.7 p90 -157.4 -175.36 5.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.173 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.77 132.35 54.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.421 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.547 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 5.6 tmm_? -128.71 131.79 23.97 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 88' ' ' MET . 87.4 Cg_endo -84.29 64.52 6.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.813 . . . . 0.0 114.158 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.435 ' HG2' ' NE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -59.27 124.4 19.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.924 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 35.31 71.23 0.12 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.6 m 50.66 36.34 13.81 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.88 148.88 39.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.14 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mm -96.68 112.65 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.981 0.42 . . . . 0.0 109.88 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.565 ' CH2' HG12 ' A' ' 106' ' ' ILE . 19.6 m95 -101.92 148.41 25.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.186 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.92 107.99 19.31 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 80' ' ' THR . 70.1 m -108.03 156.29 19.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.871 HG23 HG22 ' A' ' 80' ' ' THR . 2.0 m -141.53 150.05 41.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.458 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -106.9 113.65 27.26 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.322 0.965 . . . . 0.0 110.649 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.45 ' C ' HG13 ' A' ' 77' ' ' VAL . 1.8 mp -79.3 -24.42 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.717 -177.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 97' ' ' ALA . . . 83.04 -75.82 2.33 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.395 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' GLY . . . 17.42 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.26 -113.47 4.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.455 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.28 70.95 1.4 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.145 0.498 . . . . 0.0 111.29 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.81 77.28 1.0 Allowed Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.92 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -102.09 131.66 48.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.603 0.239 . . . . 0.0 110.959 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.24 122.31 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.136 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.14 116.05 17.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.918 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.9 m -123.16 143.89 49.71 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 p -139.9 139.67 36.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.695 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.565 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -62.46 154.77 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.508 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.62 152.67 18.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 111.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.431 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.6 OUTLIER -85.75 68.13 10.27 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.635 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 119' ' ' ILE . 62.3 mtp180 -150.56 172.04 16.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.172 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.2 m -110.62 127.2 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.561 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -138.77 147.14 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 179.225 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 2.9 tm-20 171.35 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.728 0.299 . . . . 0.0 111.206 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 97.72 -83.69 0.71 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.636 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.56 2.19 0.38 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.434 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.69 -177.93 5.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.346 0.573 . . . . 0.0 111.103 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -119.52 127.71 53.27 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -108.41 159.44 16.66 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.666 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 3.9 tmtt? -103.07 158.08 16.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.4 mp -49.12 128.13 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.675 0.274 . . . . 0.0 111.197 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.39 61.42 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.312 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -80.78 168.87 18.3 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.355 0.578 . . . . 0.0 111.397 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.46 HG22 ' CG1' ' A' ' 137' ' ' VAL . 1.4 p -138.85 152.99 48.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.04 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.443 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 43.3 p90 -141.26 84.39 1.92 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.219 0.533 . . . . 0.0 110.039 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 1.2 mpp_? -85.23 74.16 10.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -110.72 167.16 9.46 Favored Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.726 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 66.5 Cg_exo -44.08 175.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.862 2.375 . . . . 0.0 113.676 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.43 ' ND1' HD22 ' A' ' 134' ' ' LEU . 3.9 t60 -105.26 128.87 53.65 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.96 -40.24 60.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.983 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.404 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 16.3 p -98.7 15.12 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.27 -69.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.856 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 123.55 19.57 2.79 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.42 ' HE1' ' HB3' ' A' ' 150' ' ' PRO . 3.5 p90 -126.4 141.74 51.79 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.038 0.535 . . . . 0.0 109.622 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.2 ptt? -50.41 108.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.547 0.689 . . . . 0.0 111.391 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.446 ' CD1' ' HG3' ' A' ' 150' ' ' PRO . 34.3 tp -91.92 143.87 26.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.336 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 36.1 mt-10 -126.15 116.0 20.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.15 157.33 38.39 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.792 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -126.95 174.61 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.862 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.94 118.88 12.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.814 0.34 . . . . 0.0 111.164 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.51 132.3 55.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.514 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -89.58 84.42 1.4 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.667 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 -48.45 6.93 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.556 0.217 . . . . 0.0 111.114 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -140.89 -65.99 0.03 OUTLIER Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.585 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -113.26 -39.13 4.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.427 0.156 . . . . 0.0 111.158 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.25 94.49 0.1 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.623 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -106.76 150.18 26.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.578 0.228 . . . . 0.0 110.645 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.97 165.24 21.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 111.341 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.792 HG22 HG23 ' A' ' 137' ' ' VAL . 0.6 OUTLIER -145.56 121.02 10.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.605 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -130.95 149.37 52.61 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.371 0.605 . . . . 0.0 111.799 179.403 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -123.78 90.28 50.76 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.63 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 134' ' ' LEU . 1.7 Cg_endo -80.69 161.63 21.69 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.66 2.24 . . . . 0.0 114.048 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.118 179.053 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.631 0.253 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -70.74 100.22 1.85 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.366 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 p -139.71 146.89 40.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.19 139.42 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.413 ' HB2' HG23 ' A' ' 74' ' ' THR . 93.2 t80 -114.69 132.27 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -109.27 112.67 24.95 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -64.03 -16.76 62.38 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 5.8 m-85 -70.59 -45.98 64.32 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -88.8 -48.32 7.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.797 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.33 3.82 47.36 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.791 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.5 m-80 -117.3 138.5 51.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.4 0.6 . . . . 0.0 110.926 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -79.02 159.84 27.43 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.907 0.384 . . . . 0.0 110.565 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 73' ' ' ASN . 1.1 m-85 -134.52 138.62 44.82 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.622 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -79.78 165.9 22.3 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.696 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -59.54 128.29 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.115 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.66 24.67 49.23 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.996 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -113.08 122.79 48.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.974 HG22 HG23 ' A' ' 93' ' ' THR . 19.1 p -105.3 149.12 26.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.909 0.385 . . . . 0.0 111.074 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 18.4 p90 -145.25 -172.63 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.732 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -115.64 129.83 56.64 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.572 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 4.6 tmm_? -130.13 124.95 21.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.097 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 88' ' ' MET . 84.9 Cg_endo -80.55 111.55 2.58 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.841 1.694 . . . . 0.0 112.239 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.546 ' HB3' ' NE1' ' A' ' 90' ' ' TRP . 11.3 tptt -116.88 118.94 33.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.821 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 46.55 73.23 0.19 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.5 m 47.38 41.84 13.16 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.915 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.7 ttp -153.04 164.54 37.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.199 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mm -112.2 122.54 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.546 ' NE1' ' HB3' ' A' ' 85' ' ' LYS . 25.3 m95 -107.97 140.22 41.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.36 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.05 110.19 21.66 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' THR . 75.1 m -109.44 152.81 24.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.974 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -130.73 150.65 51.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.266 179.095 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 122.18 45.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 110.903 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -98.78 131.28 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.453 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.59 -169.1 25.85 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.317 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 70.99 114.54 0.05 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.808 0.443 . . . . 0.0 111.811 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.93 -136.82 12.91 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.963 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.25 23.1 9.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.107 0.479 . . . . 0.0 111.158 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.541 ' O ' HD12 ' A' ' 102' ' ' ILE . . . 80.01 70.11 1.35 Allowed Glycine 0 CA--C 1.517 0.179 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.554 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.2 140.43 56.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.535 0.207 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.541 HD12 ' O ' ' A' ' 100' ' ' GLY . 3.0 mp -109.64 121.1 62.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.307 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.547 ' HB3' HD13 ' A' ' 95' ' ' ILE . 20.3 t -114.49 121.59 43.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.378 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.1 m -124.35 136.4 54.06 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 p -138.98 141.86 38.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.452 HG13 ' CH2' ' A' ' 90' ' ' TRP . 1.5 mt -51.96 155.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.284 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.08 144.1 28.61 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -80.49 75.77 7.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.75 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -150.17 173.53 13.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.23 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 117' ' ' TYR . 13.0 p -128.64 127.99 43.29 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.1 p-80 -135.1 -143.28 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 119.495 -0.288 . . . . 0.0 111.037 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.8 175.95 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.503 0.321 . . . . 0.0 111.078 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.43 -77.25 1.74 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.751 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.15 -39.26 0.04 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.936 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -133.71 167.21 20.93 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 32.4 p -84.88 150.83 24.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 111.247 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 110' ' ' CYS . 7.0 m-85 -133.21 139.1 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 1.9 mptm? -85.25 176.31 8.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.637 0.256 . . . . 0.0 111.161 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.1 mm -74.59 124.3 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.334 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.79 -3.14 86.3 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.92 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 169.7 17.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.924 0.393 . . . . 0.0 111.459 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.834 HG22 HG23 ' A' ' 137' ' ' VAL . 30.0 p -133.9 150.31 51.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -141.28 55.21 1.54 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.27 0.557 . . . . 0.0 109.716 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -55.66 98.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.706 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.8 mtt180 -132.36 166.99 24.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.751 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 32.8 Cg_exo -39.71 177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.193 2.595 . . . . 0.0 113.956 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.487 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.4 t60 -103.11 129.58 50.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.142 0.496 . . . . 0.0 112.336 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -64.97 -40.49 95.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.276 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 66.5 p -111.38 19.36 18.32 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.8 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -144.79 174.5 24.89 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.49 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.62 28.59 8.86 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.385 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.497 ' O ' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -133.16 158.3 43.19 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.488 0.185 . . . . 0.0 110.714 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 17.9 mtt -67.26 115.94 7.48 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.452 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.569 HD12 ' HB3' ' A' ' 150' ' ' PRO . 21.5 tp -92.19 144.68 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.869 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.5 pt-20 -125.44 116.16 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.7 157.47 32.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.834 HG23 HG22 ' A' ' 122' ' ' THR . 0.4 OUTLIER -126.34 168.47 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.233 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -131.56 124.25 29.64 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.829 0.347 . . . . 0.0 111.419 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.35 127.08 55.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.28 -103.05 0.09 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.979 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.71 22.35 11.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.421 0.288 . . . . 0.0 111.765 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.55 14.9 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.918 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -160.77 -54.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.659 0.23 . . . . 0.0 111.193 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.79 60.16 0.94 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.459 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.44 160.45 15.13 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 161.86 36.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.537 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.24 127.26 16.47 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.24 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.33 148.91 50.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.091 0.472 . . . . 0.0 111.403 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -137.92 91.4 13.4 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.918 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.569 ' HB3' HD12 ' A' ' 134' ' ' LEU . 36.5 Cg_endo -69.48 164.96 32.27 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.559 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.017 179.357 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.585 0.231 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -78.5 167.88 20.62 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.302 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 p -133.3 145.94 50.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.033 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.0 m -118.16 135.49 54.2 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.5 t80 -109.24 124.2 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 10.1 t70 -98.31 103.91 15.9 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 14.9 ptpt -56.57 -27.97 59.09 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 94.0 m-85 -67.93 -39.64 83.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.772 0.32 . . . . 0.0 111.144 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -88.18 -53.45 4.7 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.73 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.48 39.51 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.406 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.54 144.06 46.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.095 0.448 . . . . 0.0 110.686 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.52 160.25 21.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.713 0.292 . . . . 0.0 110.872 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -136.76 131.45 33.42 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.252 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -75.92 140.97 42.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.515 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.46 130.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.23 0.538 . . . . 0.0 111.982 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.45 14.6 56.87 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.97 125.77 54.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.99 HG22 HG23 ' A' ' 93' ' ' THR . 18.7 p -105.04 142.24 35.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.907 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -136.71 -173.91 3.56 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.766 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 5.2 mt-10 -119.98 126.84 51.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.202 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -124.27 123.15 25.97 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.1 Cg_endo -78.39 110.01 2.77 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.132 1.888 . . . . 0.0 112.076 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.73 116.57 27.76 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.861 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 48.32 77.51 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.8 m 44.5 43.85 6.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.3 ttp -155.65 166.03 34.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.7 130.84 68.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 22.3 m95 -114.46 143.07 45.53 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -98.56 109.38 22.14 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 80' ' ' THR . 81.7 m -108.99 159.91 16.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.128 0.49 . . . . 0.0 112.29 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.99 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -138.28 153.04 49.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.633 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 6.2 t -104.05 117.92 35.44 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.545 0.688 . . . . 0.0 110.806 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.7 mp -88.89 119.93 36.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.424 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.8 -115.97 1.86 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 58.51 33.84 23.43 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.773 0.32 . . . . 0.0 111.198 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.21 45.03 92.86 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.397 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 -67.54 0.59 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.34 56.01 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 121.192 -0.527 . . . . 0.0 112.142 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.7 143.29 9.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.754 0.422 . . . . 0.0 111.737 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.46 120.01 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.257 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.571 ' HB3' HD13 ' A' ' 95' ' ' ILE . 2.0 t -111.21 111.89 23.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.7 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.4 m -121.36 127.72 51.53 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.2 p -138.91 138.98 37.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.926 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -45.37 155.86 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.292 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.59 155.29 17.37 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.81 70.94 7.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.449 ' HA ' HD12 ' A' ' 119' ' ' ILE . 91.3 mtm-85 -150.08 168.14 24.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.9 p -117.16 125.4 51.15 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.787 0.327 . . . . 0.0 110.126 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.574 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -129.76 166.42 19.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.617 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.574 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 15.1 pt-20 167.3 138.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.266 0.354 . . . . 0.0 110.923 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -37.6 3.25 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.505 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.54 -94.77 0.1 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.44 177.93 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.29 0.236 . . . . 0.0 111.306 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.4 p -120.1 125.51 48.44 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 111.492 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -95.56 157.3 15.96 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.635 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -93.06 174.53 7.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.5 mp -74.08 124.5 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.3 -4.85 82.87 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.794 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.97 160.45 30.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.82 0.31 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.763 HG22 HG23 ' A' ' 137' ' ' VAL . 18.8 p -130.9 145.42 52.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.9 p90 -136.75 53.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.355 0.598 . . . . 0.0 109.619 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.33 102.85 0.06 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.745 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 126' ' ' PRO . 97.5 mtt180 -134.92 161.77 61.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.762 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 125' ' ' ARG . 37.4 Cg_exo -40.28 174.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.176 2.584 . . . . 0.0 113.879 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.5 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.1 t60 -100.15 128.17 46.27 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 111.877 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -72.57 -32.68 66.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.718 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.447 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 16.0 p -112.42 18.43 18.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.326 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -145.21 174.62 25.18 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.582 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.87 29.11 8.32 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.122 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -136.82 162.93 31.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.491 0.186 . . . . 0.0 110.705 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 18.3 ptt? -70.93 117.16 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.243 0.544 . . . . 0.0 110.774 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.563 HD12 ' HB3' ' A' ' 150' ' ' PRO . 23.3 tp -91.67 145.47 24.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.717 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 5.1 pt-20 -129.59 116.12 18.41 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -120.8 157.34 29.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.763 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.65 173.28 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.271 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.421 ' N ' HG13 ' A' ' 137' ' ' VAL . 18.3 t -128.36 117.81 22.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.759 0.314 . . . . 0.0 110.761 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.2 mt -111.66 113.86 26.52 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.464 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.97 70.45 0.94 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 -53.31 3.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.542 0.21 . . . . 0.0 111.07 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.48 -65.36 0.97 Allowed Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.516 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 pttt -144.5 -44.59 0.25 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.417 0.151 . . . . 0.0 111.316 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -178.21 83.56 0.07 OUTLIER Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.91 159.23 18.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.23 163.79 31.92 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.5 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -146.82 126.6 13.47 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.3 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 136' ' ' CYS . 0.0 OUTLIER -124.62 149.31 47.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 110.932 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -136.36 88.74 20.24 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.837 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.563 ' HB3' HD12 ' A' ' 134' ' ' LEU . 29.2 Cg_endo -67.44 168.96 16.6 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 113.645 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.052 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 120.649 0.261 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -79.13 91.68 4.95 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 111.217 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -138.17 148.93 45.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.7 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.93 135.39 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 89.5 t80 -110.19 126.39 54.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 11.1 t70 -102.21 96.87 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.775 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 47.9 pttt -47.69 -29.38 2.99 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 84.8 m-85 -67.46 -39.87 85.32 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.6 p -87.19 -51.09 6.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 8.75 37.8 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.832 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -119.56 153.33 35.58 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.793 0.296 . . . . 0.0 110.786 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 159.81 14.71 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.08 139.71 39.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.806 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -78.76 165.08 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 95' ' ' ILE . 57.8 t -53.53 137.12 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 0.0 111.621 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.21 32.27 63.0 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.101 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.34 120.89 42.69 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.996 HG22 HG23 ' A' ' 93' ' ' THR . 22.0 p -105.26 150.19 25.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 0.0 110.906 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -153.3 179.14 9.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.96 126.83 53.51 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -126.07 126.03 24.76 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.911 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.5 Cg_endo -78.43 116.93 3.94 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.982 1.788 . . . . 0.0 111.347 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -119.02 123.65 45.04 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.262 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 42.51 74.31 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 t 46.63 42.21 11.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 29.7 ttp -154.59 164.76 38.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mm -110.32 136.58 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 20.7 m95 -121.9 159.92 25.86 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.04 108.24 18.39 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 88.6 m -108.35 162.93 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.996 HG23 HG22 ' A' ' 80' ' ' THR . 0.3 OUTLIER -141.57 151.68 43.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.11 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.15 114.41 28.59 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 77' ' ' VAL . 16.3 mm -74.47 -61.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.125 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.0 129.06 0.05 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.42 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -170.85 55.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.461 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.36 61.45 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.258 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -175.93 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.458 0.303 . . . . 0.0 111.807 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.72 80.83 0.96 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.419 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -90.0 131.99 35.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.634 0.255 . . . . 0.0 111.077 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.61 126.82 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.295 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -127.18 111.22 13.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.9 m -116.53 139.05 50.91 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.6 p -139.84 138.92 36.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.959 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.5 mt -48.7 148.05 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.11 148.37 34.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -93.28 59.25 2.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.19 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -149.15 177.38 9.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.686 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 85.8 m -110.11 128.19 55.31 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.507 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -138.94 145.36 39.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.507 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 10.6 pt-20 170.9 166.82 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.304 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.35 -93.52 1.64 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.596 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.86 0.59 1.2 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.05 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.18 -178.32 5.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.8 t -119.04 127.21 53.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.555 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.1 m-85 -104.37 159.74 15.48 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.158 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 5.2 mmtp -105.82 164.13 12.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.4 124.53 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.514 0.197 . . . . 0.0 111.409 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.3 63.0 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.355 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -71.95 159.68 33.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.388 0.594 . . . . 0.0 111.473 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.572 HG22 HG12 ' A' ' 137' ' ' VAL . 2.5 p -130.96 152.25 50.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.13 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -144.38 98.34 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 109.977 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -92.37 87.13 5.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.426 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 126' ' ' PRO . 1.0 OUTLIER -120.74 167.41 13.01 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.698 179.216 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 45.3 Cg_exo -43.15 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.0 2.467 . . . . 0.0 113.633 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.49 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.4 t60 -100.95 129.81 46.86 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 112.194 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.25 -40.33 93.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 74.0 p -112.49 20.04 17.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.777 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.461 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -144.14 173.71 24.76 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.557 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.78 30.89 7.44 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.348 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -136.15 164.52 27.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.427 0.156 . . . . 0.0 110.712 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 12.3 mtt -72.9 116.16 13.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.082 0.467 . . . . 0.0 110.472 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 150' ' ' PRO . 21.2 tp -92.23 144.56 25.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.573 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 37.4 mt-10 -120.93 115.69 23.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 92.1 m -112.73 158.2 20.36 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.98 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -135.33 169.36 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.864 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 t -138.33 123.65 19.37 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.872 0.367 . . . . 0.0 111.301 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.22 143.83 42.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.453 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.93 77.65 1.86 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.722 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 122.98 12.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.612 0.244 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.8 -90.93 1.47 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.731 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 43.36 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.04 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.696 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.78 127.59 35.99 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.708 0.29 . . . . 0.0 110.572 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -109.53 167.64 9.99 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.98 HG22 HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -149.79 145.98 26.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -141.76 149.94 41.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.427 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -135.23 90.59 20.66 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.615 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.526 ' HB3' HD12 ' A' ' 134' ' ' LEU . 38.4 Cg_endo -70.96 161.42 46.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.484 2.123 . . . . 0.0 113.63 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.011 179.183 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.671 0.272 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.98 143.48 35.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.411 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 5.0 p -125.53 142.3 51.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 147.03 43.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.963 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.2 t80 -121.75 121.13 36.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.731 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 21.9 t70 -104.94 96.38 6.5 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 51.7 pttt -48.97 -17.98 0.25 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.495 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 4.6 m-30 -65.49 -46.19 80.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.662 0.268 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.5 p -86.7 -50.03 7.06 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.26 6.73 33.54 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.207 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.95 150.23 39.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.981 0.391 . . . . 0.0 111.147 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.39 160.26 17.66 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' A' ' 68' ' ' ASP . 2.6 m-85 -134.96 131.01 36.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.563 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HG3' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -79.87 179.53 7.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.79 139.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.471 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.48 40.5 96.25 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.708 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.26 124.37 52.34 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.921 HG22 HG23 ' A' ' 93' ' ' THR . 28.7 p -105.62 149.72 26.07 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.892 0.377 . . . . 0.0 111.383 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -161.1 -178.58 6.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -118.39 132.18 56.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 111.023 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.495 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -124.24 124.23 25.87 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 88' ' ' MET . 81.1 Cg_endo -80.09 63.96 8.81 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 121.964 1.776 . . . . 0.0 112.48 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.52 128.47 36.45 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.864 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.5 t70 37.3 69.1 0.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.895 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m 46.08 47.62 12.85 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.415 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 42.5 ttp -160.51 135.81 7.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.37 132.64 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 111.522 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CH2' HG12 ' A' ' 106' ' ' ILE . 16.1 m95 -119.84 152.27 37.57 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -108.33 100.31 9.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.4 t -108.6 138.76 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.921 HG23 HG22 ' A' ' 80' ' ' THR . 1.7 m -116.54 148.18 41.09 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.67 117.7 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.731 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.1 mp -92.16 142.3 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.611 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.35 -129.62 1.04 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.521 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 62.42 110.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 111.536 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.63 -112.72 4.54 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -139.43 47.09 1.89 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.08 98.08 0.94 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.635 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -105.78 135.51 47.08 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.586 0.231 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.99 121.52 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.2 111.93 12.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.98 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 3.3 m -126.37 148.34 49.61 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 p -141.12 148.91 40.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.165 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.436 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -60.61 146.98 10.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.544 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.63 159.24 31.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.75 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.9 57.48 4.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.171 0.51 . . . . 0.0 110.596 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -144.4 171.6 14.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.9 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 2.3 p -123.23 128.47 50.05 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -134.43 154.4 51.41 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.229 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 7.3 tp10 167.35 140.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.867 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.73 -8.71 54.82 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.417 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.0 -17.79 7.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.089 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -126.04 165.44 18.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.844 0.322 . . . . 0.0 110.34 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.51 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.4 t -108.87 125.72 52.29 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.4 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.02 158.86 16.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.215 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 25.8 mtmt -99.37 161.74 13.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.454 HG23 ' HA3' ' A' ' 140' ' ' GLY . 38.0 mm -55.19 124.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.509 0.195 . . . . 0.0 111.349 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.13 -12.2 70.34 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.767 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -60.23 167.28 2.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.575 0.688 . . . . 0.0 111.777 -178.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.416 HG22 ' CG2' ' A' ' 137' ' ' VAL . 57.1 p -142.67 144.72 32.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.254 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.433 ' CG ' ' O ' ' A' ' 123' ' ' TRP . 17.5 p90 -149.74 96.61 2.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.042 0.449 . . . . 0.0 109.97 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -91.73 76.38 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 111.008 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 126' ' ' PRO . 89.1 mtt180 -108.15 163.45 16.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.094 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 125' ' ' ARG . 52.4 Cg_exo -41.08 179.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.301 2.667 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.649 ' CD2' HD22 ' A' ' 134' ' ' LEU . 15.7 t-160 -100.6 127.41 46.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.674 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.43 -34.21 72.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.742 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.415 ' H ' ' CD2' ' A' ' 127' ' ' HIS . 22.6 p -111.96 19.0 18.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.361 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.92 171.18 28.48 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.478 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -108.79 28.48 11.28 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.689 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -134.35 162.2 32.87 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.726 0.263 . . . . 0.0 110.906 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 13.1 mtt -68.59 120.74 15.09 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.317 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.649 HD22 ' CD2' ' A' ' 127' ' ' HIS . 22.3 tp -100.93 144.12 30.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 4.4 pt-20 -120.62 115.81 24.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.67 158.32 21.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 147' ' ' THR . 0.4 OUTLIER -131.81 160.32 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.372 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 121.76 37.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.709 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.0 mt -113.82 156.24 24.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.634 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.454 ' HA3' HG23 ' A' ' 119' ' ' ILE . . . -152.58 -132.77 1.83 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.034 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.58 33.33 18.35 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.915 0.388 . . . . 0.0 111.089 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.54 -52.2 0.1 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.685 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -147.67 -66.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.648 0.224 . . . . 0.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.34 79.32 0.07 OUTLIER Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.483 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -112.09 135.77 52.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 111.252 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -109.84 166.79 10.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -152.18 137.31 17.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.515 -179.116 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.95 149.95 49.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.165 0.507 . . . . 0.0 111.522 179.036 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.05 92.08 11.07 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.193 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HB3' HD12 ' A' ' 134' ' ' LEU . 38.2 Cg_endo -71.58 162.2 42.94 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.332 2.021 . . . . 0.0 113.836 -178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.012 179.246 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.57 0.224 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -102.13 158.66 16.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.214 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.1 p -128.34 155.43 44.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.186 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 75' ' ' TYR . 60.1 m -119.02 135.49 54.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.817 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.8 t80 -121.19 123.11 41.46 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -105.66 95.15 5.61 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.165 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 44.1 pttt -49.01 -21.56 0.71 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -66.3 -44.62 82.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.554 0.216 . . . . 0.0 110.7 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.497 ' HG1' ' HH ' ' A' ' 75' ' ' TYR . 17.1 p -86.8 -49.97 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.0 12.05 30.67 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.083 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -118.92 157.43 27.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.807 0.303 . . . . 0.0 110.64 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.95 159.64 14.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.497 ' HH ' ' HG1' ' A' ' 71' ' ' THR . 3.9 m-85 -135.84 127.8 29.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.98 153.28 32.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 77' ' ' VAL . 5.7 t -47.85 143.37 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.558 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 21.94 78.32 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -113.06 130.16 56.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.93 HG22 HG23 ' A' ' 93' ' ' THR . 21.1 p -105.69 150.27 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.369 . . . . 0.0 111.494 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -149.7 173.96 13.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.081 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.69 131.09 54.37 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.587 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -126.85 135.86 27.95 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.587 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 85.8 Cg_endo -81.53 62.44 8.32 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.945 1.763 . . . . 0.0 112.956 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 122.28 12.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.524 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 40.71 74.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.867 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 94.9 p 41.5 47.9 3.32 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 44.6 ttp -163.15 133.5 4.5 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.7 mm -74.07 137.31 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 111.07 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.434 ' CH2' HG12 ' A' ' 106' ' ' ILE . 17.9 m95 -122.63 164.73 17.68 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.978 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 80' ' ' THR . 48.9 m -108.61 161.19 15.31 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.93 HG23 HG22 ' A' ' 80' ' ' THR . 0.9 OUTLIER -142.2 153.98 44.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.223 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.3 t -103.33 113.23 26.56 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.94 -31.59 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.133 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.14 177.8 44.68 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.615 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.76 150.21 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.926 0.393 . . . . 0.0 111.678 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.38 39.97 41.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.679 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.02 37.1 21.41 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.708 0.29 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.86 71.46 1.13 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.605 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -80.21 149.1 30.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.818 0.309 . . . . 0.0 110.762 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.83 130.27 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.792 0.329 . . . . 0.0 111.337 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.61 111.46 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 88.3 m -117.4 145.17 44.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 p -140.05 137.97 35.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.031 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.434 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -53.08 143.84 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.04 168.07 10.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.807 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.538 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -93.33 43.79 1.13 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -134.29 159.34 41.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.943 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.6 p -112.14 126.34 55.09 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.452 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.568 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -128.93 164.16 23.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.566 -178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 41.2 tt0 165.41 126.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.441 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.39 -99.0 0.87 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.727 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.5 -17.7 1.36 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -131.9 179.03 6.32 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.223 0.512 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 27.5 t -112.94 125.43 54.38 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.981 0.419 . . . . 0.0 111.156 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -102.12 159.42 15.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -105.23 161.08 14.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 108' ' ' ASN . 1.5 mp -59.17 124.7 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.651 0.262 . . . . 0.0 110.962 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.64 -22.24 41.36 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.223 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 152.15 44.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.973 0.416 . . . . 0.0 111.649 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.715 HG22 HG23 ' A' ' 137' ' ' VAL . 44.0 p -116.34 152.76 33.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.41 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.415 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 18.5 p90 -147.11 81.12 1.54 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.21 0.529 . . . . 0.0 109.866 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -84.7 76.01 10.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.214 -178.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 126' ' ' PRO . 14.6 mtt85 -110.66 171.05 4.66 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.689 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 42.5 Cg_exo -43.0 179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.93 2.42 . . . . 0.0 113.473 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.484 ' HD1' HD22 ' A' ' 134' ' ' LEU . 3.7 t60 -103.8 136.37 43.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.43 0.634 . . . . 0.0 112.707 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.43 -40.09 62.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.373 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 61.1 p -109.09 18.25 20.79 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.84 -79.98 0.07 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.486 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 137.58 29.87 0.27 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 150' ' ' PRO . 2.8 p90 -135.52 151.45 50.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 122.878 0.471 . . . . 0.0 109.765 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.8 ttt -57.72 107.2 0.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.484 HD22 ' HD1' ' A' ' 127' ' ' HIS . 15.0 tp -91.73 144.84 25.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.974 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 30.5 mt-10 -124.56 115.88 21.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.9 OUTLIER -125.72 157.5 37.22 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.715 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -128.35 171.65 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.254 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.1 t -139.58 124.02 18.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.709 0.29 . . . . 0.0 110.903 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.07 133.16 54.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.29 76.59 1.91 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.726 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -42.47 11.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.53 0.205 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.58 -54.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.679 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -106.21 -55.48 2.32 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.41 54.51 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.12 154.03 32.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.771 0.319 . . . . 0.0 111.328 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -142.27 161.71 37.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.611 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.57 127.73 16.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.88 149.73 50.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 0.0 111.749 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -124.78 81.16 61.67 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.61 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HB2' ' CE1' ' A' ' 132' ' ' TYR . 12.9 Cg_endo -67.08 168.01 18.52 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.754 2.303 . . . . 0.0 114.479 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.977 178.696 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.712 0.292 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.64 169.99 13.79 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.352 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 p -129.43 145.69 51.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.039 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.3 m -118.49 134.48 55.04 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 83.8 t80 -110.0 124.57 51.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 12.8 t70 -97.8 97.58 9.11 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 10.8 ptmt -51.47 -28.74 14.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.524 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 82.5 m-85 -66.98 -45.8 76.55 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.67 0.271 . . . . 0.0 111.315 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.1 p -82.06 -51.05 8.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.323 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.16 5.69 43.25 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.29 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -116.86 143.7 45.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.07 0.435 . . . . 0.0 110.436 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.89 159.76 20.28 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.876 0.37 . . . . 0.0 110.907 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.4 ' HE2' ' CB ' ' A' ' 68' ' ' ASP . 9.5 m-85 -136.27 130.3 32.8 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -75.08 153.01 38.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 21.8 t -50.27 144.06 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.188 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.67 79.17 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.269 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.81 125.87 54.82 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.923 HG22 HG23 ' A' ' 93' ' ' THR . 21.4 p -104.98 129.36 53.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.905 0.384 . . . . 0.0 111.134 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 39.9 p90 -122.49 -173.65 2.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.782 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.3 mp0 -127.69 138.55 52.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.838 0.351 . . . . 0.0 110.935 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.576 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -141.04 130.44 12.85 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 88' ' ' MET . 61.3 Cg_endo -77.17 64.99 7.91 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.762 1.641 . . . . 0.0 112.851 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.91 130.37 45.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.349 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 55.65 -77.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.855 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 85' ' ' LYS . 78.4 p -158.26 30.94 0.24 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.064 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -146.89 159.13 43.91 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.7 mm -89.7 112.29 24.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.467 ' CZ2' HG12 ' A' ' 106' ' ' ILE . 28.5 m95 -98.5 144.96 27.27 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.0 111.929 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.18 106.79 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 m -107.28 165.02 11.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.469 . . . . 0.0 112.034 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.923 HG23 HG22 ' A' ' 80' ' ' THR . 0.3 OUTLIER -136.52 154.68 50.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.629 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 3.7 t -102.47 114.17 28.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.475 0.655 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 95' ' ' ILE . 2.0 mp -105.74 74.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.834 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.63 139.07 15.67 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.227 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.65 45.56 0.3 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.897 0.379 . . . . 0.0 110.571 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.75 8.52 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.298 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.14 -37.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.26 85.33 0.99 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.166 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt85 -104.69 135.27 46.4 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.735 0.303 . . . . 0.0 111.283 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.75 129.98 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.35 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.419 ' HB3' HD13 ' A' ' 95' ' ' ILE . 30.2 t -124.45 110.48 14.56 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.269 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 69.3 m -111.22 131.15 55.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.365 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.3 p -137.73 132.96 33.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.467 HG12 ' CZ2' ' A' ' 90' ' ' TRP . 2.7 mt -51.23 142.07 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.927 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.27 19.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 111.489 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -86.54 64.74 8.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -147.0 174.26 11.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.308 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 117' ' ' TYR . 24.2 p -129.89 129.98 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 3.5 p-80 -134.94 -140.7 0.17 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.601 -0.237 . . . . 0.0 110.751 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.2 163.94 0.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.86 0.362 . . . . 0.0 111.455 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.94 -83.47 1.59 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.787 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.52 -35.33 0.1 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.26 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -131.27 -178.81 5.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.896 0.348 . . . . 0.0 110.754 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.426 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 4.1 p -107.7 126.67 52.88 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 110.725 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 110' ' ' CYS . 3.0 m-85 -106.65 157.81 17.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.541 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -104.16 158.34 16.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.1 mm -50.14 124.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.75 -9.5 75.52 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.733 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.11 154.57 39.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.402 0.601 . . . . 0.0 111.54 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 HG23 ' A' ' 137' ' ' VAL . 30.9 p -122.87 149.45 44.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.743 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.443 ' CG ' ' O ' ' A' ' 123' ' ' TRP . 12.4 p90 -147.69 82.41 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.298 0.57 . . . . 0.0 109.905 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -79.3 75.03 5.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.038 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.3 mtt180 -108.76 166.6 10.54 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 63.1 Cg_exo -41.93 178.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.087 2.525 . . . . 0.0 114.077 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.687 ' CD2' HD22 ' A' ' 134' ' ' LEU . 17.4 t-160 -103.54 124.42 48.75 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 111.58 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.43 -24.85 60.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.564 ' H ' ' CD2' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -110.08 14.43 22.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.128 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.71 -179.21 30.63 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.755 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -115.24 28.29 8.02 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.428 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.501 ' O ' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.01 155.44 49.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.546 0.212 . . . . 0.0 111.177 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.518 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 11.9 mtt -63.45 114.5 3.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.098 0.475 . . . . 0.0 110.595 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.687 HD22 ' CD2' ' A' ' 127' ' ' HIS . 23.9 tp -92.46 146.9 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.739 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 26.6 mt-10 -123.04 116.23 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -123.87 157.62 33.77 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.299 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.58 HG12 HG22 ' A' ' 147' ' ' THR . 0.3 OUTLIER -126.79 171.75 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.662 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 52.7 t -132.67 125.01 29.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.94 154.93 24.53 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.081 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -146.57 55.25 0.53 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.089 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.97 -51.55 7.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.723 0.297 . . . . 0.0 110.353 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.17 -44.97 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -140.53 157.42 45.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.391 0.276 . . . . 0.0 110.31 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.28 93.43 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -114.93 162.46 16.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.16 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -142.79 164.45 30.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.283 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.58 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -147.62 124.81 11.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.879 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -125.52 149.99 47.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.585 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -141.19 99.11 6.59 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.528 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.575 ' HB3' HD12 ' A' ' 134' ' ' LEU . 53.4 Cg_endo -77.01 170.3 20.02 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.419 2.079 . . . . 0.0 113.56 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.055 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.919 179.32 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.639 0.257 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -87.91 161.22 17.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.262 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.7 p -124.16 150.13 45.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.573 ' HB3' HD13 ' A' ' 102' ' ' ILE . 85.6 m -118.54 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.371 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -113.62 124.45 52.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.757 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -103.54 99.37 9.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.43 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -57.29 -16.14 7.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.065 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.582 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 5.4 m-30 -66.96 -46.08 75.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.169 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 83' ' ' ARG . 7.3 p -91.42 -54.87 3.73 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.782 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.94 11.4 12.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.363 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.63 155.5 32.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.165 0.483 . . . . 0.0 110.792 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.16 159.8 15.13 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.716 0.293 . . . . 0.0 110.253 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.457 ' HH ' ' HG1' ' A' ' 71' ' ' THR . 4.6 m-85 -138.8 129.03 25.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -73.89 154.19 39.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.485 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 5.0 t -52.23 136.5 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.915 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.86 21.47 71.34 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.0 123.49 50.45 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.957 HG22 HG23 ' A' ' 93' ' ' THR . 16.9 p -105.59 149.17 26.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.391 . . . . 0.0 111.351 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 26.4 p90 -145.83 -175.32 4.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.071 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.2 mp0 -121.05 131.68 54.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.592 ' HG2' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -129.77 132.33 24.11 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.456 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 88' ' ' MET . 56.4 Cg_endo -80.48 114.38 3.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.567 1.511 . . . . 0.0 110.859 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -116.14 113.5 23.19 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.845 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 49.42 77.29 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t 46.06 43.83 11.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 8.9 ttp -157.59 169.5 24.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.461 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -116.82 131.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 19.0 m95 -117.72 157.84 25.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.19 111.72 23.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -108.34 156.93 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.957 HG23 HG22 ' A' ' 80' ' ' THR . 0.9 OUTLIER -141.1 154.1 45.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.412 0.685 . . . . 0.0 110.648 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -102.87 113.06 26.19 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.435 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -80.74 -31.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.189 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.61 83.04 0.39 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.835 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.54 119.88 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.9 2.07 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.676 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.12 44.92 1.23 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.046 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.07 84.38 0.54 Allowed Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.5 121.96 17.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 66' ' ' CYS . 9.8 mm -103.0 121.97 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.476 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.435 ' HB3' HD13 ' A' ' 95' ' ' ILE . 6.5 t -127.83 110.53 12.69 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.395 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.4 m -107.83 133.73 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 111.29 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.3 p -138.56 133.15 32.19 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.706 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -43.57 155.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.17 148.59 22.26 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.7 60.01 5.37 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.068 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -150.06 176.98 10.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 9.5 p -120.15 127.29 52.36 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.558 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.5 OUTLIER -136.69 142.71 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.335 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 12.9 pt-20 171.88 159.54 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.59 -79.23 1.43 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.61 -8.84 0.11 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.798 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -142.89 -178.53 5.86 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 117.624 0.712 . . . . 0.0 110.51 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p -114.43 125.84 54.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.797 0.332 . . . . 0.0 110.661 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.06 157.31 17.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.425 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -106.2 156.43 18.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.9 mm -45.85 124.65 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.46 -6.13 71.04 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.633 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 156.86 33.89 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.483 0.641 . . . . 0.0 111.391 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.637 HG22 HG23 ' A' ' 137' ' ' VAL . 21.5 p -124.14 146.31 48.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -137.84 67.47 1.42 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 0.0 109.668 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.77 108.78 2.22 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.513 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -137.88 153.02 73.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.341 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 50.4 Cg_exo -42.42 143.71 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.081 2.521 . . . . 0.0 113.701 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.722 ' CD2' HD22 ' A' ' 134' ' ' LEU . 17.4 t-160 -67.74 127.24 32.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.076 0.465 . . . . 0.0 111.719 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -75.02 -35.51 61.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.288 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.2 p -109.21 17.23 21.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -124.77 -93.91 1.01 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.305 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.92 20.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.103 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -139.9 161.6 37.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.981 0.513 . . . . 0.0 109.65 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.8 ttt -64.71 110.24 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.343 0.592 . . . . 0.0 111.024 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.722 HD22 ' CD2' ' A' ' 127' ' ' HIS . 20.1 tp -92.17 145.67 24.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.581 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.4 pt-20 -128.13 115.68 18.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.0 m -108.59 157.96 18.01 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.075 0.464 . . . . 0.0 111.928 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -128.3 170.2 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.586 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -123.28 117.81 26.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.794 0.331 . . . . 0.0 111.373 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.08 119.36 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.17 122.05 6.68 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.865 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.19 34.83 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.971 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.9 43.26 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.694 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -163.63 -54.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.095 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.83 73.55 0.54 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.289 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.16 159.9 14.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 111.142 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.47 165.62 26.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.302 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -153.37 133.37 13.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -126.45 150.46 48.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.973 0.416 . . . . 0.0 111.295 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.97 90.84 13.7 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.254 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.516 ' HB3' HD12 ' A' ' 134' ' ' LEU . 24.2 Cg_endo -66.55 167.2 19.55 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.497 2.132 . . . . 0.0 113.746 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.249 1.032 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.998 179.341 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.647 0.26 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -79.59 154.6 28.62 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.275 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 p -123.9 142.11 51.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.671 ' HB3' HD13 ' A' ' 102' ' ' ILE . 3.6 m -118.41 134.45 55.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 74' ' ' THR . 94.2 t80 -111.74 131.63 55.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.41 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 23.3 t70 -108.07 104.83 14.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.148 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 16.3 ptpt -55.17 -24.68 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.497 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 27.0 m-85 -67.73 -46.84 71.01 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -82.94 -47.5 11.71 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.364 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.6 2.7 46.87 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.18 147.94 42.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.153 0.476 . . . . 0.0 110.983 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.5 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -90.09 159.79 16.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.969 0.414 . . . . 0.0 110.357 179.007 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.41 ' OH ' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -135.56 131.89 36.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.672 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -74.31 173.16 10.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 t -61.96 139.76 20.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.18 27.06 70.82 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.302 -0.475 . . . . 0.0 113.098 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.22 122.06 46.33 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.936 HG22 HG23 ' A' ' 93' ' ' THR . 18.0 p -105.61 141.42 37.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 110.825 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.9 p90 -138.31 -172.84 3.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.564 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.34 137.98 52.08 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.677 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -138.41 124.36 12.6 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -78.52 59.27 7.1 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.766 1.644 . . . . 0.0 113.21 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -64.49 143.73 57.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.6 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 33.91 57.0 0.6 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.4 m 53.16 35.84 20.9 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 ttp -146.73 152.72 39.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 mm -90.13 110.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.196 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.513 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 33.0 m95 -99.32 139.19 35.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.946 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -94.97 104.1 15.97 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 18.2 m -107.82 139.97 41.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.936 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -112.39 152.1 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 114.48 28.75 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 109.953 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.9 mp -102.11 95.39 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.488 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.54 78.98 1.44 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.646 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.75 -48.18 4.18 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.04 -68.52 0.87 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.412 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.11 48.84 0.98 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 111.161 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.22 77.56 0.69 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.602 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -89.6 141.78 28.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.65 0.262 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' A' ' 66' ' ' CYS . 8.4 mm -102.56 125.16 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.306 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.498 ' HB3' HD13 ' A' ' 95' ' ' ILE . 45.2 t -124.56 111.52 15.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.428 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 39.4 m -108.96 130.97 55.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.894 0.378 . . . . 0.0 111.838 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 p -135.92 128.75 31.11 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 mt -42.73 137.44 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.229 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.65 161.02 30.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.746 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -79.13 61.61 3.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -150.43 174.5 12.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 117' ' ' TYR . 20.7 p -128.87 129.74 45.94 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.85 157.21 47.41 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.365 -0.209 . . . . 0.0 111.488 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 1.2 pt-20 172.09 -66.79 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.62 91.44 1.07 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.915 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 -84.7 1.24 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.353 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -108.29 176.17 5.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.567 0.223 . . . . 0.0 110.72 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.9 t -84.98 128.29 34.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.562 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' CYS . 79.3 m-85 -93.62 129.11 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.624 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -81.64 167.33 19.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.192 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 18.8 mm -53.83 135.96 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.43 -4.13 43.64 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.16 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.43 158.53 16.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.323 0.562 . . . . 0.0 110.187 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.569 HG22 ' CG2' ' A' ' 137' ' ' VAL . 58.8 p -138.5 142.06 39.38 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.987 0.422 . . . . 0.0 111.812 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -147.29 123.35 10.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.617 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.93 139.1 53.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.538 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 126' ' ' PRO . 16.1 ptt-85 -174.48 157.6 2.42 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.051 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 125' ' ' ARG . 34.9 Cg_exo -41.23 171.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.141 2.56 . . . . 0.0 113.339 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.556 ' CD2' HD22 ' A' ' 134' ' ' LEU . 9.3 t-160 -105.24 116.63 32.28 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.27 -40.36 62.38 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.158 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.3 p -96.7 22.39 8.2 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.342 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.17 -159.86 9.22 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.945 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.8 35.84 2.0 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.17 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.85 146.05 27.78 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.6 mtp -56.52 106.73 0.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.979 0.419 . . . . 0.0 109.927 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.556 HD22 ' CD2' ' A' ' 127' ' ' HIS . 34.2 tp -92.8 145.5 24.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.387 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -141.32 117.48 10.64 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.1 m -117.6 158.59 24.35 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.569 ' CG2' HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -122.44 179.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.623 178.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.441 ' N ' HG13 ' A' ' 137' ' ' VAL . 9.4 t -113.9 118.06 33.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.494 0.588 . . . . 0.0 111.34 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.427 HD12 ' HB ' ' A' ' 147' ' ' THR . 2.1 mt -111.76 155.6 23.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.362 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.15 94.34 0.15 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.837 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.76 35.95 4.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.88 0.371 . . . . 0.0 110.797 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.71 41.56 10.84 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.565 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -160.6 -48.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.439 0.161 . . . . 0.0 111.413 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.78 61.22 0.65 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.288 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.85 155.65 30.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.61 171.44 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -130.77 127.95 39.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.029 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.59 150.96 48.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.008 0.432 . . . . 0.0 111.312 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -126.28 74.22 72.94 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.513 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 39.9 Cg_endo -72.8 144.65 39.42 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.743 2.295 . . . . 0.0 112.916 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.114 179.259 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.717 0.294 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -85.2 102.91 13.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.142 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -139.79 152.22 46.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.916 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.0 m -118.27 134.46 55.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 87.2 t80 -113.39 121.83 45.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.32 96.15 7.54 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 61.3 pttt -49.14 -23.86 1.43 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 83' ' ' ARG . 20.7 m-85 -66.33 -46.67 76.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.512 0.196 . . . . 0.0 111.524 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.2 p -86.38 -49.66 7.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.077 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.55 11.23 31.49 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.804 -0.634 . . . . 0.0 113.015 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -118.17 148.39 42.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.795 0.298 . . . . 0.0 110.356 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.35 159.57 17.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 110.385 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -135.97 129.4 32.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -75.84 150.98 37.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 77.9 t -47.89 143.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.795 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.89 79.67 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.624 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -112.54 128.9 56.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.945 HG22 HG23 ' A' ' 93' ' ' THR . 19.0 p -105.33 149.71 25.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.593 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.514 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 33.1 p90 -144.73 174.82 10.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.626 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -118.52 131.9 56.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.524 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -134.26 135.6 24.4 Favored Pre-proline 0 N--CA 1.462 0.171 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 88' ' ' MET . 67.5 Cg_endo -83.61 65.11 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.77 1.647 . . . . 0.0 112.755 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.57 125.25 21.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.61 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 t70 59.33 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.075 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' LYS . 11.1 t -165.11 38.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.416 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 3.3 ttp -149.37 154.27 38.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mm -90.78 111.94 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 28.6 m95 -99.39 155.9 17.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -118.13 107.18 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 9.6 m -107.75 167.82 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 112.01 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.945 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.6 154.47 45.43 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 109.993 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.0 t -103.51 114.39 28.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.404 0.621 . . . . 0.0 109.479 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.9 mp -84.29 -52.66 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.44 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.77 63.22 4.8 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.852 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.32 -53.81 4.63 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.63 -61.69 0.66 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.313 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 54.14 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.32 83.51 0.65 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.541 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -96.59 135.36 38.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.48 128.69 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.461 ' HB3' HD13 ' A' ' 95' ' ' ILE . 8.8 t -129.29 111.08 12.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.099 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.59 138.19 46.32 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.5 p -139.24 132.26 29.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.21 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.445 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -49.93 146.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.34 167.86 19.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.538 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.09 52.78 2.2 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.999 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.8 mtm-85 -141.18 162.79 34.64 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 7.0 p -117.95 126.66 52.76 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.37 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.636 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -131.96 156.1 46.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.014 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 6.9 tp10 167.66 141.29 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.244 0.34 . . . . 0.0 111.033 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.14 -71.84 2.91 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.286 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.02 -97.59 2.07 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.456 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -96.05 -177.78 4.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.7 p -92.81 124.52 36.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.829 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.25 158.73 16.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.803 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -98.14 153.87 18.14 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.913 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.34 124.33 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.575 0.226 . . . . 0.0 111.128 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.81 -14.9 64.48 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.467 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.8 164.25 26.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.297 0.548 . . . . 0.0 111.838 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.722 HG22 HG23 ' A' ' 137' ' ' VAL . 34.3 p -126.46 147.43 49.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.993 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -138.61 34.84 2.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.601 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -50.52 119.14 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.702 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 126' ' ' PRO . 29.9 mmt180 -140.71 162.04 51.04 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.248 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 125' ' ' ARG . 59.5 Cg_exo -41.01 172.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.889 2.392 . . . . 0.0 113.825 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.502 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 1.4 t60 -86.27 124.54 32.77 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.16 -32.66 65.0 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.103 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.414 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 4.5 p -108.67 18.9 20.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.3 -176.7 30.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.587 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.86 31.15 6.97 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.884 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.502 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 17.5 p90 -130.72 161.07 32.49 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 151' ' ' ILE . 66.7 mtp -70.98 138.73 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.3 tp -123.16 140.86 52.59 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.601 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 32.2 mt-10 -127.12 116.39 20.59 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 119.833 -0.127 . . . . 0.0 110.704 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.1 m -107.32 158.12 17.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 111.724 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.722 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -134.38 165.09 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.455 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 118.33 27.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.807 0.337 . . . . 0.0 111.288 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.82 113.53 25.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.78 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.29 104.34 1.8 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.003 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.37 38.6 4.15 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.625 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.79 29.88 7.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.57 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -164.14 -54.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.725 0.262 . . . . 0.0 111.056 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.83 73.64 0.86 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.475 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.0 167.95 9.71 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.05 163.93 31.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.413 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.491 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -152.28 138.59 18.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -132.85 151.32 52.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.341 0.591 . . . . 0.0 112.391 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -125.62 111.94 25.35 Favored Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 151' ' ' ILE . 73.1 Cg_endo -74.15 170.51 19.99 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.019 1.813 . . . . 0.0 114.307 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 150' ' ' PRO . 1.1 tp . . . . . 0 C--O 1.25 1.083 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.315 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.708 0.289 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -123.12 159.71 27.97 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.398 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.6 p -131.82 144.27 50.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.86 134.73 54.65 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -111.11 122.13 47.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -99.58 98.44 9.31 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -55.23 -17.7 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.556 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 1.3 m-85 -67.28 -45.77 75.61 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.316 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.6 -52.87 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.99 12.99 16.86 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.432 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.37 148.3 42.65 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.028 0.414 . . . . 0.0 110.259 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.43 159.51 17.97 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.374 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.3 129.69 29.7 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 147.74 38.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.489 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.23 141.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.14 -177.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.32 16.74 75.53 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.563 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -112.67 126.97 55.97 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.981 HG22 HG23 ' A' ' 93' ' ' THR . 18.9 p -105.2 132.92 50.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.895 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 34.3 p90 -128.53 -177.55 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.744 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.9 mt-10 -124.45 135.41 53.23 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.895 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.556 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -141.33 147.34 46.36 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.778 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 88' ' ' MET . 94.5 Cg_endo -84.86 124.41 2.99 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.143 1.895 . . . . 0.0 111.444 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -117.58 113.93 22.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.458 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 67.06 -67.88 0.16 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 m -162.94 31.54 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -144.71 167.04 23.52 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.689 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.48 116.99 47.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 17.6 m95 -99.3 154.34 18.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.92 110.15 20.6 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 46.7 m -108.83 166.89 10.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 112.214 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.981 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.15 152.76 44.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.648 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -104.41 113.9 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.94 -43.52 24.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.913 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 54.26 63.63 5.01 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.984 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -97.38 -52.06 3.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.651 0.262 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.66 -67.9 0.49 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.337 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.84 44.62 2.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.39 73.13 0.87 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.659 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -77.13 136.68 38.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.047 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.78 123.87 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.481 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 t -118.94 110.53 17.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.7 m -117.05 131.88 56.82 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.8 p -139.89 138.03 35.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.65 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.02 152.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.03 155.98 21.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.813 0.339 . . . . 0.0 111.9 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.62 56.89 3.71 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.294 0.568 . . . . 0.0 110.256 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -148.21 171.58 15.7 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.034 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 12.2 p -120.23 127.09 52.1 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.582 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.64 149.96 49.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.713 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.582 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 0.0 OUTLIER 169.11 152.37 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.671 0.272 . . . . 0.0 111.362 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.75 -36.8 3.63 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.243 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.46 -10.47 0.29 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.282 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -134.65 175.02 9.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.171 0.486 . . . . 0.0 110.18 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 12.4 p -114.23 125.84 54.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.999 0.428 . . . . 0.0 111.161 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.91 158.02 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.459 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -105.21 158.04 16.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.907 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.5 mp -52.15 124.58 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.58 0.228 . . . . 0.0 110.767 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.6 -12.82 61.32 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.241 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 156.6 30.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.216 0.508 . . . . 0.0 111.135 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 137' ' ' VAL . 1.5 p -127.97 150.62 49.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.573 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.402 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 17.8 p90 -142.56 86.49 1.95 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.145 0.498 . . . . 0.0 109.811 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -78.66 91.07 4.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 126' ' ' PRO . 20.4 mtt-85 -123.12 163.92 30.67 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.826 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 43.3 Cg_exo -43.01 176.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.082 2.521 . . . . 0.0 113.809 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.655 ' CD2' HD22 ' A' ' 134' ' ' LEU . 16.3 t-160 -101.4 126.43 48.17 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 111.837 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -69.68 -36.56 76.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.794 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.9 p -108.5 18.6 20.75 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.52 175.62 25.86 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.575 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -113.78 28.79 8.24 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.302 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.46 ' O ' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -136.09 159.55 41.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.658 0.229 . . . . 0.0 111.055 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.2 mtt -67.59 114.57 6.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.096 0.474 . . . . 0.0 110.749 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.655 HD22 ' CD2' ' A' ' 127' ' ' HIS . 22.4 tp -91.76 145.85 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.618 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.2 mt-10 -121.96 115.52 22.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 94.3 m -111.35 158.13 19.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.996 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -134.79 171.15 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.889 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 t -133.02 118.36 18.71 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.752 0.311 . . . . 0.0 111.517 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.4 118.83 36.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.403 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.0 97.97 2.32 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.75 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -138.46 52.7 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.71 -76.66 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.492 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -130.08 -42.75 1.22 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.539 0.209 . . . . 0.0 111.393 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.78 91.17 0.08 OUTLIER Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.534 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.9 153.78 20.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.703 0.287 . . . . 0.0 110.823 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -137.22 164.79 27.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.996 HG22 HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -150.78 146.32 26.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -141.3 149.84 41.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.031 0.443 . . . . 0.0 111.393 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -135.3 90.94 19.64 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.545 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 134' ' ' LEU . 36.9 Cg_endo -70.6 168.06 23.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.478 2.119 . . . . 0.0 113.655 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.955 179.283 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.611 0.243 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HB2' HG22 ' A' ' 77' ' ' VAL . 1.4 mp0 -65.14 145.07 56.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.683 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.6 p -132.23 139.1 48.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.167 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.88 136.42 54.05 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.443 ' HB2' HG23 ' A' ' 74' ' ' THR . 94.8 t80 -112.81 131.68 55.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.402 ' HB2' ' HE2' ' A' ' 75' ' ' TYR . 40.7 t0 -108.41 105.08 14.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.209 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -59.08 -17.54 26.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -69.16 -45.89 68.9 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -89.15 -47.88 7.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.71 6.4 40.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.431 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.92 151.31 38.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.098 0.449 . . . . 0.0 110.833 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -92.78 159.62 15.32 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.118 178.507 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.402 ' HE2' ' HB2' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -136.32 131.78 34.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.301 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -76.73 157.79 31.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -46.87 135.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.155 -178.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 29.65 59.02 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.261 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -113.54 120.53 41.27 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.023 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 1.01 HG22 HG23 ' A' ' 93' ' ' THR . 15.9 p -105.88 149.54 26.45 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.3 p90 -154.61 -173.71 4.68 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -115.38 133.88 55.62 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.303 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.94 136.88 28.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 88' ' ' MET . 80.2 Cg_endo -79.5 114.3 3.24 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 121.779 1.653 . . . . 0.0 112.837 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -117.15 107.57 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 49.53 77.87 0.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m 49.25 43.48 22.88 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.634 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 39.9 ttp -164.44 162.05 21.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.23 144.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m95 -120.27 152.45 37.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.498 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.32 102.47 14.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 80' ' ' THR . 61.1 m -108.04 139.28 42.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 112.594 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.01 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -115.21 152.34 32.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.882 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.75 114.45 28.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.661 0.743 . . . . 0.0 110.237 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.71 112.06 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.192 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.97 62.64 0.29 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.682 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.02 -56.11 10.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.902 0.382 . . . . 0.0 110.303 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.96 -41.31 4.38 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.548 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.4 -87.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.552 0.341 . . . . 0.0 110.181 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.403 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -144.39 56.34 0.55 Allowed Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.761 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -62.13 143.04 57.24 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.639 0.257 . . . . 0.0 111.466 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 100' ' ' GLY . 2.9 mp -107.82 129.46 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.5 t -126.5 120.11 28.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 57.0 m -119.11 135.38 54.68 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.9 p -140.09 139.96 35.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.92 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.99 158.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.382 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.16 161.24 13.81 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.05 67.5 10.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.37 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -148.47 173.32 13.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.982 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 10.0 p -126.21 127.55 45.83 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.552 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.31 169.37 17.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.281 -179.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 13.7 pt-20 170.68 -51.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.96 0.162 . . . . 0.0 111.166 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -81.88 70.15 3.18 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.74 0.46 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.839 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.89 -177.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.877 0.471 . . . . 0.0 111.882 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -119.29 127.05 52.85 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.137 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -96.24 152.15 18.84 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.504 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -89.28 -177.98 5.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.01 124.21 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.06 -3.65 82.67 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.033 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.8 163.73 25.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.576 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.665 HG22 HG23 ' A' ' 137' ' ' VAL . 28.5 p -131.82 147.74 52.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.29 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 20.3 p90 -142.76 67.05 1.31 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.385 0.612 . . . . 0.0 109.735 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.09 90.08 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.453 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 126' ' ' PRO . 26.3 mtt-85 -121.93 167.86 12.78 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.886 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 65.5 Cg_exo -43.92 178.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.984 2.456 . . . . 0.0 113.877 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.662 ' CD2' HD22 ' A' ' 134' ' ' LEU . 16.4 t-160 -103.06 127.98 50.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -70.79 -35.31 72.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.704 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.432 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 19.4 p -109.99 18.55 19.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.369 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.95 174.7 26.68 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.557 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.92 28.99 8.38 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.404 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.479 ' O ' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -135.53 159.53 41.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.574 0.226 . . . . 0.0 110.936 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 18.2 mtm -67.27 116.01 7.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.662 HD22 ' CD2' ' A' ' 127' ' ' HIS . 26.8 tp -91.96 146.25 23.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.912 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 34.9 mt-10 -124.32 116.11 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -122.46 157.53 31.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.665 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.62 168.11 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 117.95 24.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.592 0.234 . . . . 0.0 111.056 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.41 120.98 43.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -84.26 -146.57 7.63 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.66 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.88 -64.79 0.36 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.639 0.375 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.95 -94.2 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.836 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -154.93 68.19 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 54.57 34.04 55.08 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.166 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.21 121.67 18.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.731 0.3 . . . . 0.0 110.868 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 166.26 11.3 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -146.83 127.5 14.26 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.107 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 136' ' ' CYS . 0.0 OUTLIER -125.35 149.46 48.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.467 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -139.71 96.51 8.45 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.774 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.562 ' HB3' HD12 ' A' ' 134' ' ' LEU . 55.9 Cg_endo -75.53 169.28 22.69 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.37 2.047 . . . . 0.0 113.523 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.035 179.304 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.653 0.263 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.89 160.62 19.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.054 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p -124.53 152.95 42.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.152 0.501 . . . . 0.0 111.2 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' TYR . 68.0 m -119.48 138.64 53.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.046 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -121.17 127.92 51.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.38 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -111.68 109.19 18.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.39 -13.49 51.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.575 0.226 . . . . 0.0 111.592 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.607 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 4.0 m-30 -68.86 -43.27 75.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.857 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -94.85 -50.0 5.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.76 5.12 33.87 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.856 -0.611 . . . . 0.0 114.036 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.422 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.2 m120 -117.18 141.44 48.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.714 0.757 . . . . 0.0 111.297 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.85 160.35 29.31 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.99 0.424 . . . . 0.0 110.97 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' A' ' 66' ' ' CYS . 6.5 m-85 -134.61 129.01 34.29 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.909 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -78.27 143.4 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 79.9 t -47.73 123.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.022 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.57 36.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.791 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -113.02 124.07 51.76 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.968 HG22 HG23 ' A' ' 93' ' ' THR . 11.9 p -105.81 144.42 32.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.075 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 34.6 p90 -138.89 -175.08 4.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.6 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.1 mt-10 -122.4 126.55 48.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.71 0.291 . . . . 0.0 110.769 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.607 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -120.08 128.98 25.57 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -87.19 98.46 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.082 1.854 . . . . 0.0 111.319 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 114.22 27.7 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 47.65 79.84 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.4 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.7 m 45.16 40.35 4.8 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.843 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -150.82 162.09 41.43 Favored 'General case' 0 C--N 1.335 -0.053 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.676 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mm -114.39 132.55 63.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.556 ' CH2' HG12 ' A' ' 106' ' ' ILE . 26.4 m95 -117.48 135.29 54.02 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -97.7 104.25 16.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' THR . 15.0 t -107.63 153.56 22.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.968 HG23 HG22 ' A' ' 80' ' ' THR . 0.6 OUTLIER -134.54 154.04 51.65 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.245 -179.209 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 8.9 t -101.74 113.45 26.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -54.37 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.095 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 56.25 60.89 8.15 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.001 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.32 -45.58 54.48 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.667 0.27 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.58 -58.91 0.72 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 67.14 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.18 93.37 0.48 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.751 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -120.06 151.78 38.51 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.87 119.46 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.078 0.399 . . . . 0.0 110.467 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.98 115.44 17.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.115 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 2.8 m -130.84 144.01 51.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.7 p -139.65 153.44 47.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.44 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.556 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -69.41 -168.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.669 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 106' ' ' ILE . . . 70.68 -164.93 0.15 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 52.0 m-80 82.33 -25.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.281 0.632 . . . . 0.0 111.671 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -138.35 152.65 48.64 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 117' ' ' TYR . 4.3 p -110.22 123.09 49.14 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.928 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -135.61 -174.7 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 25.2 tt0 169.41 123.95 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.735 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 68.88 165.82 4.1 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.249 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -31.46 -31.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 113' ' ' GLY . 52.0 mt-30 -93.53 127.18 39.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.155 0.977 . . . . 0.0 111.641 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -95.46 153.76 17.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.431 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 110' ' ' CYS . 13.1 m-85 -140.35 146.62 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.625 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -94.69 178.73 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.886 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.05 124.13 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.631 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.47 -3.72 84.03 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.243 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.74 151.62 28.97 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.13 0.465 . . . . 0.0 111.016 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.595 HG22 HG23 ' A' ' 137' ' ' VAL . 7.3 p -127.15 144.77 50.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.091 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -137.52 50.06 1.97 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.67 113.63 0.68 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.146 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -144.65 154.17 55.64 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 33.8 Cg_exo -39.06 149.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.246 2.63 . . . . 0.0 113.619 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.576 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.2 t60 -67.22 135.11 52.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 112.104 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -73.42 -32.71 64.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.429 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 63.5 p -120.0 18.99 12.41 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.637 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -139.83 176.1 21.41 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.571 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.55 31.98 6.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.312 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.65 170.32 16.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 110.544 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 14.1 mtt -78.24 115.1 17.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.576 HD22 ' ND1' ' A' ' 127' ' ' HIS . 21.0 tp -91.87 144.54 25.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.747 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 40.6 mt-10 -122.32 115.66 22.7 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 99.1 m -110.33 157.71 19.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.595 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -130.03 177.15 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.76 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.455 ' N ' HG13 ' A' ' 137' ' ' VAL . 2.6 t -130.49 117.13 19.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.132 0.423 . . . . 0.0 111.583 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.4 mt -112.56 113.58 25.8 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.101 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.63 87.42 0.42 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.868 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.47 -49.24 4.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.612 0.244 . . . . 0.0 110.754 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -165.43 36.1 0.26 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.705 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -171.31 -43.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.612 0.206 . . . . 0.0 111.317 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.08 67.1 0.81 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.597 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.61 152.89 21.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.664 0.268 . . . . 0.0 110.717 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 166.13 14.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.69 134.99 22.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.965 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.2 m -130.33 149.85 51.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.035 0.445 . . . . 0.0 111.387 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.27 96.47 12.54 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.598 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 134' ' ' LEU . 56.7 Cg_endo -76.48 162.95 32.76 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.267 1.978 . . . . 0.0 113.522 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.986 179.197 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.904 0.383 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.59 159.79 19.13 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 p -131.16 154.98 47.79 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.208 0.528 . . . . 0.0 111.26 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' TYR . 61.3 m -119.04 136.33 54.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.424 ' O ' HD11 ' A' ' 102' ' ' ILE . 89.2 t80 -120.56 128.32 52.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.215 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -111.87 103.95 12.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.979 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -58.97 -15.15 11.6 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.697 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.477 ' CD2' ' HD2' ' A' ' 83' ' ' ARG . 3.2 m-85 -67.45 -45.98 74.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.968 0.413 . . . . 0.0 110.346 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -50.5 5.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.056 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.93 10.18 28.78 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.44 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -118.18 153.48 33.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.117 0.458 . . . . 0.0 110.814 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.24 159.73 15.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.885 0.374 . . . . 0.0 110.259 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' CYS . 4.3 m-85 -135.06 127.95 31.36 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.662 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.0 148.65 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.553 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.465 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 17.8 t -47.86 142.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.351 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.72 20.99 79.3 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.208 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.39 127.19 56.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.911 HG22 HG23 ' A' ' 93' ' ' THR . 15.3 p -105.67 149.34 26.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.782 0.325 . . . . 0.0 110.644 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 30.3 p90 -152.17 -179.11 7.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 3.6 mt-10 -112.84 132.73 55.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.749 0.309 . . . . 0.0 110.373 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.477 ' HD2' ' CD2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -137.9 128.7 15.73 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 88' ' ' MET . 59.9 Cg_endo -74.86 119.0 5.49 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.617 1.545 . . . . 0.0 111.898 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -118.0 115.56 25.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.045 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 44.67 69.84 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 m 54.57 37.82 28.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.671 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -145.9 160.52 41.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.398 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -110.69 116.33 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.0 m95 -105.48 159.82 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.89 103.72 11.7 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 8.7 t -108.94 141.64 40.72 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.911 HG23 HG22 ' A' ' 80' ' ' THR . 0.7 OUTLIER -117.76 153.48 33.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.303 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 15.0 t -103.56 117.04 33.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.218 0.533 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.46 -46.8 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.417 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.67 -94.13 0.19 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.549 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 61.56 21.83 12.41 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.58 -71.41 0.07 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.2 mmm-85 -114.82 -88.04 0.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.03 38.09 0.38 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 ptt-85 -68.7 141.92 55.17 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.857 0.361 . . . . 0.0 110.868 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.424 HD11 ' O ' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -112.42 147.85 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.646 -178.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -125.47 111.98 15.72 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.87 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.9 m -108.55 140.34 42.04 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.5 p -140.16 146.86 39.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.54 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.2 mt -55.55 153.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.304 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.6 26.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 111.792 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.96 70.89 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -150.19 177.09 10.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.208 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 14.7 p -124.44 130.5 52.58 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.505 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 6.0 p-80 -133.75 -145.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.156 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 1.3 tp10 89.23 163.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.542 0.337 . . . . 0.0 111.124 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.28 13.4 80.74 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.349 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.91 -16.11 58.79 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.159 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -133.48 170.52 15.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.07 0.435 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 4.9 p -119.05 127.44 53.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.969 0.414 . . . . 0.0 111.068 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -109.15 157.77 18.44 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.633 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 35.5 mttt -103.36 157.14 17.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.54 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm -48.81 124.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.9 67.29 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.688 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -77.31 159.96 29.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.377 0.588 . . . . 0.0 111.709 -179.325 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.681 HG22 HG23 ' A' ' 137' ' ' VAL . 29.9 p -123.42 147.77 46.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.888 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -143.8 40.11 1.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.111 0.481 . . . . 0.0 109.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.6 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -55.77 108.06 0.41 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.191 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' PRO . 19.8 mtt180 -138.53 174.08 4.6 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.156 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 31.6 Cg_exo -41.36 -175.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.825 2.35 . . . . 0.0 113.667 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.66 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 13.1 t-160 -104.07 124.74 49.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 112.028 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.02 -37.74 64.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.115 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.443 ' HB ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -80.06 -23.07 41.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.697 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -132.5 -153.03 7.18 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.81 31.2 3.41 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.574 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.66 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 20.0 p90 -127.26 140.47 52.2 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 120.491 0.186 . . . . 0.0 111.367 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 19.9 ttt -47.83 139.39 7.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.253 0.549 . . . . 0.0 112.0 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' A' ' 127' ' ' HIS . 27.2 tp -133.58 143.72 48.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.567 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.6 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 27.5 mt-10 -127.47 116.87 21.09 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.7 OUTLIER -122.24 157.63 31.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.084 0.469 . . . . 0.0 112.11 -178.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.31 170.1 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.904 -179.23 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 t -118.55 118.37 31.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.683 0.278 . . . . 0.0 111.288 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 40.3 mt -112.47 134.66 53.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.499 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.15 -114.01 0.99 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.65 -70.37 0.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.672 0.389 . . . . 0.0 111.702 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.29 -91.37 0.83 Allowed Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.567 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -129.63 -42.71 1.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 176.14 73.6 0.05 OUTLIER Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -92.14 161.63 14.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.737 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.07 162.23 36.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.55 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.53 125.76 14.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.503 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.12 149.71 50.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.499 0.666 . . . . 0.0 112.279 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -124.69 102.62 32.12 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.55 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 6.1 Cg_exo -71.27 167.94 24.8 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.019 1.812 . . . . 0.0 114.992 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 151' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.075 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.712 0.291 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -119.43 161.7 20.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.179 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 p -132.19 150.01 52.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.8 m -118.64 139.28 51.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.55 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -120.25 126.7 51.25 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 100.83 10.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -52.56 -21.75 4.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -67.69 -46.41 72.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 p -86.16 -52.4 5.69 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.67 8.82 31.86 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.439 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.31 145.43 44.0 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.957 0.379 . . . . 0.0 110.393 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 159.43 20.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.977 0.418 . . . . 0.0 110.648 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.425 ' CE1' ' CG ' ' A' ' 81' ' ' TYR . 3.1 m-85 -134.49 128.59 33.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.3 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.13 153.05 34.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 77' ' ' VAL . 4.2 t -47.78 140.18 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.896 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.02 21.07 79.58 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.428 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.89 126.26 55.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.912 HG22 HG23 ' A' ' 93' ' ' THR . 20.4 p -105.37 132.93 50.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.889 0.376 . . . . 0.0 111.42 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 36.3 p90 -126.2 -176.23 3.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.673 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 138.56 54.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.859 0.362 . . . . 0.0 111.045 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.6 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -137.16 132.22 17.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.9 Cg_endo -79.74 59.85 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.696 1.597 . . . . 0.0 112.822 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -56.73 130.69 46.58 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.899 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 t70 35.21 63.86 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.3 m 53.9 36.04 23.27 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 18.1 mtm -143.16 149.16 37.67 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.65 109.32 21.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.458 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 18.6 m95 -100.01 151.93 20.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.414 -177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.35 110.82 22.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 33.4 m -108.88 162.33 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.912 HG23 HG22 ' A' ' 80' ' ' THR . 1.0 OUTLIER -141.54 154.01 45.22 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.198 -179.054 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 21.4 t -103.49 113.37 26.82 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.504 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -76.62 -36.47 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.483 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.4 72.64 0.82 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.582 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.05 -55.35 3.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.687 0.279 . . . . 0.0 111.409 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.82 -61.09 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.536 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 24.61 12.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.878 0.37 . . . . 0.0 111.198 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.17 90.1 0.94 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.56 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -91.36 129.48 37.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.595 0.236 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.24 124.5 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.504 ' HB3' HD13 ' A' ' 95' ' ' ILE . 13.5 t -128.58 111.52 13.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.985 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.2 m -111.72 137.22 49.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.9 p -139.28 136.24 34.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.069 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.402 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -50.95 146.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.04 154.22 26.98 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.453 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.434 ' O ' HG12 ' A' ' 119' ' ' ILE . 1.1 p-10 -85.87 63.89 8.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.099 0.476 . . . . 0.0 110.57 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -149.8 167.63 26.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.642 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 117' ' ' TYR . 2.7 p -118.95 125.61 49.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.601 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.0 145.32 47.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.746 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.601 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 5.9 pt-20 170.32 157.72 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.206 0.316 . . . . 0.0 111.197 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -77.61 1.98 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.996 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.79 -38.39 0.07 OUTLIER Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.52 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -123.55 172.17 8.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.294 0.547 . . . . 0.0 111.232 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 p -101.9 126.59 48.84 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' CYS . 2.5 m-85 -108.39 157.1 18.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.515 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -98.68 155.38 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.524 HD12 ' HA3' ' A' ' 140' ' ' GLY . 22.3 mm -54.78 131.64 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.45 -10.32 73.77 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.567 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 150.54 30.0 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 117.489 0.645 . . . . 0.0 110.439 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 137' ' ' VAL . 21.7 p -142.54 141.39 32.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.444 ' CZ2' ' HB3' ' A' ' 136' ' ' CYS . 11.2 p90 -140.31 110.63 6.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -123.72 107.57 11.59 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.114 0.483 . . . . 0.0 111.703 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -148.04 159.23 40.57 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.678 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 26.5 Cg_exo -39.77 144.75 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.862 2.375 . . . . 0.0 113.027 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.662 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.9 t60 -65.75 137.57 57.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.487 0.661 . . . . 0.0 112.559 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.82 -41.76 59.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.684 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 78.0 p -108.34 17.68 21.89 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.84 -95.33 1.14 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.385 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.53 -22.63 0.42 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.08 171.73 9.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.641 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.1 ptm -69.78 151.28 45.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.662 HD22 ' ND1' ' A' ' 127' ' ' HIS . 25.1 tp -136.34 129.25 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.7 mt-10 -118.96 119.78 35.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.001 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 147' ' ' THR . 94.3 m -116.12 158.22 23.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 111.912 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.068 HG23 HG23 ' A' ' 147' ' ' THR . 0.0 OUTLIER -141.17 165.52 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.85 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 133.34 54.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.861 0.362 . . . . 0.0 111.222 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.09 156.55 19.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.228 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.524 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -153.38 39.43 0.71 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.975 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -51.44 5.37 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.658 0.266 . . . . 0.0 110.708 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -117.09 -46.75 0.5 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.389 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -153.81 148.69 26.59 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.526 0.203 . . . . 0.0 110.576 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.94 105.69 1.0 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.464 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.4 173.81 7.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.436 ' CD1' ' HH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -117.43 146.25 43.59 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.117 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . 1.068 HG23 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -146.0 122.79 11.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -148.07 151.28 35.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.111 177.523 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -145.35 90.16 6.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.395 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.523 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 56.3 Cg_endo -73.08 158.17 49.73 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.329 2.019 . . . . 0.0 113.069 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.959 179.259 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.646 0.26 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -84.58 141.1 30.93 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.35 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 4.9 p -129.31 140.74 51.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 150.88 39.01 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.992 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 91.4 t80 -121.01 129.15 53.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -110.24 97.0 6.58 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 39.6 pttt -49.39 -19.0 0.45 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.547 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 2.9 m-85 -65.89 -45.52 81.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.832 0.349 . . . . 0.0 111.22 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -91.46 -52.61 4.7 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.67 9.81 28.04 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.321 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -117.26 138.29 51.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.932 0.366 . . . . 0.0 110.509 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.86 160.07 30.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.172 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.644 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 26.9 m-85 -130.34 128.92 42.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.475 ' HG3' HG22 ' A' ' 65' ' ' THR . 1.5 mtt180 -85.77 147.56 26.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.45 HG13 ' C ' ' A' ' 95' ' ' ILE . 2.8 t -46.92 144.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.356 -177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 27.93 71.82 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.325 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -113.31 127.24 56.08 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.871 HG22 HG23 ' A' ' 93' ' ' THR . 22.3 p -105.71 150.5 25.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.839 0.352 . . . . 0.0 111.554 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.4 ' CD1' ' CE1' ' A' ' 75' ' ' TYR . 24.7 p90 -157.4 -175.36 5.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.173 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.77 132.35 54.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.421 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.547 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 5.6 tmm_? -128.71 131.79 23.97 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 88' ' ' MET . 87.4 Cg_endo -84.29 64.52 6.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.813 . . . . 0.0 114.158 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.435 ' HG2' ' NE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -59.27 124.4 19.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.924 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 35.31 71.23 0.12 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.6 m 50.66 36.34 13.81 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.88 148.88 39.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.14 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mm -96.68 112.65 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.981 0.42 . . . . 0.0 109.88 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.565 ' CH2' HG12 ' A' ' 106' ' ' ILE . 19.6 m95 -101.92 148.41 25.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.186 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.92 107.99 19.31 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 80' ' ' THR . 70.1 m -108.03 156.29 19.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.871 HG23 HG22 ' A' ' 80' ' ' THR . 2.0 m -141.53 150.05 41.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.458 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -106.9 113.65 27.26 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.322 0.965 . . . . 0.0 110.649 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.45 ' C ' HG13 ' A' ' 77' ' ' VAL . 1.8 mp -79.3 -24.42 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.717 -177.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 97' ' ' ALA . . . 83.04 -75.82 2.33 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.395 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' GLY . . . 17.42 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.26 -113.47 4.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.455 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.28 70.95 1.4 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.145 0.498 . . . . 0.0 111.29 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.81 77.28 1.0 Allowed Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.92 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -102.09 131.66 48.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.603 0.239 . . . . 0.0 110.959 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.24 122.31 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.136 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.14 116.05 17.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.918 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.9 m -123.16 143.89 49.71 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 p -139.9 139.67 36.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.695 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.565 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -62.46 154.77 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.508 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.62 152.67 18.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 111.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.431 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.6 OUTLIER -85.75 68.13 10.27 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.635 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 119' ' ' ILE . 62.3 mtp180 -150.56 172.04 16.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.172 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.2 m -110.62 127.2 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.561 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -138.77 147.14 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 179.225 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 2.9 tm-20 171.35 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.728 0.299 . . . . 0.0 111.206 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 97.72 -83.69 0.71 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.636 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.56 2.19 0.38 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.434 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.69 -177.93 5.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.346 0.573 . . . . 0.0 111.103 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -119.52 127.71 53.27 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -108.41 159.44 16.66 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.666 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 3.9 tmtt? -103.07 158.08 16.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.4 mp -49.12 128.13 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.675 0.274 . . . . 0.0 111.197 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.39 61.42 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.312 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -80.78 168.87 18.3 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.355 0.578 . . . . 0.0 111.397 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.46 HG22 ' CG1' ' A' ' 137' ' ' VAL . 1.4 p -138.85 152.99 48.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.04 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.443 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 43.3 p90 -141.26 84.39 1.92 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.219 0.533 . . . . 0.0 110.039 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 1.2 mpp_? -85.23 74.16 10.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -110.72 167.16 9.46 Favored Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.726 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 66.5 Cg_exo -44.08 175.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.862 2.375 . . . . 0.0 113.676 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.43 ' ND1' HD22 ' A' ' 134' ' ' LEU . 3.9 t60 -105.26 128.87 53.65 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.96 -40.24 60.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.983 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.404 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 16.3 p -98.7 15.12 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.27 -69.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.856 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 123.55 19.57 2.79 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.42 ' HE1' ' HB3' ' A' ' 150' ' ' PRO . 3.5 p90 -126.4 141.74 51.79 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.038 0.535 . . . . 0.0 109.622 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.2 ptt? -50.41 108.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.547 0.689 . . . . 0.0 111.391 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.446 ' CD1' ' HG3' ' A' ' 150' ' ' PRO . 34.3 tp -91.92 143.87 26.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.336 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 36.1 mt-10 -126.15 116.0 20.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.15 157.33 38.39 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.792 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -126.95 174.61 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.862 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.94 118.88 12.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.814 0.34 . . . . 0.0 111.164 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.51 132.3 55.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.514 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -89.58 84.42 1.4 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.667 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 -48.45 6.93 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.556 0.217 . . . . 0.0 111.114 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -140.89 -65.99 0.03 OUTLIER Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.585 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -113.26 -39.13 4.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.427 0.156 . . . . 0.0 111.158 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.25 94.49 0.1 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.623 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -106.76 150.18 26.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.578 0.228 . . . . 0.0 110.645 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.97 165.24 21.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 111.341 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.792 HG22 HG23 ' A' ' 137' ' ' VAL . 0.6 OUTLIER -145.56 121.02 10.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.605 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -130.95 149.37 52.61 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.371 0.605 . . . . 0.0 111.799 179.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -123.78 90.28 50.76 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.63 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 134' ' ' LEU . 1.7 Cg_endo -80.69 161.63 21.69 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.66 2.24 . . . . 0.0 114.048 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.118 179.053 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.792 0.329 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 p -139.71 146.89 40.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.19 139.42 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.413 ' HB2' HG23 ' A' ' 74' ' ' THR . 93.2 t80 -114.69 132.27 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -109.27 112.67 24.95 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -64.03 -16.76 62.38 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 5.8 m-85 -70.59 -45.98 64.32 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -88.8 -48.32 7.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.797 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.33 3.82 47.36 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.791 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.5 m-80 -117.3 138.5 51.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.4 0.6 . . . . 0.0 110.926 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -79.02 159.84 27.43 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.907 0.384 . . . . 0.0 110.565 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 73' ' ' ASN . 1.1 m-85 -134.52 138.62 44.82 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.622 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -79.78 165.9 22.3 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -59.54 128.29 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.115 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.66 24.67 49.23 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.996 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -113.08 122.79 48.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.974 HG22 HG23 ' A' ' 93' ' ' THR . 19.1 p -105.3 149.12 26.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.909 0.385 . . . . 0.0 111.074 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 18.4 p90 -145.25 -172.63 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.732 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -115.64 129.83 56.64 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.572 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 4.6 tmm_? -130.13 124.95 21.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.097 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 88' ' ' MET . 84.9 Cg_endo -80.55 111.55 2.58 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.841 1.694 . . . . 0.0 112.239 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.546 ' HB3' ' NE1' ' A' ' 90' ' ' TRP . 11.3 tptt -116.88 118.94 33.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.821 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 46.55 73.23 0.19 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.5 m 47.38 41.84 13.16 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.915 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.7 ttp -153.04 164.54 37.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.199 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mm -112.2 122.54 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.546 ' NE1' ' HB3' ' A' ' 85' ' ' LYS . 25.3 m95 -107.97 140.22 41.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.36 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.05 110.19 21.66 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' THR . 75.1 m -109.44 152.81 24.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.974 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -130.73 150.65 51.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.266 179.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 122.18 45.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 110.903 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -98.78 131.28 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.453 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.59 -169.1 25.85 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.317 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 70.99 114.54 0.05 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.808 0.443 . . . . 0.0 111.811 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.93 -136.82 12.91 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.963 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.25 23.1 9.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.107 0.479 . . . . 0.0 111.158 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.541 ' O ' HD12 ' A' ' 102' ' ' ILE . . . 80.01 70.11 1.35 Allowed Glycine 0 CA--C 1.517 0.179 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.554 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.2 140.43 56.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.535 0.207 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.541 HD12 ' O ' ' A' ' 100' ' ' GLY . 3.0 mp -109.64 121.1 62.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.307 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.547 ' HB3' HD13 ' A' ' 95' ' ' ILE . 20.3 t -114.49 121.59 43.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.378 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.1 m -124.35 136.4 54.06 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 p -138.98 141.86 38.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.452 HG13 ' CH2' ' A' ' 90' ' ' TRP . 1.5 mt -51.96 155.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.284 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.08 144.1 28.61 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -80.49 75.77 7.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.75 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -150.17 173.53 13.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.23 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 117' ' ' TYR . 13.0 p -128.64 127.99 43.29 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.1 p-80 -135.1 -143.28 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 119.495 -0.288 . . . . 0.0 111.037 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.8 175.95 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.503 0.321 . . . . 0.0 111.078 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.43 -77.25 1.74 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.751 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.15 -39.26 0.04 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.936 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -133.71 167.21 20.93 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 32.4 p -84.88 150.83 24.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 111.247 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 110' ' ' CYS . 7.0 m-85 -133.21 139.1 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 1.9 mptm? -85.25 176.31 8.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.637 0.256 . . . . 0.0 111.161 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.1 mm -74.59 124.3 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.334 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.79 -3.14 86.3 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.92 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 169.7 17.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.924 0.393 . . . . 0.0 111.459 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.834 HG22 HG23 ' A' ' 137' ' ' VAL . 30.0 p -133.9 150.31 51.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -141.28 55.21 1.54 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.27 0.557 . . . . 0.0 109.716 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -55.66 98.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.706 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.8 mtt180 -132.36 166.99 24.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.751 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 32.8 Cg_exo -39.71 177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.193 2.595 . . . . 0.0 113.956 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.487 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.4 t60 -103.11 129.58 50.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.142 0.496 . . . . 0.0 112.336 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -64.97 -40.49 95.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.276 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 66.5 p -111.38 19.36 18.32 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.8 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -144.79 174.5 24.89 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.49 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.62 28.59 8.86 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.385 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.497 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -133.16 158.3 43.19 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.488 0.185 . . . . 0.0 110.714 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 17.9 mtt -67.26 115.94 7.48 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.452 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.569 HD12 ' HB3' ' A' ' 150' ' ' PRO . 21.5 tp -92.19 144.68 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.869 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.5 pt-20 -125.44 116.16 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.7 157.47 32.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.834 HG23 HG22 ' A' ' 122' ' ' THR . 0.4 OUTLIER -126.34 168.47 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.233 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -131.56 124.25 29.64 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.829 0.347 . . . . 0.0 111.419 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.35 127.08 55.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.28 -103.05 0.09 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.979 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.71 22.35 11.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.421 0.288 . . . . 0.0 111.765 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.55 14.9 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.918 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -160.77 -54.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.659 0.23 . . . . 0.0 111.193 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.79 60.16 0.94 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.459 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.44 160.45 15.13 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 161.86 36.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.537 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.24 127.26 16.47 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.24 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.33 148.91 50.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.091 0.472 . . . . 0.0 111.403 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -137.92 91.4 13.4 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.918 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.569 ' HB3' HD12 ' A' ' 134' ' ' LEU . 36.5 Cg_endo -69.48 164.96 32.27 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.559 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.017 179.357 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 120.666 0.27 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 p -133.3 145.94 50.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.033 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.0 m -118.16 135.49 54.2 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.5 t80 -109.24 124.2 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 10.1 t70 -98.31 103.91 15.9 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 14.9 ptpt -56.57 -27.97 59.09 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 94.0 m-85 -67.93 -39.64 83.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.772 0.32 . . . . 0.0 111.144 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -88.18 -53.45 4.7 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.73 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.48 39.51 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.406 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.54 144.06 46.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.095 0.448 . . . . 0.0 110.686 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.52 160.25 21.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.713 0.292 . . . . 0.0 110.872 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -136.76 131.45 33.42 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.252 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -75.92 140.97 42.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.515 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.46 130.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.23 0.538 . . . . 0.0 111.982 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.45 14.6 56.87 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.97 125.77 54.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.99 HG22 HG23 ' A' ' 93' ' ' THR . 18.7 p -105.04 142.24 35.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.907 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -136.71 -173.91 3.56 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.766 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 5.2 mt-10 -119.98 126.84 51.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.202 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -124.27 123.15 25.97 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.1 Cg_endo -78.39 110.01 2.77 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.132 1.888 . . . . 0.0 112.076 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.73 116.57 27.76 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.861 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 48.32 77.51 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.8 m 44.5 43.85 6.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.3 ttp -155.65 166.03 34.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.7 130.84 68.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 22.3 m95 -114.46 143.07 45.53 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -98.56 109.38 22.14 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 80' ' ' THR . 81.7 m -108.99 159.91 16.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.128 0.49 . . . . 0.0 112.29 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.99 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -138.28 153.04 49.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.633 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 6.2 t -104.05 117.92 35.44 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.545 0.688 . . . . 0.0 110.806 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.7 mp -88.89 119.93 36.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.424 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.8 -115.97 1.86 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 58.51 33.84 23.43 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.773 0.32 . . . . 0.0 111.198 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.21 45.03 92.86 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.397 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 -67.54 0.59 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.34 56.01 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 121.192 -0.527 . . . . 0.0 112.142 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.7 143.29 9.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.754 0.422 . . . . 0.0 111.737 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.46 120.01 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.257 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.571 ' HB3' HD13 ' A' ' 95' ' ' ILE . 2.0 t -111.21 111.89 23.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.7 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.4 m -121.36 127.72 51.53 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.2 p -138.91 138.98 37.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.926 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -45.37 155.86 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.292 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.59 155.29 17.37 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.81 70.94 7.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.449 ' HA ' HD12 ' A' ' 119' ' ' ILE . 91.3 mtm-85 -150.08 168.14 24.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.9 p -117.16 125.4 51.15 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.787 0.327 . . . . 0.0 110.126 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.574 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -129.76 166.42 19.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.617 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.574 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 15.1 pt-20 167.3 138.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.266 0.354 . . . . 0.0 110.923 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -37.6 3.25 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.505 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.54 -94.77 0.1 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.44 177.93 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.29 0.236 . . . . 0.0 111.306 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.4 p -120.1 125.51 48.44 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 111.492 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -95.56 157.3 15.96 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.635 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -93.06 174.53 7.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.5 mp -74.08 124.5 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.3 -4.85 82.87 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.794 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.97 160.45 30.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.82 0.31 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.763 HG22 HG23 ' A' ' 137' ' ' VAL . 18.8 p -130.9 145.42 52.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.9 p90 -136.75 53.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.355 0.598 . . . . 0.0 109.619 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.33 102.85 0.06 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.745 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 126' ' ' PRO . 97.5 mtt180 -134.92 161.77 61.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.762 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 125' ' ' ARG . 37.4 Cg_exo -40.28 174.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.176 2.584 . . . . 0.0 113.879 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.5 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.1 t60 -100.15 128.17 46.27 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 111.877 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -72.57 -32.68 66.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.718 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.447 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 16.0 p -112.42 18.43 18.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.326 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -145.21 174.62 25.18 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.582 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.87 29.11 8.32 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.122 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -136.82 162.93 31.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.491 0.186 . . . . 0.0 110.705 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 18.3 ptt? -70.93 117.16 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.243 0.544 . . . . 0.0 110.774 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.563 HD12 ' HB3' ' A' ' 150' ' ' PRO . 23.3 tp -91.67 145.47 24.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.717 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 5.1 pt-20 -129.59 116.12 18.41 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -120.8 157.34 29.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.763 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.65 173.28 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.271 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.421 ' N ' HG13 ' A' ' 137' ' ' VAL . 18.3 t -128.36 117.81 22.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.759 0.314 . . . . 0.0 110.761 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.2 mt -111.66 113.86 26.52 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.464 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.97 70.45 0.94 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 -53.31 3.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.542 0.21 . . . . 0.0 111.07 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.48 -65.36 0.97 Allowed Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.516 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 pttt -144.5 -44.59 0.25 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.417 0.151 . . . . 0.0 111.316 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -178.21 83.56 0.07 OUTLIER Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.91 159.23 18.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.23 163.79 31.92 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.5 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -146.82 126.6 13.47 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.3 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 136' ' ' CYS . 0.0 OUTLIER -124.62 149.31 47.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 110.932 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -136.36 88.74 20.24 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.837 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.563 ' HB3' HD12 ' A' ' 134' ' ' LEU . 29.2 Cg_endo -67.44 168.96 16.6 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 113.645 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.052 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -138.17 148.93 45.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.7 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.93 135.39 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 89.5 t80 -110.19 126.39 54.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 11.1 t70 -102.21 96.87 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.775 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 47.9 pttt -47.69 -29.38 2.99 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 84.8 m-85 -67.46 -39.87 85.32 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.6 p -87.19 -51.09 6.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 8.75 37.8 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.832 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -119.56 153.33 35.58 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.793 0.296 . . . . 0.0 110.786 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 159.81 14.71 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.08 139.71 39.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.806 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -78.76 165.08 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 95' ' ' ILE . 57.8 t -53.53 137.12 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 0.0 111.621 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.21 32.27 63.0 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.101 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.34 120.89 42.69 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.996 HG22 HG23 ' A' ' 93' ' ' THR . 22.0 p -105.26 150.19 25.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 0.0 110.906 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -153.3 179.14 9.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.96 126.83 53.51 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -126.07 126.03 24.76 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.911 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.5 Cg_endo -78.43 116.93 3.94 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.982 1.788 . . . . 0.0 111.347 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -119.02 123.65 45.04 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.262 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 42.51 74.31 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 t 46.63 42.21 11.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 29.7 ttp -154.59 164.76 38.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mm -110.32 136.58 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 20.7 m95 -121.9 159.92 25.86 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.04 108.24 18.39 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 88.6 m -108.35 162.93 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.996 HG23 HG22 ' A' ' 80' ' ' THR . 0.3 OUTLIER -141.57 151.68 43.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.11 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.15 114.41 28.59 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 77' ' ' VAL . 16.3 mm -74.47 -61.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.125 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.0 129.06 0.05 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.42 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -170.85 55.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.461 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.36 61.45 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.258 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -175.93 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.458 0.303 . . . . 0.0 111.807 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.72 80.83 0.96 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.419 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -90.0 131.99 35.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.634 0.255 . . . . 0.0 111.077 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.61 126.82 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.295 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -127.18 111.22 13.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.9 m -116.53 139.05 50.91 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.6 p -139.84 138.92 36.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.959 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.5 mt -48.7 148.05 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.11 148.37 34.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -93.28 59.25 2.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.19 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -149.15 177.38 9.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.686 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 85.8 m -110.11 128.19 55.31 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.507 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -138.94 145.36 39.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.507 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 10.6 pt-20 170.9 166.82 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.304 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.35 -93.52 1.64 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.596 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.86 0.59 1.2 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.05 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.18 -178.32 5.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.8 t -119.04 127.21 53.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.555 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.1 m-85 -104.37 159.74 15.48 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.158 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 5.2 mmtp -105.82 164.13 12.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.4 124.53 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.514 0.197 . . . . 0.0 111.409 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.3 63.0 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.355 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -71.95 159.68 33.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.388 0.594 . . . . 0.0 111.473 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.572 HG22 HG12 ' A' ' 137' ' ' VAL . 2.5 p -130.96 152.25 50.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.13 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -144.38 98.34 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 109.977 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -92.37 87.13 5.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.426 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 126' ' ' PRO . 1.0 OUTLIER -120.74 167.41 13.01 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.698 179.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 45.3 Cg_exo -43.15 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.0 2.467 . . . . 0.0 113.633 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.49 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.4 t60 -100.95 129.81 46.86 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 112.194 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.25 -40.33 93.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 74.0 p -112.49 20.04 17.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.777 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.461 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -144.14 173.71 24.76 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.557 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.78 30.89 7.44 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.348 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -136.15 164.52 27.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.427 0.156 . . . . 0.0 110.712 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 12.3 mtt -72.9 116.16 13.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.082 0.467 . . . . 0.0 110.472 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 150' ' ' PRO . 21.2 tp -92.23 144.56 25.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.573 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 37.4 mt-10 -120.93 115.69 23.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 92.1 m -112.73 158.2 20.36 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.98 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -135.33 169.36 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.864 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 t -138.33 123.65 19.37 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.872 0.367 . . . . 0.0 111.301 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.22 143.83 42.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.453 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.93 77.65 1.86 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.722 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 122.98 12.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.612 0.244 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.8 -90.93 1.47 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.731 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 43.36 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.04 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.696 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.78 127.59 35.99 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.708 0.29 . . . . 0.0 110.572 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -109.53 167.64 9.99 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.98 HG22 HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -149.79 145.98 26.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -141.76 149.94 41.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.427 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -135.23 90.59 20.66 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.615 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.526 ' HB3' HD12 ' A' ' 134' ' ' LEU . 38.4 Cg_endo -70.96 161.42 46.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.484 2.123 . . . . 0.0 113.63 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.011 179.183 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.686 0.279 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 5.0 p -125.53 142.3 51.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 147.03 43.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.963 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.2 t80 -121.75 121.13 36.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.731 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 21.9 t70 -104.94 96.38 6.5 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 51.7 pttt -48.97 -17.98 0.25 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.495 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 4.6 m-30 -65.49 -46.19 80.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.662 0.268 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.5 p -86.7 -50.03 7.06 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.26 6.73 33.54 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.207 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.95 150.23 39.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.981 0.391 . . . . 0.0 111.147 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.39 160.26 17.66 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' A' ' 68' ' ' ASP . 2.6 m-85 -134.96 131.01 36.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.563 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HG3' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -79.87 179.53 7.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.79 139.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.471 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.48 40.5 96.25 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.708 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.26 124.37 52.34 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.921 HG22 HG23 ' A' ' 93' ' ' THR . 28.7 p -105.62 149.72 26.07 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.892 0.377 . . . . 0.0 111.383 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -161.1 -178.58 6.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -118.39 132.18 56.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 111.023 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.495 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -124.24 124.23 25.87 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 88' ' ' MET . 81.1 Cg_endo -80.09 63.96 8.81 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 121.964 1.776 . . . . 0.0 112.48 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.52 128.47 36.45 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.864 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.5 t70 37.3 69.1 0.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.895 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m 46.08 47.62 12.85 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.415 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 42.5 ttp -160.51 135.81 7.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.37 132.64 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 111.522 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CH2' HG12 ' A' ' 106' ' ' ILE . 16.1 m95 -119.84 152.27 37.57 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -108.33 100.31 9.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.4 t -108.6 138.76 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.921 HG23 HG22 ' A' ' 80' ' ' THR . 1.7 m -116.54 148.18 41.09 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.67 117.7 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.731 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.1 mp -92.16 142.3 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.611 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.35 -129.62 1.04 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.521 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 62.42 110.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 111.536 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.63 -112.72 4.54 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -139.43 47.09 1.89 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.08 98.08 0.94 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.635 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -105.78 135.51 47.08 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.586 0.231 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.99 121.52 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.2 111.93 12.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.98 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 3.3 m -126.37 148.34 49.61 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 p -141.12 148.91 40.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.165 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.436 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -60.61 146.98 10.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.544 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.63 159.24 31.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.75 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.9 57.48 4.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.171 0.51 . . . . 0.0 110.596 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -144.4 171.6 14.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.9 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 2.3 p -123.23 128.47 50.05 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -134.43 154.4 51.41 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.229 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 7.3 tp10 167.35 140.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.867 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.73 -8.71 54.82 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.417 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.0 -17.79 7.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.089 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -126.04 165.44 18.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.844 0.322 . . . . 0.0 110.34 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.51 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.4 t -108.87 125.72 52.29 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.4 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.02 158.86 16.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.215 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 25.8 mtmt -99.37 161.74 13.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.454 HG23 ' HA3' ' A' ' 140' ' ' GLY . 38.0 mm -55.19 124.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.509 0.195 . . . . 0.0 111.349 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.13 -12.2 70.34 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.767 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -60.23 167.28 2.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.575 0.688 . . . . 0.0 111.777 -178.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.416 HG22 ' CG2' ' A' ' 137' ' ' VAL . 57.1 p -142.67 144.72 32.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.254 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.433 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 17.5 p90 -149.74 96.61 2.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.042 0.449 . . . . 0.0 109.97 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -91.73 76.38 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 111.008 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 126' ' ' PRO . 89.1 mtt180 -108.15 163.45 16.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.094 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 125' ' ' ARG . 52.4 Cg_exo -41.08 179.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.301 2.667 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.5 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.1 t60 -100.6 127.41 46.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.674 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.43 -34.21 72.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.742 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.6 p -111.96 19.0 18.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.361 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -147.92 171.18 28.48 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.478 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -108.79 28.48 11.28 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.689 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -134.35 162.2 32.87 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.726 0.263 . . . . 0.0 110.906 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 13.1 mtt -68.59 120.74 15.09 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.317 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.524 HD12 ' HB3' ' A' ' 150' ' ' PRO . 22.3 tp -100.93 144.12 30.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 4.4 pt-20 -120.62 115.81 24.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.67 158.32 21.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 147' ' ' THR . 0.4 OUTLIER -131.81 160.32 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.372 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 121.76 37.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.709 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.0 mt -113.82 156.24 24.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.634 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.454 ' HA3' HG23 ' A' ' 119' ' ' ILE . . . -152.58 -132.77 1.83 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.034 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.58 33.33 18.35 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.915 0.388 . . . . 0.0 111.089 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.54 -52.2 0.1 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.685 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -147.67 -66.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.648 0.224 . . . . 0.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.34 79.32 0.07 OUTLIER Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.483 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -112.09 135.77 52.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 111.252 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -109.84 166.79 10.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -152.18 137.31 17.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.515 -179.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.95 149.95 49.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.165 0.507 . . . . 0.0 111.522 179.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.05 92.08 11.07 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.193 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HB3' HD12 ' A' ' 134' ' ' LEU . 38.2 Cg_endo -71.58 162.2 42.94 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.332 2.021 . . . . 0.0 113.836 -178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.012 179.246 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.751 0.31 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.1 p -128.34 155.43 44.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.186 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 75' ' ' TYR . 60.1 m -119.02 135.49 54.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.817 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.8 t80 -121.19 123.11 41.46 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -105.66 95.15 5.61 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.165 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 44.1 pttt -49.01 -21.56 0.71 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -66.3 -44.62 82.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.554 0.216 . . . . 0.0 110.7 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.497 ' HG1' ' HH ' ' A' ' 75' ' ' TYR . 17.1 p -86.8 -49.97 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.0 12.05 30.67 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.083 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -118.92 157.43 27.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.807 0.303 . . . . 0.0 110.64 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.95 159.64 14.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.497 ' HH ' ' HG1' ' A' ' 71' ' ' THR . 3.9 m-85 -135.84 127.8 29.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.98 153.28 32.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 77' ' ' VAL . 5.7 t -47.85 143.37 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.558 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 21.94 78.32 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -113.06 130.16 56.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.93 HG22 HG23 ' A' ' 93' ' ' THR . 21.1 p -105.69 150.27 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.369 . . . . 0.0 111.494 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -149.7 173.96 13.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.081 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.69 131.09 54.37 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.587 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -126.85 135.86 27.95 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.587 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 85.8 Cg_endo -81.53 62.44 8.32 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.945 1.763 . . . . 0.0 112.956 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 122.28 12.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.524 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 40.71 74.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.867 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 94.9 p 41.5 47.9 3.32 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 44.6 ttp -163.15 133.5 4.5 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.7 mm -74.07 137.31 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 111.07 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.434 ' CH2' HG12 ' A' ' 106' ' ' ILE . 17.9 m95 -122.63 164.73 17.68 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.978 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 80' ' ' THR . 48.9 m -108.61 161.19 15.31 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.93 HG23 HG22 ' A' ' 80' ' ' THR . 0.9 OUTLIER -142.2 153.98 44.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.223 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.3 t -103.33 113.23 26.56 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.94 -31.59 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.133 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.14 177.8 44.68 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.615 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.76 150.21 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.926 0.393 . . . . 0.0 111.678 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.38 39.97 41.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.679 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.02 37.1 21.41 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.708 0.29 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.86 71.46 1.13 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.605 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -80.21 149.1 30.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.818 0.309 . . . . 0.0 110.762 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.83 130.27 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.792 0.329 . . . . 0.0 111.337 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.61 111.46 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 88.3 m -117.4 145.17 44.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 p -140.05 137.97 35.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.031 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.434 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -53.08 143.84 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.04 168.07 10.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.807 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.538 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -93.33 43.79 1.13 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -134.29 159.34 41.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.943 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.6 p -112.14 126.34 55.09 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.452 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.568 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -128.93 164.16 23.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.566 -178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 41.2 tt0 165.41 126.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.441 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.39 -99.0 0.87 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.727 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.5 -17.7 1.36 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -131.9 179.03 6.32 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.223 0.512 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 27.5 t -112.94 125.43 54.38 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.981 0.419 . . . . 0.0 111.156 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -102.12 159.42 15.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -105.23 161.08 14.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 108' ' ' ASN . 1.5 mp -59.17 124.7 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.651 0.262 . . . . 0.0 110.962 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.64 -22.24 41.36 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.223 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 152.15 44.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.973 0.416 . . . . 0.0 111.649 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.715 HG22 HG23 ' A' ' 137' ' ' VAL . 44.0 p -116.34 152.76 33.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.41 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.415 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 18.5 p90 -147.11 81.12 1.54 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.21 0.529 . . . . 0.0 109.866 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -84.7 76.01 10.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.214 -178.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 126' ' ' PRO . 14.6 mtt85 -110.66 171.05 4.66 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.689 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 42.5 Cg_exo -43.0 179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.93 2.42 . . . . 0.0 113.473 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.484 ' HD1' HD22 ' A' ' 134' ' ' LEU . 3.7 t60 -103.8 136.37 43.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.43 0.634 . . . . 0.0 112.707 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.43 -40.09 62.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.373 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 61.1 p -109.09 18.25 20.79 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.84 -79.98 0.07 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.486 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 137.58 29.87 0.27 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 150' ' ' PRO . 2.8 p90 -135.52 151.45 50.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 122.878 0.471 . . . . 0.0 109.765 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.8 ttt -57.72 107.2 0.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.484 HD22 ' HD1' ' A' ' 127' ' ' HIS . 15.0 tp -91.73 144.84 25.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.974 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 30.5 mt-10 -124.56 115.88 21.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.9 OUTLIER -125.72 157.5 37.22 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.715 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -128.35 171.65 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.254 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.1 t -139.58 124.02 18.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.709 0.29 . . . . 0.0 110.903 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.07 133.16 54.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.29 76.59 1.91 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.726 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -42.47 11.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.53 0.205 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.58 -54.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.679 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -106.21 -55.48 2.32 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.41 54.51 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.12 154.03 32.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.771 0.319 . . . . 0.0 111.328 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -142.27 161.71 37.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.611 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.57 127.73 16.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.88 149.73 50.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 0.0 111.749 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -124.78 81.16 61.67 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.61 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HB2' ' CE1' ' A' ' 132' ' ' TYR . 12.9 Cg_endo -67.08 168.01 18.52 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.754 2.303 . . . . 0.0 114.479 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.977 178.696 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.67 0.271 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 p -129.43 145.69 51.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.039 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.3 m -118.49 134.48 55.04 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 83.8 t80 -110.0 124.57 51.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 12.8 t70 -97.8 97.58 9.11 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 10.8 ptmt -51.47 -28.74 14.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.524 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 82.5 m-85 -66.98 -45.8 76.55 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.67 0.271 . . . . 0.0 111.315 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.1 p -82.06 -51.05 8.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.323 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.16 5.69 43.25 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.29 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -116.86 143.7 45.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.07 0.435 . . . . 0.0 110.436 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.89 159.76 20.28 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.876 0.37 . . . . 0.0 110.907 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.4 ' HE2' ' CB ' ' A' ' 68' ' ' ASP . 9.5 m-85 -136.27 130.3 32.8 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -75.08 153.01 38.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 21.8 t -50.27 144.06 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.188 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.67 79.17 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.269 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.81 125.87 54.82 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.923 HG22 HG23 ' A' ' 93' ' ' THR . 21.4 p -104.98 129.36 53.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.905 0.384 . . . . 0.0 111.134 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 39.9 p90 -122.49 -173.65 2.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.782 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.3 mp0 -127.69 138.55 52.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.838 0.351 . . . . 0.0 110.935 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.576 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -141.04 130.44 12.85 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 88' ' ' MET . 61.3 Cg_endo -77.17 64.99 7.91 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.762 1.641 . . . . 0.0 112.851 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.91 130.37 45.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.349 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 55.65 -77.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.855 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 85' ' ' LYS . 78.4 p -158.26 30.94 0.24 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.064 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -146.89 159.13 43.91 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.7 mm -89.7 112.29 24.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.467 ' CZ2' HG12 ' A' ' 106' ' ' ILE . 28.5 m95 -98.5 144.96 27.27 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.0 111.929 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.18 106.79 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 m -107.28 165.02 11.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.469 . . . . 0.0 112.034 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.923 HG23 HG22 ' A' ' 80' ' ' THR . 0.3 OUTLIER -136.52 154.68 50.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.629 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 3.7 t -102.47 114.17 28.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.475 0.655 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 95' ' ' ILE . 2.0 mp -105.74 74.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.834 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.63 139.07 15.67 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.227 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.65 45.56 0.3 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.897 0.379 . . . . 0.0 110.571 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.75 8.52 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.298 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.14 -37.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.26 85.33 0.99 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.166 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt85 -104.69 135.27 46.4 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.735 0.303 . . . . 0.0 111.283 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.75 129.98 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.35 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.419 ' HB3' HD13 ' A' ' 95' ' ' ILE . 30.2 t -124.45 110.48 14.56 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.269 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 69.3 m -111.22 131.15 55.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.365 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.3 p -137.73 132.96 33.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.467 HG12 ' CZ2' ' A' ' 90' ' ' TRP . 2.7 mt -51.23 142.07 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.927 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.27 19.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 111.489 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -86.54 64.74 8.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -147.0 174.26 11.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.308 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 117' ' ' TYR . 24.2 p -129.89 129.98 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 3.5 p-80 -134.94 -140.7 0.17 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.601 -0.237 . . . . 0.0 110.751 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.2 163.94 0.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.86 0.362 . . . . 0.0 111.455 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.94 -83.47 1.59 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.787 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.52 -35.33 0.1 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.26 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -131.27 -178.81 5.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.896 0.348 . . . . 0.0 110.754 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.426 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 4.1 p -107.7 126.67 52.88 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 110.725 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 110' ' ' CYS . 3.0 m-85 -106.65 157.81 17.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.541 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -104.16 158.34 16.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.1 mm -50.14 124.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.75 -9.5 75.52 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.733 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.11 154.57 39.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.402 0.601 . . . . 0.0 111.54 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 HG23 ' A' ' 137' ' ' VAL . 30.9 p -122.87 149.45 44.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.743 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.443 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 12.4 p90 -147.69 82.41 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.298 0.57 . . . . 0.0 109.905 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -79.3 75.03 5.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.038 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.3 mtt180 -108.76 166.6 10.54 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 63.1 Cg_exo -41.93 178.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.087 2.525 . . . . 0.0 114.077 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.488 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.4 t60 -103.54 124.42 48.75 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 111.58 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.43 -24.85 60.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.08 14.43 22.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.71 -179.21 30.63 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.755 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -115.24 28.29 8.02 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.428 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.501 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.01 155.44 49.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.546 0.212 . . . . 0.0 111.177 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.518 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 11.9 mtt -63.45 114.5 3.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.098 0.475 . . . . 0.0 110.595 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 150' ' ' PRO . 23.9 tp -92.46 146.9 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.739 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 26.6 mt-10 -123.04 116.23 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -123.87 157.62 33.77 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.58 HG12 HG22 ' A' ' 147' ' ' THR . 0.3 OUTLIER -126.79 171.75 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.662 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 52.7 t -132.67 125.01 29.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.94 154.93 24.53 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.081 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -146.57 55.25 0.53 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.089 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.97 -51.55 7.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.723 0.297 . . . . 0.0 110.353 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.17 -44.97 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -140.53 157.42 45.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.391 0.276 . . . . 0.0 110.31 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.28 93.43 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -114.93 162.46 16.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.16 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -142.79 164.45 30.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.283 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.58 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -147.62 124.81 11.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.879 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -125.52 149.99 47.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.585 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -141.19 99.11 6.59 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.528 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.575 ' HB3' HD12 ' A' ' 134' ' ' LEU . 53.4 Cg_endo -77.01 170.3 20.02 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.419 2.079 . . . . 0.0 113.56 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.055 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.919 179.32 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.69 0.281 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.7 p -124.16 150.13 45.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.573 ' HB3' HD13 ' A' ' 102' ' ' ILE . 85.6 m -118.54 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.371 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -113.62 124.45 52.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.757 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -103.54 99.37 9.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.43 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -57.29 -16.14 7.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.065 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.582 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 5.4 m-30 -66.96 -46.08 75.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.169 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 83' ' ' ARG . 7.3 p -91.42 -54.87 3.73 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.782 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.94 11.4 12.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.363 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.63 155.5 32.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.165 0.483 . . . . 0.0 110.792 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.16 159.8 15.13 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.716 0.293 . . . . 0.0 110.253 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.457 ' HH ' ' HG1' ' A' ' 71' ' ' THR . 4.6 m-85 -138.8 129.03 25.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -73.89 154.19 39.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.485 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 5.0 t -52.23 136.5 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.915 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.86 21.47 71.34 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.0 123.49 50.45 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.957 HG22 HG23 ' A' ' 93' ' ' THR . 16.9 p -105.59 149.17 26.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.391 . . . . 0.0 111.351 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 26.4 p90 -145.83 -175.32 4.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.071 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.2 mp0 -121.05 131.68 54.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.592 ' HG2' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -129.77 132.33 24.11 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.456 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 88' ' ' MET . 56.4 Cg_endo -80.48 114.38 3.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.567 1.511 . . . . 0.0 110.859 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -116.14 113.5 23.19 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.845 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 49.42 77.29 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t 46.06 43.83 11.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 8.9 ttp -157.59 169.5 24.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.461 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -116.82 131.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 19.0 m95 -117.72 157.84 25.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.19 111.72 23.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -108.34 156.93 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.957 HG23 HG22 ' A' ' 80' ' ' THR . 0.9 OUTLIER -141.1 154.1 45.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.412 0.685 . . . . 0.0 110.648 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -102.87 113.06 26.19 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.435 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -80.74 -31.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.189 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.61 83.04 0.39 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.835 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.54 119.88 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.9 2.07 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.676 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.12 44.92 1.23 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.046 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.07 84.38 0.54 Allowed Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.5 121.96 17.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 66' ' ' CYS . 9.8 mm -103.0 121.97 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.476 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.435 ' HB3' HD13 ' A' ' 95' ' ' ILE . 6.5 t -127.83 110.53 12.69 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.395 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.4 m -107.83 133.73 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 111.29 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.3 p -138.56 133.15 32.19 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.706 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -43.57 155.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.17 148.59 22.26 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.7 60.01 5.37 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.068 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -150.06 176.98 10.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 9.5 p -120.15 127.29 52.36 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.558 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.5 OUTLIER -136.69 142.71 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.335 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 12.9 pt-20 171.88 159.54 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.59 -79.23 1.43 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.61 -8.84 0.11 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.798 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -142.89 -178.53 5.86 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 117.624 0.712 . . . . 0.0 110.51 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p -114.43 125.84 54.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.797 0.332 . . . . 0.0 110.661 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.06 157.31 17.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.425 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -106.2 156.43 18.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.9 mm -45.85 124.65 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.46 -6.13 71.04 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.633 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 156.86 33.89 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.483 0.641 . . . . 0.0 111.391 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.637 HG22 HG23 ' A' ' 137' ' ' VAL . 21.5 p -124.14 146.31 48.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -137.84 67.47 1.42 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 0.0 109.668 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.77 108.78 2.22 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.513 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -137.88 153.02 73.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.341 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 50.4 Cg_exo -42.42 143.71 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.081 2.521 . . . . 0.0 113.701 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.522 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.5 t60 -67.74 127.24 32.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.076 0.465 . . . . 0.0 111.719 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -75.02 -35.51 61.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.288 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.2 p -109.21 17.23 21.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.517 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -124.77 -93.91 1.01 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.305 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.92 20.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.103 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -139.9 161.6 37.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.981 0.513 . . . . 0.0 109.65 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.8 ttt -64.71 110.24 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.343 0.592 . . . . 0.0 111.024 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.522 HD22 ' ND1' ' A' ' 127' ' ' HIS . 20.1 tp -92.17 145.67 24.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.581 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.4 pt-20 -128.13 115.68 18.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.0 m -108.59 157.96 18.01 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.075 0.464 . . . . 0.0 111.928 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -128.3 170.2 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.586 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -123.28 117.81 26.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.794 0.331 . . . . 0.0 111.373 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.08 119.36 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.17 122.05 6.68 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.865 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.19 34.83 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.971 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.9 43.26 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.694 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -163.63 -54.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.095 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.83 73.55 0.54 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.289 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.16 159.9 14.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 111.142 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.47 165.62 26.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.302 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -153.37 133.37 13.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -126.45 150.46 48.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.973 0.416 . . . . 0.0 111.295 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.97 90.84 13.7 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.254 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.516 ' HB3' HD12 ' A' ' 134' ' ' LEU . 24.2 Cg_endo -66.55 167.2 19.55 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.497 2.132 . . . . 0.0 113.746 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.249 1.032 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.998 179.341 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.685 0.278 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 p -123.9 142.11 51.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.671 ' HB3' HD13 ' A' ' 102' ' ' ILE . 3.6 m -118.41 134.45 55.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 74' ' ' THR . 94.2 t80 -111.74 131.63 55.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 23.3 t70 -108.07 104.83 14.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.148 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 16.3 ptpt -55.17 -24.68 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.497 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 27.0 m-85 -67.73 -46.84 71.01 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -82.94 -47.5 11.71 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.364 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.6 2.7 46.87 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.18 147.94 42.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.153 0.476 . . . . 0.0 110.983 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.5 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -90.09 159.79 16.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.969 0.414 . . . . 0.0 110.357 179.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.41 ' OH ' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -135.56 131.89 36.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.672 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -74.31 173.16 10.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 t -61.96 139.76 20.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.18 27.06 70.82 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.302 -0.475 . . . . 0.0 113.098 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.22 122.06 46.33 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.936 HG22 HG23 ' A' ' 93' ' ' THR . 18.0 p -105.61 141.42 37.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 110.825 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.9 p90 -138.31 -172.84 3.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.564 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.34 137.98 52.08 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.677 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -138.41 124.36 12.6 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -78.52 59.27 7.1 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.766 1.644 . . . . 0.0 113.21 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -64.49 143.73 57.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.6 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 33.91 57.0 0.6 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.4 m 53.16 35.84 20.9 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 ttp -146.73 152.72 39.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 mm -90.13 110.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.196 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.513 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 33.0 m95 -99.32 139.19 35.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.946 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -94.97 104.1 15.97 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 18.2 m -107.82 139.97 41.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.936 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -112.39 152.1 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 114.48 28.75 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 109.953 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.9 mp -102.11 95.39 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.488 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.54 78.98 1.44 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.646 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.75 -48.18 4.18 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.04 -68.52 0.87 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.412 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.11 48.84 0.98 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 111.161 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.22 77.56 0.69 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.602 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -89.6 141.78 28.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.65 0.262 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' A' ' 66' ' ' CYS . 8.4 mm -102.56 125.16 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.306 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.498 ' HB3' HD13 ' A' ' 95' ' ' ILE . 45.2 t -124.56 111.52 15.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.428 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 39.4 m -108.96 130.97 55.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.894 0.378 . . . . 0.0 111.838 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 p -135.92 128.75 31.11 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 mt -42.73 137.44 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.229 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.65 161.02 30.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.746 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -79.13 61.61 3.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -150.43 174.5 12.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 117' ' ' TYR . 20.7 p -128.87 129.74 45.94 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.85 157.21 47.41 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.365 -0.209 . . . . 0.0 111.488 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 1.2 pt-20 172.09 -66.79 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.62 91.44 1.07 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.915 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 -84.7 1.24 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.353 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -108.29 176.17 5.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.567 0.223 . . . . 0.0 110.72 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.9 t -84.98 128.29 34.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.562 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' CYS . 79.3 m-85 -93.62 129.11 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.624 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -81.64 167.33 19.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.192 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 18.8 mm -53.83 135.96 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.43 -4.13 43.64 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.16 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.43 158.53 16.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.323 0.562 . . . . 0.0 110.187 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.569 HG22 ' CG2' ' A' ' 137' ' ' VAL . 58.8 p -138.5 142.06 39.38 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.987 0.422 . . . . 0.0 111.812 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -147.29 123.35 10.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.617 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.93 139.1 53.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.538 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 126' ' ' PRO . 16.1 ptt-85 -174.48 157.6 2.42 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.051 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 125' ' ' ARG . 34.9 Cg_exo -41.23 171.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.141 2.56 . . . . 0.0 113.339 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.549 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.3 t60 -105.24 116.63 32.28 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.27 -40.36 62.38 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.158 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.445 ' OG1' ' CE1' ' A' ' 127' ' ' HIS . 4.3 p -96.7 22.39 8.2 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.342 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.549 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -152.17 -159.86 9.22 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.945 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.8 35.84 2.0 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.17 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.85 146.05 27.78 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.6 mtp -56.52 106.73 0.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.979 0.419 . . . . 0.0 109.927 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.513 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 34.2 tp -92.8 145.5 24.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.387 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -141.32 117.48 10.64 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.1 m -117.6 158.59 24.35 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.569 ' CG2' HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -122.44 179.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.623 178.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.441 ' N ' HG13 ' A' ' 137' ' ' VAL . 9.4 t -113.9 118.06 33.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.494 0.588 . . . . 0.0 111.34 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.427 HD12 ' HB ' ' A' ' 147' ' ' THR . 2.1 mt -111.76 155.6 23.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.362 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.15 94.34 0.15 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.837 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.76 35.95 4.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.88 0.371 . . . . 0.0 110.797 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.71 41.56 10.84 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.565 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -160.6 -48.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.439 0.161 . . . . 0.0 111.413 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.78 61.22 0.65 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.288 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.85 155.65 30.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.61 171.44 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -130.77 127.95 39.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.029 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.59 150.96 48.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.008 0.432 . . . . 0.0 111.312 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -126.28 74.22 72.94 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.513 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 39.9 Cg_endo -72.8 144.65 39.42 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.743 2.295 . . . . 0.0 112.916 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.114 179.259 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.849 0.356 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -139.79 152.22 46.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.916 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.0 m -118.27 134.46 55.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 87.2 t80 -113.39 121.83 45.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.32 96.15 7.54 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 61.3 pttt -49.14 -23.86 1.43 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 83' ' ' ARG . 20.7 m-85 -66.33 -46.67 76.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.512 0.196 . . . . 0.0 111.524 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.2 p -86.38 -49.66 7.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.077 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.55 11.23 31.49 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.804 -0.634 . . . . 0.0 113.015 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -118.17 148.39 42.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.795 0.298 . . . . 0.0 110.356 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.35 159.57 17.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 110.385 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -135.97 129.4 32.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -75.84 150.98 37.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 77.9 t -47.89 143.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.795 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.89 79.67 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.624 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -112.54 128.9 56.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.945 HG22 HG23 ' A' ' 93' ' ' THR . 19.0 p -105.33 149.71 25.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.593 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.514 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 33.1 p90 -144.73 174.82 10.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.626 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -118.52 131.9 56.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.524 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -134.26 135.6 24.4 Favored Pre-proline 0 N--CA 1.462 0.171 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 88' ' ' MET . 67.5 Cg_endo -83.61 65.11 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.77 1.647 . . . . 0.0 112.755 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.57 125.25 21.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.61 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 t70 59.33 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.075 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' LYS . 11.1 t -165.11 38.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.416 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 3.3 ttp -149.37 154.27 38.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mm -90.78 111.94 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 28.6 m95 -99.39 155.9 17.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -118.13 107.18 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 9.6 m -107.75 167.82 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 112.01 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.945 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.6 154.47 45.43 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 109.993 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.0 t -103.51 114.39 28.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.404 0.621 . . . . 0.0 109.479 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.9 mp -84.29 -52.66 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.44 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.77 63.22 4.8 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.852 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.32 -53.81 4.63 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.63 -61.69 0.66 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.313 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 54.14 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.32 83.51 0.65 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.541 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -96.59 135.36 38.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.48 128.69 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.461 ' HB3' HD13 ' A' ' 95' ' ' ILE . 8.8 t -129.29 111.08 12.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.099 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.59 138.19 46.32 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.5 p -139.24 132.26 29.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.21 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.445 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -49.93 146.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.34 167.86 19.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.538 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.09 52.78 2.2 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.999 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.8 mtm-85 -141.18 162.79 34.64 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 7.0 p -117.95 126.66 52.76 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.37 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.636 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -131.96 156.1 46.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.014 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 6.9 tp10 167.66 141.29 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.244 0.34 . . . . 0.0 111.033 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.14 -71.84 2.91 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.286 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.02 -97.59 2.07 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.456 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -96.05 -177.78 4.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.7 p -92.81 124.52 36.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.829 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.25 158.73 16.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.803 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -98.14 153.87 18.14 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.913 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.34 124.33 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.575 0.226 . . . . 0.0 111.128 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.81 -14.9 64.48 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.467 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.8 164.25 26.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.297 0.548 . . . . 0.0 111.838 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.722 HG22 HG23 ' A' ' 137' ' ' VAL . 34.3 p -126.46 147.43 49.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.993 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -138.61 34.84 2.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.601 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -50.52 119.14 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.702 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 126' ' ' PRO . 29.9 mmt180 -140.71 162.04 51.04 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.248 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 125' ' ' ARG . 59.5 Cg_exo -41.01 172.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.889 2.392 . . . . 0.0 113.825 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.502 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 1.4 t60 -86.27 124.54 32.77 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.16 -32.66 65.0 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.103 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.414 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 4.5 p -108.67 18.9 20.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.3 -176.7 30.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.587 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.86 31.15 6.97 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.884 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.502 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 17.5 p90 -130.72 161.07 32.49 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 151' ' ' ILE . 66.7 mtp -70.98 138.73 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.3 tp -123.16 140.86 52.59 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.601 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 32.2 mt-10 -127.12 116.39 20.59 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 119.833 -0.127 . . . . 0.0 110.704 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.1 m -107.32 158.12 17.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 111.724 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.722 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -134.38 165.09 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.455 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 118.33 27.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.807 0.337 . . . . 0.0 111.288 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.82 113.53 25.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.78 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.29 104.34 1.8 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.003 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.37 38.6 4.15 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.625 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.79 29.88 7.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.57 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -164.14 -54.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.725 0.262 . . . . 0.0 111.056 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.83 73.64 0.86 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.475 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.0 167.95 9.71 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.05 163.93 31.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.413 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.491 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -152.28 138.59 18.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -132.85 151.32 52.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.341 0.591 . . . . 0.0 112.391 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -125.62 111.94 25.35 Favored Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 151' ' ' ILE . 73.1 Cg_endo -74.15 170.51 19.99 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.019 1.813 . . . . 0.0 114.307 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 150' ' ' PRO . 1.1 tp . . . . . 0 C--O 1.25 1.083 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.315 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.806 0.336 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.6 p -131.82 144.27 50.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.86 134.73 54.65 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -111.11 122.13 47.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -99.58 98.44 9.31 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -55.23 -17.7 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.556 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 1.3 m-85 -67.28 -45.77 75.61 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.316 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.6 -52.87 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.99 12.99 16.86 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.432 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.37 148.3 42.65 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.028 0.414 . . . . 0.0 110.259 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.43 159.51 17.97 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.374 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.3 129.69 29.7 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 147.74 38.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.489 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.23 141.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.14 -177.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.32 16.74 75.53 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.563 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -112.67 126.97 55.97 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.981 HG22 HG23 ' A' ' 93' ' ' THR . 18.9 p -105.2 132.92 50.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.895 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 34.3 p90 -128.53 -177.55 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.744 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.9 mt-10 -124.45 135.41 53.23 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.895 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.556 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -141.33 147.34 46.36 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.778 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 88' ' ' MET . 94.5 Cg_endo -84.86 124.41 2.99 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.143 1.895 . . . . 0.0 111.444 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -117.58 113.93 22.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.458 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 67.06 -67.88 0.16 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 m -162.94 31.54 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -144.71 167.04 23.52 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.689 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.48 116.99 47.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 17.6 m95 -99.3 154.34 18.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.92 110.15 20.6 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 46.7 m -108.83 166.89 10.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 112.214 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.981 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.15 152.76 44.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.648 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -104.41 113.9 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.94 -43.52 24.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.913 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 54.26 63.63 5.01 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.984 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -97.38 -52.06 3.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.651 0.262 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.66 -67.9 0.49 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.337 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.84 44.62 2.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.39 73.13 0.87 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.659 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -77.13 136.68 38.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.047 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.78 123.87 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.481 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 t -118.94 110.53 17.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.7 m -117.05 131.88 56.82 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.8 p -139.89 138.03 35.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.65 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.02 152.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.03 155.98 21.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.813 0.339 . . . . 0.0 111.9 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.62 56.89 3.71 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.294 0.568 . . . . 0.0 110.256 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -148.21 171.58 15.7 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.034 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 12.2 p -120.23 127.09 52.1 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.582 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.64 149.96 49.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.713 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.582 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 0.0 OUTLIER 169.11 152.37 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.671 0.272 . . . . 0.0 111.362 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.75 -36.8 3.63 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.243 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.46 -10.47 0.29 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.282 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -134.65 175.02 9.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.171 0.486 . . . . 0.0 110.18 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 12.4 p -114.23 125.84 54.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.999 0.428 . . . . 0.0 111.161 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.91 158.02 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.459 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -105.21 158.04 16.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.907 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.5 mp -52.15 124.58 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.58 0.228 . . . . 0.0 110.767 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.6 -12.82 61.32 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.241 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 156.6 30.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.216 0.508 . . . . 0.0 111.135 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 137' ' ' VAL . 1.5 p -127.97 150.62 49.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.573 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.402 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 17.8 p90 -142.56 86.49 1.95 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.145 0.498 . . . . 0.0 109.811 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -78.66 91.07 4.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 126' ' ' PRO . 20.4 mtt-85 -123.12 163.92 30.67 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.826 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 43.3 Cg_exo -43.01 176.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.082 2.521 . . . . 0.0 113.809 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.502 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.2 t60 -101.4 126.43 48.17 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 111.837 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -69.68 -36.56 76.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.794 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.41 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 18.9 p -108.5 18.6 20.75 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.502 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -146.52 175.62 25.86 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.575 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -113.78 28.79 8.24 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.302 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.46 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -136.09 159.55 41.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.658 0.229 . . . . 0.0 111.055 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.2 mtt -67.59 114.57 6.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.096 0.474 . . . . 0.0 110.749 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 150' ' ' PRO . 22.4 tp -91.76 145.85 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.618 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.2 mt-10 -121.96 115.52 22.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 94.3 m -111.35 158.13 19.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.996 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -134.79 171.15 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.889 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 t -133.02 118.36 18.71 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.752 0.311 . . . . 0.0 111.517 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.4 118.83 36.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.403 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.0 97.97 2.32 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.75 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -138.46 52.7 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.71 -76.66 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.492 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -130.08 -42.75 1.22 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.539 0.209 . . . . 0.0 111.393 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.78 91.17 0.08 OUTLIER Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.534 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.9 153.78 20.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.703 0.287 . . . . 0.0 110.823 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -137.22 164.79 27.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.996 HG22 HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -150.78 146.32 26.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -141.3 149.84 41.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.031 0.443 . . . . 0.0 111.393 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -135.3 90.94 19.64 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.545 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 134' ' ' LEU . 36.9 Cg_endo -70.6 168.06 23.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.478 2.119 . . . . 0.0 113.655 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.955 179.283 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HB2' HG22 ' A' ' 77' ' ' VAL . 1.4 mp0 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.683 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.6 p -132.23 139.1 48.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.167 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.88 136.42 54.05 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.443 ' HB2' HG23 ' A' ' 74' ' ' THR . 94.8 t80 -112.81 131.68 55.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.402 ' HB2' ' HE2' ' A' ' 75' ' ' TYR . 40.7 t0 -108.41 105.08 14.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.209 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -59.08 -17.54 26.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -69.16 -45.89 68.9 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -89.15 -47.88 7.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.71 6.4 40.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.431 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.92 151.31 38.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.098 0.449 . . . . 0.0 110.833 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -92.78 159.62 15.32 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.118 178.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.402 ' HE2' ' HB2' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -136.32 131.78 34.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.301 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -76.73 157.79 31.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -46.87 135.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.155 -178.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 29.65 59.02 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.261 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -113.54 120.53 41.27 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 1.01 HG22 HG23 ' A' ' 93' ' ' THR . 15.9 p -105.88 149.54 26.45 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.3 p90 -154.61 -173.71 4.68 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -115.38 133.88 55.62 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.94 136.88 28.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 88' ' ' MET . 80.2 Cg_endo -79.5 114.3 3.24 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 121.779 1.653 . . . . 0.0 112.837 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -117.15 107.57 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 49.53 77.87 0.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m 49.25 43.48 22.88 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.634 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 39.9 ttp -164.44 162.05 21.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.23 144.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m95 -120.27 152.45 37.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.498 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.32 102.47 14.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 80' ' ' THR . 61.1 m -108.04 139.28 42.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 112.594 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 1.01 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -115.21 152.34 32.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.882 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.75 114.45 28.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.661 0.743 . . . . 0.0 110.237 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.71 112.06 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.192 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.97 62.64 0.29 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.682 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.02 -56.11 10.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.902 0.382 . . . . 0.0 110.303 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.96 -41.31 4.38 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.548 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.4 -87.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.552 0.341 . . . . 0.0 110.181 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.403 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -144.39 56.34 0.55 Allowed Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.761 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -62.13 143.04 57.24 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.639 0.257 . . . . 0.0 111.466 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 100' ' ' GLY . 2.9 mp -107.82 129.46 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.5 t -126.5 120.11 28.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 57.0 m -119.11 135.38 54.68 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.9 p -140.09 139.96 35.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.92 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.99 158.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.382 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.16 161.24 13.81 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.05 67.5 10.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.37 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -148.47 173.32 13.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.982 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 10.0 p -126.21 127.55 45.83 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.552 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.31 169.37 17.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.281 -179.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 13.7 pt-20 170.68 -51.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.96 0.162 . . . . 0.0 111.166 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -81.88 70.15 3.18 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.74 0.46 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.839 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.89 -177.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.877 0.471 . . . . 0.0 111.882 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -119.29 127.05 52.85 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.137 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -96.24 152.15 18.84 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.504 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -89.28 -177.98 5.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.01 124.21 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.06 -3.65 82.67 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.033 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.8 163.73 25.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.576 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.665 HG22 HG23 ' A' ' 137' ' ' VAL . 28.5 p -131.82 147.74 52.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.29 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 20.3 p90 -142.76 67.05 1.31 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.385 0.612 . . . . 0.0 109.735 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.09 90.08 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.453 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 126' ' ' PRO . 26.3 mtt-85 -121.93 167.86 12.78 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.886 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 65.5 Cg_exo -43.92 178.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.984 2.456 . . . . 0.0 113.877 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.499 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.2 t60 -103.06 127.98 50.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -70.79 -35.31 72.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.704 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.467 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 19.4 p -109.99 18.55 19.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.369 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.499 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -146.95 174.7 26.68 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.557 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.92 28.99 8.38 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.404 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.479 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -135.53 159.53 41.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.574 0.226 . . . . 0.0 110.936 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 18.2 mtm -67.27 116.01 7.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 150' ' ' PRO . 26.8 tp -91.96 146.25 23.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.912 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 34.9 mt-10 -124.32 116.11 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -122.46 157.53 31.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.665 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.62 168.11 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 117.95 24.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.592 0.234 . . . . 0.0 111.056 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.41 120.98 43.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -84.26 -146.57 7.63 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.66 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.88 -64.79 0.36 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.639 0.375 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.95 -94.2 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.836 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -154.93 68.19 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 54.57 34.04 55.08 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.166 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.21 121.67 18.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.731 0.3 . . . . 0.0 110.868 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 166.26 11.3 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -146.83 127.5 14.26 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.107 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 136' ' ' CYS . 0.0 OUTLIER -125.35 149.46 48.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.467 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -139.71 96.51 8.45 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.774 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.562 ' HB3' HD12 ' A' ' 134' ' ' LEU . 55.9 Cg_endo -75.53 169.28 22.69 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.37 2.047 . . . . 0.0 113.523 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.035 179.304 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.532 0.206 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p -124.53 152.95 42.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.152 0.501 . . . . 0.0 111.2 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' TYR . 68.0 m -119.48 138.64 53.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.046 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -121.17 127.92 51.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.38 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -111.68 109.19 18.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.39 -13.49 51.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.575 0.226 . . . . 0.0 111.592 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.607 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 4.0 m-30 -68.86 -43.27 75.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.857 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -94.85 -50.0 5.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.76 5.12 33.87 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.856 -0.611 . . . . 0.0 114.036 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.422 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.2 m120 -117.18 141.44 48.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.714 0.757 . . . . 0.0 111.297 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.85 160.35 29.31 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.99 0.424 . . . . 0.0 110.97 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' A' ' 66' ' ' CYS . 6.5 m-85 -134.61 129.01 34.29 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.909 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -78.27 143.4 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 79.9 t -47.73 123.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.022 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.57 36.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.791 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -113.02 124.07 51.76 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.968 HG22 HG23 ' A' ' 93' ' ' THR . 11.9 p -105.81 144.42 32.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.075 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 34.6 p90 -138.89 -175.08 4.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.6 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.1 mt-10 -122.4 126.55 48.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.71 0.291 . . . . 0.0 110.769 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.607 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -120.08 128.98 25.57 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -87.19 98.46 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.082 1.854 . . . . 0.0 111.319 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 114.22 27.7 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 47.65 79.84 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.4 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.7 m 45.16 40.35 4.8 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.843 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -150.82 162.09 41.43 Favored 'General case' 0 C--N 1.335 -0.053 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.676 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mm -114.39 132.55 63.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.556 ' CH2' HG12 ' A' ' 106' ' ' ILE . 26.4 m95 -117.48 135.29 54.02 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -97.7 104.25 16.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' THR . 15.0 t -107.63 153.56 22.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.968 HG23 HG22 ' A' ' 80' ' ' THR . 0.6 OUTLIER -134.54 154.04 51.65 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.245 -179.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 8.9 t -101.74 113.45 26.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -54.37 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.095 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 56.25 60.89 8.15 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.001 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.32 -45.58 54.48 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.667 0.27 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.58 -58.91 0.72 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 67.14 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.18 93.37 0.48 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.751 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -120.06 151.78 38.51 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.87 119.46 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.078 0.399 . . . . 0.0 110.467 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.98 115.44 17.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.115 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 2.8 m -130.84 144.01 51.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.7 p -139.65 153.44 47.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.44 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.556 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -69.41 -168.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.669 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 106' ' ' ILE . . . 70.68 -164.93 0.15 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 52.0 m-80 82.33 -25.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.281 0.632 . . . . 0.0 111.671 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -138.35 152.65 48.64 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 117' ' ' TYR . 4.3 p -110.22 123.09 49.14 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.928 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -135.61 -174.7 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 25.2 tt0 169.41 123.95 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.735 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 68.88 165.82 4.1 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.249 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -31.46 -31.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 113' ' ' GLY . 52.0 mt-30 -93.53 127.18 39.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.155 0.977 . . . . 0.0 111.641 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -95.46 153.76 17.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.431 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 110' ' ' CYS . 13.1 m-85 -140.35 146.62 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.625 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -94.69 178.73 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.886 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.05 124.13 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.631 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.47 -3.72 84.03 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.243 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.74 151.62 28.97 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.13 0.465 . . . . 0.0 111.016 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.595 HG22 HG23 ' A' ' 137' ' ' VAL . 7.3 p -127.15 144.77 50.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.091 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -137.52 50.06 1.97 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.67 113.63 0.68 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.146 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -144.65 154.17 55.64 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 33.8 Cg_exo -39.06 149.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.246 2.63 . . . . 0.0 113.619 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.576 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.2 t60 -67.22 135.11 52.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 112.104 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -73.42 -32.71 64.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.429 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 63.5 p -120.0 18.99 12.41 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.637 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -139.83 176.1 21.41 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.571 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.55 31.98 6.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.312 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.65 170.32 16.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 110.544 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 14.1 mtt -78.24 115.1 17.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.576 HD22 ' ND1' ' A' ' 127' ' ' HIS . 21.0 tp -91.87 144.54 25.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.747 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 40.6 mt-10 -122.32 115.66 22.7 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 99.1 m -110.33 157.71 19.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.595 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -130.03 177.15 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.76 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.455 ' N ' HG13 ' A' ' 137' ' ' VAL . 2.6 t -130.49 117.13 19.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.132 0.423 . . . . 0.0 111.583 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.4 mt -112.56 113.58 25.8 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.101 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.63 87.42 0.42 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.868 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.47 -49.24 4.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.612 0.244 . . . . 0.0 110.754 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -165.43 36.1 0.26 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.705 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -171.31 -43.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.612 0.206 . . . . 0.0 111.317 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.08 67.1 0.81 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.597 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.61 152.89 21.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.664 0.268 . . . . 0.0 110.717 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 166.13 14.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.69 134.99 22.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.965 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.2 m -130.33 149.85 51.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.035 0.445 . . . . 0.0 111.387 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.27 96.47 12.54 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.598 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 134' ' ' LEU . 56.7 Cg_endo -76.48 162.95 32.76 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.267 1.978 . . . . 0.0 113.522 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.986 179.197 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.683 0.278 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 p -131.16 154.98 47.79 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.208 0.528 . . . . 0.0 111.26 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' TYR . 61.3 m -119.04 136.33 54.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.424 ' O ' HD11 ' A' ' 102' ' ' ILE . 89.2 t80 -120.56 128.32 52.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.215 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -111.87 103.95 12.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.979 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -58.97 -15.15 11.6 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.697 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.477 ' CD2' ' HD2' ' A' ' 83' ' ' ARG . 3.2 m-85 -67.45 -45.98 74.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.968 0.413 . . . . 0.0 110.346 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -50.5 5.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.056 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.93 10.18 28.78 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.44 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -118.18 153.48 33.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.117 0.458 . . . . 0.0 110.814 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.24 159.73 15.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.885 0.374 . . . . 0.0 110.259 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' CYS . 4.3 m-85 -135.06 127.95 31.36 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.662 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.0 148.65 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.465 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 17.8 t -47.86 142.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.351 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.72 20.99 79.3 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.208 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.39 127.19 56.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.911 HG22 HG23 ' A' ' 93' ' ' THR . 15.3 p -105.67 149.34 26.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.782 0.325 . . . . 0.0 110.644 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 30.3 p90 -152.17 -179.11 7.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 3.6 mt-10 -112.84 132.73 55.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.749 0.309 . . . . 0.0 110.373 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.477 ' HD2' ' CD2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -137.9 128.7 15.73 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 88' ' ' MET . 59.9 Cg_endo -74.86 119.0 5.49 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.617 1.545 . . . . 0.0 111.898 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -118.0 115.56 25.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.045 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 44.67 69.84 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 m 54.57 37.82 28.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.671 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -145.9 160.52 41.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.398 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -110.69 116.33 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.0 m95 -105.48 159.82 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.89 103.72 11.7 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 8.7 t -108.94 141.64 40.72 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.911 HG23 HG22 ' A' ' 80' ' ' THR . 0.7 OUTLIER -117.76 153.48 33.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.303 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 15.0 t -103.56 117.04 33.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.218 0.533 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.46 -46.8 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.417 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.67 -94.13 0.19 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.549 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 61.56 21.83 12.41 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.58 -71.41 0.07 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.2 mmm-85 -114.82 -88.04 0.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.03 38.09 0.38 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 ptt-85 -68.7 141.92 55.17 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.857 0.361 . . . . 0.0 110.868 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.424 HD11 ' O ' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -112.42 147.85 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.646 -178.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -125.47 111.98 15.72 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.87 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.9 m -108.55 140.34 42.04 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.5 p -140.16 146.86 39.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.54 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.2 mt -55.55 153.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.304 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.6 26.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 111.792 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.96 70.89 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -150.19 177.09 10.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.208 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 14.7 p -124.44 130.5 52.58 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.505 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 6.0 p-80 -133.75 -145.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.156 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 1.3 tp10 89.23 163.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.542 0.337 . . . . 0.0 111.124 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.28 13.4 80.74 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.349 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.91 -16.11 58.79 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.159 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -133.48 170.52 15.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.07 0.435 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 4.9 p -119.05 127.44 53.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.969 0.414 . . . . 0.0 111.068 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -109.15 157.77 18.44 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.633 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 35.5 mttt -103.36 157.14 17.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.54 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm -48.81 124.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.9 67.29 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.688 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -77.31 159.96 29.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.377 0.588 . . . . 0.0 111.709 -179.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.681 HG22 HG23 ' A' ' 137' ' ' VAL . 29.9 p -123.42 147.77 46.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.888 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -143.8 40.11 1.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.111 0.481 . . . . 0.0 109.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.6 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -55.77 108.06 0.41 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.191 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' PRO . 19.8 mtt180 -138.53 174.08 4.6 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.156 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 31.6 Cg_exo -41.36 -175.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.825 2.35 . . . . 0.0 113.667 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.66 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 2.6 t60 -104.07 124.74 49.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 112.028 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.02 -37.74 64.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.115 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.535 ' HB ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -80.06 -23.07 41.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.697 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -132.5 -153.03 7.18 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.81 31.2 3.41 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.574 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.66 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 20.0 p90 -127.26 140.47 52.2 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 120.491 0.186 . . . . 0.0 111.367 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 19.9 ttt -47.83 139.39 7.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.253 0.549 . . . . 0.0 112.0 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 125' ' ' ARG . 27.2 tp -133.58 143.72 48.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.567 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.6 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 27.5 mt-10 -127.47 116.87 21.09 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.7 OUTLIER -122.24 157.63 31.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.084 0.469 . . . . 0.0 112.11 -178.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.31 170.1 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.904 -179.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 t -118.55 118.37 31.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.683 0.278 . . . . 0.0 111.288 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 40.3 mt -112.47 134.66 53.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.499 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.15 -114.01 0.99 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.65 -70.37 0.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.672 0.389 . . . . 0.0 111.702 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.29 -91.37 0.83 Allowed Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.567 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -129.63 -42.71 1.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 176.14 73.6 0.05 OUTLIER Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -92.14 161.63 14.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.737 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.07 162.23 36.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.55 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.53 125.76 14.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.503 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.12 149.71 50.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.499 0.666 . . . . 0.0 112.279 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -124.69 102.62 32.12 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.55 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 6.1 Cg_exo -71.27 167.94 24.8 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.019 1.812 . . . . 0.0 114.992 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 151' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.075 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.811 0.339 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 p -132.19 150.01 52.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.8 m -118.64 139.28 51.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.55 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -120.25 126.7 51.25 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 100.83 10.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -52.56 -21.75 4.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -67.69 -46.41 72.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 p -86.16 -52.4 5.69 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.67 8.82 31.86 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.439 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.31 145.43 44.0 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.957 0.379 . . . . 0.0 110.393 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 159.43 20.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.977 0.418 . . . . 0.0 110.648 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.425 ' CE1' ' CG ' ' A' ' 81' ' ' TYR . 3.1 m-85 -134.49 128.59 33.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.3 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.13 153.05 34.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 77' ' ' VAL . 4.2 t -47.78 140.18 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.896 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.02 21.07 79.58 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.428 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.89 126.26 55.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.912 HG22 HG23 ' A' ' 93' ' ' THR . 20.4 p -105.37 132.93 50.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.889 0.376 . . . . 0.0 111.42 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 36.3 p90 -126.2 -176.23 3.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.673 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 138.56 54.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.859 0.362 . . . . 0.0 111.045 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.6 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -137.16 132.22 17.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.9 Cg_endo -79.74 59.85 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.696 1.597 . . . . 0.0 112.822 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -56.73 130.69 46.58 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.899 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 t70 35.21 63.86 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.3 m 53.9 36.04 23.27 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 18.1 mtm -143.16 149.16 37.67 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.65 109.32 21.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.458 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 18.6 m95 -100.01 151.93 20.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.414 -177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.35 110.82 22.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 33.4 m -108.88 162.33 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.912 HG23 HG22 ' A' ' 80' ' ' THR . 1.0 OUTLIER -141.54 154.01 45.22 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.198 -179.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 21.4 t -103.49 113.37 26.82 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.504 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -76.62 -36.47 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.483 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.4 72.64 0.82 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.582 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.05 -55.35 3.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.687 0.279 . . . . 0.0 111.409 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.82 -61.09 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.536 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 24.61 12.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.878 0.37 . . . . 0.0 111.198 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.17 90.1 0.94 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.56 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -91.36 129.48 37.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.595 0.236 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.24 124.5 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.504 ' HB3' HD13 ' A' ' 95' ' ' ILE . 13.5 t -128.58 111.52 13.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.985 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.2 m -111.72 137.22 49.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.9 p -139.28 136.24 34.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.069 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.402 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -50.95 146.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.04 154.22 26.98 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.453 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.434 ' O ' HG12 ' A' ' 119' ' ' ILE . 4.2 p30 -85.87 63.89 8.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.099 0.476 . . . . 0.0 110.57 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -149.8 167.63 26.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.642 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 117' ' ' TYR . 2.7 p -118.95 125.61 49.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.601 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.0 145.32 47.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.746 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.601 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 5.9 pt-20 170.32 157.72 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.206 0.316 . . . . 0.0 111.197 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -77.61 1.98 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.996 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.79 -38.39 0.07 OUTLIER Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.52 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -123.55 172.17 8.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.294 0.547 . . . . 0.0 111.232 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 p -101.9 126.59 48.84 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' CYS . 2.5 m-85 -108.39 157.1 18.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.515 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -98.68 155.38 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.524 HD12 ' HA3' ' A' ' 140' ' ' GLY . 22.3 mm -54.78 131.64 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.45 -10.32 73.77 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.567 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 150.54 30.0 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 117.489 0.645 . . . . 0.0 110.439 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 137' ' ' VAL . 21.7 p -142.54 141.39 32.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.444 ' CZ2' ' HB3' ' A' ' 136' ' ' CYS . 11.2 p90 -140.31 110.63 6.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -123.72 107.57 11.59 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.114 0.483 . . . . 0.0 111.703 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -148.04 159.23 40.57 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.678 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 26.5 Cg_exo -39.77 144.75 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.862 2.375 . . . . 0.0 113.027 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.662 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.9 t60 -65.75 137.57 57.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.487 0.661 . . . . 0.0 112.559 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.82 -41.76 59.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.684 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 78.0 p -108.34 17.68 21.89 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.84 -95.33 1.14 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.385 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.53 -22.63 0.42 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.08 171.73 9.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.641 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.1 ptm -69.78 151.28 45.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.662 HD22 ' ND1' ' A' ' 127' ' ' HIS . 25.1 tp -136.34 129.25 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.7 mt-10 -118.96 119.78 35.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.001 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 147' ' ' THR . 94.3 m -116.12 158.22 23.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 111.912 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.068 HG23 HG23 ' A' ' 147' ' ' THR . 0.0 OUTLIER -141.17 165.52 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.85 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 133.34 54.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.861 0.362 . . . . 0.0 111.222 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.09 156.55 19.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.228 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.524 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -153.38 39.43 0.71 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.975 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -51.44 5.37 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.658 0.266 . . . . 0.0 110.708 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -117.09 -46.75 0.5 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.389 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -153.81 148.69 26.59 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.526 0.203 . . . . 0.0 110.576 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.94 105.69 1.0 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.464 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.4 173.81 7.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.436 ' CD1' ' HH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -117.43 146.25 43.59 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.117 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 1.068 HG23 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -146.0 122.79 11.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -148.07 151.28 35.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.111 177.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -145.35 90.16 6.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.395 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.523 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 56.3 Cg_endo -73.08 158.17 49.73 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.329 2.019 . . . . 0.0 113.069 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.959 179.259 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.737 0.304 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 4.9 p -129.31 140.74 51.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 150.88 39.01 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.992 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 91.4 t80 -121.01 129.15 53.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -110.24 97.0 6.58 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 39.6 pttt -49.39 -19.0 0.45 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.547 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 2.9 m-85 -65.89 -45.52 81.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.832 0.349 . . . . 0.0 111.22 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -91.46 -52.61 4.7 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.67 9.81 28.04 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.321 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -117.26 138.29 51.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.932 0.366 . . . . 0.0 110.509 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.86 160.07 30.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.172 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.644 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 26.9 m-85 -130.34 128.92 42.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.475 ' HG3' HG22 ' A' ' 65' ' ' THR . 1.5 mtt180 -85.77 147.56 26.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.45 HG13 ' C ' ' A' ' 95' ' ' ILE . 2.8 t -46.92 144.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.356 -177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 27.93 71.82 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.325 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -113.31 127.24 56.08 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.871 HG22 HG23 ' A' ' 93' ' ' THR . 22.3 p -105.71 150.5 25.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.839 0.352 . . . . 0.0 111.554 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.4 ' CD1' ' CE1' ' A' ' 75' ' ' TYR . 24.7 p90 -157.4 -175.36 5.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.173 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.77 132.35 54.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.421 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.547 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 5.6 tmm_? -128.71 131.79 23.97 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 88' ' ' MET . 87.4 Cg_endo -84.29 64.52 6.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.813 . . . . 0.0 114.158 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.435 ' HG2' ' NE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -59.27 124.4 19.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.924 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 35.31 71.23 0.12 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.6 m 50.66 36.34 13.81 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.88 148.88 39.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mm -96.68 112.65 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.981 0.42 . . . . 0.0 109.88 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.565 ' CH2' HG12 ' A' ' 106' ' ' ILE . 19.6 m95 -101.92 148.41 25.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.186 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.92 107.99 19.31 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 80' ' ' THR . 70.1 m -108.03 156.29 19.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.871 HG23 HG22 ' A' ' 80' ' ' THR . 2.0 m -141.53 150.05 41.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.458 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -106.9 113.65 27.26 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.322 0.965 . . . . 0.0 110.649 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.45 ' C ' HG13 ' A' ' 77' ' ' VAL . 1.8 mp -79.3 -24.42 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.717 -177.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 97' ' ' ALA . . . 83.04 -75.82 2.33 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.395 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' GLY . . . 17.42 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.26 -113.47 4.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.455 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.28 70.95 1.4 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.145 0.498 . . . . 0.0 111.29 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.81 77.28 1.0 Allowed Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.92 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -102.09 131.66 48.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.603 0.239 . . . . 0.0 110.959 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.24 122.31 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.136 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.14 116.05 17.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.918 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.9 m -123.16 143.89 49.71 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 p -139.9 139.67 36.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.695 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.565 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -62.46 154.77 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.508 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.62 152.67 18.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 111.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.431 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.6 OUTLIER -85.75 68.13 10.27 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.635 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 119' ' ' ILE . 62.3 mtp180 -150.56 172.04 16.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.172 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.2 m -110.62 127.2 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.561 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -138.77 147.14 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 179.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 2.9 tm-20 171.35 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.728 0.299 . . . . 0.0 111.206 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 97.72 -83.69 0.71 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.636 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.56 2.19 0.38 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.434 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.69 -177.93 5.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.346 0.573 . . . . 0.0 111.103 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -119.52 127.71 53.27 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -108.41 159.44 16.66 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.666 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 3.9 tmtt? -103.07 158.08 16.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.4 mp -49.12 128.13 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.675 0.274 . . . . 0.0 111.197 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.39 61.42 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.312 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -80.78 168.87 18.3 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.355 0.578 . . . . 0.0 111.397 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.46 HG22 ' CG1' ' A' ' 137' ' ' VAL . 1.4 p -138.85 152.99 48.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.04 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.443 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 43.3 p90 -141.26 84.39 1.92 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.219 0.533 . . . . 0.0 110.039 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 1.2 mpp_? -85.23 74.16 10.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -110.72 167.16 9.46 Favored Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.726 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 66.5 Cg_exo -44.08 175.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.862 2.375 . . . . 0.0 113.676 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.43 ' ND1' HD22 ' A' ' 134' ' ' LEU . 3.9 t60 -105.26 128.87 53.65 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.96 -40.24 60.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.983 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.404 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 16.3 p -98.7 15.12 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.27 -69.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.856 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 123.55 19.57 2.79 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.42 ' HE1' ' HB3' ' A' ' 150' ' ' PRO . 3.5 p90 -126.4 141.74 51.79 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.038 0.535 . . . . 0.0 109.622 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.2 ptt? -50.41 108.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.547 0.689 . . . . 0.0 111.391 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.446 ' CD1' ' HG3' ' A' ' 150' ' ' PRO . 34.3 tp -91.92 143.87 26.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.336 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 36.1 mt-10 -126.15 116.0 20.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.15 157.33 38.39 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.792 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -126.95 174.61 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.862 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.94 118.88 12.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.814 0.34 . . . . 0.0 111.164 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.51 132.3 55.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.514 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -89.58 84.42 1.4 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.667 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 -48.45 6.93 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.556 0.217 . . . . 0.0 111.114 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -140.89 -65.99 0.03 OUTLIER Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.585 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -113.26 -39.13 4.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.427 0.156 . . . . 0.0 111.158 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.25 94.49 0.1 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.623 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -106.76 150.18 26.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.578 0.228 . . . . 0.0 110.645 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.97 165.24 21.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 111.341 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.792 HG22 HG23 ' A' ' 137' ' ' VAL . 0.6 OUTLIER -145.56 121.02 10.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.605 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -130.95 149.37 52.61 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.371 0.605 . . . . 0.0 111.799 179.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -123.78 90.28 50.76 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.63 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 134' ' ' LEU . 1.7 Cg_endo -80.69 161.63 21.69 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.66 2.24 . . . . 0.0 114.048 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.118 179.053 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.631 0.253 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -70.74 100.22 1.85 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.366 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 p -139.71 146.89 40.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.19 139.42 51.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.413 ' HB2' HG23 ' A' ' 74' ' ' THR . 93.2 t80 -114.69 132.27 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -109.27 112.67 24.95 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -64.03 -16.76 62.38 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.572 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 5.8 m-85 -70.59 -45.98 64.32 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -88.8 -48.32 7.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.797 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.33 3.82 47.36 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.791 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.463 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.5 m-80 -117.3 138.5 51.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 117.4 0.6 . . . . 0.0 110.926 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -79.02 159.84 27.43 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.907 0.384 . . . . 0.0 110.565 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 73' ' ' ASN . 1.1 m-85 -134.52 138.62 44.82 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.622 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -79.78 165.9 22.3 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 t -59.54 128.29 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.115 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.66 24.67 49.23 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.996 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -113.08 122.79 48.63 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.974 HG22 HG23 ' A' ' 93' ' ' THR . 19.1 p -105.3 149.12 26.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.909 0.385 . . . . 0.0 111.074 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 18.4 p90 -145.25 -172.63 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.732 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -115.64 129.83 56.64 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.572 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 4.6 tmm_? -130.13 124.95 21.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.097 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 88' ' ' MET . 84.9 Cg_endo -80.55 111.55 2.58 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 121.841 1.694 . . . . 0.0 112.239 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.546 ' HB3' ' NE1' ' A' ' 90' ' ' TRP . 11.3 tptt -116.88 118.94 33.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.821 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 46.55 73.23 0.19 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.5 m 47.38 41.84 13.16 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.915 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.7 ttp -153.04 164.54 37.8 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.199 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mm -112.2 122.54 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.546 ' NE1' ' HB3' ' A' ' 85' ' ' LYS . 25.3 m95 -107.97 140.22 41.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.36 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.05 110.19 21.66 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' THR . 75.1 m -109.44 152.81 24.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.974 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -130.73 150.65 51.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.266 179.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 122.18 45.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.352 0.596 . . . . 0.0 110.903 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -98.78 131.28 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.453 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.59 -169.1 25.85 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.317 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 70.99 114.54 0.05 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.808 0.443 . . . . 0.0 111.811 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.93 -136.82 12.91 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.963 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.25 23.1 9.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.107 0.479 . . . . 0.0 111.158 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.541 ' O ' HD12 ' A' ' 102' ' ' ILE . . . 80.01 70.11 1.35 Allowed Glycine 0 CA--C 1.517 0.179 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.554 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -60.2 140.43 56.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.535 0.207 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.541 HD12 ' O ' ' A' ' 100' ' ' GLY . 3.0 mp -109.64 121.1 62.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.307 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.547 ' HB3' HD13 ' A' ' 95' ' ' ILE . 20.3 t -114.49 121.59 43.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.378 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.1 m -124.35 136.4 54.06 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 p -138.98 141.86 38.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.678 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.452 HG13 ' CH2' ' A' ' 90' ' ' TRP . 1.5 mt -51.96 155.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.284 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.08 144.1 28.61 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -80.49 75.77 7.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.75 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HG2' ' HA ' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -150.17 173.53 13.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.23 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 117' ' ' TYR . 13.0 p -128.64 127.99 43.29 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 1.1 p-80 -135.1 -143.28 0.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 119.495 -0.288 . . . . 0.0 111.037 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.8 175.95 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.503 0.321 . . . . 0.0 111.078 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.43 -77.25 1.74 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.751 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.15 -39.26 0.04 OUTLIER Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.936 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -133.71 167.21 20.93 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 32.4 p -84.88 150.83 24.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 111.247 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 110' ' ' CYS . 7.0 m-85 -133.21 139.1 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 1.9 mptm? -85.25 176.31 8.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.637 0.256 . . . . 0.0 111.161 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.1 mm -74.59 124.3 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.334 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.79 -3.14 86.3 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.92 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 169.7 17.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.924 0.393 . . . . 0.0 111.459 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.834 HG22 HG23 ' A' ' 137' ' ' VAL . 30.0 p -133.9 150.31 51.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -141.28 55.21 1.54 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.27 0.557 . . . . 0.0 109.716 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -55.66 98.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.706 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.8 mtt180 -132.36 166.99 24.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.751 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 32.8 Cg_exo -39.71 177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.193 2.595 . . . . 0.0 113.956 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.487 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.4 t60 -103.11 129.58 50.01 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.142 0.496 . . . . 0.0 112.336 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -64.97 -40.49 95.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.276 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 66.5 p -111.38 19.36 18.32 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.8 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -144.79 174.5 24.89 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.49 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.62 28.59 8.86 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.385 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.497 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -133.16 158.3 43.19 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.488 0.185 . . . . 0.0 110.714 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 17.9 mtt -67.26 115.94 7.48 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.452 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.569 HD12 ' HB3' ' A' ' 150' ' ' PRO . 21.5 tp -92.19 144.68 25.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.869 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.5 pt-20 -125.44 116.16 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.7 157.47 32.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.834 HG23 HG22 ' A' ' 122' ' ' THR . 0.4 OUTLIER -126.34 168.47 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.233 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -131.56 124.25 29.64 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.829 0.347 . . . . 0.0 111.419 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.35 127.08 55.54 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.195 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.28 -103.05 0.09 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.979 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.71 22.35 11.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.421 0.288 . . . . 0.0 111.765 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.35 56.55 14.9 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.918 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -160.77 -54.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.659 0.23 . . . . 0.0 111.193 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.79 60.16 0.94 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.459 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.44 160.45 15.13 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.729 0.299 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.33 161.86 36.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.537 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.24 127.26 16.47 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.24 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.33 148.91 50.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.091 0.472 . . . . 0.0 111.403 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -137.92 91.4 13.4 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.918 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.569 ' HB3' HD12 ' A' ' 134' ' ' LEU . 36.5 Cg_endo -69.48 164.96 32.27 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.424 2.083 . . . . 0.0 113.559 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.017 179.357 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.585 0.231 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -78.5 167.88 20.62 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.302 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.3 p -133.3 145.94 50.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.033 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.0 m -118.16 135.49 54.2 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.5 t80 -109.24 124.2 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 10.1 t70 -98.31 103.91 15.9 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 14.9 ptpt -56.57 -27.97 59.09 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 94.0 m-85 -67.93 -39.64 83.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.772 0.32 . . . . 0.0 111.144 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -88.18 -53.45 4.7 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.73 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.48 39.51 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.406 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.54 144.06 46.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.095 0.448 . . . . 0.0 110.686 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.52 160.25 21.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.713 0.292 . . . . 0.0 110.872 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -136.76 131.45 33.42 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.252 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -75.92 140.97 42.39 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.515 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.46 130.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.23 0.538 . . . . 0.0 111.982 -177.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.45 14.6 56.87 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.677 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.97 125.77 54.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.99 HG22 HG23 ' A' ' 93' ' ' THR . 18.7 p -105.04 142.24 35.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.907 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -136.71 -173.91 3.56 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.766 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 5.2 mt-10 -119.98 126.84 51.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.202 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -124.27 123.15 25.97 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.271 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.1 Cg_endo -78.39 110.01 2.77 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.132 1.888 . . . . 0.0 112.076 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.73 116.57 27.76 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.861 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 48.32 77.51 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.8 m 44.5 43.85 6.66 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 19.3 ttp -155.65 166.03 34.75 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.345 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.7 130.84 68.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 22.3 m95 -114.46 143.07 45.53 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -98.56 109.38 22.14 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 80' ' ' THR . 81.7 m -108.99 159.91 16.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.128 0.49 . . . . 0.0 112.29 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.99 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -138.28 153.04 49.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.633 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 6.2 t -104.05 117.92 35.44 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.545 0.688 . . . . 0.0 110.806 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.7 mp -88.89 119.93 36.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.424 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.8 -115.97 1.86 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.968 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 58.51 33.84 23.43 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.773 0.32 . . . . 0.0 111.198 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.21 45.03 92.86 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.397 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 -67.54 0.59 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.34 56.01 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 121.192 -0.527 . . . . 0.0 112.142 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.7 143.29 9.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.754 0.422 . . . . 0.0 111.737 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.46 120.01 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.257 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.571 ' HB3' HD13 ' A' ' 95' ' ' ILE . 2.0 t -111.21 111.89 23.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.7 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.4 m -121.36 127.72 51.53 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.2 p -138.91 138.98 37.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.926 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -45.37 155.86 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.292 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.59 155.29 17.37 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.81 70.94 7.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.449 ' HA ' HD12 ' A' ' 119' ' ' ILE . 91.3 mtm-85 -150.08 168.14 24.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.9 p -117.16 125.4 51.15 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.787 0.327 . . . . 0.0 110.126 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.574 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -129.76 166.42 19.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.617 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.574 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 15.1 pt-20 167.3 138.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.266 0.354 . . . . 0.0 110.923 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -37.6 3.25 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.505 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.54 -94.77 0.1 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.44 177.93 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.29 0.236 . . . . 0.0 111.306 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.4 p -120.1 125.51 48.44 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.927 0.394 . . . . 0.0 111.492 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.7 m-85 -95.56 157.3 15.96 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.635 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -93.06 174.53 7.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.5 mp -74.08 124.5 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.3 -4.85 82.87 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.794 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.97 160.45 30.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.82 0.31 . . . . 0.0 110.991 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.763 HG22 HG23 ' A' ' 137' ' ' VAL . 18.8 p -130.9 145.42 52.01 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 29.9 p90 -136.75 53.14 1.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.355 0.598 . . . . 0.0 109.619 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.33 102.85 0.06 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.745 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 126' ' ' PRO . 97.5 mtt180 -134.92 161.77 61.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.762 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 125' ' ' ARG . 37.4 Cg_exo -40.28 174.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.176 2.584 . . . . 0.0 113.879 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.5 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.1 t60 -100.15 128.17 46.27 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 111.877 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -72.57 -32.68 66.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.718 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.447 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 16.0 p -112.42 18.43 18.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.326 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -145.21 174.62 25.18 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.582 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.87 29.11 8.32 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.122 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -136.82 162.93 31.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.491 0.186 . . . . 0.0 110.705 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 18.3 ptt? -70.93 117.16 12.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.243 0.544 . . . . 0.0 110.774 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.563 HD12 ' HB3' ' A' ' 150' ' ' PRO . 23.3 tp -91.67 145.47 24.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.717 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 5.1 pt-20 -129.59 116.12 18.41 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -120.8 157.34 29.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.763 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.65 173.28 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.271 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.421 ' N ' HG13 ' A' ' 137' ' ' VAL . 18.3 t -128.36 117.81 22.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.759 0.314 . . . . 0.0 110.761 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.2 mt -111.66 113.86 26.52 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.464 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.97 70.45 0.94 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 -53.31 3.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.542 0.21 . . . . 0.0 111.07 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -95.48 -65.36 0.97 Allowed Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.516 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 pttt -144.5 -44.59 0.25 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.417 0.151 . . . . 0.0 111.316 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -178.21 83.56 0.07 OUTLIER Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.91 159.23 18.57 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.23 163.79 31.92 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.5 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -146.82 126.6 13.47 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.3 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 136' ' ' CYS . 0.0 OUTLIER -124.62 149.31 47.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.058 0.456 . . . . 0.0 110.932 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -136.36 88.74 20.24 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.837 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.563 ' HB3' HD12 ' A' ' 134' ' ' LEU . 29.2 Cg_endo -67.44 168.96 16.6 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.443 2.095 . . . . 0.0 113.645 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.052 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 120.649 0.261 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -79.13 91.68 4.95 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 111.217 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 p -138.17 148.93 45.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.7 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.93 135.39 54.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 89.5 t80 -110.19 126.39 54.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 11.1 t70 -102.21 96.87 7.27 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.775 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 47.9 pttt -47.69 -29.38 2.99 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 84.8 m-85 -67.46 -39.87 85.32 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.6 p -87.19 -51.09 6.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 110.526 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.29 8.75 37.8 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.832 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -119.56 153.33 35.58 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.793 0.296 . . . . 0.0 110.786 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 159.81 14.71 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.08 139.71 39.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.806 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -78.76 165.08 23.99 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 95' ' ' ILE . 57.8 t -53.53 137.12 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 0.0 111.621 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.21 32.27 63.0 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.101 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.34 120.89 42.69 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.996 HG22 HG23 ' A' ' 93' ' ' THR . 22.0 p -105.26 150.19 25.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 0.0 110.906 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -153.3 179.14 9.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.567 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.96 126.83 53.51 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -126.07 126.03 24.76 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.911 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.5 Cg_endo -78.43 116.93 3.94 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.982 1.788 . . . . 0.0 111.347 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -119.02 123.65 45.04 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.262 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 42.51 74.31 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 t 46.63 42.21 11.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 29.7 ttp -154.59 164.76 38.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mm -110.32 136.58 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 20.7 m95 -121.9 159.92 25.86 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -110.04 108.24 18.39 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 88.6 m -108.35 162.93 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.996 HG23 HG22 ' A' ' 80' ' ' THR . 0.3 OUTLIER -141.57 151.68 43.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.11 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.15 114.41 28.59 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 77' ' ' VAL . 16.3 mm -74.47 -61.42 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.125 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.0 129.06 0.05 OUTLIER Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.42 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -170.85 55.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.869 0.366 . . . . 0.0 110.461 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.36 61.45 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.258 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -175.93 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.458 0.303 . . . . 0.0 111.807 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.72 80.83 0.96 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.419 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -90.0 131.99 35.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.634 0.255 . . . . 0.0 111.077 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.61 126.82 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.295 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -127.18 111.22 13.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 97.9 m -116.53 139.05 50.91 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.6 p -139.84 138.92 36.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.959 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.5 mt -48.7 148.05 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.11 148.37 34.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -93.28 59.25 2.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.19 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -149.15 177.38 9.67 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.686 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 85.8 m -110.11 128.19 55.31 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.507 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -138.94 145.36 39.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.507 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 10.6 pt-20 170.9 166.82 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.614 0.245 . . . . 0.0 111.304 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.35 -93.52 1.64 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.596 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.86 0.59 1.2 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.05 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.18 -178.32 5.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.8 t -119.04 127.21 53.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.555 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 7.1 m-85 -104.37 159.74 15.48 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.158 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 5.2 mmtp -105.82 164.13 12.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.9 mm -54.4 124.53 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.514 0.197 . . . . 0.0 111.409 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.3 63.0 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.355 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -71.95 159.68 33.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.388 0.594 . . . . 0.0 111.473 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.572 HG22 HG12 ' A' ' 137' ' ' VAL . 2.5 p -130.96 152.25 50.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.13 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -144.38 98.34 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 109.977 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -92.37 87.13 5.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.426 -178.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 126' ' ' PRO . 1.0 OUTLIER -120.74 167.41 13.01 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.698 179.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 45.3 Cg_exo -43.15 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.0 2.467 . . . . 0.0 113.633 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.49 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.4 t60 -100.95 129.81 46.86 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.095 0.474 . . . . 0.0 112.194 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.25 -40.33 93.85 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 74.0 p -112.49 20.04 17.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.777 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.461 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -144.14 173.71 24.76 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.557 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.78 30.89 7.44 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.348 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -136.15 164.52 27.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.427 0.156 . . . . 0.0 110.712 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 12.3 mtt -72.9 116.16 13.06 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.082 0.467 . . . . 0.0 110.472 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 150' ' ' PRO . 21.2 tp -92.23 144.56 25.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.573 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 37.4 mt-10 -120.93 115.69 23.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 92.1 m -112.73 158.2 20.36 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.98 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -135.33 169.36 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.864 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 7.4 t -138.33 123.65 19.37 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.872 0.367 . . . . 0.0 111.301 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 mt -112.22 143.83 42.62 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.453 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.93 77.65 1.86 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.722 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 122.98 12.3 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.612 0.244 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.8 -90.93 1.47 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.731 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 43.36 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.04 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.696 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.78 127.59 35.99 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.708 0.29 . . . . 0.0 110.572 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -109.53 167.64 9.99 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.98 HG22 HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -149.79 145.98 26.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -141.76 149.94 41.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.427 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -135.23 90.59 20.66 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.615 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.526 ' HB3' HD12 ' A' ' 134' ' ' LEU . 38.4 Cg_endo -70.96 161.42 46.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.484 2.123 . . . . 0.0 113.63 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.011 179.183 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.671 0.272 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.98 143.48 35.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.411 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 5.0 p -125.53 142.3 51.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 147.03 43.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.963 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.2 t80 -121.75 121.13 36.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.731 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 21.9 t70 -104.94 96.38 6.5 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 51.7 pttt -48.97 -17.98 0.25 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.495 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 4.6 m-30 -65.49 -46.19 80.69 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.662 0.268 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.5 p -86.7 -50.03 7.06 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.26 6.73 33.54 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.207 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.95 150.23 39.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.981 0.391 . . . . 0.0 111.147 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.39 160.26 17.66 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' A' ' 68' ' ' ASP . 2.6 m-85 -134.96 131.01 36.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.563 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HG3' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -79.87 179.53 7.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.79 139.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.471 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.48 40.5 96.25 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.708 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.26 124.37 52.34 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.921 HG22 HG23 ' A' ' 93' ' ' THR . 28.7 p -105.62 149.72 26.07 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.892 0.377 . . . . 0.0 111.383 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -161.1 -178.58 6.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -118.39 132.18 56.27 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 111.023 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.495 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 0.8 OUTLIER -124.24 124.23 25.87 Favored Pre-proline 0 N--CA 1.465 0.283 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 88' ' ' MET . 81.1 Cg_endo -80.09 63.96 8.81 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 121.964 1.776 . . . . 0.0 112.48 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.52 128.47 36.45 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.864 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.5 t70 37.3 69.1 0.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.895 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m 46.08 47.62 12.85 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.415 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 42.5 ttp -160.51 135.81 7.95 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.37 132.64 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 111.522 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CH2' HG12 ' A' ' 106' ' ' ILE . 16.1 m95 -119.84 152.27 37.57 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -108.33 100.31 9.62 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.4 t -108.6 138.76 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.921 HG23 HG22 ' A' ' 80' ' ' THR . 1.7 m -116.54 148.18 41.09 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.67 117.7 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.731 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 95' ' ' ILE . 2.1 mp -92.16 142.3 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.611 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.35 -129.62 1.04 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.521 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 62.42 110.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 111.536 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.63 -112.72 4.54 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -139.43 47.09 1.89 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.08 98.08 0.94 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.635 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -105.78 135.51 47.08 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.586 0.231 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.99 121.52 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.2 111.93 12.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.98 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 3.3 m -126.37 148.34 49.61 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 p -141.12 148.91 40.84 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.165 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.436 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -60.61 146.98 10.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.544 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.63 159.24 31.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.75 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.9 57.48 4.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.171 0.51 . . . . 0.0 110.596 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -144.4 171.6 14.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.9 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 2.3 p -123.23 128.47 50.05 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -134.43 154.4 51.41 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.229 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 7.3 tp10 167.35 140.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.867 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.73 -8.71 54.82 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.417 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.0 -17.79 7.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.089 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -126.04 165.44 18.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.844 0.322 . . . . 0.0 110.34 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.51 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.4 t -108.87 125.72 52.29 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.4 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -106.02 158.86 16.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.215 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 25.8 mtmt -99.37 161.74 13.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.454 HG23 ' HA3' ' A' ' 140' ' ' GLY . 38.0 mm -55.19 124.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.509 0.195 . . . . 0.0 111.349 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.13 -12.2 70.34 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.767 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -60.23 167.28 2.49 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 117.575 0.688 . . . . 0.0 111.777 -178.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.416 HG22 ' CG2' ' A' ' 137' ' ' VAL . 57.1 p -142.67 144.72 32.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.254 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.433 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 17.5 p90 -149.74 96.61 2.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.042 0.449 . . . . 0.0 109.97 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -91.73 76.38 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 111.008 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 126' ' ' PRO . 89.1 mtt180 -108.15 163.45 16.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.094 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 125' ' ' ARG . 52.4 Cg_exo -41.08 179.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.301 2.667 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.5 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.1 t60 -100.6 127.41 46.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.674 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.43 -34.21 72.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.742 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.6 p -111.96 19.0 18.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.361 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -147.92 171.18 28.48 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.478 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -108.79 28.48 11.28 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.689 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -134.35 162.2 32.87 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.726 0.263 . . . . 0.0 110.906 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 13.1 mtt -68.59 120.74 15.09 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.317 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.524 HD12 ' HB3' ' A' ' 150' ' ' PRO . 22.3 tp -100.93 144.12 30.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.341 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 4.4 pt-20 -120.62 115.81 24.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 96.4 m -113.67 158.32 21.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 147' ' ' THR . 0.4 OUTLIER -131.81 160.32 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.372 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 121.76 37.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.709 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.0 mt -113.82 156.24 24.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.634 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.454 ' HA3' HG23 ' A' ' 119' ' ' ILE . . . -152.58 -132.77 1.83 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.034 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.58 33.33 18.35 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.915 0.388 . . . . 0.0 111.089 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.54 -52.2 0.1 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.685 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -147.67 -66.65 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.648 0.224 . . . . 0.0 111.33 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 138.34 79.32 0.07 OUTLIER Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.483 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -112.09 135.77 52.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.953 0.406 . . . . 0.0 111.252 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -109.84 166.79 10.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.626 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -152.18 137.31 17.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.515 -179.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.95 149.95 49.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.165 0.507 . . . . 0.0 111.522 179.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.05 92.08 11.07 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.193 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HB3' HD12 ' A' ' 134' ' ' LEU . 38.2 Cg_endo -71.58 162.2 42.94 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.332 2.021 . . . . 0.0 113.836 -178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.012 179.246 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.57 0.224 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -102.13 158.66 16.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.214 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.1 p -128.34 155.43 44.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.186 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 75' ' ' TYR . 60.1 m -119.02 135.49 54.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.817 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 88.8 t80 -121.19 123.11 41.46 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -105.66 95.15 5.61 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.165 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 44.1 pttt -49.01 -21.56 0.71 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -66.3 -44.62 82.95 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.554 0.216 . . . . 0.0 110.7 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.497 ' HG1' ' HH ' ' A' ' 75' ' ' TYR . 17.1 p -86.8 -49.97 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.0 12.05 30.67 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.083 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -118.92 157.43 27.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.807 0.303 . . . . 0.0 110.64 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.95 159.64 14.8 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.987 0.422 . . . . 0.0 110.364 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.497 ' HH ' ' HG1' ' A' ' 71' ' ' THR . 3.9 m-85 -135.84 127.8 29.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.98 153.28 32.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 177.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 77' ' ' VAL . 5.7 t -47.85 143.37 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.558 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.96 21.94 78.32 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -113.06 130.16 56.25 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.93 HG22 HG23 ' A' ' 93' ' ' THR . 21.1 p -105.69 150.27 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.369 . . . . 0.0 111.494 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -149.7 173.96 13.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.081 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.69 131.09 54.37 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.587 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -126.85 135.86 27.95 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.587 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 85.8 Cg_endo -81.53 62.44 8.32 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.945 1.763 . . . . 0.0 112.956 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 122.28 12.93 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.524 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 40.71 74.27 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.867 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 94.9 p 41.5 47.9 3.32 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 44.6 ttp -163.15 133.5 4.5 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.7 mm -74.07 137.31 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.754 0.311 . . . . 0.0 111.07 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.434 ' CH2' HG12 ' A' ' 106' ' ' ILE . 17.9 m95 -122.63 164.73 17.68 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.978 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -121.78 106.49 11.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 80' ' ' THR . 48.9 m -108.61 161.19 15.31 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.93 HG23 HG22 ' A' ' 80' ' ' THR . 0.9 OUTLIER -142.2 153.98 44.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.223 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.3 t -103.33 113.23 26.56 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.94 -31.59 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.133 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.14 177.8 44.68 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.615 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 65.76 150.21 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.926 0.393 . . . . 0.0 111.678 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.38 39.97 41.49 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.679 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.02 37.1 21.41 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.708 0.29 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.86 71.46 1.13 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.605 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -80.21 149.1 30.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.818 0.309 . . . . 0.0 110.762 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 26.8 mm -105.83 130.27 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.792 0.329 . . . . 0.0 111.337 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.61 111.46 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.903 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 88.3 m -117.4 145.17 44.27 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 p -140.05 137.97 35.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.031 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.434 HG12 ' CH2' ' A' ' 90' ' ' TRP . 1.1 mt -53.08 143.84 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.04 168.07 10.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.807 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.538 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -93.33 43.79 1.13 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -134.29 159.34 41.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.943 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 25.6 p -112.14 126.34 55.09 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.452 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.568 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -128.93 164.16 23.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.566 -178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 41.2 tt0 165.41 126.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.441 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.39 -99.0 0.87 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.727 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.5 -17.7 1.36 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.391 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -131.9 179.03 6.32 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.223 0.512 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 27.5 t -112.94 125.43 54.38 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.981 0.419 . . . . 0.0 111.156 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -102.12 159.42 15.4 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.494 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -105.23 161.08 14.58 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 108' ' ' ASN . 1.5 mp -59.17 124.7 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.651 0.262 . . . . 0.0 110.962 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.64 -22.24 41.36 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.223 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.18 152.15 44.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.973 0.416 . . . . 0.0 111.649 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.715 HG22 HG23 ' A' ' 137' ' ' VAL . 44.0 p -116.34 152.76 33.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.41 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.415 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 18.5 p90 -147.11 81.12 1.54 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.21 0.529 . . . . 0.0 109.866 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -84.7 76.01 10.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.214 -178.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 126' ' ' PRO . 14.6 mtt85 -110.66 171.05 4.66 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.689 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 42.5 Cg_exo -43.0 179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.93 2.42 . . . . 0.0 113.473 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.484 ' HD1' HD22 ' A' ' 134' ' ' LEU . 3.7 t60 -103.8 136.37 43.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.43 0.634 . . . . 0.0 112.707 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -74.43 -40.09 62.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.373 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 61.1 p -109.09 18.25 20.79 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.84 -79.98 0.07 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.486 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 137.58 29.87 0.27 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 150' ' ' PRO . 2.8 p90 -135.52 151.45 50.35 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 122.878 0.471 . . . . 0.0 109.765 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.8 ttt -57.72 107.2 0.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.484 HD22 ' HD1' ' A' ' 127' ' ' HIS . 15.0 tp -91.73 144.84 25.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.974 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 30.5 mt-10 -124.56 115.88 21.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.9 OUTLIER -125.72 157.5 37.22 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.715 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -128.35 171.65 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.254 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.1 t -139.58 124.02 18.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.709 0.29 . . . . 0.0 110.903 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.07 133.16 54.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -88.29 76.59 1.91 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.726 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -42.47 11.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.53 0.205 . . . . 0.0 111.248 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.58 -54.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.679 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -106.21 -55.48 2.32 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.41 54.51 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.505 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.12 154.03 32.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.771 0.319 . . . . 0.0 111.328 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -142.27 161.71 37.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.055 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.611 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.57 127.73 16.65 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.049 -179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -127.88 149.73 50.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 0.0 111.749 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -124.78 81.16 61.67 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.61 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HB2' ' CE1' ' A' ' 132' ' ' TYR . 12.9 Cg_endo -67.08 168.01 18.52 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.754 2.303 . . . . 0.0 114.479 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.977 178.696 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.712 0.292 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.64 169.99 13.79 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.352 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 p -129.43 145.69 51.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.039 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.3 m -118.49 134.48 55.04 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 83.8 t80 -110.0 124.57 51.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 70' ' ' TYR . 12.8 t70 -97.8 97.58 9.11 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 10.8 ptmt -51.47 -28.74 14.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.524 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 82.5 m-85 -66.98 -45.8 76.55 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.67 0.271 . . . . 0.0 111.315 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.1 p -82.06 -51.05 8.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.323 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.16 5.69 43.25 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.29 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -116.86 143.7 45.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.07 0.435 . . . . 0.0 110.436 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.89 159.76 20.28 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.876 0.37 . . . . 0.0 110.907 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.4 ' HE2' ' CB ' ' A' ' 68' ' ' ASP . 9.5 m-85 -136.27 130.3 32.8 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -75.08 153.01 38.55 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 21.8 t -50.27 144.06 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.188 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.94 18.67 79.17 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.958 -0.564 . . . . 0.0 113.269 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.81 125.87 54.82 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.923 HG22 HG23 ' A' ' 93' ' ' THR . 21.4 p -104.98 129.36 53.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.905 0.384 . . . . 0.0 111.134 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 39.9 p90 -122.49 -173.65 2.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.782 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.3 mp0 -127.69 138.55 52.84 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.838 0.351 . . . . 0.0 110.935 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.576 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -141.04 130.44 12.85 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 88' ' ' MET . 61.3 Cg_endo -77.17 64.99 7.91 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.762 1.641 . . . . 0.0 112.851 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.91 130.37 45.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.349 -179.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 55.65 -77.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.855 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 85' ' ' LYS . 78.4 p -158.26 30.94 0.24 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.064 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -146.89 159.13 43.91 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.7 mm -89.7 112.29 24.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.467 ' CZ2' HG12 ' A' ' 106' ' ' ILE . 28.5 m95 -98.5 144.96 27.27 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.0 111.929 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.18 106.79 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 m -107.28 165.02 11.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.086 0.469 . . . . 0.0 112.034 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.923 HG23 HG22 ' A' ' 80' ' ' THR . 0.3 OUTLIER -136.52 154.68 50.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.629 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 3.7 t -102.47 114.17 28.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.475 0.655 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 95' ' ' ILE . 2.0 mp -105.74 74.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.834 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.63 139.07 15.67 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.227 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.65 45.56 0.3 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.897 0.379 . . . . 0.0 110.571 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.75 8.52 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.298 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -170.14 -37.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.26 85.33 0.99 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.166 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt85 -104.69 135.27 46.4 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.735 0.303 . . . . 0.0 111.283 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.75 129.98 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.35 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.419 ' HB3' HD13 ' A' ' 95' ' ' ILE . 30.2 t -124.45 110.48 14.56 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.269 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 69.3 m -111.22 131.15 55.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.365 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.3 p -137.73 132.96 33.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.467 HG12 ' CZ2' ' A' ' 90' ' ' TRP . 2.7 mt -51.23 142.07 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.927 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.27 19.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.703 0.287 . . . . 0.0 111.489 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -86.54 64.74 8.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -147.0 174.26 11.69 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.308 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 117' ' ' TYR . 24.2 p -129.89 129.98 44.59 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 3.5 p-80 -134.94 -140.7 0.17 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.601 -0.237 . . . . 0.0 110.751 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 3.9 tt0 89.2 163.94 0.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.86 0.362 . . . . 0.0 111.455 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.94 -83.47 1.59 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.787 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.52 -35.33 0.1 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.26 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -131.27 -178.81 5.01 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.896 0.348 . . . . 0.0 110.754 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.426 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 4.1 p -107.7 126.67 52.88 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 110.725 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 110' ' ' CYS . 3.0 m-85 -106.65 157.81 17.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.541 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -104.16 158.34 16.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.1 mm -50.14 124.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.75 -9.5 75.52 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.733 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.11 154.57 39.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.402 0.601 . . . . 0.0 111.54 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.579 HG22 HG23 ' A' ' 137' ' ' VAL . 30.9 p -122.87 149.45 44.19 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.743 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.443 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 12.4 p90 -147.69 82.41 1.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.298 0.57 . . . . 0.0 109.905 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -79.3 75.03 5.88 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.038 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 126' ' ' PRO . 70.3 mtt180 -108.76 166.6 10.54 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.933 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 63.1 Cg_exo -41.93 178.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.087 2.525 . . . . 0.0 114.077 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.488 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.4 t60 -103.54 124.42 48.75 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 111.58 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -73.43 -24.85 60.31 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.928 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.08 14.43 22.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.71 -179.21 30.63 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.755 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -115.24 28.29 8.02 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.428 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.501 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.01 155.44 49.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.546 0.212 . . . . 0.0 111.177 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.518 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 11.9 mtt -63.45 114.5 3.92 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.098 0.475 . . . . 0.0 110.595 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 150' ' ' PRO . 23.9 tp -92.46 146.9 23.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.739 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 26.6 mt-10 -123.04 116.23 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -123.87 157.62 33.77 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.58 HG12 HG22 ' A' ' 147' ' ' THR . 0.3 OUTLIER -126.79 171.75 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.662 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 52.7 t -132.67 125.01 29.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.9 mt -111.94 154.93 24.53 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.081 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -146.57 55.25 0.53 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.089 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.97 -51.55 7.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.723 0.297 . . . . 0.0 110.353 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -122.17 -44.97 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -140.53 157.42 45.52 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.391 0.276 . . . . 0.0 110.31 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.28 93.43 0.09 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -114.93 162.46 16.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.16 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -142.79 164.45 30.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.283 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.58 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -147.62 124.81 11.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.879 -179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -125.52 149.99 47.82 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.269 0.557 . . . . 0.0 111.585 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -141.19 99.11 6.59 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.528 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.575 ' HB3' HD12 ' A' ' 134' ' ' LEU . 53.4 Cg_endo -77.01 170.3 20.02 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.419 2.079 . . . . 0.0 113.56 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.249 1.055 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.919 179.32 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.639 0.257 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -87.91 161.22 17.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.262 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.7 p -124.16 150.13 45.5 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.573 ' HB3' HD13 ' A' ' 102' ' ' ILE . 85.6 m -118.54 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.371 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -113.62 124.45 52.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.757 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -103.54 99.37 9.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.43 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -57.29 -16.14 7.9 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.065 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.582 ' HB3' ' NE ' ' A' ' 83' ' ' ARG . 5.4 m-30 -66.96 -46.08 75.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.169 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 83' ' ' ARG . 7.3 p -91.42 -54.87 3.73 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.782 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.94 11.4 12.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.363 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.63 155.5 32.19 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.165 0.483 . . . . 0.0 110.792 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.16 159.8 15.13 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.716 0.293 . . . . 0.0 110.253 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.457 ' HH ' ' HG1' ' A' ' 71' ' ' THR . 4.6 m-85 -138.8 129.03 25.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.991 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -73.89 154.19 39.52 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.485 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 5.0 t -52.23 136.5 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.915 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.86 21.47 71.34 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.0 123.49 50.45 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.957 HG22 HG23 ' A' ' 93' ' ' THR . 16.9 p -105.59 149.17 26.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.391 . . . . 0.0 111.351 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 26.4 p90 -145.83 -175.32 4.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.071 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.2 mp0 -121.05 131.68 54.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.592 ' HG2' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -129.77 132.33 24.11 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.456 178.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 88' ' ' MET . 56.4 Cg_endo -80.48 114.38 3.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.567 1.511 . . . . 0.0 110.859 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -116.14 113.5 23.19 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.845 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 t70 49.42 77.29 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 t 46.06 43.83 11.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 8.9 ttp -157.59 169.5 24.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.461 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -116.82 131.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 19.0 m95 -117.72 157.84 25.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -109.19 111.72 23.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -108.34 156.93 18.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.957 HG23 HG22 ' A' ' 80' ' ' THR . 0.9 OUTLIER -141.1 154.1 45.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.412 0.685 . . . . 0.0 110.648 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -102.87 113.06 26.19 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.435 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -80.74 -31.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.189 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.61 83.04 0.39 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.835 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.54 119.88 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.9 2.07 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.676 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.12 44.92 1.23 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.979 0.418 . . . . 0.0 111.046 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.07 84.38 0.54 Allowed Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.5 121.96 17.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 66' ' ' CYS . 9.8 mm -103.0 121.97 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.476 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.435 ' HB3' HD13 ' A' ' 95' ' ' ILE . 6.5 t -127.83 110.53 12.69 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.395 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.4 m -107.83 133.73 51.78 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 111.29 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.3 p -138.56 133.15 32.19 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.706 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -43.57 155.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.17 148.59 22.26 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.7 60.01 5.37 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.068 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -150.06 176.98 10.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 9.5 p -120.15 127.29 52.36 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.558 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.5 OUTLIER -136.69 142.71 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.335 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 12.9 pt-20 171.88 159.54 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.701 0.286 . . . . 0.0 111.747 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.59 -79.23 1.43 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.813 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.61 -8.84 0.11 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.798 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -142.89 -178.53 5.86 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 117.624 0.712 . . . . 0.0 110.51 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p -114.43 125.84 54.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.797 0.332 . . . . 0.0 110.661 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.06 157.31 17.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.425 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -106.2 156.43 18.47 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.9 mm -45.85 124.65 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.46 -6.13 71.04 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.633 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 156.86 33.89 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.483 0.641 . . . . 0.0 111.391 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.637 HG22 HG23 ' A' ' 137' ' ' VAL . 21.5 p -124.14 146.31 48.73 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.455 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -137.84 67.47 1.42 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 0.0 109.668 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.77 108.78 2.22 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.513 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -137.88 153.02 73.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.341 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 50.4 Cg_exo -42.42 143.71 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.081 2.521 . . . . 0.0 113.701 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.522 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.5 t60 -67.74 127.24 32.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.076 0.465 . . . . 0.0 111.719 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -75.02 -35.51 61.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.288 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.2 p -109.21 17.23 21.8 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.517 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -124.77 -93.91 1.01 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.305 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.92 20.42 0.07 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.103 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -139.9 161.6 37.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.981 0.513 . . . . 0.0 109.65 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.8 ttt -64.71 110.24 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.343 0.592 . . . . 0.0 111.024 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.522 HD22 ' ND1' ' A' ' 127' ' ' HIS . 20.1 tp -92.17 145.67 24.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.581 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 4.4 pt-20 -128.13 115.68 18.78 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.0 m -108.59 157.96 18.01 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.075 0.464 . . . . 0.0 111.928 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -128.3 170.2 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.586 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -123.28 117.81 26.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.794 0.331 . . . . 0.0 111.373 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 22.2 mt -112.08 119.36 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.17 122.05 6.68 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.865 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.19 34.83 0.99 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 110.971 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.9 43.26 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.694 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -163.63 -54.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.229 . . . . 0.0 111.095 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.83 73.55 0.54 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.289 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.16 159.9 14.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 111.142 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.47 165.62 26.9 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.302 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -153.37 133.37 13.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -126.45 150.46 48.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.973 0.416 . . . . 0.0 111.295 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.97 90.84 13.7 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.254 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.516 ' HB3' HD12 ' A' ' 134' ' ' LEU . 24.2 Cg_endo -66.55 167.2 19.55 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.497 2.132 . . . . 0.0 113.746 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.249 1.032 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.998 179.341 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.647 0.26 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -79.59 154.6 28.62 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.275 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 p -123.9 142.11 51.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.671 ' HB3' HD13 ' A' ' 102' ' ' ILE . 3.6 m -118.41 134.45 55.05 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 74' ' ' THR . 94.2 t80 -111.74 131.63 55.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.41 ' HB3' ' OH ' ' A' ' 75' ' ' TYR . 23.3 t70 -108.07 104.83 14.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.148 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 16.3 ptpt -55.17 -24.68 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.497 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 27.0 m-85 -67.73 -46.84 71.01 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -82.94 -47.5 11.71 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.364 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.6 2.7 46.87 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.501 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -117.18 147.94 42.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.153 0.476 . . . . 0.0 110.983 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.5 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -90.09 159.79 16.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.969 0.414 . . . . 0.0 110.357 179.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.41 ' OH ' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -135.56 131.89 36.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.672 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -74.31 173.16 10.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 t -61.96 139.76 20.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.605 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.18 27.06 70.82 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.302 -0.475 . . . . 0.0 113.098 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.22 122.06 46.33 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.936 HG22 HG23 ' A' ' 93' ' ' THR . 18.0 p -105.61 141.42 37.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 110.825 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.9 p90 -138.31 -172.84 3.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.564 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -117.34 137.98 52.08 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.677 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -138.41 124.36 12.6 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -78.52 59.27 7.1 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.766 1.644 . . . . 0.0 113.21 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -64.49 143.73 57.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.6 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 33.91 57.0 0.6 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.4 m 53.16 35.84 20.9 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 37.4 ttp -146.73 152.72 39.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 mm -90.13 110.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.714 0.293 . . . . 0.0 111.196 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.513 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 33.0 m95 -99.32 139.19 35.34 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.946 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -94.97 104.1 15.97 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 18.2 m -107.82 139.97 41.61 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -175.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.936 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -112.39 152.1 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 114.48 28.75 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 109.953 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.9 mp -102.11 95.39 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.488 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.54 78.98 1.44 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.646 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.75 -48.18 4.18 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -100.04 -68.52 0.87 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.412 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.11 48.84 0.98 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.909 0.385 . . . . 0.0 111.161 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 75.22 77.56 0.69 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.602 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -89.6 141.78 28.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.65 0.262 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' A' ' 66' ' ' CYS . 8.4 mm -102.56 125.16 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.306 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.498 ' HB3' HD13 ' A' ' 95' ' ' ILE . 45.2 t -124.56 111.52 15.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.428 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 39.4 m -108.96 130.97 55.47 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.894 0.378 . . . . 0.0 111.838 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 p -135.92 128.75 31.11 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 mt -42.73 137.44 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.229 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.65 161.02 30.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.746 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -79.13 61.61 3.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -150.43 174.5 12.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 117' ' ' TYR . 20.7 p -128.87 129.74 45.94 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.85 157.21 47.41 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.365 -0.209 . . . . 0.0 111.488 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 1.2 pt-20 172.09 -66.79 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.62 91.44 1.07 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.915 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 79.18 -84.7 1.24 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.353 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -108.29 176.17 5.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.567 0.223 . . . . 0.0 110.72 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.9 t -84.98 128.29 34.56 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.562 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' CYS . 79.3 m-85 -93.62 129.11 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.624 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -81.64 167.33 19.33 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.192 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 18.8 mm -53.83 135.96 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.43 -4.13 43.64 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.16 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.43 158.53 16.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.323 0.562 . . . . 0.0 110.187 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.569 HG22 ' CG2' ' A' ' 137' ' ' VAL . 58.8 p -138.5 142.06 39.38 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.987 0.422 . . . . 0.0 111.812 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.6 p90 -147.29 123.35 10.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.617 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.93 139.1 53.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.948 0.404 . . . . 0.0 111.538 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 126' ' ' PRO . 16.1 ptt-85 -174.48 157.6 2.42 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.051 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 125' ' ' ARG . 34.9 Cg_exo -41.23 171.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.141 2.56 . . . . 0.0 113.339 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.549 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.3 t60 -105.24 116.63 32.28 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.27 -40.36 62.38 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.158 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.445 ' OG1' ' CE1' ' A' ' 127' ' ' HIS . 4.3 p -96.7 22.39 8.2 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.342 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.549 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -152.17 -159.86 9.22 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.945 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.8 35.84 2.0 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.17 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.85 146.05 27.78 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.6 mtp -56.52 106.73 0.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.979 0.419 . . . . 0.0 109.927 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.513 ' CD1' ' HB3' ' A' ' 150' ' ' PRO . 34.2 tp -92.8 145.5 24.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.387 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -141.32 117.48 10.64 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.1 m -117.6 158.59 24.35 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.569 ' CG2' HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -122.44 179.49 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.623 178.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.441 ' N ' HG13 ' A' ' 137' ' ' VAL . 9.4 t -113.9 118.06 33.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.494 0.588 . . . . 0.0 111.34 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.427 HD12 ' HB ' ' A' ' 147' ' ' THR . 2.1 mt -111.76 155.6 23.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.362 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.15 94.34 0.15 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.837 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.76 35.95 4.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.88 0.371 . . . . 0.0 110.797 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.71 41.56 10.84 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.565 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -160.6 -48.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.439 0.161 . . . . 0.0 111.413 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.78 61.22 0.65 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.288 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.85 155.65 30.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -118.61 171.44 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -130.77 127.95 39.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.029 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.59 150.96 48.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.008 0.432 . . . . 0.0 111.312 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -126.28 74.22 72.94 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.513 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 39.9 Cg_endo -72.8 144.65 39.42 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.743 2.295 . . . . 0.0 112.916 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.114 179.259 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.717 0.294 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -85.2 102.91 13.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.142 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -139.79 152.22 46.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.916 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.0 m -118.27 134.46 55.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 87.2 t80 -113.39 121.83 45.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.32 96.15 7.54 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 61.3 pttt -49.14 -23.86 1.43 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 83' ' ' ARG . 20.7 m-85 -66.33 -46.67 76.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.512 0.196 . . . . 0.0 111.524 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.2 p -86.38 -49.66 7.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.077 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.55 11.23 31.49 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.804 -0.634 . . . . 0.0 113.015 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -118.17 148.39 42.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.795 0.298 . . . . 0.0 110.356 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.35 159.57 17.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 110.385 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -135.97 129.4 32.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -75.84 150.98 37.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 77.9 t -47.89 143.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.795 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.89 79.67 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 113.624 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -112.54 128.9 56.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.945 HG22 HG23 ' A' ' 93' ' ' THR . 19.0 p -105.33 149.71 25.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.593 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.514 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 33.1 p90 -144.73 174.82 10.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.626 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -118.52 131.9 56.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.524 ' HD3' ' C ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -134.26 135.6 24.4 Favored Pre-proline 0 N--CA 1.462 0.171 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 88' ' ' MET . 67.5 Cg_endo -83.61 65.11 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.77 1.647 . . . . 0.0 112.755 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -56.57 125.25 21.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.61 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 t70 59.33 -72.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.075 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' LYS . 11.1 t -165.11 38.39 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.416 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 3.3 ttp -149.37 154.27 38.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.9 mm -90.78 111.94 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 28.6 m95 -99.39 155.9 17.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -118.13 107.18 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 9.6 m -107.75 167.82 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.979 0.419 . . . . 0.0 112.01 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.945 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.6 154.47 45.43 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 109.993 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.0 t -103.51 114.39 28.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.404 0.621 . . . . 0.0 109.479 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.9 mp -84.29 -52.66 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.44 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.77 63.22 4.8 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.852 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.32 -53.81 4.63 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.63 -61.69 0.66 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.313 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 54.14 0.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.32 83.51 0.65 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.541 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -96.59 135.36 38.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.542 0.21 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.48 128.69 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.461 ' HB3' HD13 ' A' ' 95' ' ' ILE . 8.8 t -129.29 111.08 12.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.099 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.59 138.19 46.32 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.5 p -139.24 132.26 29.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.21 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.445 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -49.93 146.11 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.34 167.86 19.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.538 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.09 52.78 2.2 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.038 0.447 . . . . 0.0 110.999 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.8 mtm-85 -141.18 162.79 34.64 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 7.0 p -117.95 126.66 52.76 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 110.37 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.636 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -131.96 156.1 46.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.014 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 6.9 tp10 167.66 141.29 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.244 0.34 . . . . 0.0 111.033 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.14 -71.84 2.91 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.286 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.02 -97.59 2.07 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.456 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -96.05 -177.78 4.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 28.7 p -92.81 124.52 36.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.829 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.25 158.73 16.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.803 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -98.14 153.87 18.14 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.913 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.34 124.33 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.575 0.226 . . . . 0.0 111.128 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.81 -14.9 64.48 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.467 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.8 164.25 26.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.297 0.548 . . . . 0.0 111.838 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.722 HG22 HG23 ' A' ' 137' ' ' VAL . 34.3 p -126.46 147.43 49.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.993 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -138.61 34.84 2.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.601 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -50.52 119.14 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.702 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 126' ' ' PRO . 29.9 mmt180 -140.71 162.04 51.04 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.248 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 125' ' ' ARG . 59.5 Cg_exo -41.01 172.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.889 2.392 . . . . 0.0 113.825 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.502 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 1.4 t60 -86.27 124.54 32.77 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.16 -32.66 65.0 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.103 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.414 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 4.5 p -108.67 18.9 20.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.3 -176.7 30.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.587 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.86 31.15 6.97 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.884 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.502 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 17.5 p90 -130.72 161.07 32.49 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 151' ' ' ILE . 66.7 mtp -70.98 138.73 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.33 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.3 tp -123.16 140.86 52.59 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.601 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 32.2 mt-10 -127.12 116.39 20.59 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 119.833 -0.127 . . . . 0.0 110.704 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.1 m -107.32 158.12 17.39 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.012 0.434 . . . . 0.0 111.724 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.722 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -134.38 165.09 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.455 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 118.33 27.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.807 0.337 . . . . 0.0 111.288 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.82 113.53 25.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.78 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.29 104.34 1.8 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.003 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.37 38.6 4.15 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.625 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.79 29.88 7.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.57 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -164.14 -54.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.725 0.262 . . . . 0.0 111.056 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.83 73.64 0.86 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.475 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.0 167.95 9.71 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.05 163.93 31.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.413 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.491 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -152.28 138.59 18.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -132.85 151.32 52.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.341 0.591 . . . . 0.0 112.391 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -125.62 111.94 25.35 Favored Pre-proline 0 C--O 1.234 0.24 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 151' ' ' ILE . 73.1 Cg_endo -74.15 170.51 19.99 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.019 1.813 . . . . 0.0 114.307 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 150' ' ' PRO . 1.1 tp . . . . . 0 C--O 1.25 1.083 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.315 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.708 0.289 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -123.12 159.71 27.97 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.398 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.6 p -131.82 144.27 50.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.86 134.73 54.65 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -111.11 122.13 47.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -99.58 98.44 9.31 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -55.23 -17.7 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.556 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 1.3 m-85 -67.28 -45.77 75.61 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.87 0.367 . . . . 0.0 110.316 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.6 -52.87 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.99 12.99 16.86 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.432 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.37 148.3 42.65 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.028 0.414 . . . . 0.0 110.259 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.43 159.51 17.97 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.374 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.3 129.69 29.7 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.28 147.74 38.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.489 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -47.23 141.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.14 -177.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.32 16.74 75.53 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.563 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -112.67 126.97 55.97 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.981 HG22 HG23 ' A' ' 93' ' ' THR . 18.9 p -105.2 132.92 50.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.895 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 34.3 p90 -128.53 -177.55 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.744 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.9 mt-10 -124.45 135.41 53.23 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.895 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.556 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -141.33 147.34 46.36 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.778 179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 88' ' ' MET . 94.5 Cg_endo -84.86 124.41 2.99 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.143 1.895 . . . . 0.0 111.444 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -117.58 113.93 22.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.458 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.4 t70 67.06 -67.88 0.16 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 m -162.94 31.54 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -144.71 167.04 23.52 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.689 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.48 116.99 47.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 17.6 m95 -99.3 154.34 18.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.92 110.15 20.6 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 46.7 m -108.83 166.89 10.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 112.214 -177.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.981 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -141.15 152.76 44.94 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.648 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -104.41 113.9 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.94 -43.52 24.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.913 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 54.26 63.63 5.01 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.984 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -97.38 -52.06 3.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.651 0.262 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.66 -67.9 0.49 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.337 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.84 44.62 2.93 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 72.39 73.13 0.87 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.659 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -77.13 136.68 38.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 111.047 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.0 mp -101.78 123.87 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.481 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 t -118.94 110.53 17.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.7 m -117.05 131.88 56.82 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.8 p -139.89 138.03 35.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.65 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -49.02 152.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.03 155.98 21.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.813 0.339 . . . . 0.0 111.9 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.62 56.89 3.71 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.294 0.568 . . . . 0.0 110.256 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -148.21 171.58 15.7 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.034 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 12.2 p -120.23 127.09 52.1 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.582 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.64 149.96 49.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.713 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.582 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 0.0 OUTLIER 169.11 152.37 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.671 0.272 . . . . 0.0 111.362 179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.75 -36.8 3.63 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.243 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.46 -10.47 0.29 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.282 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -134.65 175.02 9.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.171 0.486 . . . . 0.0 110.18 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 12.4 p -114.23 125.84 54.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.999 0.428 . . . . 0.0 111.161 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -109.91 158.02 18.63 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.459 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -105.21 158.04 16.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.907 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.5 mp -52.15 124.58 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.58 0.228 . . . . 0.0 110.767 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.6 -12.82 61.32 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.241 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 156.6 30.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.216 0.508 . . . . 0.0 111.135 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.6 HG22 HG12 ' A' ' 137' ' ' VAL . 1.5 p -127.97 150.62 49.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.573 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.402 ' O ' ' CG ' ' A' ' 123' ' ' TRP . 17.8 p90 -142.56 86.49 1.95 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.145 0.498 . . . . 0.0 109.811 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -78.66 91.07 4.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.476 -178.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 126' ' ' PRO . 20.4 mtt-85 -123.12 163.92 30.67 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.826 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 43.3 Cg_exo -43.01 176.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.082 2.521 . . . . 0.0 113.809 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.502 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.2 t60 -101.4 126.43 48.17 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 111.837 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -69.68 -36.56 76.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.794 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.41 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 18.9 p -108.5 18.6 20.75 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.502 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -146.52 175.62 25.86 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.575 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -113.78 28.79 8.24 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.302 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.46 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -136.09 159.55 41.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.658 0.229 . . . . 0.0 111.055 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.2 mtt -67.59 114.57 6.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.096 0.474 . . . . 0.0 110.749 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 150' ' ' PRO . 22.4 tp -91.76 145.85 24.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.618 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.2 mt-10 -121.96 115.52 22.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 94.3 m -111.35 158.13 19.41 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.996 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -134.79 171.15 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.889 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 t -133.02 118.36 18.71 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.752 0.311 . . . . 0.0 111.517 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.4 118.83 36.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.403 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.0 97.97 2.32 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.75 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -138.46 52.7 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.71 -76.66 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.492 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -130.08 -42.75 1.22 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.539 0.209 . . . . 0.0 111.393 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 163.78 91.17 0.08 OUTLIER Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.534 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -103.9 153.78 20.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.703 0.287 . . . . 0.0 110.823 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -137.22 164.79 27.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.996 HG22 HG23 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -150.78 146.32 26.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.9 OUTLIER -141.3 149.84 41.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.031 0.443 . . . . 0.0 111.393 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -135.3 90.94 19.64 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.545 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.547 ' HB3' HD12 ' A' ' 134' ' ' LEU . 36.9 Cg_endo -70.6 168.06 23.74 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.478 2.119 . . . . 0.0 113.655 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.955 179.283 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.611 0.243 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HB2' HG22 ' A' ' 77' ' ' VAL . 1.4 mp0 -65.14 145.07 56.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.683 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.6 p -132.23 139.1 48.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.167 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.8 m -118.88 136.42 54.05 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.443 ' HB2' HG23 ' A' ' 74' ' ' THR . 94.8 t80 -112.81 131.68 55.59 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.402 ' HB2' ' HE2' ' A' ' 75' ' ' TYR . 40.7 t0 -108.41 105.08 14.59 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.209 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -59.08 -17.54 26.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -69.16 -45.89 68.9 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.988 0.423 . . . . 0.0 110.996 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -89.15 -47.88 7.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.716 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.71 6.4 40.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.431 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.92 151.31 38.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.098 0.449 . . . . 0.0 110.833 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -92.78 159.62 15.32 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.118 178.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.402 ' HE2' ' HB2' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -136.32 131.78 34.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.301 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -76.73 157.79 31.43 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -46.87 135.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.155 -178.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 29.65 59.02 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.261 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -113.54 120.53 41.27 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 1.01 HG22 HG23 ' A' ' 93' ' ' THR . 15.9 p -105.88 149.54 26.45 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 32.3 p90 -154.61 -173.71 4.68 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.514 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -115.38 133.88 55.62 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.94 136.88 28.42 Favored Pre-proline 0 N--CA 1.466 0.374 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 88' ' ' MET . 80.2 Cg_endo -79.5 114.3 3.24 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 121.779 1.653 . . . . 0.0 112.837 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -117.15 107.57 14.64 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 49.53 77.87 0.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.6 m 49.25 43.48 22.88 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.634 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 39.9 ttp -164.44 162.05 21.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.23 144.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 14.4 m95 -120.27 152.45 37.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.498 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -96.32 102.47 14.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 80' ' ' THR . 61.1 m -108.04 139.28 42.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 112.594 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.01 HG23 HG22 ' A' ' 80' ' ' THR . 0.2 OUTLIER -115.21 152.34 32.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.882 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.75 114.45 28.72 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.661 0.743 . . . . 0.0 110.237 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.71 112.06 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.192 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.97 62.64 0.29 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.682 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.02 -56.11 10.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.902 0.382 . . . . 0.0 110.303 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.96 -41.31 4.38 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.548 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.4 -87.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.552 0.341 . . . . 0.0 110.181 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.403 ' O ' HD12 ' A' ' 102' ' ' ILE . . . -144.39 56.34 0.55 Allowed Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.761 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -62.13 143.04 57.24 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.639 0.257 . . . . 0.0 111.466 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 100' ' ' GLY . 2.9 mp -107.82 129.46 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.5 t -126.5 120.11 28.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 57.0 m -119.11 135.38 54.68 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.9 p -140.09 139.96 35.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.92 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -53.99 158.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.382 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.16 161.24 13.81 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.05 67.5 10.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.37 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -148.47 173.32 13.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.982 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 10.0 p -126.21 127.55 45.83 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.897 0.38 . . . . 0.0 110.459 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.552 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -134.31 169.37 17.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.281 -179.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 13.7 pt-20 170.68 -51.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.96 0.162 . . . . 0.0 111.166 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -81.88 70.15 3.18 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.8 -88.74 0.46 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.839 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -61.89 -177.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.877 0.471 . . . . 0.0 111.882 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -119.29 127.05 52.85 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.137 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -96.24 152.15 18.84 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.504 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -89.28 -177.98 5.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.01 124.21 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.06 -3.65 82.67 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.321 -0.943 . . . . 0.0 113.033 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.8 163.73 25.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.576 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.665 HG22 HG23 ' A' ' 137' ' ' VAL . 28.5 p -131.82 147.74 52.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.29 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 20.3 p90 -142.76 67.05 1.31 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.385 0.612 . . . . 0.0 109.735 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.09 90.08 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.453 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 126' ' ' PRO . 26.3 mtt-85 -121.93 167.86 12.78 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.886 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 65.5 Cg_exo -43.92 178.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.984 2.456 . . . . 0.0 113.877 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.499 ' CD2' ' HA3' ' A' ' 130' ' ' GLY . 1.2 t60 -103.06 127.98 50.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -70.79 -35.31 72.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.704 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.467 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 19.4 p -109.99 18.55 19.95 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.369 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.499 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -146.95 174.7 26.68 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.557 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -112.92 28.99 8.38 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.404 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.479 ' HD1' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -135.53 159.53 41.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.574 0.226 . . . . 0.0 110.936 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 18.2 mtm -67.27 116.01 7.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 110.545 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 150' ' ' PRO . 26.8 tp -91.96 146.25 23.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.912 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 34.9 mt-10 -124.32 116.11 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -122.46 157.53 31.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.665 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.62 168.11 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 117.95 24.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.592 0.234 . . . . 0.0 111.056 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.41 120.98 43.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.586 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -84.26 -146.57 7.63 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.66 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.88 -64.79 0.36 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.639 0.375 . . . . 0.0 111.613 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.95 -94.2 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.836 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.8 tttt -154.93 68.19 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 54.57 34.04 55.08 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.166 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.21 121.67 18.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.731 0.3 . . . . 0.0 110.868 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -111.59 166.26 11.3 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -146.83 127.5 14.26 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.107 -179.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 136' ' ' CYS . 0.0 OUTLIER -125.35 149.46 48.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 111.467 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -139.71 96.51 8.45 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.774 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.562 ' HB3' HD12 ' A' ' 134' ' ' LEU . 55.9 Cg_endo -75.53 169.28 22.69 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.37 2.047 . . . . 0.0 113.523 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.035 179.304 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.653 0.263 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.89 160.62 19.36 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.054 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p -124.53 152.95 42.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.152 0.501 . . . . 0.0 111.2 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' TYR . 68.0 m -119.48 138.64 53.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.046 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -121.17 127.92 51.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.38 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -111.68 109.19 18.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -64.39 -13.49 51.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.575 0.226 . . . . 0.0 111.592 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.607 ' HB3' ' HD3' ' A' ' 83' ' ' ARG . 4.0 m-30 -68.86 -43.27 75.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.857 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -94.85 -50.0 5.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.76 5.12 33.87 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.856 -0.611 . . . . 0.0 114.036 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.422 ' O ' ' CZ ' ' A' ' 75' ' ' TYR . 5.2 m120 -117.18 141.44 48.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.714 0.757 . . . . 0.0 111.297 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.85 160.35 29.31 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.99 0.424 . . . . 0.0 110.97 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' A' ' 66' ' ' CYS . 6.5 m-85 -134.61 129.01 34.29 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.909 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ttt180 -78.27 143.4 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 79.9 t -47.73 123.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.022 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.57 36.72 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.791 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.2 OUTLIER -113.02 124.07 51.76 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.968 HG22 HG23 ' A' ' 93' ' ' THR . 11.9 p -105.81 144.42 32.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.075 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 34.6 p90 -138.89 -175.08 4.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.6 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 4.1 mt-10 -122.4 126.55 48.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.71 0.291 . . . . 0.0 110.769 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.607 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -120.08 128.98 25.57 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 88' ' ' MET . 72.8 Cg_endo -87.19 98.46 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.082 1.854 . . . . 0.0 111.319 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.39 114.22 27.7 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 47.65 79.84 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.4 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.7 m 45.16 40.35 4.8 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.843 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -150.82 162.09 41.43 Favored 'General case' 0 C--N 1.335 -0.053 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.676 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mm -114.39 132.55 63.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.556 ' CH2' HG12 ' A' ' 106' ' ' ILE . 26.4 m95 -117.48 135.29 54.02 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -97.7 104.25 16.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' THR . 15.0 t -107.63 153.56 22.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.968 HG23 HG22 ' A' ' 80' ' ' THR . 0.6 OUTLIER -134.54 154.04 51.65 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.245 -179.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 8.9 t -101.74 113.45 26.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.45 -54.37 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.095 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 56.25 60.89 8.15 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.001 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.32 -45.58 54.48 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.667 0.27 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -103.58 -58.91 0.72 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.222 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 67.14 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.18 93.37 0.48 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.751 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -120.06 151.78 38.51 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.87 119.46 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 118.078 0.399 . . . . 0.0 110.467 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.98 115.44 17.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.115 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 2.8 m -130.84 144.01 51.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.739 0.304 . . . . 0.0 111.46 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.7 p -139.65 153.44 47.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.44 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.556 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -69.41 -168.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.669 179.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 106' ' ' ILE . . . 70.68 -164.93 0.15 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 52.0 m-80 82.33 -25.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.281 0.632 . . . . 0.0 111.671 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -138.35 152.65 48.64 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 117' ' ' TYR . 4.3 p -110.22 123.09 49.14 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.928 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -135.61 -174.7 3.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 25.2 tt0 169.41 123.95 0.01 OUTLIER 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.735 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 115' ' ' GLN . . . 68.88 165.82 4.1 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.249 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -31.46 -31.26 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 113' ' ' GLY . 52.0 mt-30 -93.53 127.18 39.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.155 0.977 . . . . 0.0 111.641 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.2 p -95.46 153.76 17.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.431 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 110' ' ' CYS . 13.1 m-85 -140.35 146.62 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.625 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -94.69 178.73 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.886 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.05 124.13 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.631 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.47 -3.72 84.03 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.243 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.74 151.62 28.97 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.13 0.465 . . . . 0.0 111.016 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.595 HG22 HG23 ' A' ' 137' ' ' VAL . 7.3 p -127.15 144.77 50.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.091 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -137.52 50.06 1.97 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.67 113.63 0.68 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.146 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -144.65 154.17 55.64 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 33.8 Cg_exo -39.06 149.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.246 2.63 . . . . 0.0 113.619 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.576 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.2 t60 -67.22 135.11 52.93 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 112.104 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -73.42 -32.71 64.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.429 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 63.5 p -120.0 18.99 12.41 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.637 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 127' ' ' HIS . . . -139.83 176.1 21.41 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.571 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.55 31.98 6.74 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.312 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.65 170.32 16.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 110.544 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 14.1 mtt -78.24 115.1 17.72 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.576 HD22 ' ND1' ' A' ' 127' ' ' HIS . 21.0 tp -91.87 144.54 25.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.747 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 40.6 mt-10 -122.32 115.66 22.7 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 99.1 m -110.33 157.71 19.21 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.595 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -130.03 177.15 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.76 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.455 ' N ' HG13 ' A' ' 137' ' ' VAL . 2.6 t -130.49 117.13 19.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.132 0.423 . . . . 0.0 111.583 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.4 mt -112.56 113.58 25.8 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.101 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.63 87.42 0.42 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.868 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.47 -49.24 4.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.612 0.244 . . . . 0.0 110.754 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -165.43 36.1 0.26 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.705 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -171.31 -43.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.612 0.206 . . . . 0.0 111.317 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.08 67.1 0.81 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.597 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -104.61 152.89 21.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.664 0.268 . . . . 0.0 110.717 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 166.13 14.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.69 134.99 22.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.965 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.2 m -130.33 149.85 51.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.035 0.445 . . . . 0.0 111.387 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.27 96.47 12.54 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.598 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 134' ' ' LEU . 56.7 Cg_endo -76.48 162.95 32.76 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.267 1.978 . . . . 0.0 113.522 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.986 179.197 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.904 0.383 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.59 159.79 19.13 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 p -131.16 154.98 47.79 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.208 0.528 . . . . 0.0 111.26 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 75' ' ' TYR . 61.3 m -119.04 136.33 54.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.662 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.424 ' O ' HD11 ' A' ' 102' ' ' ILE . 89.2 t80 -120.56 128.32 52.97 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.215 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -111.87 103.95 12.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.511 -0.768 . . . . 0.0 108.979 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -58.97 -15.15 11.6 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.697 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.477 ' CD2' ' HD2' ' A' ' 83' ' ' ARG . 3.2 m-85 -67.45 -45.98 74.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.968 0.413 . . . . 0.0 110.346 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -50.5 5.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.056 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.93 10.18 28.78 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.44 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -118.18 153.48 33.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.117 0.458 . . . . 0.0 110.814 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.24 159.73 15.89 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.885 0.374 . . . . 0.0 110.259 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' CYS . 4.3 m-85 -135.06 127.95 31.36 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.662 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.0 148.65 36.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.465 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 17.8 t -47.86 142.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.351 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.72 20.99 79.3 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.208 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -113.39 127.19 56.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.911 HG22 HG23 ' A' ' 93' ' ' THR . 15.3 p -105.67 149.34 26.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.782 0.325 . . . . 0.0 110.644 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 92' ' ' CYS . 30.3 p90 -152.17 -179.11 7.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' TRP . 3.6 mt-10 -112.84 132.73 55.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.749 0.309 . . . . 0.0 110.373 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.477 ' HD2' ' CD2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -137.9 128.7 15.73 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 88' ' ' MET . 59.9 Cg_endo -74.86 119.0 5.49 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.617 1.545 . . . . 0.0 111.898 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -118.0 115.56 25.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.045 178.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 44.67 69.84 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 m 54.57 37.82 28.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.671 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -145.9 160.52 41.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.398 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mm -110.69 116.33 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 82' ' ' GLU . 19.0 m95 -105.48 159.82 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.89 103.72 11.7 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 81' ' ' TYR . 8.7 t -108.94 141.64 40.72 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.911 HG23 HG22 ' A' ' 80' ' ' THR . 0.7 OUTLIER -117.76 153.48 33.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.303 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 77' ' ' VAL . 15.0 t -103.56 117.04 33.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.218 0.533 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.46 -46.8 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.417 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.67 -94.13 0.19 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.549 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 61.56 21.83 12.41 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.58 -71.41 0.07 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.2 mmm-85 -114.82 -88.04 0.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.03 38.09 0.38 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 ptt-85 -68.7 141.92 55.17 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.857 0.361 . . . . 0.0 110.868 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.424 HD11 ' O ' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -112.42 147.85 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.646 -178.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -125.47 111.98 15.72 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.87 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.9 m -108.55 140.34 42.04 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.5 p -140.16 146.86 39.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.54 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.2 mt -55.55 153.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.304 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.44 145.6 26.03 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 111.792 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.96 70.89 10.52 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -150.19 177.09 10.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.208 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 14.7 p -124.44 130.5 52.58 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.505 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 6.0 p-80 -133.75 -145.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.156 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 1.3 tp10 89.23 163.74 0.05 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.542 0.337 . . . . 0.0 111.124 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.28 13.4 80.74 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.349 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.91 -16.11 58.79 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.961 -0.637 . . . . 0.0 113.159 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -133.48 170.52 15.37 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.07 0.435 . . . . 0.0 110.769 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 111' ' ' HIS . 4.9 p -119.05 127.44 53.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.969 0.414 . . . . 0.0 111.068 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -109.15 157.77 18.44 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.633 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 35.5 mttt -103.36 157.14 17.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.54 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm -48.81 124.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.9 67.29 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.688 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -77.31 159.96 29.18 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.377 0.588 . . . . 0.0 111.709 -179.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.681 HG22 HG23 ' A' ' 137' ' ' VAL . 29.9 p -123.42 147.77 46.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.888 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -143.8 40.11 1.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.111 0.481 . . . . 0.0 109.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.6 ' CB ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -55.77 108.06 0.41 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.191 -179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 126' ' ' PRO . 19.8 mtt180 -138.53 174.08 4.6 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.156 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 31.6 Cg_exo -41.36 -175.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.825 2.35 . . . . 0.0 113.667 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.66 ' HB2' ' O ' ' A' ' 132' ' ' TYR . 2.6 t60 -104.07 124.74 49.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.914 0.388 . . . . 0.0 112.028 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.02 -37.74 64.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.115 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.535 ' HB ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -80.06 -23.07 41.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.697 -179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -132.5 -153.03 7.18 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.81 31.2 3.41 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.574 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.66 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 20.0 p90 -127.26 140.47 52.2 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 120.491 0.186 . . . . 0.0 111.367 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 19.9 ttt -47.83 139.39 7.65 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.253 0.549 . . . . 0.0 112.0 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 125' ' ' ARG . 27.2 tp -133.58 143.72 48.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.567 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.6 ' HA ' ' CB ' ' A' ' 124' ' ' ARG . 27.5 mt-10 -127.47 116.87 21.09 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 148' ' ' CYS . 0.7 OUTLIER -122.24 157.63 31.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.084 0.469 . . . . 0.0 112.11 -178.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -125.31 170.1 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.904 -179.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 t -118.55 118.37 31.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.683 0.278 . . . . 0.0 111.288 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 40.3 mt -112.47 134.66 53.88 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.499 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.15 -114.01 0.99 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.65 -70.37 0.13 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.672 0.389 . . . . 0.0 111.702 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.29 -91.37 0.83 Allowed Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.567 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -129.63 -42.71 1.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 176.14 73.6 0.05 OUTLIER Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.721 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -92.14 161.63 14.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.737 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -143.07 162.23 36.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.55 HG22 HG12 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -144.53 125.76 14.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.503 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.12 149.71 50.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.499 0.666 . . . . 0.0 112.279 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -124.69 102.62 32.12 Favored Pre-proline 0 C--O 1.233 0.215 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.55 ' HB3' ' HE1' ' A' ' 132' ' ' TYR . 6.1 Cg_exo -71.27 167.94 24.8 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.019 1.812 . . . . 0.0 114.992 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 151' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.075 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.712 0.291 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -119.43 161.7 20.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.179 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 p -132.19 150.01 52.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.996 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.8 m -118.64 139.28 51.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.55 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -120.25 126.7 51.25 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.71 100.83 10.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -52.56 -21.75 4.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -67.69 -46.41 72.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 p -86.16 -52.4 5.69 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.67 8.82 31.86 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.439 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.31 145.43 44.0 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.957 0.379 . . . . 0.0 110.393 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 159.43 20.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.977 0.418 . . . . 0.0 110.648 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.425 ' CE1' ' CG ' ' A' ' 81' ' ' TYR . 3.1 m-85 -134.49 128.59 33.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.3 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -77.13 153.05 34.62 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 77' ' ' VAL . 4.2 t -47.78 140.18 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.896 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.02 21.07 79.58 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.428 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -112.89 126.26 55.27 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.912 HG22 HG23 ' A' ' 93' ' ' THR . 20.4 p -105.37 132.93 50.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.889 0.376 . . . . 0.0 111.42 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 92' ' ' CYS . 36.3 p90 -126.2 -176.23 3.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.673 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 138.56 54.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.859 0.362 . . . . 0.0 111.045 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.6 ' HD2' ' N ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER -137.16 132.22 17.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 88' ' ' MET . 73.9 Cg_endo -79.74 59.85 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.696 1.597 . . . . 0.0 112.822 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -56.73 130.69 46.58 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.899 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.3 t70 35.21 63.86 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.3 m 53.9 36.04 23.27 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 18.1 mtm -143.16 149.16 37.67 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.65 109.32 21.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.458 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 18.6 m95 -100.01 151.93 20.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.414 -177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.35 110.82 22.09 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 81' ' ' TYR . 33.4 m -108.88 162.33 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.912 HG23 HG22 ' A' ' 80' ' ' THR . 1.0 OUTLIER -141.54 154.01 45.22 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.198 -179.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 21.4 t -103.49 113.37 26.82 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.504 HD13 ' HB3' ' A' ' 103' ' ' SER . 1.8 mp -76.62 -36.47 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.483 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.4 72.64 0.82 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.582 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.05 -55.35 3.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.687 0.279 . . . . 0.0 111.409 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.82 -61.09 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.536 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 24.61 12.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.878 0.37 . . . . 0.0 111.198 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.17 90.1 0.94 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.56 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -91.36 129.48 37.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.595 0.236 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.24 124.5 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.504 ' HB3' HD13 ' A' ' 95' ' ' ILE . 13.5 t -128.58 111.52 13.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.985 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 68.2 m -111.72 137.22 49.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.9 p -139.28 136.24 34.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.069 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.402 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -50.95 146.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.932 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.04 154.22 26.98 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.453 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.434 ' O ' HG12 ' A' ' 119' ' ' ILE . 4.2 p30 -85.87 63.89 8.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.099 0.476 . . . . 0.0 110.57 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -149.8 167.63 26.0 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.642 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 117' ' ' TYR . 2.7 p -118.95 125.61 49.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.601 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -135.0 145.32 47.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.746 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.601 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 5.9 pt-20 170.32 157.72 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.206 0.316 . . . . 0.0 111.197 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -77.61 1.98 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.996 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.79 -38.39 0.07 OUTLIER Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.52 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -123.55 172.17 8.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.294 0.547 . . . . 0.0 111.232 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 p -101.9 126.59 48.84 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' CYS . 2.5 m-85 -108.39 157.1 18.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.515 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -98.68 155.38 17.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.524 HD12 ' HA3' ' A' ' 140' ' ' GLY . 22.3 mm -54.78 131.64 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.45 -10.32 73.77 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.567 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.27 150.54 30.0 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 117.489 0.645 . . . . 0.0 110.439 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.61 HG22 HG12 ' A' ' 137' ' ' VAL . 21.7 p -142.54 141.39 32.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.444 ' CZ2' ' HB3' ' A' ' 136' ' ' CYS . 11.2 p90 -140.31 110.63 6.64 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -123.72 107.57 11.59 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.114 0.483 . . . . 0.0 111.703 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -148.04 159.23 40.57 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.678 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 26.5 Cg_exo -39.77 144.75 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.862 2.375 . . . . 0.0 113.027 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.662 ' ND1' HD22 ' A' ' 134' ' ' LEU . 1.9 t60 -65.75 137.57 57.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.487 0.661 . . . . 0.0 112.559 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.82 -41.76 59.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.684 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 78.0 p -108.34 17.68 21.89 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -123.84 -95.33 1.14 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.385 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 157.53 -22.63 0.42 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.08 171.73 9.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.641 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 16.1 ptm -69.78 151.28 45.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.662 HD22 ' ND1' ' A' ' 127' ' ' HIS . 25.1 tp -136.34 129.25 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 39.7 mt-10 -118.96 119.78 35.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.001 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 147' ' ' THR . 94.3 m -116.12 158.22 23.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 111.912 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.068 HG23 HG23 ' A' ' 147' ' ' THR . 0.0 OUTLIER -141.17 165.52 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.85 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 133.34 54.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.861 0.362 . . . . 0.0 111.222 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.09 156.55 19.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.228 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.524 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -153.38 39.43 0.71 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.975 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 -51.44 5.37 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.658 0.266 . . . . 0.0 110.708 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -117.09 -46.75 0.5 Allowed Glycine 0 C--N 1.334 0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.389 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -153.81 148.69 26.59 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.526 0.203 . . . . 0.0 110.576 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.94 105.69 1.0 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.464 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.4 173.81 7.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.436 ' CD1' ' HH2' ' A' ' 123' ' ' TRP . 1.0 OUTLIER -117.43 146.25 43.59 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.117 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 1.068 HG23 HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -146.0 122.79 11.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -148.07 151.28 35.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.467 . . . . 0.0 111.111 177.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -145.35 90.16 6.15 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.395 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.523 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 56.3 Cg_endo -73.08 158.17 49.73 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.329 2.019 . . . . 0.0 113.069 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.959 179.259 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.646 0.26 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -84.58 141.1 30.93 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.35 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 4.9 p -129.31 140.74 51.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 150.88 39.01 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.992 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 69' ' ' LYS . 91.4 t80 -121.01 129.15 53.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -110.24 97.0 6.58 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 39.6 pttt -49.39 -19.0 0.45 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.547 ' CD2' ' HD3' ' A' ' 83' ' ' ARG . 2.9 m-85 -65.89 -45.52 81.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.832 0.349 . . . . 0.0 111.22 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 p -91.46 -52.61 4.7 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.395 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.67 9.81 28.04 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.321 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -117.26 138.29 51.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.932 0.366 . . . . 0.0 110.509 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.86 160.07 30.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.172 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.644 ' HB2' ' SG ' ' A' ' 94' ' ' CYS . 26.9 m-85 -130.34 128.92 42.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.475 ' HG3' HG22 ' A' ' 65' ' ' THR . 1.5 mtt180 -85.77 147.56 26.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.45 HG13 ' C ' ' A' ' 95' ' ' ILE . 2.8 t -46.92 144.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.356 -177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 27.93 71.82 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.325 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -113.31 127.24 56.08 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.871 HG22 HG23 ' A' ' 93' ' ' THR . 22.3 p -105.71 150.5 25.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.839 0.352 . . . . 0.0 111.554 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.4 ' CD1' ' CE1' ' A' ' 75' ' ' TYR . 24.7 p90 -157.4 -175.36 5.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.173 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.77 132.35 54.56 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.421 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.547 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 5.6 tmm_? -128.71 131.79 23.97 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 88' ' ' MET . 87.4 Cg_endo -84.29 64.52 6.88 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.813 . . . . 0.0 114.158 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.435 ' HG2' ' NE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -59.27 124.4 19.87 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.924 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 t70 35.31 71.23 0.12 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.6 m 50.66 36.34 13.81 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.702 ' O ' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.88 148.88 39.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.8 mm -96.68 112.65 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.981 0.42 . . . . 0.0 109.88 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.565 ' CH2' HG12 ' A' ' 106' ' ' ILE . 19.6 m95 -101.92 148.41 25.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.186 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -101.92 107.99 19.31 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 80' ' ' THR . 70.1 m -108.03 156.29 19.41 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.871 HG23 HG22 ' A' ' 80' ' ' THR . 2.0 m -141.53 150.05 41.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.458 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -106.9 113.65 27.26 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.322 0.965 . . . . 0.0 110.649 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.45 ' C ' HG13 ' A' ' 77' ' ' VAL . 1.8 mp -79.3 -24.42 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 114.067 -1.424 . . . . 0.0 112.717 -177.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 97' ' ' ALA . . . 83.04 -75.82 2.33 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.395 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' GLY . . . 17.42 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.26 -113.47 4.31 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.455 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.28 70.95 1.4 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.145 0.498 . . . . 0.0 111.29 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.81 77.28 1.0 Allowed Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.92 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -102.09 131.66 48.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.603 0.239 . . . . 0.0 110.959 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.24 122.31 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.136 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.14 116.05 17.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.918 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.9 m -123.16 143.89 49.71 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.4 p -139.9 139.67 36.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.695 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.565 HG12 ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -62.46 154.77 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.508 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.62 152.67 18.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 111.666 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.431 ' O ' HD13 ' A' ' 119' ' ' ILE . 0.6 OUTLIER -85.75 68.13 10.27 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.115 0.483 . . . . 0.0 110.635 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.604 ' HA ' HD12 ' A' ' 119' ' ' ILE . 62.3 mtp180 -150.56 172.04 16.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.172 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 72.2 m -110.62 127.2 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.561 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -138.77 147.14 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 179.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 2.9 tm-20 171.35 147.37 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.728 0.299 . . . . 0.0 111.206 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 97.72 -83.69 0.71 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.636 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.56 2.19 0.38 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.434 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -147.69 -177.93 5.98 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.346 0.573 . . . . 0.0 111.103 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -119.52 127.71 53.27 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -108.41 159.44 16.66 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.666 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 121' ' ' ASP . 3.9 tmtt? -103.07 158.08 16.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 109' ' ' ARG . 1.4 mp -49.12 128.13 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.675 0.274 . . . . 0.0 111.197 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.39 61.42 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.312 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -80.78 168.87 18.3 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.355 0.578 . . . . 0.0 111.397 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.46 HG22 ' CG1' ' A' ' 137' ' ' VAL . 1.4 p -138.85 152.99 48.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.04 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.443 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 43.3 p90 -141.26 84.39 1.92 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.219 0.533 . . . . 0.0 110.039 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 1.2 mpp_? -85.23 74.16 10.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.2 mtt85 -110.72 167.16 9.46 Favored Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.726 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 133' ' ' MET . 66.5 Cg_exo -44.08 175.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.862 2.375 . . . . 0.0 113.676 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.43 ' ND1' HD22 ' A' ' 134' ' ' LEU . 3.9 t60 -105.26 128.87 53.65 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.96 -40.24 60.87 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.983 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.404 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 16.3 p -98.7 15.12 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -140.27 -69.26 0.04 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.856 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 123.55 19.57 2.79 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.42 ' HE1' ' HB3' ' A' ' 150' ' ' PRO . 3.5 p90 -126.4 141.74 51.79 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.038 0.535 . . . . 0.0 109.622 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 10.2 ptt? -50.41 108.63 0.24 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.547 0.689 . . . . 0.0 111.391 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.446 ' CD1' ' HG3' ' A' ' 150' ' ' PRO . 34.3 tp -91.92 143.87 26.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.336 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 148' ' ' CYS . 36.1 mt-10 -126.15 116.0 20.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.15 157.33 38.39 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.792 HG23 HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -126.95 174.61 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.862 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.94 118.88 12.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.814 0.34 . . . . 0.0 111.164 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.2 mt -112.51 132.3 55.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.514 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -89.58 84.42 1.4 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.667 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 -48.45 6.93 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.556 0.217 . . . . 0.0 111.114 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -140.89 -65.99 0.03 OUTLIER Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.585 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -113.26 -39.13 4.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.427 0.156 . . . . 0.0 111.158 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.25 94.49 0.1 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.623 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -106.76 150.18 26.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.578 0.228 . . . . 0.0 110.645 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.97 165.24 21.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.943 0.402 . . . . 0.0 111.341 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.792 HG22 HG23 ' A' ' 137' ' ' VAL . 0.6 OUTLIER -145.56 121.02 10.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.605 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -130.95 149.37 52.61 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.371 0.605 . . . . 0.0 111.799 179.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -123.78 90.28 50.76 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.63 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 134' ' ' LEU . 1.7 Cg_endo -80.69 161.63 21.69 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.66 2.24 . . . . 0.0 114.048 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.118 179.053 . . . . . . . . 0 0 . 1 stop_ save_